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ABSTRACT
Multiple Sclerosis (MS) is a complex neurological disease affecting the central
nervous system and is driven by a complex autoimmune cascade. The peak age of
onset is between the ages of 20 and 40 years and shows a female preponderance of
3:1. The most common form of the disease affecting 85% of people living with the
illness is called relapsing remitting MS (RRMS), and is characterised by
unpredictable relapses or exacerbations which usually last a few weeks before
returning to baseline function. There is the possibility of disease progression and
non-reversible disability after many years. RRMS is also characterised by a
complicated array of symptoms which may affect sensory function, motor function,
vision, gait, cognition, mood, bladder, bowel and sexual function. There is currently
no curative treatment for RRMS, although recently there have been major advances
in more efficacious treatments called disease modifying therapies (DMTs) to control
relapses and possibly future disability.
The aim of this study was to gain insights and understanding into the lived
experience of RRMS in order to inform patient-centred nursing care. Although there
is an abundance of literature dealing with various aspects of the MS experience, there
is a paucity of literature specifically exploring the general life experience of living
with the disease and considering a broader understanding. Life history methodology,
a form of focused ethnography, was used to explore the illness experience across the
lifespan of 13 study participants living with RRMS. Semi-structured interviews were
used to gather data and later transcribed by the researcher, before undergoing data
analysis. Braun and Clarke’s (2006) method of thematic data analysis ensured a
systematic and robust exploration of the lived experience and revealed eight key
themes, 30 subthemes and 44 sub-subthemes, providing clarity and insight into the
experience of living with RRMS.
Several novel findings were revealed by the thematic analysis including an
appreciation of the importance of early life events prior to the onset of RRMS and
their potential impact on later coping, adjustment and resilience after diagnosis. A
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key study finding was of people living with RRMS experiencing “Surplus
Suffering”, a form of suffering over and above that caused by the disease itself and
inflicted most often by health care professionals and significant others. Other themes
explored concepts of “Piecing together the Puzzle” of RRMS at the beginning of the
journey, “(Re)defining self” in the wake of an RRMS diagnosis, “Battling the
Demons” that RRMS uncovers, dealing with invisible symptoms of the disease,
managing the DMTs necessary to control the disease and their side effects, and
ultimately “Taming the Beast” that is RRMS and “Holding Hands with Hope”.
The life history approach revealed these themes to be reflective of the ebbs and flows
of life, intertwining with each other and changing positions of importance according
to life events, whether directly related to RRMS or indirectly related. Numerous
recommendations for clinical practice in MS care have been developed from the
study findings which are anticipated to improve clinical care and to enhance the
quality of life for people living with RRMS, along the life trajectory.
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CHAPTER 1: INTRODUCTION
Introduction
Life history, a form of focused ethnography, was employed in this study to explore
the experiences of people living with a specific type of Multiple Sclerosis (MS)
called Relapsing Remitting Multiple Sclerosis (RRMS). The study uncovered
participants’ personal meaning and understanding as they learned to live with a
chronic neurological illness that followed an unpredictable and uncertain disease
course. Participants discussed and described the impact of RRMS on themselves, on
their aspirations, their family, their friends, their work and their social and
community lives. Interactions with various health care professionals (HCPs) formed
the basis of many of their experiences related to living with RRMS and were
highlighted as being both satisfying and challenging. Study participants were frank
and open about their life experiences, drawing the researcher into their world and
providing powerful and impactful knowledge to provide a truly meaningful
understanding of what it feels like to live with RRMS.
This chapter introduces key concepts about RRMS, providing a baseline
understanding of the condition which will be fully explored throughout chapters 2
and 3. Thereafter follows a discussion of the research question and specific aims of
the study and the significance of the research, in the context of nursing research and
in the context of knowledge about the disease. A short discussion regarding nuances
of the terminology that will be used throughout the thesis will help provide
consistency and clarity to the following chapters. Finally, an outline of the structure
of the entire thesis will be presented.

Background
MS is one of the world’s most common neurologic disorders, with 2.3 million people
diagnosed with the disease and the rate steadily increasing (Browne et al., 2014).
The most common form of MS at diagnosis is RRMS, affecting 85% of people living
with the disease (Compston & Coles, 2008). The remainder of MS cases are
characterised as Primary Progressive Multiple Sclerosis (PPMS), which has a
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different prognosis and different characteristics to RRMS (Compston & Coles,
2008). RRMS is characterised by unpredictable relapses (also called exacerbations,
attacks or flare-ups) which usually last several weeks before the individual returns to
baseline functioning (Lublin et al., 2014). Although there may appear to be a return
to function after a relapse, it has been reported that there is a measurable and
sustained effect on disability (Lublin, Baier, & Cutter, 2003). The degree of disease
progression and disability is unpredictable at the outset of RRMS and may lead to the
sequale of Secondary Progressive Multiple Sclerosis (SPMS) in later years where
people with an initial relapsing course develop irreversible disability without a
relapse, although relapses are still possible (Lorscheider et al., 2016). RRMS is also
characterised by a complicated array of symptoms, which may affect sensory
function, motor function, vision, gait, cognition, mood, bladder, bowel and sexual
function amongst other many other signs and symptoms (Ben-Zacharia, 2011). There
is currently no curative treatment for RRMS, although recently there have been
major advances in more efficacious treatments called disease modifying therapies
(DMTs) to minimise relapses and possibly prevent future disability (Stüve & Racke,
2016).
Although there exists an abundance of literature examining the many different
aspects of MS and MS symptoms, there is a paucity of literature which explores the
whole life experience of living with MS and more specifically, RRMS. Several
seminal studies in the 1990’s and 2000’s started to explore the lived experience of
people living with MS, but some did not disclose the specific type of MS included in
the study (Hainsworth, 1994., Clair, 2003; Courts, Buchanan, & Werstlein, 2004) or
else used groups of mixed MS types with varying levels of disability (Koopman &
Scheitzer, 1999; Barker-Collo, Cartwright, & Read, 2006) making it challenging to
be able to assess transferability of findings to the individual’s circumstance. It has
become more important in the last two decades to differentiate between the types of
MS, as DMTs are only available to treat RRMS; although there have been some
advances recently for treating progressive types of MS. Miller (1997) was one of the
first to explore the lived experience of people living with RRMS as 10 participants
were interviewed as they attended MS clinics in the United States. Interpretative
phenomenological analysis was used to present a story of the interplay of social
networks in RRMS, coping skills, issues with control and conflict, unpredictability
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and loss, fear and relief, getting to know RRMS and of the relationships of revealing
and concealing the diagnosis (Miller, 1997). This seminal study is the most closely
linked to the current study question, aims and goals, however it is important to note
that this study took place before medications were available to treat relapses, unlike
the current study. There is an absolute dearth of literature exploring the lived
experience of people living with RRMS (PwRRMS) since this time and this concept
will be explored further in the literature review in Chapter 3.

Aims of the study
The purpose of this research study was to gain insights and understanding into the
lived experience of RRMS. More than just listening, describing and appreciating, this
study aimed to produce a rich, thick account of how it feels for people to live with
this disease, what is felt and how it is felt, the entire experience along the life
trajectory. By gaining such insights, MS Nurses may have a deeper understanding of
their patients’ experience and be able to plan and adjust their nursing care
accordingly. The ultimate aim of the study is for the findings to have the capacity
and diversity to improve nursing care and the quality of life for people living with
RRMS at all stages of their life path and illness trajectory.

The research question
To address these specific aims, the study seeks to answer the research question:
“What is the experience of living with Relapsing Remitting Multiple Sclerosis?”

Methodology
Qualitative research focuses on the way people make sense of their experiences
(Holloway & Wheeler, 2013) and attempts to make the world visible (Denzin &
Lincoln, 2000). The very nature of the research question immediately informed the
choice of methodology. Using a qualitative approach to understand the lived
experience would ensure the person living with RRMS is firmly at the centre of the
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research process and their lived experience the focus of the research. The sampling
method was purposive. Data was collected by conducting 13 semi-structured
interviews with adults living with a diagnosis of RRMS. A life history approach
explored the entire life lived to date; with and without RRMS. Thematic analysis
using the recommendations of Braun and Clarke (2006, 2013) provided a systematic
and robust method for data analysis, uncovering eight primary themes and over 70
subthemes and sub-subthemes to further clarify and explain the data and to offer
meaning and understanding of the lived experience of RRMS.

Significance of the study
Through sharing stories people come to understand their experiences, legitimise their
behaviour and share their emotional experience with others in holistic form
(Holloway & Freshwater, 2007a). Stories of illness and disability are often not heard,
and as the paucity of lived experience literature in the field of RRMS suggests, it is
time for that to change. By understanding the patient experience, MS Nurses and
other HCPs can realise that there are more realities beyond the beliefs and
perspectives they hold in their practice. The seminal work of Miller (1997) in RRMS
was performed prior to the introduction of medications and modern treatments for
RRMS, therefore it is critical that further research into the contemporary experience
explores if and how things have changed for the patient and if subsequently the role
of the MS Nurse needs to change. Miller’s (1997) seminal recommendations for MS
nursing practice may need to be reviewed and updated to reflect modern practice.
As a qualitative nurse researcher, my aim in conducting the research was to follow
Munhall’s (2012) recommendations to add the following to the knowledge base of
nursing: description, understanding, discovery, meaning, interpretation and
explanation; all within and amongst genders, regions and cultures. By approaching
the research question in a qualitative way, I searched for meaning that was different
from the statistical, from the survey-reported general information often described in
the literature. I searched for deeper meaning that could ultimately help with
improving the quality of life for PwRRMS, and to make MS care more humane, safer
and equalitarian (Munhall, 2012). A major personal goal was to develop
recommendations for clinical practice based on patient focused nursing care. I
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strongly believed this would allow MS Nurses to truly understand what PwRRMS
experience on their life journey and ultimately allow MS Nurses to be in a position to
make this journey happier, healthier and more rewarding.
As the reporting of scientific and biomedical knowledge in MS has dramatically
increased in recent years, there has been a shift in focus away from the patient
experience and on to the next medication, the next molecule, the next blockbuster
discovery. Instead, I argue that it is vital to go back to basics (to understand how
patients feel and what they need) in order for any of these new discoveries to have
their maximum impact. This then highlights what MS Nurses and HCPs can do in
order to make each patient’s life journey with RRMS the best it can possibly be.

Nuances of the thesis writing style and terminology
Throughout this thesis, there will be certain instances or situations that are specific to
the context of living with RRMS. I will discuss these now to ensure clarity and
consistency throughout the thesis.
Firstly, the term PwMS refers to “a person/people living with MS” and the term
PwRRMS refers to “a person/people living with “Relapsing Remitting MS”.
Although this research study is primarily concerned with one type of MS, RRMS,
often previous literature may just refer to MS in general with no distinction between
different types of MS studied. This makes it difficult to know the degree of relevance
to RRMS specifically. Literature in this category was mainly prior to the introduction
of treatments for RRMS (after which delineation of RRMS became more necessary),
but has also been seen in some more recent work referred to in the current study. In
these cases the more generic term “PwMS” will be used, reflecting the author’s
reporting of the information. At other times, the idea or concept will be specific to
RRMS or researched only in RRMS, and so the term “PwRRMS” will be used when
this is certain. Each situation and use of the term will have been carefully assessed to
ensure the correct terminology appropriate to the case.
The second area requiring clarification pertains to the terms “patient” and
“participant”, which are both used extensively throughout this thesis. Where the
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discussion refers to a current study participant taking part in the study, the term
participant will be used, an accepted term in qualitative research (Holloway &
Wheeler, 2013; Braun & Clarke, 2013). Where the discussion refers to a patient
rather than a participant, this will be as a result of the specific term patient being
used in the literature. In the case of the overview of MS in chapter 2 and the clinical
recommendations in chapter 9, the term patient has been used. This is because it is
appropriate to the more general context of patients and medicine/nursing concepts
under discussion in those chapters.
Thirdly, as this is a nursing thesis being undertaken at the School of Nursing,
University of Notre Dame, the primary audience of this thesis is likely to be an MS
Nurse, therefore professional references are made to MS Nurse/s, unless a finding or
comment relates specifically to another member of the health care team (where the
role will be specified), or to HCPs in general. However, the study findings from this
thesis and clinical recommendations are likely to universally apply to all MS HCPs,
no matter what specialty they practice in.
Importantly, much of the qualitative literature referred to throughout the thesis, and
particularly in chapter 4, is seminal work and as such, can date back decades. Unlike
scientific and quantitative work which places great value on the most up to date
information and references, qualitative research texts and terminology very often
refers to this seminal work, usually as it is the most outstanding representation of the
qualitative paradigm available. Where more recent explanations or supporting
evidence is available, it will be used in this thesis. Traditional reporting of
quantitative findings provides exact numbers, quantities and percentages (Polit &
Beck, 2010). However, as recommended by Braun and Clarke (2013), findings of
this qualitative study will use terms such as “some”, “several”, “many”, “most” and
“all” to refer themes and subthemes generated by the data. This is because in
qualitative research, just counting numbers misses the point (Pyett, 2003), whether
something is insightful or important for shedding light on the research question is not
determined by numbers (Buetow, 2010; Braun & Clarke, 2013). The goal of
qualitative research is not to generalise, but to provide a rich, descriptive,
contextualised understanding of some aspect of human experience (Polit & Beck,
2010).
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The peak organisation in Australia providing assistance, education and support to
PwMS has had several name changes over the years. In the state of New South
Wales (NSW) where the current study was performed, the MS Society (MSS) later
became MS Limited (MSL), and is now named MS Australia (MSA). Direct quotes
from the participants will be unchanged, however all other references made will be to
the current organisational name, MSA.
Medications have both generic and trade names. In this thesis, they will be referred
to by their generic names in the more formal discussions. However, medication
trade names will also be referred to where necessary to ensure clarity as, very often,
the study participants referred to their medications by the trade name.

Overview of the thesis
This first chapter has provided a rudimentary overview of RRMS, providing context
for the research study. The study aims and research question are stated and a clear
justification for the study is argued.
Chapter 2 will provide a more comprehensive overview of the disease, outlining
characteristics and features which have an impact on a life lived with RRMS. This
chapter contextualises the work as one exploring a complex, dynamic and
unpredictable disease.
Chapter 3 provides a critical review of the existing literature. It is argued that,
although there has been much research conducted in specific areas of MS care,
understanding the broader context of the lived experience is poorly understood. The
significant gaps in the literature indicate that the lived experience in RRMS is underresearched. Rather than a traditional thesis layout of the literature review in its
entirety, chapter 3 provides a basic overview of the important work related to the
lived experience of MS and, if it is specifically referred to by the authors, RRMS.
However, the study findings located in chapters 6, 7 and 8 will weave more specific
areas of MS/RRMS knowledge throughout each of the themes to firmly position the
study findings within the current understanding of these phenomena.
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A description and justification of the methodology and method that were employed
to meet the study aims and answer the research question are detailed in chapter 4,
along with a discussion regarding data management, ethical considerations, study
rigour and reflexivity.
The individual narratives for each study participant are presented in chapter 5. A
short life story is presented to provide context to their unique lives. This introduces
the reader to each participant and provides context for the study finding chapters that
follow in chapters 6, 7 and 8. In these later chapters, direct quotes from the study
participants will be used to provide evidence to justify the study themes.
The findings for the study are presented and integrated with the relevant literature in
chapter 6 titled “Walking the Low Road” and Chapter 7 titled “Finding the High
Road”, where a total of eight primary themes are revealed. The main focus of chapter
6 is the early journey with RRMS, putting together the little hints that something
might be wrong, seeking help, being diagnosed with RRMS and living with the
challenges the early days present, some of them serious and confronting; others a
chance to (re)define self and make new discoveries. The main focus of Chapter 7 is
finding a path to a brighter future and discovering the skills to live well with RRMS,
skills critical to “Taming the Beast” and looking forward to life with positivity and
hope.
Chapter 8 is called “The Life Journey - Ebbs and Flows of Living with RRMS” and
weaves the study themes together with life history methodology, demonstrating the
effectiveness of using this novel method in qualitative MS nursing research. This
chapter provides meaning and understanding of the lived experience of RRMS and
highlights how this methodology works with the long-term trajectory of a chronic
illness.
Chapter 9 concludes the thesis by presenting a summary of the research process and
the major study findings. Recommendations for clinical practice in MS nursing care
are presented and are linked to the key themes identified in the study. Limitations of
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the research are discussed, as well as suggested directions for future research in
RRMS.
Conclusion
This study aimed to uncover deep and rich understanding of the experience of living
with RRMS. Using a life history approach, semi-structured interviews and thematic
data analysis, themes were developed which detail the stories of people living with
RRMS as they go about the challenges and joys of their daily lives. Using the life
history approach also enabled particular attention to each participant’s life before
RRMS in order to appreciate what came afterwards, with the diagnosis of RRMS and
(re)defining of self. Chapter 2 provides an overview of the disease, outlining the
specific challenges for individuals living with RRMS and the modern day treatment
paradigm. This provides a context for understanding the complexities and intricacies
of the disease, allowing an appreciation of what it means to be diagnosed with
RRMS.
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CHAPTER 2: OVERVIEW OF MULTIPLE SCLEROSIS
Following on from the brief introduction of MS in the previous chapter, chapter 2
will provide a more comprehensive overview of MS. This is primarily to support
situating the context of the study as people living with an unpredictable and
potentially serious threat to health and wellbeing but also to give an understanding of
the many possible symptoms of RRMS and the specific issues that relate to living
with the disease. RRMS has a great variability of possible presentations and disease
courses, as well as being a complex disease to clinically diagnose and manage.
Having an understanding of the overall picture of MS and more specifically RRMS
will help the reader to appreciate the impact of the themes and sub-themes of the
study findings and to realise the overall significance of the research in terms of
potentially improving clinical care for PwRRMS in the future.

What is MS?
MS is a disease of the central nervous system (CNS) affecting the brain, spinal cord
and optic nerves. MS is a progressive inflammatory disorder in which there is
damage to key components of the nerve cells, namely myelin and axons (Compston
& Coles, 2008). The pathological processes involved in MS are immune mediated
and directed against the myelin sheath, the protective covering of the axons, termed
demyelination (Calabresi, 2004). More recently it has become apparent that grey
matter disease occurs early in the disease process, causing additional inflammation
and neurodegeneration and possibly playing a role in physical and cognitive
disability (Calabrese et al., 2015).
As a result of demyelination and the subsequent healing process, sclerotic plaques
(scars) develop in multiple areas of the CNS. This pattern needs to occur more than
once to fulfil the diagnosis of MS - multiple sclerotic lesions in multiple locations.
However, over time, the disease becomes one of chronic neurodegeneration rather
than acute inflammation, with progressive accumulation of disability due to nerve
loss (Compston & Coles, 2008). The impaired nerve conduction, resulting from
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demyelination and axonal loss, leads to many of the signs and symptoms of MS. The
course of MS is highly variable and patients may develop irreversible disability, with
MS remaining a major cause of disability in young adults (Brownlee et al., 2016).
MS remains incurable, although recent breakthroughs in understanding MS and more
targeted treatments are resulting in a brighter future for people recently diagnosed
with the disease.
Clinically Isolated Syndrome (CIS)
Most cases of MS present with an acute first episode, known as the clinically isolated
syndrome (CIS) (Compston & Coles, 2008). Until recently, a diagnosis of MS was
not able to be made at the time of CIS, even if highly suspected, because there
needed to be two clinical relapses more than 30 days apart to meet the diagnostic
guidelines of a multiple relapsing MS course (Poser 1983; McDonald et al., 2001;
Polman et al., 2005). This situation was often frightening for many patients after
suffering a first relapse, with no clear answers and just a “wait and see” approach. In
recent years, it has become possible with the revised diagnostic guidelines to
diagnose MS after one CIS, if the magnetic resonance imaging (MRI) and other
testing meets certain criteria to demonstrate multiple relapses (Polman et al.,,2011;
Thompson, Banwell, & Barkof, 2018). Internationally, the currently used criteria for
diagnosing MS are known as the 2017 McDonald criteria (Thompson et al., 2018).
Once the McDonald criteria have been met and the diagnosis of MS has been
confirmed, there are three clinical course descriptions (phenotypes) of MS that will
categorise the disease and thereby guide future treatment, prognostication and
management strategies (Lublin et al., 2014). These are relapsing remitting MS,
secondary progressive MS and primary progressive MS. Educating patients and
families about the differences between these phenotypes is essential, as they are very
different disease courses each with different treatment options.
Relapsing Remitting MS (RRMS)
The majority of people diagnosed with MS (up to 85%) begin with a diagnosis of
RRMS (Milo & Miller, 2014; Brownlee et al., 2016). A relapse is defined as “patient
reported or objectively observed events typical of an acute inflammatory event in the
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central nervous system (CNS), current or historical, with duration of at least 24
hours, in the absence of fever or infection” (Polman et al., 2011, p.293). Relapses are
also referred to as “exacerbations”, “attacks” and “flare-ups” but the term relapse
will be used throughout this thesis for clarity and consistency. New relapses occur
erratically but seldom occur more than one to two times per year (Compston &
Coles, 2008). Typically, people recover from a relapse and return to baseline (before
the relapse) function over a period of four to eight weeks, but recovery can be
uncertain, variable and incomplete (Sorensen, 2014). Additionally, although it may
appear that physical function is returned following a relapse, there is still a
measurable and sustained effect on disability from relapses (Lublin et al., 2003).
Relapse symptoms are generally considered to resolve over time, even if not treated
(Ross, Halper, & Harris, 2012). However, if the relapse symptoms are bothersome or
affecting function, treatment may be considered to speed up the process of recovery,
usually involving a short course of high dose corticosteroids to reduce the acute
inflammation (Bevan & Gefland, 2015; Kalincik, 2015; Yamasaki et al., 2016).
Relapses can be a significant physical, emotional and economic burden with the
reduction of relapses by using disease modifying therapy (DMT) an important goal
of treatment in order to reduce future neurological disability (Kalincik, 2015). The
forms of DMT available to treat RRMS and their implications will be discussed later
in this chapter.
At present there is no tool or test that can advise what the future clinical course of
RRMS will be for an individual, adding to the uncertainty at the time of diagnosis
(Bergamaschi et al., 2015) where no specific information on prognosis can be given.
However, there are prognostic risk factors which can provide some guidance,
including a better prognostic outlook for PwRRMS who are female, experiencing
sensory rather than motor relapses and showing minimal burden of disease on
imaging (Weinshenker, 1995). There are groups of people with RRMS who
experience very few symptoms and little clinical activity and yet others have highly
active clinical and radiological disease (Hum, Lapierre, Scott, Duquette, & Mayo,
2017). MS progression can be so variable that there was a time when it was thought
that no common disease course existed and that each patient followed a unique path
(Minderhoud, van der Hoeven, & Prange, 1988).
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Secondary Progressive MS (SPMS)
Over time, recovery from relapses in RRMS is incomplete and accumulation of
disability begins (Compston & Coles, 2008). SPMS is diagnosed retrospectively by a
history of gradual worsening, after an initial relapsing course, with or without acute
relapses during the progressive course (Lublin et al., 2014). There are no clear
criteria to determine exactly when this transition occurs, it can be an unpredictable
and uncertain period of time for PwRRMS (Bergamaschi et al., 2015) and also for
their HCPs. The natural history data on the course of MS suggests that on average,
SPMS occurs about 19 years after RRMS onset, with PwSPMS taking an average of
20 years to progress to using a walking stick and 30 years for wheelchair dependance
(Vukusic & Confaveux, 2006). Reaching SPMS at a younger age and with only a
short RRMS course has also been asssociated with a more rapid disease progression
(Tremlett, Zhao & Devonshire, 2008).
Primary Progressive MS (PPMS)
PPMS is a separate clinical phenotype affecting 10-15% of people diagnosed with
MS (Milo & Miller, 2014). PPMS is progressive in nature from disease onset with
gradual worsening of neurological function and no relapses occurring (Compston &
Coles, 2002). It has been hypothesised that PPMS represents a distinct, noninflammatory form of MS (Lassmann, van Horssen, & Mahad, 2012), which may
explain why the traditional DMTs (which are effective in RRMS) do not alter the
disease course in PPMS. However, there has also been recent literature to suggest
that in PPMS there may be some inflammatory activity, but it is different in nature to
RRMS and SPMS and features axonal destruction and eventually brain atrophy
(Mahad, Trapp, & Lasmann, 2015). Compared with RRMS, people with PPMS are
older at onset and a higher proportion are men (Lassmann, van Horssen, & Mahad,
2012). There has recently been a breakthrough in a new treatment for PPMS with
Ocrelizumab, a CD-20 monoclonal antibody,leading to depletion of B-cells and
demonstrating effectiveness in PPMS by slowing disease progression (Hauser,
2015). Ocrelizumab has very recently been approved for use in Australia and
internationally.
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New classifications for MS
There has recently been a suggestion to reclassify the phenotypes of MS, taking into
account disease activity; reclassifying PwMS as experiencing either a relapsing or
progressive path and with either active or inactive disease and either progression or
non-progression (Lublin et al., 2014). However, this has not universally been
adopted at present, so reference to the original phenotypes outlined above will be
used throughout this thesis.

Natural History of MS
Much is known about the natural history of MS, mainly because there were no
treatments or disease modifying drugs until the 1990’s (Jacobs et al.,1996). The
natural history pattern is highly variable. The seminal natural history data from
Weinshenker (1994) suggests that at 15 years from disease onset, 50% of patients are
disabled to the point of needing a walking stick to ambulate. Additionally, an early
age at onset, female sex, relapsing-remitting course at onset, optic neuritis or sensory
symptoms and relatively few attacks in the first two years are associated with a more
favourable course (Weinshenker, 1994). Conversely, patients with the greatest risk of
disability are those with PPMS or RRMS patients who are older at onset, have
pyramidal or cerebellar involvement, and who have frequent or prolonged attacks
with incomplete recovery. The biological basis for the variation in the course of MS
is poorly understood.

Epidemiology
In many countries MS is the leading cause of non-traumatic neurologic disability in
young adults (Browne et al., 2014). The Australian Bureau of Statistics (ABS)
estimate a total of 23,700 people in Australia to be living with MS (ABS, 2009).
However, more recent data from Multiple Sclerosis Research Australia (MSRA)
suggests this number may now be as high as 25,600, with an average of more than 10
people being diagnosed in Australia every week (MSRA, 2018). The increasing
incidence and prevalence of MS over the last five decades (Pugliatti et al., 2006;
Koch-Henricksen & Sorensen, 2010) is concerning and requires continued research
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to better understand the potential environmental factors impacting on the
development of the disease.
Interestingly, the prevalence of MS has a female preponderance with women almost
three times more likely than men to develop the disease (Koch-Henriksen &
Sorensen, 2010). RRMS can occur at any age, but the most common age for
diagnosis is as a young adult between 18 and 40 years, with a mean age of 30 years
(Compston & Coles, 2008). However, paediatric MS occurs in about 5% of cases
with onset before the age of 18 years (Lulu, Graves, & Waubant, 2016) and is more
prevalent in adolescents than younger children (Waldman et al., 2016).

Causes of MS
The cause of MS is unknown, however there are several clues about how MS begins
(Spencer & Karceski, 2015). It is thought that MS is caused by a complex interplay
between the immune system and environmental factors (Compston & Coles, 2008).
It seems unlikely that MS results from a single causative event, but rather the disease
develops in a genetically susceptible population as a result of environmental
exposures (Ramagopalan & Sadovnick, 2011). Exposure to environmental risk
factors in MS is thought to occur before the age of 15 years (Belbasis, Belbu,
Evanelou, Ionnidis, & Tzoulaki, 2015). The risk factors thought to be associated with
an increased risk of MS include Epstein-Barr and other viral and bacterial infections,
vitamin D levels, geographical location/latitude gradient (the closer to the poles, the
greater the prevalence of MS), cigarette smoke exposure, and certain human
genotypes (Banwell, Bar-Or, Giovannoni, Dale, & Tardieu, 2011; Sellner et al.,
2011) as well as obesity, gut microbiota and pregnancy exposures (Belbasis, Belbu,
Evangelou, Ionnidis, & Tzoulaki, 2015). The infection exposure theory is currently
thought to originate in childhood, where antibodies are formed against an infectious
agent (an as yet identified virus or bacteria) and for reasons that are unknown, these
antibodies attach to a protein in the myelin coating of the axons resulting in the body
becoming confused and destroying the protective myelin (Spencer & Karceski,
2015).
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MS has a familial recurrence rate of about 5% for siblings and about 2% for children
and parents (Compston & Coles, 2008), suggesting genetic links but not heritability
of the disease, with most PwMS having no affected relative (Coyle, 2016). Recent
genetic research has accelerated the understanding of genetic MS theories with the
identification of non-human leukocyte antigen (HLA) risk genes that are related to
immune function (Waubant et al., 2016), opening exciting new areas of hope for
answering questions about the causes of MS in the future.

Diagnosing MS
The diagnosis of MS is based on neurological signs and symptoms and is primarily a
clinical diagnosis, assisted by specific investigations (Brownlee et al., 2016). Often
there are significant delays before a person with symptoms suggestive of MS sees a
neurologist and receives a diagnosis (Giovannoni et al., 2016). There are several
reasons for this delay including lack of recognition of symptoms by the person, the
family doctor not referring on, lack of available neurology care and appointments
and symptoms being both vague and intermittent in nature.
In most PwRRMS, clinical manifestations (the symptoms) reflect the area of
demyelination in the CNS and indicate the involvement of motor, sensory, visual,
and autonomic systems, but many other symptoms and signs can occur (Compston &
Coles, 2008). Adding to the difficulties with diagnosis, very few clinical features are
disease-specific and there is no pathognomonic test for MS. Specifically, there is not
one symptom, sign, or paraclinical result that provides an unfailingly accurate
diagnosis of MS (Giesser, 2011). This can be a time of extreme frustration for
patients as often the diagnosis involves many tests and investigations and can
sometimes not be definitive, and in some cases, not definitive for many years.
Over the last four decades, certain criteria have been developed to help guide the
diagnosis of MS, beginning with Poser et al. (1983) and followed by the “McDonald
criteria” (McDonald et al., 2001), which incorporated the MRI scan for the first time.
The McDonald criteria were updated in 2005 (Polman et al., 2005), again in 2010
(Polman et al., 2011) and more recently in 2017 (Thompson et al., 2018) to reflect
changes in MS knowledge and practice. The most recent changes have made an
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important impact, allowing for an earlier diagnosis of MS, leading to more rapid
treatment initiation and reducing the risk of disease progression (Mantero, Abate,
Balgera, La Mantia, & Salmaggi, 2018). This has led to an increase in MS cases
being diagnosed but still requires careful assessment to prevent misdiagnosis and
mistreatments (Mantero et al., 2018). However, this can also create significant
emotional and coping issues as people can be diagnosed with RRMS in just one visit
to the neurologist, and then also face difficult and complex treatment decisions
simultaneously.

Investigations used to diagnose MS
In addition to neurological and clinical examinations, diagnosing MS often depends
on excluding other disorders that can mimic MS (Filippi et al., 2016). Some of these
investigations include the MRI scan, neurophysiological tests such as evoked
potentials and extensive blood tests. A spinal tap or lumbar puncture (LP) can also be
performed to obtain cerebrospinal fluid (CSF) for examination to assess for the
evidence of oligoclonal bands, which can assist in confirming an MS diagnosis. Most
of the investigations are not painful but can be uncomfortable at times (MRI, LP,
blood tests), difficult (LP) or induce feelings of claustrophobia (MRI).
The Expanded Disability Status Scale
The Expanded Disability Status Scale (EDSS) is used to quantify the degree of MS
related disability in individual patients (Kurtze, 1955; 1983). Many studies show that
MS relapses can leave permanent neurological deficits and play a role in disability
accumulation (Goodin et al., 2016). The EDSS aims to measure the neurological
function and provide a score to reflect neurological deficits. A clinical examination
of eight functional systems impacted by the CNS (pyramidal, cerebellar, brain stem,
sensory, bowel/bladder, visual, cerebral and other) results in individual scores which
are compiled together with ambulatory data to form a total score, the EDSS. The
final score ranges between 0 and 10, with 0.5 measurements between each level. A
score of 0 indicates no neurological impairment, a score of 1.0 indicates mild
disability in a single area, a score of 4.0 indicates that a person is fully ambulatory
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but accruing significant disability in several functional areas, a score of 6.0 indicates
assistance required to ambulate with a unilateral walking assistance, 6.5 bilateral
walking assistance or walker, a score of 7.0 indicates wheelchair dependence and a
score of 9.0 indicates confinement to bed. An EDSS score of 10 relates to death
from MS.

Common symptoms in MS
The initial presentation of MS varies according to both the location and size of
lesions and the type of onset (relapsing or progressive onset) (Brownlee et al., 2016).
Common symptoms in MS can greatly affect quality of life (QOL) and rarely occur
in isolation (Crayton & Rossman, 2006; Newland, Thomas, Riley, Flick, & Fearing,
2012). These symptoms include fatigue, depression, anxiety, cognition issues,
bladder and bowel dysfunction, sexual dysfunction, pain, spasticity, motor weakness,
sensory dysfunction, visual disturbances, ataxia and gait disturbances. Symptoms
usually result directly from nerve conduction issues secondary to demyelination,
either in response to an acute relapse, or as long-term consequence of previous
demyelination and axonal loss. Additionally, many of these symptoms are not
immediately obvious to others and are described as “hidden” or “invisible”
symptoms of MS, which can lead to possible stigmatisation or poor understanding by
others who do not have the disease (Joachim & Acorn, 2000).
Symptom management in MS is an integral part of its care, with accurate assessment
and management providing increased quality of life (Ben-Zacharia, 2011). It has
been suggested that MS-related fatigue is different to normal fatigue due to its
severity and the ability to significantly impact upon daily activities (Newton,
Griffiths, & Soundy, 2016), being complex, multidimensional and poorly understood
(Smith, Hale, Olson, Baxter, & Schneiders, 2013). There are two symptoms, not
diagnostic of, but often peculiar to, demyelination in MS. These are L’hermittes sign,
which is an electric shock-like feeling when flexing the neck forward and is caused
by inflammation in the spinal cord (Al-Araji & Oger, 2005). The second is Uhthoff’s
phenomena, MS symptoms which can be worsened or triggered by factors such as
the menstrual period, exercise, infection, fever and stress and refers to symptoms
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coming on paroxysmally and being reversible (Frohman et al., 2013). “Pseudorelapses” can occur in RRMS and describe fatigue occurring in isolation or a
transient fever-related worsening of MS symptoms (Polman et al., 2011).
Aside from the highly variable disease state and multitude of possible neurological
symptoms, MS can also cause numerous secondary and tertiary effects. Issues may
develop in highly personal areas of intimacy and sexuality, relationships and
employment. MS often causes challenges for people coping with the disease and the
associated changes in life (Rommer, Koenig, Suhnel, & Zettl, 2015).
MS and mental health issues
MS is often diagnosed at an exciting time of life, when young adults are graduating
from school or university, getting married, starting a family or advancing a career,
MS therefore has the potential to cause significant emotional stress in the lives of
people diagnosed with the disease. As a result of the current shortened diagnostic
workup, people with RRMS can be rapidly confronted with a disease of uncertain
prognosis that requires complex treatment decisions (Solari et al., 2014). This can
also be at a time of great vulnerability when PwRRMS could be ill-equipped to make
these decisions due to recent high dose steroid treatments, feelings of stress and
worry, other mental health issues, confusion over the meaning of the disease and the
wealth and complexity of available information and resources. Anxiety and
depression in particular have both been associated with less adherence to medication,
increased risk of relapses, cognitive impairment, increased use of health resources,
mortality, fatigue and pain in PwMS (de Jong & Uitdehaag, 2018). An additional
area of concern is the rate of suicide in people living with MS, which is up to seven
times greater than the general population (Pompili, 2012).

Anxiety
It is not surprising that the unpredictable nature of RRMS, specifically with respect
to relapses and potential for disability, leads to anxiety (Morrow, 2018). Anxiety is a
diagnosable mental health illness under the Diagnostic and Statistical Manual of
Mental Disorders (DSM-V®) with a variety of criteria and specific anxiety disorders
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(APA, 2013). Several studies exploring anxiety in MS have shown that anxiety is
more prevalent in the MS population than in the general population (Feinstein,
Magalhaes, Richard, Audet, & Moore, 2014) and may be as high as 36% in PwMS
(Hoang, Laursen, Stenager, & Stenager, 2016). A large cohort study (n=5084) of MS
patients matched with a control population, has reported that during both the pre and
post diagnostic period, MS patients had an increased risk of anxiety and medication
usage when compared to the general population (Hoang et al., 2016). In RRMS,
anxiety may be severe and prolonged due to the uncertain nature of the disease, in
terms of relapses, symptoms and disease progression (Janssens et al., 2004).
Furthermore, anxiety has been strongly associated with lower QOL scores across all
levels of illness severity, from mild impairment to severe (Ionescu et al., 2012).
Anxiety is more prevalent in females than males in PwMS (Theaudin, Romero, &
Feinstein, 2016) and needs regular assessment and evaluation. There is also a higher
likelihood of alcohol use, substance abuse and smoking associated with anxiety in
PwMS (Marrie et al., 2015).
Anxiety has also been identified as being significantly associated with low levels of
disease acceptance and mindfulness in MS (Pakenham & Samios, 2013), which may
have direct consequences on adherence to DMTs and to MS wellness prescriptions.
Anxiety is most highly associated with depression, low self-efficacy, stress, emotion
focused coping, pain, fatigue and QOL, factors that may be amenable to intervention
if identified and actioned by MS HCPs (Butler, Matcham, & Chalder, 2016).

Depression
As with anxiety disorders, depressive disorders are a diagnosable mental health
illness under the DSM-V® with listed criteria including depressed mood, loss of
interest and enjoyment in usual activities, reduced energy, reduced self esteem and
confidence, ideas of guilt and unworthiness, pessimistic thoughts, disturbed sleep
and appetite and ideas of self harm (APA, 2013). For people with MS the lifetime
prevalence rate of a depressive disorder has been reported as greater than 50%
(Hoang et al., 2016) and is three times higher than the general population (Kessler et
al., 2012; Patten, Beck, Williams, Barbui, & Metz, 2003). Depression in MS is still
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undertreated and under-recognised and most importantly, depression can be fatal
(Feinstein, 2011; Newsome et al., 2017)
A multitude of aetiologic factors contribute to depression in MS, including biological
(lesion burden, location of lesions and brain atrophy) as well as the stresses, losses
and threats that accompany living with an unpredictable and potentially disabling
disease (Patten et al., 2003). Depression in MS is extremely complex and
complicated by other factors such as fatigue, cognition and physical impairment,
which can also mimic depression and prevent accurate diagnosis (Gunzler et al.,
2015). Turner and Alschuler (2018) suggest that depressed mood and MS symptoms
such as fatigue, cognition and pain have a bidirectional relationship, each causing the
other to be worse. Depression in MS possibly has a different pathophysiology to the
general population and has been described as chronic rather than episodic in nature
(Koch et al., 2015). Additionally, depressive syndromes occur with significant
frequency across the natural history of MS, including patients with very mild forms
of MS, and do not correlate well with the severity of neurologic disability (Perez,
Gonzales, & Lazaro, 2015).

Treatments for RRMS

Disease modifying treatments for MS
There have been many recent developments in treatments for RRMS, however a cure
for the disease remains elusive. The immune dysregulation in the development of
MS leads to a cascade of events resulting in inflammation and axonal degeneration in
the CNS (Grigoriadis & van Pesch, 2015). The DMTs act to interrupt this cascade at
varying points of the process. The goal of the DMT is to delay the accumulation of
disability and to delay transition to the more progressive and disabling SPMS (Liu et
al., 2016). The occurrence of a relapse on a DMT is usually considered an indication
of breakthrough disease and suboptimal response (Liu et al., 2016) and often results
in a “switch” of DMT to another therapy, usually to a more efficacious medication
(Bevan & Gelfand, 2015). However, as no current DMT completely eradicates
disease activity, there is much debate currently about what constitutes breakthrough

36

disease and what the primary aim of treatment is; as treatment goals move and
monitoring of outcomes is more active (Giovannoni et al., 2015).
In the past 20 years RRMS has been transformed from a disease of relative
hopelessness, with few, if any, treatment options to one of optimism and robust
therapeutic promise (Ross & Thrower, 2010). The approval of immune modifying
medications for RRMS is often cited as a major advance in our understanding,
however many questions still remain unanswered (Stüve & Racke, 2016). Whilst the
number of DMTs are rapidly increasing, there is still need to define which patients
will respond to which drug and who is at higher risk of side effects (Stuve & Racke,
2016). The option of individualised optimal treatment is complicated because of the
unpredictable natural behavior of the disease, the different phenotypes and stages,
the diversity of different therapies, and the serious and sometimes life-threatening
side-effects of some of the treatments (Rio, Comabella, & Montalban, 2011).
With advances in DMTs, survival in RRMS has increased and a slower accumulation
of disability has resulted (Tremlett, Zhao, Rieckmann, & Hutchinson, 2010) with the
natural history of the disease shown to be altered in randomized clinical trials
(Wingerchuk & Carter, 2014). Treatment options for the disease are most effective
during the relapsing remitting phase and are recommended to start early after
diagnosis for the best clinical outcomes (Broadley et al., 2015; Kavaliunas et al.,
2017). Australia is in a fortunate situation in terms of registered and government
supported programs for DMTs to treat RRMS. There are set criteria to follow in
order to gain Pharmaceutical Benefits Scheme (PBS) approval, but once these
criteria are met, patients can be prescribed a range of DMTs, benefitting from an
individualised approach to choose the DMT most appropriate for their level of
disease activity and based on pathpohysiology and illness patterns. The cost of these
medications is high, but the DMTs are made available to patients in Australia at
greatly subsidised rates. All available medications have been tested clinically for
safety and efficacy in large, multicentre clinical trials in people with RRMS. Many
other countries (currently such as Great Britain) have restrictions on which
medications may be used at which stage of the disease or have regulations on which
medications need to be used as first, second or third line therapy (Giovannoni et al.,
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2016) or other countries (such as the United States) need to rely on approval from
insurance companies to begin a certain DMT (Parise et al., 2013).
There are currently 12 DMTs approved to treat RRMS in Australia; the injectable
medications which the patient learns to self-inject (four forms of interferon beta, two
forms of glatiramer acetate) the oral medications (fingolimod, dimethyl fumarate and
teriflunomide) and the intravenous monoclonal antibody medications (natalizumab,
alemtuzumab and ocrelizumab). A current list of DMTs approved in Australia is
listed in Table 1. The many options for treatment can be complex and challenging to
negotiate, however there are suggested guidelines that can be followed to assist in
choosing the most appropriate DMT for patients with RRMS (Broadley et al., 2014a;
Finkelsztejn, 2014).
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Table 1. Currently approved and marketed DMTs for RRMS in Australia
Generic name

Trade name

Mode of
delivery
subcutaneous
injection

Frequency
of dosing
every other
day

Interferon
beta-1b

Betaferon®

Interferon
beta -1a
Interferon
beta- 1a
Interferon
beta- 1apegylated
glatiramer
acetate

Rebif®

subcutaneous
injection
Intramuscular
injection
subcutaneous
injection

three times
a week
weekly
fortnightly

as above

subcutaneous
injection

daily or
three
times/week

Teriflunomide Aubagio®

Oral

daily

Dimethyl
fumarate

Tecfidera®

Oral

twice daily

fingolimod

Gilenya®

Oral

daily

Natalizumab

Tysabri®

Intravenous
infusion

Every 4
weeks

Alemtuzumab

Lemtrada®

Intravenous
Annually x
infusion cycle 2 years

Ocrelizumab

Ocrevus®

Intravenous
infusion

injection site reactions,
lipoatrophy
“immediate post
injection reaction”
liver enzyme elevations,
hair thinning,
nausea
gastrointestinal
disturbances, flushing,
rare PML
first-dose cardiac
effects, infections,
macular oedema, liver
enzyme elevations, skin
malignancies, rare PML
infusion related side
effects, variable risk of
PML
infusion related side
effects, autoimmune
side effects (thyroid,
blood and renal)
infusion related side
effects, ?malignancies

Avonex®
Plegridy®
Copaxone®

6 monthly

Common side effects or
serious side effects
influenza-like
symptoms (fever,
chills), injection site
reactions, depression
as above
as above

All of the DMTs have side effects associated with their use, some of which (such as
injection site reactions and intermittent mild diarrhoea) can be easily managed. Some
of the newer treatments (the monoclonal antibodies) are more efficacious than the
injectable therapies, reducing relapse rates by 50-70% compared to approximately
30% for injectables (Kalincik et al., 2017). However, they do possess significant
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additional safety concerns. The newer DMTs require specific monitoring for adverse
events, some of which can be fatal if not recognised early (Finkelsztejn, 2014). The
added pressures of greater efficacy balanced with an increased side effect profile can
cause significant stress and emotional burden for PwRRMS. Additionally, factors
such as cognition issues, tolerance for side effects, cost and fatigue play havoc with
adherence to treatments (Kopke, Solari, Khan, Heeson, & Giordano, 2014).
Some of the more serious side effects related to DMTs came up frequently in the
data collection for the current study. Progressive multifocal leukoencephalopathy
(PML) is a brain infection caused by the John Cunningham virus (JCV) and has been
associated with natalizumab treatment, and to a much lesser degree with the oral
treatments fingolimod and dimethyl fumarate (Broadley et al., 2015; Clifford &
Nath, 2010). The PML infection has been reported in over 750 cases of RRMS with
a greater than 20% fatality rate and a substantial morbidity in survivors (Biogen,
2018). PML is difficult to differentiate in PwRRMS because the symptoms of the
brain infection can mimic MS symptoms and can be missed. There are algorithms to
help MS HCPs and PwRRMS determine specific risks dependant on individual
levels of JCV antibodies (measured on a blood test), on the number of infusions
administered and on previously prescribed MS treatments. Other serious DMT side
effects are related to treatment with alemtuzumab, and include serious autoimmune
thyroid issues, idiopathic thrombocytapaenia purpura (a blood clotting disorder) and
autoimmune renal disease (Coles et al., 2012). Ocrelizumab was not approved for
use in Australia at time of data collection and did not feature in discussion in the
participant interviews.
The current treatment landscape in Australia has a myriad of first line treatment
choices for people diagnosed with RRMS, all with varying degrees of efficacy, risks
and side effect profiles. Coupled with a rapidly expanding digital world with
growing information of unknown quality and accuracy, it is no wonder that people
diagnosed with MS face considerable stress coping with not just the disease and the
decision making processes that go along with DMT treatment options, but also the
uncertainty and unpredictability which are features of the disease. The lack of an
accurate prognostication tool at the beginning of the disease trajectory can be both
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frightening and frustrating for people diagnosed with MS and make it difficult to
reach a comfortable decision on DMT choice (together with their MS HCP).
Controversial therapies
Even though there are many rigorously clinically proven DMTs to treat RRMS,
patients can be so desperate for a cure that they will overlook the lack of carefully
tested scientific evidence and consider unproven and potentially dangerous
treatments (Bowman, Racke, Kissel, & Imitola, 2015). This is understandable as
vulnerable patients search for answers to their illness, not just in the absence of a
cure, but also in the setting of very serious effects from DMTs and the risk of disease
progression, even when compliant with DMT.
One form of treatment which has been controversial in the past, but with continued
research is becoming more accepted as a potential treatment in RRMS, is
haematopoietic stem cell transplant (HSCT). This emerging therapy is being used for
aggressive RRMS unresponsive to current DMTs, and is currently the subject of
several international clinical trials (Dorr, 2016). Early results show great promise in
improving neurological function and preventing new MS lesions (Atkins et al.,
2016), however there is also a 5% mortality reported with the procedure and a
general consensus on protocols and safety have not yet been established (Dorr,
2016). The evidence for using HSCT in certain individuals with RRMS is increasing
and may be an effective treatment for specific situations, in the setting of careful
patient selection and experienced staff (Alexander et al., 2018). However, outside of
the clinical trials, some PwRRMS have resorted to “stem cell tourism” which a rising
internet based industry that offers unproven procedures to people with incurable
diseases, and in most cases involving travel overseas (Bowman et al., 2015). Once
again, an understandable option to consider for people living with an unpredictable
disease and uncertain future. It has been suggested that instead of seeing people who
pursue unproven therapies as “desperate individuals duped by medical racketeers”,
they could be seen as “empowered citizens who have taken an informed decision to
pursue an experimental therapy” (Mazanderani, Kelly, & Ducey, 2018, p.232).
A controversial treatment that has been shown to be ineffective in MS, but is still
sought out occasionally by PwMS, is liberation therapy. This type of angioplasty was
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postulated to correct a possible cause of MS, chronic cerebrospinal venous
insufficiency (CCSVI), but has been proven to be ineffective (Zivadinov &
Weinstock-Guttman, 2018). Combating the spread of viral internet popularity for this
therapy proved difficult, as the value of the MS neurologist and HCP expertise was
largely ignored in favour of emotionally resonant blogs, despite reported mortality of
the procedure (Green, Kamel, & Josephson, 2018). In a recent study of 168
participants all living with RRMS, Chacinska et al. (2017) found that in their search
for a cure, PwRRMS were likely to accept very risky treatments, with 81% of
participants accepting a 1:100 mortality for the chance of a cure.
New therapies
Besides HSCT clinical studies described above, there are many new therapies for MS
currently in development, with over 20 phase two and three studies in progress
(Shirani, Okuda, & Stüve, 2016). Several of the new biological molecules, such as
amiselimod, have shown promise in efficacy with improved side effect profiles over
the current DMTs (Kappos et al., 2016), leading to a great deal of hope about future
treatments and their positive and safer impact on not just RRMS, but all forms of
MS.

Neurorehabilitation
An important adjunct to DMTs, especially after a relapse, is neurorehabilitation and
physical therapy (Davies et al., 2016). Various forms of exercise such as weight
training, Pilates and yoga have also been found to be useful in alleviating symptoms
of MS and in building strength (Feinstein, Freeman, & Lo; 2015). Rehabilitation in
both physical and cognitive forms is a key treatment for all phenotypes of MS
(Haselkorn et al., 2015; Khan et al., 2016; Mitolo, Venneri, Wilkinson, & Sharrack,
2015).

MS and Pregnancy
As RRMS predominately affects women, is on the rise in young women and has a
mean onset of 30 years of age, many affected by RRMS will be in the childbearing
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years of their lives (Coyle, 2016; Miller, 2016). Pregnancy does offer some
protection against relapses (most effectively in the final trimester) although there is a
return to baseline risk as soon as the baby is born (Miller, 2016). There has also been
the suggestion that there are long-term benefits from pregnancy on progression of the
disease (Masera et al., 2015; Ponsonby et al., 2012) and that there are no negative
effects from pregnancy on MS prognosis (Coyle, 2016).
Many DMTs are not approved for pregnancy and need to be ceased prior to
conception, which is often difficult to manage in a person with active disease who
wishes to conceive and become pregnant (Coyle, 2016). Women with RRMS also
often face decisional conflict regarding motherhood, although pregnancy has been
found to be safe for mother and baby (Prunty, Sharpe, Butow, & Fulcher, 2008).

Contemporary Issues in MS
Although many people with RRMS continue to work and be independent, there are
impacts on self esteem, relationships and friendships, community involvement and
social activities that can be all-encompassing (Holland & Madonna, 2005). PwMS
often have concerns that their disease will have negative economic and psychosocial
effects for them and their family, impacts on childbearing and parenting and also
burdening their partner with the disease (Alwan et al., 2013). There have been
reports of an increased rate of broken relationships in PwMS particularly with the
onset of other co-morbidities after the diagnosis of MS, suggested as relating to
increased stress and demands placed on the relationship (Thormann et al., 2017).
Perceptions by the PwMS and their partner of being “less able” can also lead to
feelings of loss within a marriage and increased frustrations in maintaining
relationships (Tabuleau-Harrison, Haslan, & Mewse, 2016).
There has been a focus on lifestyle matters for PwMS in the last few years, as
awareness of the impact of positive lifestyle choices on MS has heightened. These
include adopting a holistic approach to the management of MS and to the positive
effects of exercise, smoking cessation, reduction of alcohol consumption, activities
that improve cognitive reserve and a healthy diet (Giovannoni et al., 2016).
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Support and resources for people living with MS in Australia
The number of MS groups and organisations worldwide has increased over recent
years as demand for services and support has increased along with patient numbers
diagnosed with MS (Browne et al., 2014). Support services are perhaps more
important now than ever, as treatments evolve and patient management becomes
more complex. In Australia, the growth of public and private based MS clinics over
the last decade have increased dramatically to meet the needs of patients, to enable
timely and efficacious treatments and to monitor disease activity and patient safety as
the new DMTs become part of the complicated treatment paradigm.
It has been reported that coordinated, multidisciplinary care is of greater benefit than
medical care alone in MS (Thompson, 2011). The goal of MS clinics is to offer
specialized, targeted multidisciplinary care. Recently, patient engagement in their
own healthcare has been described as “the blockbuster drug of the century” and vital
for improving outcomes in people with MS (Rieckmann et al., 2015). Achieving
patient engagement happens in the setting of education, confidence building,
encouraging treatment adherence, valuing the importance of quality of life,
empowering through responsibility and providing credible sources of information
(Rieckmann et al., 2015) These are all important functions of MS clinics and MS
organizations in Australia, involving an expansive and multidisciplinary approach.
The importance of continuity of care and in particular communication between
hospital and community, has never been more important and MS Neurologists, MS
Nurses and MS organizations are integral in this regard.
MS Australia (MSA) is the national peak body for people living with MS in
Australia; active in research, advocacy, disease awareness, communications,
information and support for people affected by MS, their families and carers (MSA,
2018). Working alongside MSA is Multiple Sclerosis Research Australia (MSRA),
dedicated to funding, co-ordinating and accelerating MS research, with the aim of
ultimately finding a cure for MS (MSRA, 2018). Both organisations are integral for
patients and MS HCPs alike, by providing considerable support, advocacy and
information resources.
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Modern communication technology and MS
Since the advent of the electronic and digital age, information and support is much
more easily and freely available for people living with MS. The way people retrieve
health information has changed due to an abundance of new media technologies and
a remarkable growth in health information being available online (Haase,
Schultheiss, Kempcke, Thomas, & Ziemssen, 2012). Websites from all of the major
country MS societies and research groups are frequently accessed across the globe
for information on all aspects of MS. Blogs and online support groups are also
popular with patients and their families and also provide a means of communicating
for people who may otherwise be isolated.
However, there are also negative aspects associated with these forms of electronic
communication, including information overload, accessing inaccurate and outdated
information, and misrepresentation of information. The rapidly growing production
of healthcare information increasingly leads to a situation of information overload
for all people involved in healthcare, patients, doctors and nurses (Klerings,
Weinhandl, & Thaler, 2015). Having web-based information is an important and rich
resource in healthcare to support practice and learning, but can also create conflicting
evidence and security in the information (Bullock, 2014). The issues of technology
and the digital age bring their known set of issues to living with MS and may impact
greatly on patient care, in both a positive and a negative way.

The role of the MS Nurse
MS nursing has developed as a specialty after first being introduced in the United
Kingdom on the early 1990’s (Quinn, Leary, & Bowen, 2014). Evolution of the role
has intensified over the last decade as new and more complicated therapies have
been developed, greatly expanding the skillset and knowledge base of the MS Nurse
as a specialist (Burke, Dishon, McEwan, & Smrtka, 2011). Most developed countries
recognise this unique specialty, although some countries report no nurses with this
specific expertise (Browne et al., 2014). Australia has a strong MS Nurse educational
and resource organisation supporting MS Nurses in their practice, Multiple Sclerosis
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Nurses Australasia (MSNA), which is a member of the International Organisation of
MS Nurses (IOMSN).
The MS Nurse plays a critical role in assisting patients at the time of MS diagnosis
and understanding options for disease treatment and management (Ross & Thrower,
2010). MS Nurses also play a central role in assisting patients with finding outside
support to assist them in coping with their MS and in recognizing conversion to MS
from CIS at an earlier stage (Kennedy, 2013). Additionally, fostering hope to combat
feelings of hopelessness in MS is pivotal to the nursing role (Morgante, 2000).
In a survey of patients with MS, it was commonly felt that they had received
insufficient support and education from healthcare providers in understanding and
dealing with their diagnosis (Solari et al., 2007). Many people will have difficulty
coming to terms with the diagnosis of MS and will worry about the possibility of
becoming disabled and the future impact on employment, income, relationships, and
activities of daily living (Ross & Thrower, 2010). Nurses, as integral members of the
multidisciplinary healthcare team, play a major role in the education and support of
the patient, and often at crucial times in living with MS.

Situating the current study in MS care
This overview of MS in general and the intricacies and complexities of RRMS in
particular that have been presented in this chapter, have demonstrated that RRMS is
a difficult and uncertain disease to live with. There are so many facets to MS care, so
many possible symptomologies and so much unpredictability. Negotiating “normal”
life alongside RRMS brings many challenges that need to be understood by MS
Nurses and other HCPs in order to provide optimal clinical care to each individual.
The following chapter will orientate previous research and knowledge of the lived
experience of RRMS to the current research study in the form of a literature review.
The significant gaps in the literature will also be discussed and the strengths of the
current study in addressing these gaps will be presented.
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CHAPTER 3: THE LITERATURE REVIEW
Format and scope of the literature review
There is a plethora of articles, studies and descriptive reviews reporting on the lived
experience of MS. However, the great majority of this literature focuses on a certain
aspect of living with the disease, whether it is a symptomatic aspect such as fatigue,
bladder dysfunction or gait disturbance or a psychological aspect such as coping with
diagnosis or change in symptoms. Others have reported on physical aspects such as
falls, social aspects such as negotiating a changed world after diagnosis, or an
adaptive aspect of MS, such as adapting to disability. This expansive array of
literature also covers all phenotypes of the disease, CIS, RRMS, SPMS and PPMS,
sometimes together and sometimes separately. Interestingly, however, there is a
paucity of literature published on the overall, whole life experience of living with the
phenotype of RRMS. In terms of life history research specifically, there is one article
reporting on one particular symptom in MS, fatigue, but no in depth life history
studies reported. The reasons for this could include the fact that the subject is so
broad and heterogeneous that it is simply too vast a topic and needs to be broken
down into smaller components; or it could be the time consuming nature of analysing
qualitative work, especially when using the ethnographic life history approach.
This chapter, the literature review, will concentrate only on literature which
addresses the experience of living with RRMS or MS in general, not reporting on
specific characteristics or features of the disease, such as MS symptoms or disability.
Later in the thesis, the findings and discussion chapters (6, 7 and 8) will integrate
particular literature relating specifically to the study themes, reflecting on how the
themes relate to what is already known. This approach has been recommended by
others (Silverman 2010., Wolcott, 1994) as a process of conducting the bulk of the
literature review in and around the specific data collection and data analysis rather
than generally before the study commences. As supported by Silverman (2010), one
of my study aims was to be innovative and creative in relating the literature to the
study findings. To develop, rather than just present, ideas and concepts related to the
themes advanced directly from the data. As Wolcott (1994) suggests, this calls for
introducing related research towards the end of the study rather than at the beginning,
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in an attempt to keep the literature more connected with the data analysis. Therefore,
this traditional literature review in chapter 3 presents a critique and synthesis of the
most significant research in the last three decades; research that is most akin to the
current research study. In the subsequent chapters, I will present literature more
directly connected with the study findings, some of which are presented in this
chapter, but some literature the result of more specialised research in particular
domains of MS.
The literature review in this chapter will be approached chronologically to show the
progression of research and to demonstrate how new findings have built on what was
already known. This approach also reflects how biomedical knowledge about MS
developed and strengthened over time, allowing access to new and exciting areas of
MS, supplementing the extensive quantitative and scientific work with qualitative,
people-focused research.
Several search databases for academic literature were used in this literature review,
in addition to medical, nursing and science search databases. These included
CINAHL (nursing and allied health), PubMed (biomedical and life sciences), Scopus
(scientific, medical, nursing and social sciences), PsycINFO (psychological), Embase
(biomedical), Web of Life, Australian Bureau of Statistics, Libraries Australia,
Joanna Briggs Institute, Cochrane library, Google Scholar, the Notre Dame
University search engine “Summon” and Trove for dissertations/theses retrieval.
Keywords used to search for the relevant literature were: life history, life experience,
life story, lived experience, life journey, living with, battling, feelings in, meaning of,
needs in, paediatric, aged, elderly, qualitative inquiry, qualitative methods,
qualitative research, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis,
Progressive Multiple Sclerosis, MS, RRMS, SPMS, PPMS, chronic illness,
neurological disease, neurodegenerative disease, acquired disability and disability
were used in a combination of ways to acquire the literature search.

The Literature Review
As already outlined in chapter 2, medications used to effectively treat RRMS did not
become clinically available until just over twenty years ago, with the first treatment
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for relapsing MS (Beta interferon-1b) approved by the American Food and Drug
Administration in 1995 (Jacobs et al., 1996). Until that time, a considerable
proportion of the qualitative MS literature was centred on coping and adjustment to
the disease (Miller, 1997) with only a few descriptive reports, mostly centring on
individual experiences living with MS (Robinson, 1990; Toombs 1988, 1990, 1992),
but no studies offering explanations or latent meaning to the experiences.
Just under three decades ago, a study investigated the burden of disease and
adaptation in 211 adults with rheumatoid arthritis (RA), hypertension and MS
(Pollock, Christian, & Sands, 1990). Findings relevant to MS demonstrated that the
MS group suffered more psychological stress than the other groups, even though the
RA group were more physically burdened by disease than the MS participants
(Pollock et al., 1990).
Moving forward through the early 1990’s, a study by Hainsworth (1994) used a
mixed methods approach to determine the presence of chronic sorrow in people
living with MS; unfortunately the MS phenotypes were not disclosed nor levels of
disability of the participants reported. Ten participants (nine female, one male) were
interviewed individually and completed the Burke/NCRCS chronic sorrow
questionnaire. The age of the study participants was 28-55 years and the length of
time from diagnosis one to 22 years. Data was analysed using content analysis.
Participants reported feelings of sadness, anger, frustration, fear and helplessness,
with one participant describing their feelings when diagnosed with MS as “I felt a
stabbing in my heart” and another as “it was a feeling of helplessness”. The study
also reported on strategies used by the participants to cope with chronic sorrow,
including continuing to work, gaining support from family and friends, gathering
information and thinking positively. Study participants also reported that empathic
nursing support was helpful to them and an important part of their coping strategy.
Even though the MS phenotypes were not disclosed, the presence of eight of the ten
study participants reporting chronic sorrow as part of the MS journey possibly
indicated the likelihood that many of the participants suffered from progressive
forms of MS rather than RRMS, as this has not been a feature of the recent RRMS
literature.
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The first study using phenomenological methodology to examine the lived
experience of people with RRMS was performed by Miller (1997) an MS Nurse in
the United States, as part of her doctoral dissertation. This study is the most alike to
the current study of all studies published in the literature in terms of the research
question and the study sample. The significant difference however, is the data
analysis method, which will be discussed in later chapters. The research question
“What is it like for you living with MS?” was asked of 10 PwRRMS (seven female,
three male) with an average age of 49 years and average duration of RRMS diagnosis
of 20 years. Patients were recruited by convenience sampling to the study as they
presented for neurological appointments at two MS clinics in New York over a
period of about six months. To be eligible for the study participants needed to have
an EDSS score of less than 3.5; indicating that they had mild-moderate physical
impairment from MS and were able to mobilise independently. Semi-structured
interviews were conducted on site, audio-taped, transcribed and analysed
concurrently. Hermeneutic phenomenology was used to analyse the transcripts.
Miller (1997) abstracted a total of 12 themes from the study data. These themes
covered many domains and included social networks (spouse, family, HCPs, can be
both positive and negative), coping with the disease (changes to life because of MS,
independence, resting to avoid fatigue), hope/hopelessness (initially “doom and
gloom”, later hope after seeing the neurologist, hope for a brighter future), issues
relating to control (difficulty with unpredictability, maintain independence) and
conflict (conflict with HCPs, employers, family), uncertainty (unpredictable day-today), issues associated with loss (of independence, employment, relationships,
abilities), fear (before diagnosis of brain tumour, relapses, losing support networks)
and reveal/conceal issues (concealing from others who don’t understand, HCPs
keeping MS suspicions to themselves, concealing from family to avoid too much
concern). More positive themes centred on a feeling of relief with diagnosis (many
feared a worse diagnosis) and gaining control getting to know MS (resources,
observing others with MS). Importantly, the themes identified were supported with
direct quotes from the participants to strengthen the theme development.
The themes from this study provided the first understanding of what it was like for
people diagnosed with RRMS navigating the rapidly changing world around them,
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with the first treatment for the disease on the horizon. The themes captured many
aspects of life and living with illness, highlighting both the positives and the
negatives. Miller (1997) did not find that chronic sorrow was a part of the experience
in patients recruited for this study, as previous work had claimed (Hainsworth,
1994), this may have been a reflection of Miller’s study focusing only on people with
RRMS and possibly living with lower levels of disability than participants of
Hainsworth’s (1994) earlier study where the MS phenotype was not disclosed.
Miller (1997) identified that people with RRMS appeared to thrive on a sense of
hope for, and control of, their MS and a strong drive to really know their disease.
This was the first study to document these findings. Incredibly, until this time there
had been arguments at length on whether clinicians should even inform patients of
their MS diagnosis, due to the unpredictable course of disease, uncertainty of
diagnosis, concern for stress triggering symptoms and potential emotional
devastation (Sencer 1988). Miller (1997) argued the need for health care
professionals (HCPs) to teach families to be supportive rather than stifling in their
interactions, the role of independence and normalcy for people with RRMS, the need
for nurses to explain the difference between relapsing and progressive forms of MS
and the need for patients to be given information about the disease. To this day, these
findings form the basis of many nursing interactions with newly diagnosed patients
with RRMS and have influenced nursing practice in the specialty of MS
considerably.
A major strength of this study was that Miller (1997) presented the themes back to
patients in order to verify that the themes were congruent with their own experience.
Additionally men with RRMS were also recruited and reflected the natural
preponderance of MS incidence of 3:1/female:male (Compston & Coles, 2008), men
had not been included in many of the qualitative studies up until this time.
Limitations of the research primarily relate to the geographically limiting nature of a
rural region in the USA and the fact that all patients interviewed were under the care
of an MS clinic (and presumably receiving best practice care), potentially biasing the
scope of the findings. There was also no reference to whether themes were saturated
at this point, or if new themes were still emerging with the final participants enrolled
in the study. However, this seminal study was one of the most important qualitative
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studies in MS at this time, as the first phenomenological nursing study to examine
the lived experience of RRMS. It is important to revisit the lived experience of
RRMS in current times, with a completely different treatment paradigm, different
management strategies, exciting biomedical and scientific MS discoveries. This will
be discussed in further detail in chapter 8, after the current study findings have been
reported.
Another seminal paper from Koopman and Schweitzer (1999) followed shortly after
Miller’s study (1997), and consisted of a qualitative project exploring the journey to
MS of five participants, three females and two males with a mixture of disease
courses of RRMS and PPMS. Participants were all diagnosed with MS within the
previous 12 months, were aged 29-40 years and had experienced symptom onset
with MS for between six months and 22 years. Although concentrating on the period
up to and around diagnosis, the study aimed to discover the “essence of the lived
experience”. Individual semi-structured interviews were performed starting with the
question “What was it like to have symptoms of an illness and then to be told you
have MS?”. Data analysis was not discussed in depth, but was reported as being
performed using “common threads and patterns”, one would imagine this being an
early form of thematic analysis. Four major themes were identified from the data and
were conceptualised as Whispered Beginnings (onset of symptoms, creating possible
answers), Echoes of Silence (intermittent symptoms, come and go, worry and wait),
The Spoken Words (unexpected diagnosis, pain, have to tell others, shock,
numbness) and Recreating Voice (claiming the diagnosis, losses and gains,
refocusing and changing life plans)
Koopman and Schweitzer (1999) concluded that the diagnosis of MS led to
uncertainty and variability and participants needed to develop strategies to cope with
the challenges of a disease with no cure. Although the themes provided new insights
into understanding the experience, a deeper discussion about the methods of data
analysis and separating the results for the different phenotypes of the participants
would have led to readers being able to make informed decisions about
generalisability to their particular situations and contexts. Similar to Miller (1997),
this study identified worry, fear and feelings of loss in the participants as major
themes living with MS.
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A growing body of literature began to emerge exploring how people with MS were
making sense of their world, their lived experience. Differences between MS as a
“disease” and as an “illness” were seen as important to continuing the dialogue. Clair
(2003) suggested that disease is seen as an objective measure of pathological change
within the body and illness as the “human experience” of the disease. An exploratory
study of 16 women diagnosed with MS (phenotypes not disclosed) initially used
narrative data collection from focus group interviews with six participants, to
generate an agenda of topics to explore during the second phase of the study with ten
semi-structured interviews at a later date (Clair, 2003). Participants were recruited
through a local New Zealand MS Society and purposive sampling was used to select
women from a variety of settings and situations for the interviews. Data was
analysed using a computer based software package to assist coding and analysis and
symbolic interactionism was used to build a theoretical foundation for interpreting
the illness. Symbolic interactionism has been described as looking for meaning by
human beings, with the meaning derived from social interactions they encounter and
subsequently process (Blumer, 1969).
Findings suggested that to live in a world of MS is to live in a world with uncertainty
and little to no control. Essentially, two separate datasets were evident: women
striving to identify the cause of their illness and find meaning, and women who
transformed themselves and their illness, reclaiming control and finding peace and
harmony (Clair, 2003). Intuitively, the women in the study engaged in story telling to
make sense of their illness and regain control over their lives. Employing an in-depth
interview method enabled the women to tell their stories, often for the first time, to
convey their lived experience with MS. Clair (2003) surmised that MS can be seen in
one of four ways, firstly MS as an aggressor (fight it head on, or let it run its course),
or MS as a saviour (delivered to save the person from the person they were or were
becoming), MS as a guest (but find ways to minimise the intrusiveness) or MS as an
adversary (inspiring to overcome obstacles). These findings echoed some of the
earlier findings from Miller (1997) and Koopman and Schweitzer (1999) in terms of
seeing MS as an adversary and the feelings of participants losing control living with
uncertainty. Coping with the disease, previously reported by Miller (1997) is aligned
somewhat with Clair’s (2003) viewing of MS as an aggressor and fighting the
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disease, or MS as a guest and finding ways to reduce the disease impact. However,
the findings of MS as a saviour were novel and interesting to consider for HCPs
caring for PwMS.
Limitations to the study were due to only women being included and that the
participants interviewed were located in a regional area of New Zealand (NZ).
Unfortunately the phenotypes of MS of the study participants were not disclosed, it
would be interesting to know if the themes predominantly reflected a relapsing form
of MS or if the participants were living with progressive MS. A major strength of the
study included a purposive sampling method to obtain maximum variation in order to
reach participants across a wide range of demographics. This improves
generalisability of the study findings to others. It is also worth noting that although
published in 2003, the study took place in 1996, before DMTs were available to
people with MS living in NZ, rendering a replication of the study worthwhile.
The nature of invisible symptoms in MS and the uncertainty of what lies ahead when
living with an unpredictable disease provided the inspiration for researchers to
explore the lived experience of MS using separate focus groups for men (n=4) and
women (n=6) (Courts et al., 2004). Again, unfortunately the MS phenotypes were
not disclosed (Courts et al., 2004). The data was analysed by searching for themes,
but no supporting information on how this was achieved was outlined in the article.
Study findings identified four main themes; Nobody Listened (nobody takes
symptoms seriously, a long time to diagnosis), Symptom Devastation (overwhelming
symptoms, battle for normalcy, pain and anger), Picking and Choosing (making
choices to regain control, using denial) and Fight Your Own Fight (self advocacy,
taking charge). Once again, issues of control and conflict with HCPs, as reported by
Miller (1997) were also a feature of these study findings. The theme of Fighting
Your Own Fight by taking charge was somewhat seen previously in Miller’s (1997)
themes of getting to know MS and control, but the presentation of the other themes
offered new approaches to understanding MS.
Participants in this study described creative solutions to the continual challenges and
changes of MS interfering with goals in their lives. At times they described feeling
depressed, dejected and desperate. Their most poignant need was for someone to
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listen to them and teach them, as they identified knowledge as power (Courts et al.,
2004). The authors suggested that nurses should utilise interventions to empower
patients and also to teach self-management strategies.
The concept of the devastation experienced with symptom onset was reported by the
researchers to be greatly helped by patient knowledge of their disease, which
subsequently assists nurses in planning education sessions for patients and this
finding is consistent with previous suggestions for practice (Miller, 1997). These
themes again build on earlier work, as well as introducing new concepts for further
research. The most notable being the importance of people with MS making their
own decisions and practicing self-advocacy, which remain as major teaching
elements in the MS Nurse repertoire to this day. By examining the lived experience,
nurses are encouraged by the authors to build partnerships with patients, listen to
patients, teach patients how to navigate the health care system, provide information
and to teach self-advocacy and self-management.
Limitations to the study by Courts et al. (2004) included the study being confined to
one small geographical area. A description of the data analysis phase of the study
was overlooked in the report, which therefore limits readers being able to replicate
the study in their own environment. Once again, no MS phenotypes were disclosed,
it would have been interesting to note whether there were differences between
relapsing or progressive courses. Strengths of the study centred on recruiting both
men and women with MS to better represent both genders. Having the three
investigators attend all focus groups together, and reaching a consensus on theme
identification also strengthened the study results.
The life-world of one person with early onset RRMS was explored in great depth and
richness during an unstructured interview at the end of the participant’s first year of
living with RRMS (Finlay, 2003). This dissertation used a case study method to
focus on one individual’s MS experience. Phenomenological methodology was used
to access and describe life-world experience, however no meanings or abstractions
were explained during the course of the research. The interview began with the
general question “What is living with multiple sclerosis like for you?” and continued
for a period of two hours, with prompts and requests for examples from the
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researcher. Analysis of study results took place in two phases. Firstly, a narrative was
created using verbatim quotes and secondly analytic methods suggested by Wertz
(1983) involved repeated, systematic readings of the transcript, dwelling on the
phenomenon through immersion and reflection, then describing the recurring themes
that were present (Finlay, 2003).
The rich description of this lived experience illustrates the overwhelming impact of
illness on the life-world and introduces the concept of embodiment in MS nursing
research (Finlay, 2003). The lived experience in one persons’ body is their own,
personal experience. By focusing on the impact of physical illness, we are better able
to understand that our embodied experiencing cannot be separated from the essence
of who we are as a person and our place in the world (Finlay, 2003). It is just that –
simply one person’s lived experience.
The major limitation to this study is the focus on just this one individual. However,
such a rich narrative may provide nurses with greater understanding, which can then
be applied to others with MS, in ways deemed appropriate by the nurse to the
context. The second possible limitation to this study is that the subject and researcher
had been friends for 15 years prior to the study, possibly introducing some bias and
assumed knowledge into the interview. However that may also be seen as a particular
strength of the study; with strong rapport, trust and openness already existing
between researcher and participant. This may have resulted in less censorship and
more open responses.
Two years later, the life journey of one study participant with RRMS was also
explored by Fawcett and Lucas (2006) exploring the journey from the first disease
symptoms of a fit, active female subject aged in her early thirties who was a friend of
one researcher. This study revealed the following key points; nurses play a pivotal
role in MS care, the beginning of the journey is fraught with questions, GPs may not
recognise symptoms as being MS, the impact of the diagnosis of MS should not be
underestimated, uncertainty is a challenge, understanding and getting to know MS is
an important step and that support from family and friends is valued by PwMS.
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Similarly to Finlay’s (2003) study, limitations to this work takes account that one
researcher and the participant were friends before the study took place. However, as
already mentioned, this could have strengthened the study findings based on the trust
and rapport they already shared. Nevertheless, this in-depth case study adds to our
insights and understanding of RRMS. Identifying the nurse as being in a pivotal role
in the MS journey, the challenge of uncertainty, the under-recognition of MS
symptoms in the community, the value of family and friend support and the need for
resources to get to know MS further supports the previous research of others (Miller,
1997; Clair, 2003).
Barker-Collo et al. (2006) performed a qualitative study using semi-structured
interviews to obtain narratives from 16 people, half living with RRMS and the other
half with progressive MS. The age range for the study was 27-72 years with five
males and 11 females. The primary aim of the study was to expand on the earlier
work of Koopman and Schweitzer (1999) using a larger sample to explore the
experience and subsequent journey at the time of MS diagnosis. The research was
analysed using thematic analysis. The strength of this study was the separation and
comparison of RRMS and progressive MS in the findings and discussion. A marked
difference was found between PwRRMS and progressive MS. RRMS narratives
tended to reflect variability and unpredictability for the patient and for their family
“it’s the not knowing”. This contrasts with progressive MS where the prevailing
theme was a sense of hopelessness in relation to the inevitability of disease related
decline “you have this thing that will eventually make you a burden”. Other themes
in general, where RRMS and progressive MS results were reported together,
included the impact of changes to life roles, the fear of impact from MS on others,
the possibility of positive effects on relationships and on lifestyle and health, the
potential for isolation from others, the need for appropriate MS related information
and the central role of the MS nurse in patient care.
Once again, similar themes to previous work from Miller (1997) and others were
identified, however the emphasis on the positive effects from living with MS were a
welcome addition to our knowledge about living with MS. The concept that this
devastating illness could bring fresh and new insights to PwMS and cause positive
change to lifestyles and relationships was innovative information.
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Malcomson, Lowe-Strong and Dunwoody (2008) aimed to explore the personal
accounts of people living with MS in order to gain insights for HCPs and to identify
effective self management strategies for patients. This study used focus groups to
interview 13 individuals, nine females and four males, six participants lived with
RRMS and the rest of the sample with progressive MS. Five study participants were
no longer ambulant. The study results were analysed using thematic analysis, but
again unfortunately, findings were not separated according to MS phenotype.
Themes identified included learning something was wrong (distress, uncertainty,
fear), getting a name (the diagnosis, unhelpful feelings), getting help (lack of
psychosocial

support),

consequences

to

lifestyle

(interpersonal,

changing

employment circumstances, challenges), getting on with day to day life (proactivity,
perspective and control), providing advice for others (peer support, self management)
and providing advice for HCPs (personal needs, guidance and information, peer
groups). The concept of patients providing advice for HCPs is particularly
enlightening and nowadays is an important part of shared decision making in clinical
care. One would imagine it was a surprising finding when it was first identified,
before making its way into recommended MS care in recent times (Giovannoni et al,
2016).
A possible limitation to generalising the study to others with MS is that the study
participants were invited into the study because they felt “able to cope” with MS and
may have thus represented only part of the MS population. The method of focus
groups rather than individual interviews may have also limited the information
people were prepared to divulge in a group setting in front of strangers, especially in
regards to sensitive topics such as sexuality and cognition. The findings however are
useful as they provide an in-depth exploration of a very important time of the MS
journey (up to, during and just after MS diagnosis) and also considers the insights of
both males and females.
A more recent qualitative study used interpretative phenomenological analysis (IPA)
to understand the experience of young adults living with RRMS, and was undertaken
as part of a nursing dissertation (Beshears, 2010). The research question was “What
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is the meaning of the experience of living with RRMS for the young adult?” with the
purpose of understanding the lived experience in order to propose education and
support for this specific MS population. The cross sectional study used convenience,
purposive sampling to recruit six female participants between 20 and 40 years of age.
Data collection involved three in depth interviews, which were transcribed, and data
analysed using a Miles and Huberman approach and the Heideggerian method. This
form of IPA uses the researcher as the data collection instrument, uncovering
meanings in the narratives of the participants (Miles & Huberman, 1994).
Specifically the study aimed to discover the meaning of changes occurring in the
participant since their diagnosis of RRMS, to uncover how the participants made
meaning of the expectations of others in their lives and how they learnt new ways of
being during MS relapses.
Beshears (2010) presented many ideas from the data analysis, including the
participants wishing for opportunities to talk to others about MS, living day by day,
of MS being “scary”, the importance of planning ahead and the value of listening to
one’s body. These findings led to the compilation of four broader themes; firstly
participants realising that MS involves uncertainty, their discovery that RRMS is
frustrating, concepts of being scared and fearful getting to know MS and that RRMS
is always in the backdrop of life.
Beshears (2010) hoped to interview both sexes in the study, but no men volunteered,
so unfortunately only women were included in this study, again potentially limiting
the generalisability of results to men and extending the significant gap in the
literature relating to RRMS in males. All participants in the study were married with
the spouse being the household wage earner, thereby further hindering
generalisability of the results to other social situations. Recruitment of participants
was in a rural region of the US, with potential local influences biasing the data in
unknown ways, for example local health care systems and the availability of
neurology care in the rural area. A major strength of the study is the rich data in the
six narratives and a strong focus on intimacy and relationships, which are important
developmental milestones in adult development (Busch & Hofer, 2012).
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The most recent study to explore the experience of living with MS comes from
Jordan in the Middle East (Al-Sharman et al., 2018) and is from the speciality of
rehabilitation. A total of 16 participants (equal numbers of male and female) with an
average age of 36 years and average time since diagnosis of seven years, participated
in a total of four focus groups directed by an interview guide. The study aimed to
explore and describe the daily living experiences and challenges of PwMS. The
study sample was a convenience sample representing two geographical areas in
Jordan and was the first of its kind to be undertaken in the region. Unfortunately, no
phenotype was disclosed for the study participants, however the average EDSS was
3.5, indicating mild-moderate disability for most of the participants with one
participant having an EDSS of 6.0 (needing a unilateral walking stick to mobilise).
The focus groups were split into one gender only to encourage open discussion,
which may have been impacted in this region by cultural conditions inhibiting
females from discussing important insights in front of males (Metcalfe, 2008).
Two major themes were developed by the researchers: firstly, experiences related to
the disease itself (physical decline, psychosocial withdrawal and fear of the future)
and secondly, experiences related to the health care system (difficulty of diagnosis,
poor communication and rapport with HCPs, lack of awareness about MS and MS
rehabilitation)
The researchers recommended greater attention be given to MS in Jordan, with
improved awareness of MS for both HCPs and for the general public. In addition, AlSharman et al. (2018) also recommended optimising and enhancing rehabilitation
services for PwMS. The study is limited by the geographical region and cultural
differences to the western world, however the study is strengthened considerably by
the inclusion of eight males in the research, a demographic which until now had been
greatly under-represented in qualitative MS research.

Life history research and RRMS
There is only one brief piece of research exploring the life of a PwMS using a life
history approach (de Chesnay, Rassilyer-Bomers, Webb, & Peil, 2008). This was a
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four page narrative presented in a book chapter discussion about performing life
history studies where the purpose was to present an abbreviated story, told by the
participant and interpreted by the researcher, to teach others about overcoming
obstacles in chronic illness (de Chesnay et al., 2008). The author of this particular
MS life history narrative within the combined chapter story (Webb) presented a
single life history of a 46 year old female who successfully overcame her debilitating
MS-related fatigue. The data is limited by the study purpose, dealing with only one
aspect of her MS experience. The current study aims to explore all facets of living
with RRMS and in many participants.

The lived experience in progressive forms of MS
As the current study focused solely on RRMS, only a very short literature review
will be presented on progressive MS to provide some perspective of the overall
situation. Several qualitative studies have concentrated on the lived experience of
people living with progressive forms of MS (Edmonds, Vivat, Burman, Silber, &
Higginson, 2007; Olsson, Skär, & Söderberg, 2010; Strupp et al., 2012). Although
these phenotypes are distinctly different from the proposed study group, people
living with SPMS did originally start their journey with RRMS, and may have
important insights to offer when considering living with RRMS.
The most relevant of these studies to the current study, is a recent dissertation in the
field of psychology (O’Loughlin, 2015). The investigator aimed to gain rich insight
into the experiences of people with SPMS during the critical, but poorly understood,
time of disease transition and change of labelled disease phenotype from RRMS to
SPMS. A total of 16 people took part in the research, nine PwSPMS and seven
HCPs involved in MS care. Thematic analysis was used to explore the experiences,
coping strategies and needs of people during transition from RRMS to SPMS. Four
themes were developed by O’Loughlin (2015) in exploring SPMS: is this really
happening? (noticing decline, feeling “in limbo”), SPMS becoming a reality (shock,
meaning, turning points), feelings of living a life of struggle (“it’s all downhill now”)
and the concept of brushing oneself off and moving on (accepting, making the best in
the circumstances).
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Recommendations from this study included the need for HCPs to undergo education
regarding the psychological impact of SPMS during the transition, the provision of
peer support, and exploration of existing resources and coping strategies that
PwSPMS may already have. A great strength to the study is the fact that participants
were recruited within 12 months of their SPMS transition, possibly enhancing the
accuracy of their recall of events.
As a university research Professor, Toombs (1988, 1990, 1992, 1995, 2001) began a
series of phenomenological work exploring her own experience of living with MS,
whilst navigating the world as a researcher. Toombs (1995, p.12) writes:
“For MS, like every other illness, is experienced not just as the breakdown of
the body, but as the disruption of the life that is lived in that body. To live
with MS is to experience a global sense of disorder; a disorder which
incorporates a changed relation with one’s body, a transformation in the
surrounding world, a threat to self, and a change in one’s relation to others”.
Such intimate and descriptive detail adds to the understanding of the individual’s
lived experience with MS. Toombs (1988, 1990, 1992, 1995, 2001) provided
reflections of her personal experience of living with progressive MS over many years
to provide a phenomenological account of the human experience of disability.
Particularly moving and striking in its simplicity, Toombs (1995) suggested that the
loss of upright posture, as disability takes hold in MS, diminishes autonomy for the
person and affects the way one is treated by others, disrupting social connections and
leading to a loss of dignity. This insight from Toombs profoundly changed the way I
viewed patients as I consulted in the MS clinic. In particular, it led to many changes
in how I considered visits and appointments for patients, paying greater attention to
positioning and clinic set-up to try and restore as much dignity as possible to the
lives of PwMS visiting the clinic.

The lived experience of children and adolescents diagnosed with RRMS
Significantly fewer studies have focused on the lived experience of children and
adolescents with MS, mainly due to the rarity of this condition in children younger
than 18 years. An explorative qualitative study used a phenomenological approach to
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explore experiences of children living with MS (Boyd & MacMillan, 2005). Patients
from a children’s hospital in Canada (n=12) were interviewed using a semistructured format. A software package was utilised to sort data and then narrative
analysis was used to generate themes and subthemes. The investigators found that
the children described similar themes to their adult counterparts described earlier in
this chapter; that is, worrying about burdens on families, fear of disclosure, hiding
symptoms, dealing with uncertainty and fear of rejection from their peers (Boyd &
MacMillan, 2005). A major difference was that the children and adolescents in this
study reported conflict with their parents and lack of understanding from teachers,
rather than the experience reported with adults who described this same conflict, but
with the medical professionals (Miller, 1997). The great strength of the study is that
it fills an enormous gap in knowledge regarding paediatric MS lived experiences and
provides an excellent starting point for further research, possibly involving more
centres and greater numbers.
A further research study in 2009 employed grounded theory to develop a theoretical
model to understand psychosocial experiences of paediatrics with MS (Thannhauser,
2009). The study looked at the interplay between grief and peer relationships, which
adds to the knowledge about paediatric MS, but not the lived experience. It has been
suggested by others that there are significant gaps in qualitative literature in
paediatric neurological conditions (Audulv, Packer, & Versnel, 2014).

Other aspects of MS and the lived experience
At the other end of the life trajectory, there is a paucity of research investigating the
lived experience of the aged population with MS. Currently a quarter of people living
with MS are aged over 65 years of age and experiencing a decreased health related
quality of life (Buhse, 2015). This demographic of MS research demonstrates a
significant gap in the literature and also needs immediate attention.
There have also been several studies investigating the lived experience of caregivers
and partners of people with MS, but they have not been individually reviewed here
as it is not aligned with the research question focused on people living themselves
with RRMS (Aoun, McConigley, Abernethy, & Currow, 2010; Bjorgvinsdottir &
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Halldorsdottir, 2014; Buhse, 2008; Buhse, Dela Ratta, Galiczewski, & Eckhardt,
2015; Cheung & Hocking, 2004; Corry & While, 2009; Pakenham & Samios, 2013;
Strickland, Worth, & Kennedy, 2015).

The lived experience of other chronic illnesses
There are many illness states which have overlapping symptoms or share certain
features with MS, which may also provide MS Nurses and HCPs with insights to
help them understand what it is like to live with chronic illness. These lived
experience studies include those in motor neuron disease (Brown & Addington-Hall,
2008; O’Brien, Whitehead, Jack & Mitchell, 2012), in stroke (Burton, 2000), in
spinal cord injuries (Desanto-Madeya, 2006), in Parkinson’s disease (Soundy,
Stubbs, & Roskell, 2014), in medically unexplained symptoms (Nettleton, 2006), in
fibromyaligia (Lempp, Hatch, Carville, & Choy, 2009), in the rare illness
lymphangioleiomyomatosis (Haylen, 2015) and in lupus (Mendelson, 2006;
Beckerman, 2011). There are some commonalities in the findings between these
chronic conditions and RRMS, most notably feelings of being unheard and voiceless
(Nettleton, 2006) of uncertainty (Haylen, 2015) and of invisible symptoms
(Beckerman, 2015).

The significant gaps in the literature
A significant amount of literature regarding MS has been published in the last
decade, as important advances in earlier diagnosis of the disease and the advent of
more efficacious drug treatments have transformed MS care. A search in Google
Scholar reveals 210,000 articles in MS since 2011. However, the great majority of
this research has been biological, scientific and medical in nature. Qualitative
research in particular has been lacking in this specialty.
This literature review did not reveal any other studies using life history methodology
to explore the experience of people living with MS (besides a short four page
narrative). Why is this so? Using life history in researching chronic illness reflects
the complexity of the human experience it is examining (de Chesnay, 2014),
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presenting an ideal methodology to gain insights and understanding. However, there
are many challenges inherent in using this methodology, including deeply personal
narratives which may affect the researcher emotionally and the fact that the
interviews and follow-up are time consuming and lengthy. Perhaps it is because life
history is an under-recognised methodology in nursing. These aspects will be
discussed further under methodology in the next chapter, together with the reasons
why life history is an ideal approach to explore the entire life experience of living
with RRMS.
From this literature review examining the experiences of people living with MS,
three things are abundantly clear. Firstly, there is an enormous gap in recent
literature surrounding what it is like to live with and experience RRMS. There were
several pivotal studies in the early to mid 1990’s, most likely they arose at this point
because drug treatments were not yet available and major breakthroughs in genetics
and understanding scientific aspects of the disease were still several years away. In
this setting most of the nursing research centred on trying to understand the patient
experience, in order to inform patient education and symptom management
strategies. A seminal paper by Miller (1997) outlined the lived experience of people
with RRMS using a phenomenological approach and was the first of its kind to
examine how it felt to be the person at the centre of the MS experience (Miller,
1997). This informed health professionals to become aware of the patient experience,
that patients wanted to learn more about their disease, to take control and to be in
charge, to teach families to be supportive and not stifling in assisting with their loved
one’s care and for nurses to be at the forefront of educating patients about the
different phenotypes of MS. Unbelievably, up until shortly before this time, it was
still regularly debated in medicine whether patients should actually be told their
diagnosis, for fear of causing emotional devastation in a disease with no available
treatments (Elian & Dean, 1985; Sencer, 1988). Miller’s (1997) findings set up
important conceptual frameworks for MS nursing practice to understand the concerns
of people living with MS.
Several studies in the last two decades have continued to explore the experiences of
people living with RRMS, but recent studies are lacking. This gap in qualitative
literature is of prime importance as the landscape of treatments for MS, the potential
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side effect profiles of these pharmacological treatments and the emergence of even
more new therapies continues to grow and become even more complicated for people
with RRMS. How do patients feel? What is it like to be living with MS today? It is
imperative that qualitative research answers these questions so that nursing practice
and intervention reflects the needs of patients and that nursing theory and
frameworks take these needs into consideration and develop as our understanding of
the disease matures. Many of the studies presented above either did not discuss the
phenotype of the participants, or only partly included PwRRMS in the research.
Many of the themes identified in progressive MS research are vastly different to
RRMS and therefore cannot be extrapolated. If study findings refer to both groups of
participants, there should be a discussion (where possible) outlining any differences
between the two groups.
The second area identified with significant gaps in the literature is research involving
males living with RRMS. Many of the studies described here selectively, or
coincidentally, recruited only or mainly women. Although the preponderance
towards women developing RRMS at a rate of 3:1 is widely known, this still leaves a
significant portion of men in the community whose experience living with RRMS is
under-researched and unknown. Recruiting men into the current study is an attempt
to ensure men are adequately represented and by doing so will enhance our
understanding of the current experience of both genders living with RRMS.
The third areas of significant literature gap in this field involves research into the
experience of both ends of the lifespan spectrum; children and adolescents, as well as
the aged population living with MS. In regards to paediatrics and adolescents living
with MS, this is an acknowledged area of deficit (Audulv et al., 2014). However, this
will not be the focus of the research question in this proposal due to the specialty of
the area and lack of experience and skills of the researcher in paediatrics, experience
which would be essential to undertake such a study. The current study unfortunately
did not see any PwRRMS over the age of 65 years volunteer to participate.
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Summary
The current study aims to fill the significant gaps in the qualitative literature
exploring the experience of adults living with RRMS. To achieve this goal, the study
sample has targeted both males and females to add to the body of knowledge in the
area of RRMS. A body of knowledge which is striking for its burgeoning scientific
and biomedical research, but scarcity of contemporary lived experience literature.
The findings and discussion following in chapters five to seven will bring into the
conversation literature relevant to each theme and subtheme as they are explored, to
provide further knowledge, background and linkage with previous research and
theory.
There are no studies reported in the literature that have been performed using the
same methodology and methods as the current study. In many ways, this was
daunting at the beginning of the study, but as the study progressed and my faith in
the methodology and methods strengthened with each interview, there was a quite
confidence I developed in the operational framework of the study as the life histories
from the participants were so strong with relevant data. These concepts will be
discussed in the next chapter and will support how the life history methodology,
underused in MS research (and illness research in general), provides a dynamic and
useful tool to learn as much as possible about the experience of living with RRMS.
The final chapter will connect the studies discussed in this chapter’s literature review
with the findings from the current study, with additional concentration on the
research from Miller (1997), Clair (2003) Courts et al. (2004) and Beshears (2010) as
the most alike to the current study, either in study aims or study sample. However,
the data analysis for these studies used hermeneutic phenomenology, symbolic
interactionism, searching for themes and interpretative phenomenological analysis
respectively in their data analysis to uncover meaning rather than the current study
method, which used thematic analysis (Braun & Clarke, 2006, 2013).
The following chapter, Methodology and Methods, will outline the ontological and
epistemological viewpoints of the study, and the study process and procedures.
Chapter 4 will also explain why the selection of the life history approach is an ideal
methodology to answer the research question “What is the experience of living with
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RRMS?” in a novel and insightful way, to add to the body of knowledge on the
experience of living with RRMS. The current research approach differs from
previous research in that it is contemporary, takes into consideration recent advances
in MS care and provides a unique viewpoint looking at the whole life experience and
incorporating previous life events into how RRMS is experienced.
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CHAPTER 4: METHODOLOGY AND METHODS
The purpose of this chapter is to discuss and justify the qualitative research paradigm
chosen for the current study, the ontological and epistemological frameworks
employed to guide the study and the overall research design. This chapter will also
present a clear justification of the methodology and methods implemented, including
a discussion of how they link in with the overall ontology and epistemology of the
current study. The roles of ethical considerations, study rigour and reflexivity in the
current study will also be discussed.

The qualitative research paradigm
A paradigm may be viewed as a set of basic beliefs dealing with principles, a
framework representing a worldview, defining the nature of the world and the
individual’s place in it (Guba & Lincoln, 1994). Qualitative research as a paradigm is
a form of social inquiry that focuses on the way people make sense of their
experiences and the world in which they live, with the goal of understanding,
describing and interpreting phenomena as perceived by individuals and groups
(Holloway & Wheeler, 2013). Strong advocates for qualitative research,
Denzin & Lincoln (2000, p.3) have defined qualitative research as:
“A set of interpretative, material practices that make the world visible – these
practices transform the world. They turn the world into a series of
representations…qualitative research studies things in their natural settings,
attempting to make sense of or interpret phenomena in terms of the meanings
that people bring to them.”
Several elements make up the qualitative research paradigm, and these elements are
important points of difference from the number focused, hypothesis based, theory
testing elements of quantitative research (Braun & Clarke, 2013). Holloway &
Wheeler (2013) suggest the following characteristics as being integral to qualitative
research; the data have primacy, the theoretical framework is not predetermined, but
derives directly from the data, the data is context bound, the immersion of the
researcher into the natural setting of the study participants, a focus on the “emic”
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perspective (the views of the people being studied), the use of “thick” descriptions
(dense and detailed [Denzin, 1989]), the presence of reflexivity, identifying the
researcher as the main research tool and explicitly stating the position of the
researcher in the study.

Choosing the qualitative paradigm
Central to the qualitative paradigm is a humanistic commitment to always study the
world from the perspective of the study participant (Lincoln & Denzin, 1994). In the
early phases of developing the research question and identifying the study aims, I felt
that the qualitative paradigm, with its roots in gaining insights and deep
understanding into the experiences of people, would suit the study aims very well.
The research question required a methodology that would gain deep, rich insights
and understanding of the experience of living with RRMS. Qualitative research
retains complexities and nuances and respects the uniqueness of each individual,
giving importance to the narratives and context of the participant’s stories (Ormston,
Spencer, Barnard, & Snape, 2014).
In seeking to understand and interpret meaning within context, qualitative research
also focuses on being inductive (developed directly from the data) and seeks patterns
in data, but also has an appreciation for differences in data. I was adamant from the
start of the study that I did not wish for the individual stories of study participants to
“get lost”, I wanted to have their voices clearly heard because there is so little
literature available which explores their world and considers the perspective of the
PwRRMS. I therefore chose a purely qualitative approach early in the research
design as the best “fit” to meet the goals of this research study.
Qualitative research involves much more than “simply reporting the facts”, it
involves a great variety of interpretation (Miller & Dingwall, 1997). In general,
qualitative research is a group of methods and ways of collecting and analysing data
that are exploratory, interpretative and have a focus on meaning, with reality
developed collaboratively by both the researcher and the study participant (Smith &
Noble, 2014). The qualitative paradigm recognises the strength of bringing my own
subjectivity as an expert MS nurse as a valuable tool to the research process
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(Silverman, 2001). Constructing the research together with the study participants also
greatly appealed to my epistemological outlook, which will be discussed in greater
detail later in this chapter.

Qualitative research in health and nursing
Qualitative research has been conducted across many areas; education, business,
sociology, psychology and health in particular. Especially relevant to the research
question in this study, qualitative health research focuses more specifically on
exploring health and illness as they are perceived by people themselves, focusing on
their experiences, how they feel and maintaining patient centrality in the story
(Morse, 2012). Over the last two decades, there has been an upsurge in collecting
and valuing stories from patients, as Morse (2012, p. 27) observed, “illness was
coming out from the closet, and as the door opened, it revealed all of its emotions
and sensory secrets”. Finding individual meaning and understanding in stories from
patients is fundamental to the caring and compassionate culture of nursing, and
something nurses strive for in daily practice (Munhall, 2012). Nurses base their
clinical practice on learning as much as possible about the people under their care,
detecting commonalities and differences in order to ultimately individualise their
care and management (Thorne, Ternulf Nyhlin, & Paterson, 2000). Traditionally,
nurses are attracted to qualitative research as they value the richness of deep
understanding and the perspective of the patient, and in doing so, nurses are able to
develop culturally appropriate interventions and improve competence of care in
diverse and vulnerable populations (Desantis & Ugarriza, 2000). PwRRMS are both
diverse and vulnerable, and this will be explored and argued throughout this thesis,
particularly in the later chapters discussing the study findings and themes.
Morse (2012) suggests that HCPs working in the clinical arena can be considered as
“street smart”, that is, already having an understanding of the health system. HCPs
are ideally positioned to conduct qualitative research, having working knowledge of
the patient population, the ability to monitor patients during the process (for
symptoms such as fatigue, distress) and being well placed to make clinical
recommendations at the completion of the research (Morse, 2012). Munhall (2012)
has proposed a range of elements that qualitative nurse researchers enrich their
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practice with as a result of their research. These elements include caring for the
individual, legitimization, understanding of experience, acceptance, change,
emancipation, compassion, understanding of meaning, empathy, understanding needs
of individuals and groups and critical needs for healthcare changes (Munhall, 2012);
all of which are consistent with the personal aims I hoped would result from the
current study.
As Munhall (2012) also suggests, nursing is a human science, and human sciences
depend on a perspective from the inside to the outside. This contrasts with natural
sciences, which investigate objects from outside to inside (Munhall, 2012). As an
MS Nurse balancing both a clinical role consulting MS patients and a research role
(in a mainly scientific and quantitative research environment) I often wondered how
patients felt coming in for their treatments and appointments. I contemplated what
was going through their minds, how they told their families about feelings and
symtpoms, what motivated them and how they coped with various aspects of the
disease. Of course, I would find out some information as we chatted informally
between tests, but I wanted to know more. I yearned to sit down for an uninterrupted
hour and just talk, to know more about their motivation to give up their time for
others, how they viewed their disease and how their life changed because of the
disease. In the busy, biomedical focused world I worked in, there was insufficient
time or opportunity to talk and share this vital, yet often overlooked information. As
I could see that no change in the work environment was possible, it was time to
explore how I could satisfy this curiosity through research.

Ontological and Epistemological Perspectives
In qualitative research appropriateness of the choice of methodology and method is
paramount (Holloway & Todres, 2003) and the research design must clarify the
contributions of epistemology, methodology and methods (Carter & Little, 2007).
This required prolonged discussions and considerable thought as to how the research
design could enable the best “fit” to answering the research question and in a way
that was sensitive to the overarching ontology and epistemology I selected to provide
the framework for this study.
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Our own subjective world evolves from all of our previous experiences, those as a
child, our relationships, the culture we live in, our age, our gender. Our subjective
perspective is the result of these experiences, forming the context of where we are in
the world at present, our “situated context” (Munhall, 2012). In constructing and
defining the overarching ontology and epistemology for this study, I needed to
evaluate where I sat presently in terms of “situated context”, how I felt about the
world, what it was possible to know and how it could be known. Several key
concepts characterizing qualitative research as suggested by Munhall (2012) drew
me to the paradigm, and ultimately influenced the stance I took in this regard; these
concepts included believing in a multiplicity of views in the world, perceptivity of
phenomena, polyvocality of many voices, and the existence of multiple realities. I
did not believe there was a singular reality or only one answer to the research
question I posed.
I believed that my source of knowledge to answer the research question was not
going to come from books and articles, but from the “knowers” (Munhall, 2012); the
PwRRMS. I could begin to “know” by having conversations with people whose
world I wanted to gain insights and understanding into. Talking to these informants
allowed me to construct knowledge with them and learn about their lived world
(Kvale & Brinkmann, 2007). I considered the PwRRMS as the experts in this
situation (Windle, 2011). Thus began my allegiance with the qualitative ontology
and epistemology, a strong belief in the co-construction of knowledge between the
PwRRMS and myself.

Ontology
Ontology refers to the nature of reality and what there is to know about the world
(Ormston et al., 2014). Essentially ontology is about how things really are and how
they work (Guba & Lincoln, 1994). There are many variations along the spectrum in
ontology, depending upon how the researcher views the relationship between the
world and human interactions and practices within it (Braun & Clarke, 2013). The
ontological beliefs I used to underpin this study were in line with constructivism,
centred on the world being context specific, co-creating knowledge between the
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researcher and study participant, being open to revision and possessing multiple
realities.
Constructivism’s hermeneutic/dialectic methodology is aimed at the reconstruction
of previously held constructions, and is open to new interpretations as the
sophistication of the information improves throughout the research process (Guba &
Lincoln, 1994). This means that knowledge is ever changing, represents various
interpretations and is context bound. Under the paradigm of constructivism, the
concept of relativism also provided an excellent “fit” for the current study.
Relativism explores the concept that all truth is “constructed” by humans and
situated within an historical moment and social context and that multiple meanings
of the same data may exist (Cresswell, 2008) and was particularly applicable to the
values of the current study. Thus, an ontological foundation of constructivism and
relativism was applied to the current study.

Epistemology
Epistemology has been defined as the nature of the relationship between the
“knower” and what can be known (Guba & Lincoln, 1994). The essence of
epistemology is the question of what is possible to know (Braun & Clarke, 2013) and
how we come to know it. As with ontology, there are also many variations of
epistemological stance dependant upon the views of the researcher; what they feel is
possible to know, and the meaning of this knowledge (Braun & Clarke, 2013).
Constructivist epistemologies state that there are knowledges existing, rather than
singular knowledge, that knowledge is a product of how we come to understand it,
and therefore how we construct it (Braun & Clarke, 2013). Knowledge construction
involves the input of both the researcher and the study participant.
The epistemological base of life history is grounded in a pragmatic approach to
knowledge, concerned with depicting the lived experience as actual members of the
culture (in this study it is the PwRRMS) understand their experiences, but also
understanding that this truth may not be universal (Faraday & Plummer, 1979). The
constructivist epistemological stance for this research study involved the assumption
by myself, as the researcher, that people living with RRMS had information to reveal
74

to me that MS Nurses and HCPs could benefit greatly in knowing. Believing that
patient views are valuable and by asking questions of past experiences I could gain
insights into understanding what it feels like to live with this disease. I viewed this as
vitally important in order to better understand RRMS and its effect on people my
colleagues and I were caring for. Understanding RRMS from a “lived experience”
perspective would help MS Nurses and other HCPs make deeper connections with
patients, enhance their understanding of the disease and promote patient adherence to
both treatment and management strategies, improve quality of life, and provide truly
empathetic and compassionate care. This is important to provide greater satisfaction
and connection in work life for the MS Nurses and HCPs, and to ultimately improve
quality of life for the patients, the PwRRMS.
Constructivist epistemology formed the basis of what I believed and ultimately
influenced the selection of methodology and methods I selected in order to answer
the research question in the best way possible. To guide the appropriate choice of
methodology and methods for this study, it was necessary to gain this depth of
understanding about my epistemological position and to keep the three elements of
epistemology, methodology and methods consistent (Carter & Little, 2007).

The use of the first person in the study
A conscious choice was made to use the first person “I” in writing up and reporting
this research study. The reason behind this was to use my subjective voice, as the cocreator of the findings (with the study participants) as recommended by Munhall
(2012). The methodological and method choices were mine to make and to justify,
and I needed to personalise those decisions. The use of the first person has
commonly been recommended in qualitative research, especially in ethnographic
work (Denzin, 1994; Richardson & Lockridge, 1998; Tierney & Lincoln, 1997;
Tierney, 2000). Using the first person expresses greater vulnerability, keeps
emotions in the process of knowledge production and promotes the researcher as
central to the process, rather than being a disengaged observer (Tierney, 2000).
These concepts were all central to my ontological and epistemological viewpoints,
therefore the use of the first person was adopted to write the thesis.
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Methodology
Methodology refers to the framework within which the research is conducted. It
provides a theory of how the research should proceed and produce valid knowledge,
while making sense of the research in terms of design and process (Braun & Clarke,
2013). Choosing a methodological approach that serves the inquiry under study is
essential, as it acts as the initial guide to dictate the decisions made in a study to
answer the research question in the best, and most thorough way possible (Holloway
& Todres, 2003). Methodology also assumes what counts as research, how it is
conducted and what methods (sample, data collection, analysis) are appropriate for
the study (Braun & Clarke, 2013). Various forms of qualitative methodology were
considered for this study, and a form of focused ethnography, life history, was
chosen to answer the research question. Other forms of methodology that were
considered for this study were grounded theory (and its many forms), interpretative
phenomenological analysis and content analysis. The rationale for choosing the
ethnographically based life history approach (and for rejecting the other qualitative
forms of methodology) will be discussed in further detail in the data analysis
procedures, where the procedural differences will be highlighted.

Ethnography as a research methodology
Ethnography is a research methodology which involves the process of learning about
people by learning from them (Roper & Shapira, 2000) and has its historical roots
embedded in social and cultural anthropology (Holloway & Todres 2003). Despite
being popular at the beginning of last century, a long period of remission followed
through the mid century, before a significant revival in popularity since the 1990’s
(Plummer, 2001). Ethnography involves key informants who represent the culture
under study discussing their lives, so that others can better understand the culture (de
Chesnay, 2014). Traditional ethnographic techniques involved long-term participant
observation and interviewing, of researchers deeply engaging the socially organized
settings they sought to describe and analyse (Miller & Dingwall, 1997). The goals of
ethnography are to describe, interpret and understand characteristics of a particular
social setting, taking into consideration the diversity and multiplicity of voices from
key informants, the experts who have rich knowledge of the subject under research
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(Holloway & Todres, 2003). Ethnography has a place in health research, particularly
with its focus on the emic, or the patient perspective (Morse, 2012), being holistic,
contextual and reflexive (Boyle, 1994). This ensured an excellent fit for the
epistemological foundations and aligned with the broader goals of this study.
Ethnography takes on many forms and has been adapted for use in different settings,
depending on the goals of the research. Early ethnographers spent long amounts of
time in the field (“fieldwork”) getting to know the study participant/s and
encouraging them to share their life stories, often forming personal relationships (de
Chesnay, 2014). More currently, time constraints are considered to inhibit such long
encounters between researchers and study participant/s, especially in the field of
nursing. In keeping with the important aspects of traditional ethnography (insights,
understanding and culture), focused ethnography

developed, where researchers

attempt to learn about certain conditions by asking about the experiences of those
living with the condition (Cruz & Higginbottom, 2013; de Chesnay, 2014). Focused
ethnography has become more popular in health research generally, as it is an
effective method to gain information from a culture who may not necessarily have
contact with one another (Morse, 2012). Exploring experiences in smaller subcultural units such as a shared illness, honors the ethnographic assumptions and is
effective for eliciting information on a specific topic (Richards & Morse, 2007) and
being less time consuming, is therefore more practical for most researchers.
Central to the way that ethnographers think about human social action is the idea that
people construct the social world, through both their interpretation of it and through
actions based on those interpretations (Atkinson, Okada, & Talmy; 2011). This is
consistent with the epistemological framework for this study of constructivism. The
version of the culture reported by the researcher is simply one version of the world,
amongst many possible others.

Life history as a form of Ethnography
The life history is a “retrospective account by the individual of his or her life in
whole or part, in written or oral form, that has been elicited or prompted by another
person” (Watson & Watson-Franke, 1985, p.2). Life history is the story that a person
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chooses to tell about the life he or she has lived, told as completely and honestly as
possible (Atkinson, 1998). Immersing in accounts of people’s stories about their
lives, in their own words and in local context, the life history is a way to grasp
meaning from a culture (Fetterman, 1998). The terms life history and life story are
sometimes used interchangeably (Plummer, 2001). For the purposes of consistency
and clarity in this study I defined life history as the story told by a person to me as a
researcher (de Chesnay, 2014) and life story as the narrative analysis I created of the
person’s life from the life history they told me (Atkinson, 1998).
The history of life history as a method is interesting, as life history was used in
psychology with Sigmund Freud’s case studies, which later helped establish life
history as a social science method (Connell, 2010). The genre of social science
research was highlighted by important life histories earlier in the 20th century by
Thomas and Znaniecki (1927), who explored the culture and society of immigrants.
Connell (2010) suggested that this founding social research inspired new areas of life
history research in gender exploring masculinity and sport (Messner 1992), life
history studies in feminist sociology (Laslett & Thorne 1997), and race and racism in
the context of people’s lives (Blauner, 1989). Of course, important life history
advances were made with Plummer’s (1983, 2001) “Documents of Life” series
comprehensively exploring and championing the use of social science life stories and
providing important background to using the methodology. The value of life history
is that the value of the participant’s own perspective is highlighted in the research, as
Connell (2010, p.67) so eloquently describes “the passages in an interview transcript
that in traditional qualitative research are likely to be cherry-picked…in life history
research become revealing details in a tapestry”.
Life history in general is an underused methodology in nursing, but is perfectly
suited to the profession, as nurses have always valued the stories and insights
patients are able to provide to improve understanding of their world (de Chesnay
2014). Hagemaster (1992) has advocated the use of life history in nursing research,
and although still developing, many more nurse researchers have used life history
over the last two decades. Using life history in nursing research explores a person’s
microhistorical (personal) experiences within a macrohistorical (over time)
framework, enabling the researcher to deeply analyse relationships, attitudes and
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behaviours in a way that might not be possible using other methodologies
(Hagemaster, 1992). Nursing studies using focused ethnography have been used to
explore illness in homeless youth (Ensign & Bell, 2004), investigate health in
immigrant adolescents (Garcia & Saewyc, 2007), report the experiences of
community mental health nurses (Spiers & Wood, 2010) and to examine the
experiences of a rare chronic health condition, lymphangioleiomyomatosis (Haylen
& Fisher, 2014).
Given its ability to provide a comprehensive holistic examination of the subjective
life experience, the life history method was chosen as the most appropriate design for
this study, for the purpose of identifying important themes experienced by individual
PwRRMS, which may also be experienced by their peers (Field & Morse, 1985). A
great advantage of life history it that it retains the whole individual story and locates
it in a wider social, cultural and historical moment (Plummer, 2001). Life history
allows the exploration of experience over time in the context of the whole life,
including both the individual social context and the broader historical context. Life
history examines events and how they impact individuals and their life trajectory,
revealing turning points, epiphanies and transformations that may occur over the
course of the life living with disease (Haylen & Fisher, 2014). It also provides a way
of understanding the meaning of illness and how this meaning might change over
time.

Conceptualising life history in this study
The life history can be seen as a journey towards an inner quest for self, as part of a
composed life or creation and allowing voices to be heard (Plummer, 2001). As
suggested by de Chesnay and Fisher (2014), the purpose of the life history approach
in the current study was to collect a focused history around a disease (RRMS), to
document the story of each participant, but being careful not to frame this within a
broader ethnography of all people living with RRMS. The life history methodology
reflected the cultural and social contexts of each participant, allowed them to
approach their life history in any way they chose, not necessarily in chronological
order or centred only on their RRMS diagnosis. Interestingly, many participants
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talked of other events in their lives being just as pivotal or more so, than their RRMS
illness diagnosis.
In life history, the researcher and the participant come together as collaborators,
composing and constructing a story (Atkinson, 1998), consistent with the ontology
and epistemology of the study. A good relationship between the researcher and study
participant is important and life history involves establishing a close relationship
between the two (Plummer, 2001). Figure 1 is based primarily on the work of
Plummer (2001, p.44), but also includes influences from Blumer (1969) and Tierney
(1994). This illustration acts as a conceptual model to explain the relationships
between the life history construction, the researcher and participant, what is
unknown, what is knowable and the very important role of context. Contextual
consideration is essential to enable readers of the research to assess for transparency,
credibility, trustworthiness and transferability, by providing the detail required to
ascertain how and why the research may be applicable to their own particular context
or situation.
.
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Figure 1. Conceptual model highlighting the relationships between the life history
construction, the researcher and participant, what is unknown, what is knowable and
the role of context

Motivations in life history
The purpose of using this methodology was to gain insights into the world of living
with RRMS that could ultimately enhance knowledge in this area for MS Nurses and
other HCPs, and thereby to potentially improve consultations, disease management
and understanding. I was also clear that my motivation was part of the wider picture
of gaining a higher degree in the process, although I was confident in myself that this
was a secondary motivation. I ensured the study participants were provided with a
clear discussion regarding my motivation in seeking out PwRRMS and the life
history method in particular.
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What motivated the study participants to be involved in the research? Allport (1942)
suggests that there are many reasons why people volunteer to be the subject of a life
history, and these include the factors already discussed, as well as self-justification, a
desire for order, relief from tension, filling in one’s life and as a form of confession.
Others have reported the benefits of telling stories as being cathartic (Pennebaker,
2000) or to attribute praise or place blame (Holloway & Freshwater, 2007b). It has
also been suggested that there could even be improvements in physical and mental
health after emotions and experiences are made into stories; a result of helping the
participant to feel visible (Pennebaker, 2000). I often wondered why the study
participants agreed to be part of the research, to be interviewed, to think about their
life and to give up their time to a stranger. Several participants openly disclosed their
own motivations to volunteer for the research; these included wanting to help others
(altruism), wanting to further research in MS specifically, as a form of therapeutic
encounter and some participants simply wanted to talk to someone who was
interested in their story. All study participants told me after the interviews that they
had found the experience of telling their life history valuable, helpful and a positive
experience.

Methods
“Everything has the potential to be data, but nothing becomes data without
the intervention of a researcher that takes note - and often makes note - of
some things at the exclusion of others”. Wolcott, 1994, p 3-4.
Methods in qualitative research are techniques and procedures used in collecting and
interpreting data about social settings (Miller & Dingwall, 1997). Sometimes
methods are recommended within a qualitative methodology as part as the intrinsic
framework of that methodology (which is the case for both grounded theory and
interpretative phenomenological analysis), with guidelines to follow for data
collection and data analysis (Braun & Clarke, 2013). However, ethnography
methodology allows for flexibility in method selection and it was up to me as the
researcher, to design a framework for the methods that would meet the goals of the
study and adequately answer the research question. To guide this process, I followed
a conceptual model from Carter and Little (2007), which outlined the relationships
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between methodology and method and the connection they both had to the
epistemology of the study. It was a model where I had to consider if the
epistemology of life history (as the methodology) would meet the study objectives,
and thereby justify the methods chosen to produce knowledge. Having already
identified the congruence between the study methodology and epistemology in the
previous section, the influence of epistemology on the various study methods will
also be discussed.
The current study utilised several different methods that were employed at separate
stages of the research process and these are discussed as they occurred
chronologically in the research design; firstly sampling and recruitment methods,
followed by data collection methods, data management methods and the methods of
data analysis.
Methods: Sampling
The sample
Purposive sampling guided recruitment for the current study, targeting people living
with RRMS. Participants were deliberately selected to serve the task of a specific
research intention (Morse, 2012). This approach was congruent with the
epistemological position of the study, seeking to gain insights directly from people
living with RRMS and co-construct knowledge.
The purposive sample was supported by inclusion criteria to ensure that potential
study participants met a pre-defined measure to enable fair recruitment and that they
were in a position to be able to answer the research question within the Human
Research Ethics Committee (HREC) approval for the study.
Inclusion criteria:
•

Diagnosed by a physician with RRMS

•

Aged 18 years or over

•

Able to speak and understand English

•

Ambulant (be able to walk unassisted)
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The criteria of being formally diagnosed with RRMS by a physician was to ensure
authenticity of their life experience in terms of living with RRMS and not from
another disease. The age of 18 years was in line with the HREC approval for adults
in this particular study, and not for the paediatric (under 18 years) population. This
was primarily because I wanted to explore the life history of living with RRMS over
some years and I felt that the purposive sample inclusion criteria of being over 18
years would achieve this.
Reluctantly, I was only able to interview in the English language. I have respect for
all cultures, and including people from a non-English speaking background would
have added considerable depth to the study. As the interviews were conversation
based and up to three hours in length, I simply did not have the financial support to
allow for the considerable expense of interpreters or for translation services. This
remains a goal for future research. The criterion to be ambulant was to capture the
essence of RRMS. I felt that if a potential participant was wheelchair bound that
there may be elements of SPMS from gradual progression of the disease and
therefore a different diagnosis. Whilst I was mindful of the importance of life
experiences for all PwMS, I wished to fully capture all of the other experiences of
RRMS as much as possible and concentrate on one disease classification. Hopefully,
exploring the life experiences of SPMS/PPMS may also be the subject of post
graduate work.
Recruitment
People living with RRMS were recruited to take part in the study through the local
state MS Australia (MSA) office, branch of NSW. A copy of the HREC approval for
the study (Appendix 1) and flyers briefly explaining the study (Appendix 2) were
provided to the State Manager of MSA. They were displayed in the Sydney offices
where people living with RRMS were attending the gymnasium, and were also sent
internally to regional staff of MSA by email for distribution locally.
A total of 14 expressions of interest were received over a period of ten months from
March 2016 until January 2017. After making initial enquiries into exactly what the
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study entailed, 13 PwRRMS agreed to be interviewed. One person making an
enquiry about the study declined to take part after a brief telephone call and
discussion, but did not provide a reason. Enquiries about the study filtered in slowly
and consistently over this time, and I did not need to re-advertise again for
volunteers. Most participants became aware of the study through the MSA network,
but one participant was the result of the snow-balling technique (becoming aware of
the study through someone else who had already taken part in the study), one
participant heard of the study through a contact at the university I am studying at and
four participants were alerted to the study by their MS HCP who directed them to the
MSA flyer.
I was hopeful to attract participants with diverse characteristics to enhance my depth
of understanding of the phenomena. I identified these characteristics as including
both sexes, employed and unemployed, married/unmarried, parents/childless,
rural/city based, newly diagnosed/long term diagnosed and also varying levels of
disability. I was fortunate to be able to interview all volunteers and to be able to
cover all of these characteristics comprehensively. This happened organically.
The study sample size was not initially stipulated in the study design, it was
estimated that between 10 and 20 participants would be ideal. However, that number
would depend on the amount and quality of data generated from the interviews,
which was not known at the commencement of the study (this will be discussed in
detail later in this chapter under study rigour). In conjunction with my study
Supervisors, it was decided at each monthly meeting if interviews should continue.
Once 13 participants had been enrolled, interviews performed and transcriptions
completed, it was apparent that there was a considerable amount of data and it was
felt that coding should commence before more participants were recruited and the
situation reassessed again. However, further recruitment was deemed unnecessary
after data coding due to the overwhelming amount of information and codes
developed from the 13 interviews and transcripts. I felt that recruiting more
participants would have lessened my ability to engage so deeply with the data and to
understand the complexities of the data within the time frame of the study
(Onwuegbuzie & Leech, 2005). The data was so detailed and plentiful that complete
data analysis took just over a year working on the study as a full time student. I also
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began to notice recurring themes across the study interviews from an early stage,
increasing my confidence in the sample number being adequate.
Enrolled Sample
The demographics of the study participants (n=13) enrolled in the study are outlined
in Table 2. The first person enrolled into the study was interviewed on the 14th of
April 2016 and the last interview took place on the 31st of March 2017.
Table 1: Study demographics for enrolled study participants.
Study

Pseudonym

M/F

number

Age

at

interview

Marital

Years

status

since

Parent

Working

RRMS
diagnosis

01

Piper

F

38

m

2

✓

p/t

02

Margot

F

57

m

16

✓

r

03

Kate

F

46

m

24

✓

u

04

Rudi

F

40

m

4

✓

p/t

05

Joy

F

57

d

12

✓

f/t

06

Jane

F

42

s

10

✗

p/t

07

Paul

M

38

m

2

✓

f/t

08

Ruby

F

36

m

4

✓

f/t

09

Will

M

32

m

4

✓

f/t

10

Griff

M

62

m

10

✓

u

11

Susan

F

40

m

14

✓

p/t

12

Davina

F

54

m

32

✓

f/t

13

Evie

F

39

s

20

✗

f/t

Note: F = female, M = male, age is in years, m = married, d = divorced, s = single,
p/t = employed part-time, f/t = employed full time, r = retired, u = unemployed, ✓=
yes , ✗= no
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Methods: Data Collection
Semi-structured life history interviews
The qualitative interview is a construction site for knowledge (Kvale & Brinkmann,
2007) and forms the basis of the constructivist epistemological foundation for this
study in relation to the chosen method of data collection. Semi-structured interviews
were the chosen data collection method, performed in person and individually, with
just the researcher and study participant present. A semi-structured interview has the
purpose of obtaining descriptions of the life world of the participant with respect to
interpreting the meaning of the described phenomena (Kvale & Brinkmann, 2007),
making it especially suited to life history research. Semi-structured interviews have
some pre-defined questions built-in to the interview, but the researcher is also
permitted to probe further and ask additional questions as the participant responds,
often leading to the collection of powerful data in the form of insights, experiences
and perceptions (Peters & Halcomb, 2015). Semi-structured interviews are also
unique among interview methods for the relevancy they provide a topic, whilst
remaining responsive to the participant (Bartholomew, Henderson, & Marcia, 2000).
At the commencement of the interview, participants were provided with a verbal
overview of the study, outlining my background and the study aims. I then asked
each participant to tell their life history, in any order they wished, and covering
anything they wished to, with particular thought to the question “What is the
experience of living with RRMS?”. This approach ensured the information I gathered
was consistent, rich and participant centred.
Although predominately unstructured in nature, I categorized the interviews as semistructured for two reasons. Firstly, I provided reflection questions to study
participants which gave some direction to the information I was seeking. Secondly,
because the RRMS component of the research question gave direction about the
topic I wished to explore in relation to their life history. The reflection questions
were based on suggestions from Gubrium (1993) and Atkinson (1998) on key topics
to guide life history and life stories (see Appendix 3) and were provided to
participants by email approximately a week prior to the interviews. This process, as
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suggested by Patching and Lawler (2009), allowed the participants to see the style
and depth of the information required, as well as providing adequate time for
consideration. The reflection questions served as a general framework for eliciting
data about the participants lives, cultural background and the events around their
diagnosis of, and living with, RRMS. Participants were instructed that they could use
the reflection questions to think about their life, that they could use some of the
questions, or they could to elect not to use these reflection questions at all. The
majority of participants used the reflection questions only as a starting point for
thoughts and did not refer to them during the interview or bring them to the
interview. One participant chose not to look at the reflection questions at all,
preferring to tell his life story with no prompters.
Considering other data collection methods
One on one interviews were deemed to be a better fit to answer the research question
than surveys, which do not allow for extensive exploration. They were also
preferable to focus groups where participants may have felt inhibited to talk
truthfully about their experiences in front of others. Focus groups in a permissive and
comfortable environment can prove to be greatly beneficial for encouraging data
generation with support from others in similar situations (Krueger & Casey, 2015).
As I was clear that I wanted to understand each life history in considerable depth, I
felt that a one on one interview would support this aim. Telephone or video
interviews were also considered, but I felt that these might lack personal connection
and rapport, which may have proven important to uncover sensitive parts of the life
history. As will be discussed in the study findings, at times it was my observation of
the study participant which added considerable depth to the story when witnessing
physical reactions recalling emotions such as distress or joy. I was able to explore
these emotions further, an opportunity that may have been missed entirely with
telephone interviews.
Preparing for the interviews
As a registered nurse with over 30 years experience, I had developed a repertoire of
interviewing skills, particularly as a clinical consultant in the last 20 years
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performing solo consultations with patients in clinics. However, as part of my
reflexive position (to be discussed in detail later in this chapter), I was aware that life
history interviewing was going to be a very different form of interviewing than I was
used to. In anticipation of this, I practiced conducting life history interviews with
several work colleagues and friends in the months prior to commencing data
collection. I refined and improved my technique considerably. This was to be an
ongoing procedure throughout the study interviews, and I reflected after each
interview in my field notes, on strategies I could use to improve for the next
interview. Safety for myself was also a consideration as I entered people’s homes to
conduct most of the interviews. I had a short checklist to ask each study participant a
series of questions by telephone prior to the interview date (see Appendix 4). In
conjunction with my Supervisors, I developed a policy whereby I would notify a
nominated Supervisor of my planned entry to an interview (in “real” time), and then
again at the end of the interview when I had left the premises (Appendix 5).
I also consulted texts and methods for interviewing tips, especially in regards to the
life history technique. Plummer (2001) recommended being aware of potential
practical difficulties, performing dress rehearsals, considering seating arrangements
(always on the same level facing each other), arriving early and being well
organized, practicing relaxation techniques and keeping a list of interesting topics for
discussion and probes should the interview come to a standstill.
Benefits of the interview techniques
One strength of the study was the lack of a formal structure in the interviews, thereby
adopting a semi-structured approach. This allowed participants to express themselves
openly and naturally and talk about their experiences as they wished, rather than
using pre-determined questions. The personal interaction within the unfolding of
stories and new insights were rewarding for both myself as the researcher, and the
participant as the story teller, consistent with the thoughts of others (Atkinson, 1998;
Plummer, 2001; Kvale & Brinkmann, 2007).

89

Methods: Data management
Good organisation and a systematic management of the data was key for later
analytical thoroughness in the study (Tuckett, 2005). There was an overwhelming
amount of data from the verbatim transcripts and also from the coding process, but
every step of this lengthy process was viewed as an opportunity to further interpret
the story on a deeper level. Core files of all data in unedited form were arranged in
chronological order electronically and several hard copy transcripts were kept for
different purposes; “noticings”, coding, story excerpts and quotes, as recommended
by Plummer (2001).
Transcriptions
Interviews were recorded using two audio recorders, a primary recorder was used to
transcribe the interviews while the second recorder was used as a secondary back up
in case of battery failure during the interviews (which occurred in one interview, the
first one performed). Interviews were then transcribed by myself verbatim as part of
total immersion in and familiarisation with the data, as recommended by Braun &
Clarke (2006, 2013). All interviews were transcribed completely within a week of
the interview to retain as much detail as possible. I was able to engage deeply with
the data and begin initial data analysis at an early stage.
Interviews were transcribed into a Word document in a half page vertical format with
the writing on the left side so that “noticings” and “coding” could be applied on the
right side of the page during the data analysis phase (these terms will be discussed in
the next section). Line numbers were also added on the left side of each page for
easy identification of quotes and location of important ideas during the findings and
discussion section of the thesis. All observational data relevant to the interview, such
as non-verbal behaviour I had noted (crying, tearful, expressions of joy) were
inserted into the transcript as suggested by Miles and Huberman (1994), and
pauses/times of silence were also noted. I often found these meaningful in
interpretation, e.g. long pauses could alert me to intense consideration of the question
and a particularly intense and meaningful answer.
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An electronic copy of each interview was stored on a password-protected computer
under a study number and pseudonym for each study participant, and also stored on a
secure digital card (SD card) as a separate file. Following the transcriptions, each
interview was listened to several times whilst reading the transcript to ensure
accuracy of the transcript and to decipher words that may have been difficult to hear
or misheard on the earlier transcription.
Field Notes
Field notes are writing up observations and comments on impressions and
descriptions of participants and the study process after the interviews (Tuckett,
2005). I looked on these observations as an early method of data analysis. I took field
notes as soon as possible after the interview (usually immediately) making it part of
my personal debriefing ritual after I had left the interview. Field notes also helped
me to remember details later in the analytical process and effectively took me back to
the scene of the interview, which I often found extremely helpful to remember details
specific to that particular participant. For example, what they were wearing and the
setting of the interview that then helped me recall the meaning and emotions related
to their facial expressions and other non-verbal behaviour. I closely observed the
participants during the study interviews not just for non-verbal behaviour in general
(laughing, crying, anger for example), but also specifically for signs of fatigue, and
we took breaks when necessary. Field notes on each study participant detailed
objective and subjective features of the interview as discussed, but also my thoughts,
interpretations and advice to myself for future data collections. An example of the
information collated in the field notes is shown in Appendix 6.
Data security
Using electronic technology both with data collection methods and in transcription, I
needed to be mindful to prevent compromising participant confidentiality with lapses
in data security. As suggested by Barnhill & Barnhill (2014), I maintained computer
security on all hard drives, I used strong passwords on computers and devices, I used
firewalls in hard and software, I avoided open networks and I disposed of deleted
soft copy and hard copy information appropriately. This was in addition to using
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participant numbers and pseudonyms instead of real names and also carefully
removing potential identifiers from the transcripts.

Methods: Data Analysis
The life history aims to document a person’s life (or significant part thereof) as a
narrative, telling a representation of a story (Plummer, 2001). The participant
constructs the history, but as Denzin (1989) suggests, it is up to the researcher to
interpret and reconstruct the account into a story, which then provides understanding
and perspective of the experience (de Chesnay & Fisher, 2014). The analytic process
in the qualitative paradigm is all about moving from “pieces to patterns” (Thorne,
2008). It involves assembling or reconstructing the data into a meaningful fashion, in
a way that is transparent, rigourous and thorough, whilst remaining true to the
accounts of the participants (Smith & Noble, 2014). Several methodologies (such as
interpretative phenomenological analysis and grounded theory) dictate specific and
detailed methods of data analysis as part of their process, however this is not the case
for focused ethnography and the life history. I found the freedom to choose from a
variety of methods of data analysis a welcome component of the study design.
Data analysis is an interactive process where data is systematically searched and
analysed in order to provide a description of phenomena (Smith & Noble, 2014). An
important factor for any researcher to consider when determining the qualitative
methodology or method to apply to their research design is what will be the best fit to
answer the research questions. Having (what I saw as) the great benefit of no
overarching methodology attached to focused ethnography/life history dictating the
methods for data analysis in the current study, I was able to consider many possible
methods of data analysis and apply them directly to the research question and goals. I
was certain that I wished to use a robust and systematic method for data analysis, the
idea that themes and patterns would simply “emerge” from the data after reading and
re-reading transcripts (Morse, 2012) did not sit well with me, I needed guidance and
a solid framework to ensure the data analysis was the most robust it could be. When
examining the fundamental aims for answering the research question, “What is the
experience of living with RRMS?” the analytic framework of thematic analysis, as
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described by Braun & Clarke (2006, 2013), stood out as an excellent candidate.
Thematic analysis involves looking for patterns in participant experiences across an
entire dataset and has the capability I required in terms of being both robust and
organised.

Considering the best method of data analysis for this study
There are many types of data analysis, and some are directly linked with an
overarching methodology and are an essential part of that framework, such as those
used in grounded theory and interpretative phenomenological analysis (Braun &
Clarke, 2013). Other analytic methods such as content analysis and thematic analysis
consider themes and patterns in data, and although often used interchangeably, there
are important differences.

Content analysis and thematic analysis can be more

suitable for studies employing a lower level of interpretation compared to grounded
theory and interpretative phenomenological analysis, which require a higher level of
interpretation (Vaismoradi, Turunen, & Bondas, 2013), however thematic analysis in
the current study was employed for a high level of interpretation. Alternative forms
of data analysis such as narrative analysis and discourse analysis concentrate more
on how things are said in data collection, rather than what is said and therefore were
not suitable for the purpose of this study. The relative merits and drawbacks of
employing these methods of analysis in the current research study will be discussed
in further detail.

Comparing thematic analysis against other methods of data analysis
As briefly discussed, other forms of data analysis were explored before concluding
that thematic analysis was the “best fit” for this research study. As discourse analysis
and narrative analysis concentrate more on how things are said and the style and
linguistics of words rather than what was said, they were eliminated early in the
exploration of data analysis methods. However, there are shared elements of data
analysis between the methods of interpretative phenomenological analysis, grounded
theory, content analysis and thematic analysis that could have made those approaches
a consideration for the current study. These will be briefly compared and discussed,
and the use of thematic analysis justified.
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Interpretive Phenomenological Analysis
There are some important differences between interpretative phenomenological
analysis and thematic analysis, but the end result can look very similar (Braun &
Clarke, 2013). Both interpretative phenomenological analysis and thematic analysis
as qualitative methods of data analysis are particularly useful to answer research
questions about the lived experience of people and their viewpoints and outlooks on
life (Smith, Flowers, & Larkin, 2008). Thematic analysis has been referred to as a
phenomenological method (Guest, MacQueen, & Namey, 2012) however Braun and
Clarke (2013) identify thematic analysis as just an analytic method rather an overall
methodology. Identifying interpretative phenomenological analysis as a methodology
means that the overall study design is already specified as part of the ontological and
epistemological foundations for interpretative phenomenological analysis, being
critical realist and contextual in nature and based on the theory of phenomenology
(Larkin, Watts, & Clifton, 2006).
Interpretative phenomenological analysis also targets a small homogenous sample,
which would not be appropriate for this particular study exploring a heterogeneous
disease such as MS, where there can be a wide variance of experience, with no two
people experiencing the same course of the disease. A key difference is that in using
interpretative phenomenological analysis the researcher codes the first data item then
progresses to developing themes for that data item, rather than coding across the
entire dataset, and then progressing to theme development as occurs in thematic
analysis (Braun & Clarke, 2013). Overall, interpretative phenomenological analysis
procedures focus on the unique characteristics of each individual participant,
specifying coding and theme development along the way for each data item. This
differs from the procedures of thematic analysis where the researcher identifies
patterns across the entire dataset. I wanted to understand the meaning of living with
RRMS across all of the participants, both individually and as a group, and in order to
do so, thematic analysis provided a better “fit” than interpretative phenomenological
analysis.
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Grounded Theory
Grounded theory is a research methodology which discovers patterns and generates
theory from data using a process of constant comparison (Braun & Clarke, 2013).
Grounded theory was developed in the 1960s (Glaser, 1965; Glaser & Strauss, 1967)
and was one of the first endeavours to develop a systematic method for analysing
qualitative data. Currently there are now many versions of grounded theory, each
with distinctive theoretical underpinnings and procedures. A key difference between
grounded theory and thematic analysis is that grounded theory is a whole
methodology, not just a method. As with interpretative phenomenological analysis,
grounded theory comes with its own theoretical framework and ontological and
epistemological position, and advocates the use of particular types of research
questions with a focus on social processes or the factors that influence a particular
phenomenon (Braun & Clarke, 2013).
Grounded theory differs from other manifestations of qualitative research in that the
emphasis is on the theory as a product of analysis (Charmaz, 2006), unlike thematic
analysis, which does not attempt to develop a theory (Braun & Clarke, 2013). As
theory generation was not the aim of the current research study, grounded theory was
not pursued as a viable option for data analysis.
Another point of difference between grounded theory and thematic analysis involves
engagement with the literature. A common practice in grounded theory methodology
is to not engage with the relevant literature prior to beginning data analysis, to avoid
the analysis being shaped by preconceptions from existing research. As part of the
preparation for identifying exactly where the significant gaps were in understanding
the experiences of people living with RRMS, the topic was thoroughly researched
over many years in advance prior to the final study design. Additionally, as reading
the relevant clinical and research literature as it is published in MS is part of the
expected clinical, educational and research role I was working in at the time of the
study commencing, “not engaging” with the relevant literature was impossible. Due
to these overwhelming factors, grounded theory was not going to be harmonious
with this particular data analysis.
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Content Analysis
The terms content analysis and thematic analysis have often been used
interchangeably to refer to very similar approaches to qualitative data analysis,
further confused by the fact that the boundaries between the two methods have not
been clearly specified (Braun & Clarke, 2013; Vaismoradi et al., 2013). Content
analysis is a general term used to describe a number of different strategies to analyse
the subject matter of data (Powers & Knapp, 2006) and uses a systematic coding and
categorizing approach to determine trends and patterns of words used by the
participants during during their interview, often in a large volume of text
(Vaismoradi et al., 2013). This may involve looking at frequency of words, and the
relationships between words (Grbich, 2007). The purpose of content analysis is to
summarise quantitative messages (Neuendorf, 2002), whereas thematic analysis aims
to identify, analyse and report patterns within the data (Braun & Clarke, 2006). The
purpose of this research is the latter, rendering thematic analysis a stronger and more
appropriate choice than content analysis for this particular study.

Choosing thematic analysis
After careful consideration of the methodologies/methods for data analysis described
above, I chose thematic analysis to be the most congruent with my research
ontology,

epistemology,

with

the

overarching

methodology

of

focused

ethnography/life history and with the other research methods chosen for sampling,
data collection and data management. The various components of the research design
fit together well to provide a robust framework for operationalising the study and
meeting the study goals. Another form of data analysis, poetical analysis, was also
used in this study, although in a very minor capacity. Poetical analysis was used to
enhance the study findings from the thematic analysis and will also be discussed at
the end of this section.
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Method of Data Analysis 1: Thematic Analysis
The following section will briefly describe the historical development of the thematic
analysis method, explore thematic analysis in more detail and outline how it differs
from other methods of qualitative data analysis. An in-depth exploration of thematic
analysis, as suggested by Braun and Clarke (2006, 2013) will demonstrate why this
method of data analysis is congruent with the aims and goals of this research study
and will also provide an overview of the framework used to guide data analysis.
Thematic analysis involves the search for common principles that extend through an
entire dataset (DeSantis & Ugarriza, 2000). It is a method for identifying, analysing
and reporting patterns or themes within a dataset, ultimately organising and
describing the data in rich detail (Boyatzis, 1998; Braun & Clarke, 2006). Searching
for patterns and themes is a common method in data analysis in general, and several
methodologies in qualitative research (such as interpretative phenomenological
analysis and grounded theory) actually use forms of thematic analysis as an
important and basic part of their framework. However, fundamentally thematic
analysis differs from other analytic methods seeking to describe patterns in
qualitative data as it is not bound to any one type of theory or methodology, it is
simply a method of data analysis (Braun & Clarke, 2013). This leaves the researcher
free to choose their own ontological and epistemological framework and data
collection method, improving flexibility in answering research questions in the best
possible way.
As an adaptable method, thematic analysis can be approached in a number of
different ways, and several of these are specifically aligned with the aims of this
research study. Thematic analysis can be inductive, the data are examined from the
“bottom up” and coding and theme development are directed by the content of the
data. This approach is integral to answering the research question in the current
study, exploring and finding meaning in the experiences of people living with RRMS
from the those considered the experts when performing qualitative research - the
participants themselves (Windle, 2011). This study is not based on any predetermined theories, but will be shaped by the experiences of the individual
participants and the group as a whole, from the emic perspective, which is also
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congruent with thematic analysis. Moreover, thematic analysis can be semantic,
deriving codes and themes from the precise, explicit content of the data, or more
latent, reporting concepts and assumptions underpinning the data and interpreting the
data at a deeper level. This is consistent with one of the aims of this research study,
to provide both semantic and latent analysis of the themes and provide interpretations
on how these themes may be important.
Congruence between methodology and analytic method
Thematic analysis can be a method to reflect reality and to “unpick” the surface of
reality (Braun & Clarke, 2006), making it ideal for this research study seeking
insights into the experience of people living with RRMS in the real world. Thematic
analysis allows examination of the data within a relativist approach, focusing on
reporting an assumed reality, but is also able to look at the data in a constructionist
fashion (Braun & Clarke, 2006). This is congruent with the ontology (constructivist,
relativist) and epistemology (constructivist) for the current study where the
researcher and participant will co-create the data and the researcher will provide
latent and abstract explanations from the data. Additionally, the researcher is able to
determine the level of analysis and choose how to present the data in a way that is
accessible to others interested in the field of study (Braun & Clarke, 2013). As an
important goal of the research is to disseminate the information gained from the
study across as many health professional domains of MS as possible, thematic
analysis supports this approach.

The thematic analysis method as presented by Braun and Clarke (2006, 2013) suits
the research question, fits the exploratory topic, allows choice of ontological and
epistemological viewpoints, aligns with the data collection method, allows the
researcher to grow and develop as experience is gained with the method, allows
focus on the context of the research question, is robust and systematic, and allows
both latent and semantic interpretation of study data. This is an ideal match for this
research study and promotes congruence between ontology, epistemology,
methodology and method, essential components of successful qualitative research
(Carter & Little, 2007).
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The history of thematic analysis
Thematic analysis was first named as a method by Gerald Holton in the 1970’s
(Merton, 1975). Initially thematic analysis was described in very simple terms only
(Leininger, 1985) with little guidance provided in terms of process to actually
perform the thematic analysis and no clear agreement about what the method entailed
(Attride-Stirling, 2001). In particular, researchers often described themes “emerging”
or being “discovered” from the data (Braun & Clarke, 2013; Ely, Vinz, Downing, &
Anzul, 1997) providing very little in terms of process, transparency and confidence
to the reader. This has been described as a passive account of the process when the
process of analysis is very active and engaging and needs a clear description to
enable others to evaluate the integrity of the data analysis and to understand the
process (Braun & Clarke, 2006).

Frustrated by a lack of processes underpinning thematic analysis and poor
demarcation of the method, Braun and Clarke (2006) outlined the theory, application
and evaluation of their version of thematic analysis to the psychology community.
Over the last decade, thematic analysis has grown to encompass many disciplines of
health research with the “in psychology” reference to the method now largely
disregarded (Braun & Clarke, 2013). However, some factors in the data analysis
technique have remained in common with original descriptions (Merton, 1975;
Aronson, 1995; Boyatzis, 1998) but with differing methodological paradigms and
subtle analytic departures.

Several other authors have also described and explored thematic analysis as an
analytical method (Boyatzis, 1998; Joffe & Yardley, 2004; Guest et al., 2012). The
main difference between these method versions and the Braun and Clarke (2006)
method of thematic analysis is that the former all promote the development of coding
frames within the method, to enable multiple researchers with different expertise and
perspectives, to code the same data in order to improve inter-rater reliability. This
was identified early as being challenging when applied to this research study, as I
brought to the study my own assumptions and beliefs about RRMS (based on many
years of working in the specialty) consistent with the stated epistemology and my
reflexive stance. Invariably applying this experience to the codes and later themes
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would differ from those that others might determine from the same data. As coding is
an active and reflexive process that inevitably and inescapably bears the mark of the
researcher, with no one ‘accurate’ way to code data, the logic behind inter-rater
reliability disappears (Braun & Clarke, 2006). Braun and Clarke (2013) further argue
that inter-rater reliability scores can be viewed as two researchers being trained to
code data in the same way, rather than that their coding being accurate (Braun &
Clarke, 2013). As this study was only to be coded and themes developed by myself
as the principal researcher, the Braun and Clarke method (2006, 2013) of thematic
analysis was the preferred choice.

In summary, thematic analysis has gained more popularity as a method of data
analysis in recent years, particularly since Braun and Clarke (2006) have detailed and
described this qualitative data analysis method and made it more accessible for
researchers. It is one of a group of methods that focus on identifying patterns across a
dataset and is now anchored firmly as a flexible, robust, systematic framework
suitable for many types of qualitative research (Braun, Clarke, & Terry, 2014). The
specific method of thematic analysis based on Braun and Clarke (2006, 2013)
teachings will now be discussed and explored in further detail.

An overview of the Braun and Clarke (2006, 2013) method of thematic analysis
The Braun and Clarke (2006, 2013) method of thematic analysis involves key stages,
following directly on from each other: transcription, reading and familiarisation of
the data, coding, searching for themes, reviewing themes, producing a ‘thematic
map’, defining/naming themes and writing up the research. The major elements of
the Braun and Clarke (2006, 2013) process of thematic analysis are outlined below.

1: Familiarisation with the data

This phase involves reading and re-reading the transcribed interviews, to become
immersed and intimately familiar with the content. Transcribing the interviews
personally can be an excellent way to start familiarising the researcher with the data
(Riessman, 1990) but is not essential to the method. I elected to transcribe the
interviews myself to promote deep engagement and connection with the data from
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the earliest stage.

Familiarising with the data is an active process, pondering repeatedly about what the
data could mean. In this research study, I would also go back and re-listen to the
original audiotapes regularly. Hearing participant voices helped formulate a
recreation of the interview to visualise facial expressions and other non-verbal cues,
enhancing recall of the emotional aspects of the interview. As the method is
recursive, the opportunity remains for the researcher to come back to this phase
repeatedly as needed and perhaps identify new insights further in the process. I found
this extremely helpful throughout the data analysis.

Immersing in the data and getting to know the words and feelings of the participants
opens up areas of interest for the researcher, helping to notice things that might be
important to answering the research question. Braun and Clarke (2006), term these
thoughts as “noticings” and an important first step in engaging and analysing the
data. At this early stage it is not a systematic and precise procedure, just more similar
to first impressions of the data.

2. Generating initial codes:

The second phase involves generating succinct labels called “codes” which identify
important features of the data that might be relevant to answering the research
question. Codes identify a feature of the data at it’s most “basic segment” (Boyatzis,
1998). Coding may be semantic (explicit) or more latent (hidden and awaiting
development) in nature. The researcher codes the entire dataset, working
systematically and giving full and equal attention to each data item identifying
interesting aspects that may form the basis of later themes. Coding should be
performed widely and thoroughly and be constantly mindful of context.

3. Searching for themes:

The focus of the analysis now shifts to examining the codes and collated data to
identify significant patterns of meaning, the broader level of developing themes.
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Potential themes, known as “candidate” themes are developed and data related to
each theme is collated to examine and support the viability of the candidate themes.
4. Reviewing themes:

This phase involves checking the candidate themes against the dataset, to determine
if they tell a convincing story of the data, and a story that answers the research
question. At this stage, themes develop and are refined, which sometimes involves
themes being split into sub-themes to further clarify meaning, being combined with
other themes, or being discarded altogether. A key component of the phase is
developing a detailed analysis of each theme, working out the scope and focus of
each theme; determining the ‘story’ of each theme individually.

5. Defining and naming themes:
The key feature of this phase is determining that each theme has a central organizing
concept to securely and confidently anchor the theme in the dataset. A central
organizing concept is the essence of a theme and is critical to sound theme
development. Capturing something important about the data, the central organising
concept unifies the data extracts and is essential for demonstrating coherence of a
theme (Braun & Clarke, 2013). Each theme presented in the study findings will be
introduced with a short discussion of the central organizing concept and how it unites
the theme and subthemes, and how it is meaningful to answering the research
question. A name for each theme is developed, ideally being both informative and
succinct.
A thematic map of the data, capturing the “essence” of what each theme is about and
demonstrating links between the themes often assists this phase of the analysis.
Constant reference to data extracts by the researcher helps to organise the data into a
coherent and internally consistent account. Sub-themes are assigned if they are
needed to give structure to the dataset and also reveal the hierarchy of meaning
within the data. A sub theme can be a less prominent theme that exists under an
umbrella theme, or it may be an important feature of the stand-alone theme. By the
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end of this stage, themes should be clearly defined and concise, demonstrating that
the researcher has a clear sense of what the theme is about and have a clear, defined
central organizing concept.

6. Producing the report

The final phase of the Braun and Clarke (2006) method of thematic analysis involves
weaving together the analytic narrative from the participant, and contextualising the
analysis in relation to existing literature. Data extracts are embedded in the analytic
narrative to illustrate the story of the data and to go beyond a simple description of
the setting and instead comprehensively answer the research question.
Although these phases are sequential, and each builds on the previous, Braun and
Clarke (2006, 2013) emphasise that thematic analysis is typically a recursive process,
with movement back and forth between different phases. In fact, some of the phases
can often blur together, rather than having clear lines of separation, as the researcher
moves around the data and explores different labels and themes. The process of
thematic analysis can be time consuming, laborious and requires intensive effort
(Guest et al., 2012). Additionally, the researcher needs to rely on their own opinions
and develop their own understanding of the values and assumptions of different
research paradigms and their own subjective positioning within those methods to
ensure rigour in their findings (Braun & Clarke, 2013).
Intensive review of each component of the Braun & Clarke (2006, 2013) method of
thematic analysis
The coding process
A code is a textual description of the semantic boundaries of a theme and is a short,
descriptive mnemonic from the data (Guest et al., 2012). Coding is the process of
identifying aspects of the data, which directly relate to the research question (Braun
& Clarke, 2013) and is an important process to start early sense-making of the data
(Averill, 2014). The coding process involves the researcher seeing important
characteristics in the data and encoding it before interpretation begins, so that the
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data is organised and reduced before developing themes (Boyatzis, 1998). Coding
provides logical data organisation to form the basis for later data analysis (Miles &
Huberman, 1994).

A fundamental step of all coding is to verify the applicability of the code to the raw
information (Boyatzis, 1998). A researcher should be able to take away the unedited
data from the codes and still be able to evoke the feeling of the data (Clarke &
Braun, 2013). This provides an internal validity check prior to progressing to theme
development and I performed this often to ensure I could “feel” the data in the code
and that it was still appropriate when separated from the original participant
transcript. In the current study, working through the stages of code development
allowed ideas about candidate themes to slowly develop, sometimes days and weeks
after the first coding exercise.
Coding is an important and integral step for most forms of qualitative analysis and
different approaches have different labels inherent in their methodology for these
codes, often with very similar goals and meanings. Braun and Clarke (2006) consider
that there are two methods of coding practice - selective coding and complete coding.

Selective coding involves looking for instances of the topic of research interest and
purposefully selecting only those instances in order to obtain data reduction. This is
not applicable to this particular research study where there is a high degree of
inclusion to explore the research question thoroughly.

Complete coding has a much broader focus and aims to identify anything at all
within the entire dataset which may show potential to answering the research
question. For this reason complete coding is more closely aligned with this particular
research study than selective coding. All data potentially relevant to the experience
of living with RRMS was coded from the transcriptions in this study, only becoming
more selective later in the analytic process. This helped to ensure no data that may be
important was missed, especially as themes are developed later in the process. Each
code is essentially a “pithy” label (a brief, concise but meaningful label), which
captures the core or essence of the data collected (Braun & Clarke, 2013). In
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complex and data rich datasets, sometimes a second or third round of coding is
needed to further reduce the data (Saldana, 2015). In the current study, over 2,000
initial codes were identified from the transcripts in the first round of coding. A
second round of coding was required to reduce the data even further for theme
development and resulted in approximately 300 codes, after codes displaying similar
characteristics were grouped together.
The Braun and Clarke (2006) method of thematic analysis provides guidance on
complete coding which was the chosen coding method in this study. The principles
of the method require eliminating irrelevant data to answering the research question,
but still coding everything which may potentially be important, coding widely and
extensively and using data in as many ways as relevant to the research question.
Examining the collated data for similarities and grouping together like codes
occurred later in the process.

Semantic and latent codes in thematic analysis
Braun and Clarke (2013) identify semantic codes as reflecting the words and
concepts of the participants directly, they are entirely overt within the data. When the
researcher goes beyond this overt content and starts to invoke conceptual and
theoretical frameworks to identify meanings implicit in the data, latent codes are
developed (Braun & Clarke, 2013). Latent codes are developed by the researcher
based on what they “see” within the data, not based on what is “said” by the
participant directly. In general, a much deeper engagement with the data is needed
for latent coding (Braun & Clarke, 2013). An example of the development of
semantic and latent codes in the current study is shown in Appendix 7. This research
study aimed to use both semantic and latent coding in data analysis.

Developing codes into themes
Processing techniques for collating the codes to develop themes can be performed
electronically or manually. Cutting and sorting written codes and themes manually is
a common method employed by researchers and involves identifying text that appear
to fit together, placing the text into piles and moving them around until they
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represent a theme where they appear to belong (Ryan and Bernard, 2003). As with all
facets of thematic analysis this process is recursive, and may involve many steps
forward and back before an ideal match is reached. I used a manual method to group
codes together in a pile, using a different colour card for each participant code to
group like codes together to later develop candidate themes. The more colours in a
pile, the more heavily patterned the theme was. However, this colouring did not
dictate the importance of the code, it merely raised the possibility of a beginning
theme.

Manual and computer coding in thematic analysis
The term “computer-assisted qualitative data analysis software” (CAQDAS) refers to
a range of computer programs used in data analysis. The value of CAQDAS depends
on the purpose it is used for and the methodological underpinnings of the research
study. Although CAQDAS can be very effective and assist in interpretation of data
and developing theories (Silverman, 2016), it is still only a tool to assist with coding
and analysis (Braun & Clarke, 2013). No computer programs are capable of the
intellectual and conceptual processes needed to transform data into meaningful
findings (Thorne, 2000), rendering the researcher the most important instrument in
the process of developing latent or hidden, more abstract themes. CAQDAS may
prevent the researcher “immersing” in the data and may cause some detachment from
the transcriptions of the participants in this study (Braun & Clarke, 2013). If used
inappropriately, there is also the risk in coding becoming related to quantity of times
a concept is mentioned in the data and taking away from the significance of the data.

I briefly considered using a software program to assist with thematic data analysis,
but I felt that deep engagement with the study data might be compromised if I did not
manually code the data myself. I wanted to “embed” myself in the data and stay as
close to the data as possible (Munhall, 2012). I was also concerned that using
software to analyse the data thematically might remove context from the stories and
reduce the stories to categories and frequencies.
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Themes and sub-themes in thematic analysis
One of the earliest concepts of a theme was described by an anthropologist, Morris
Opler (1945):

“In every culture are found a limited number of dynamic affirmations,
called “themes” which control behaviour or stimulate activity…the term
theme… is used to denote a postulate or position, declared or
implied…which is tacitly approved or openly promoted in a society” (Opler
1945, p.198)

This work was further built upon by Spradley (1979), who described themes as:

“larger units of thought…they consist of a number of symbols linked into
meaningful relationships…Themes are assertions that have a high degree of
generality…they apply to numerous situations…some themes occur within a
restricted context” (Spradley, 1979, p.186-187)
Desantis and Ugarriza (2000) have examined many nursing research texts in an effort
to provide a uniform definition of a “theme” in the context of nursing. The concept
of “theme” was examined and explored across 27 qualitative nursing research texts
to ultimately define the concept of a theme as “an abstract entity that brings meaning
and identity to a recurrent experience and its variant manifestations” (DeSantis &
Ugarriza, 2000). A theme captures something important about the data in relation to
the research data set (Braun & Clarke, 2006) and brings together components of
ideas or experiences, which are often meaningless when viewed alone (Leininger,
1985).
How many themes compose thematic analysis?
There is no precise formula for determining the number of themes in thematic
analysis, as it depends on many other factors, including the data itself, the research
question, the length of the analytic report, and the focus of the analysis (Braun &
Clarke, 2013). Thematic analysis can range from detailed and intensive reporting of
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one theme as a focus for a research study, to a complete and wide-ranging overview
of entire and multiple datasets, with less focus on individual themes. Therefore,
dictating an ideal number of themes and subthemes to demonstrate rigour within an
analysis is impossible and is not the aim of thematic analysis.
How does a theme achieve importance in thematic analysis?
Referencing exact numbers of participants in describing theme occurrence is also a
challenge in thematic analysis, and one which Braun and Clarke (2013) address for
researchers in their recommendations. Rather than using numerical expressions to
report occurrence, they instead advocate using phrases such as “a common theme” or
“many participants commented”, and this is for several reasons. Firstly, counting
responses misses the point of qualitative research, as frequency does not necessarily
equate to the value and importance of a theme (Pyett, 2003). Ideally, a theme will
present itself a number of times across the data, however, the number of times the
theme presents itself is not indicative of the importance of the theme (Buetow, 2010).
When using unstructured or semi-structured interview method, the absence of a
theme in an interview should not be regarded as an assumption that the participant
does not experience or behold the theme as important or relevant. It may simply be
that topic did not present itself in that particular interview. As the interviews were all
flexible and interactive, different issues came up in each conversation, which were
not necessarily discussed with other participants.

In regards to the importance of a particular theme, more instances of a theme across a
dataset does not necessarily mean that one theme was more important than another,
rather researcher judgment is crucial to determine what constitutes theme
significance (Braun & Clarke, 2006). Additionally, the importance of a theme is not
dictated by the prevalence of that theme across an entire or partial dataset. Themes
will be discussed individually in the study finding chapters 6 and 7, and they will
also be discussed in terms of how they link together to explore the journey of living
with RRMS in chapter 8. This approach supports the gestalt of qualitative research
analysis, ensuring that all data is analysed and presented as completely and
thoroughly as possible.

108

Developing themes and sub-themes across the dataset
Identifying themes from coded data is entirely an active process with the researcher
examining the codes to create potential patterns (Taylor & Ussher, 2001) and finding
hidden treasure within the data (Braun & Clarke, 2013). Clarifying and making
transparent the techniques used to develop themes is important for several reasons; as
discovering themes is the basis of much social science research, it allows readers to
assess methodological choices and also promotes research communication across
disciplines and epistemological positions (Ryan & Bernard, 2003). Providing a step
by step process of theme development demonstrates transparency in the analysis and
promotes rigour in the method, as does using excerpts from the data to ensure that
data analysis remains directly and firmly linked to the words of the participants
(Fereday & Muir-Cochrane, 2006).

A sub-theme exists as a sub-category of a theme and shares the same central
organising concept as the theme, but focuses on one specific element (Braun &
Clarke, 2013). Sub-themes should generally be used in moderation, and only when
there is one particular element of a theme that has a specific focal point, or is
particularly important for the research question (Braun & Clarke, 2013).

Organising themes in thematic analysis
Collating and organising the themes and sub-themes is an integral part of the
analytical method, and requires a process in order to demonstrate rigour (Fereday &
Muir-Cochrane, 2006). There are several methods available for researchers to
organise themes and provide structure to thematic analysis, including diagrams such
as thematic networks and thematic maps.

Thematic networks are web-like illustrations that summarise the main themes of text
in thematic analysis and provide a tool to systematically present analyses (AttrideStirling, 2001). Thematic networks consist of different levels of themes, a global
theme overarches an organising theme, which overarches a basic theme to build the
overall network (Attride-Stirling, 2001). Similar to these networks are thematic
maps, which are simple drawings to reflect relationships between themes and sub-
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themes (Braun & Clarke, 2013). As a key part of the Braun and Clarke (2006)
method, thematic maps have been developed as part of the data analysis for the
current study (Braun & Clarke, 2006) and were used at every step of the analytic
process. A thematic map is essentially a visual aid, which uses a drawing to
summarise, define and name themes and sub-themes. It is simply a visual
representation of how themes and subthemes may fit together to tell the story. As the
study progressed, thematic maps changed to reflect new ways I was seeing the data
and how themes and subthemes were linking in with each other and developing a
story. I referred to the thematic maps regularly to act as a framework for the final
analysis and to demonstrate theme maturation. An example of a thematic map used
during the study data analysis is shown in Appendix 8.

Method of data analysis 2: Poetical Analysis
Poetical thinking is felt experience, being in the flow of what is being experienced
and capturing and understanding the feelings of that experience (Freeman, 2017). It
is a form of thinking that has roots in phenomenology, dealing with concepts of
experience, perception and language (Freeman, 2017). It has been suggested that
through poetry, names are given to ideas which were formerly nameless and
formless, but already felt (Lorde, 2009). By using poetry as a form of art, we can
experience moving the mind from routinely taken-for-granted assumptions towards a
sharper focus on a situation (de la Fuente, 2014).

During the data management phase of the study, I began to write the feelings I was
experiencing as poetry whilst listening to the recordings and reading the transcripts. I
began writing without explaining, just feeling the words as they flowed for each
participant. This continued in the theme maturation process of the data analysis, and
as each theme developed, I then purposely tried to capture the essence of what I was
feeling from the experiences of the study participants.

The aim of the current research study was not to pursue a poetic form of inquiry (de
la Fuente, 2014; Freeman, 2017), it was a traditional and method specific systematic
thematic analysis, but the opportunity presented itself to consider poetical analysis as
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I dealt with my own feelings and emotions of constantly re-living the interviews and
experiences of the study participants, especially through the theme development
phase. The great majority of the study findings related to the thematic analysis, but I
have strategically placed poetry (my own and others) in the thematic findings as an
important adjunct to the data analysis and as a way of connecting and adding
meaning to the data. Poetical thinking also honours my epistemological viewpoint of
the researcher and study participant co-creating the study data and findings, by
listening to the participant stories and finding methods to experience and feel the
emotions of the study participants. It was a way to intertwine their experiences, my
reactions and co-construct a new knowledge.
What differentiates poetical thinking from analytic thinking is the reach beyond
searching for meaning or knowledge, into the difficult to grasp, experiential world
(Freeman, 2017). I found the poetical thinking and the words that emerged from this
provided me with a vehicle to release profound feelings I was experiencing, listening
repeatedly to stories of suffering, of sadness and of constant battle. It was a catharsis
of sorts and I positioned the poetry at the appropriate places so that readers might
also gain an enhanced perspective of the data. In some instances, I found a better
representation of my thoughts and feelings from other poets in the literature and they
are included where appropriate. As Freeman (2017) notes, making sense of the
complex interaction between theory and practice (being there, listening, seeking
understanding) is difficult and poetry may enhance understanding as lived,
experienced and yet undefined.

In qualitative analysis there is the opportunity to enhance and enrich ideas with deep
contemplation, which cannot be expressed in other ways such as scholarly text
(Averill, 2014). I wished to convey additional meaning to the insights I was
gathering and beginning to understand during the data collection and data analysis,
and sought to find ways to complement the study themes as findings. Where I have
used the poetry written by others, it is appropriately named, otherwise the poetry is
my own work (marked as TB).
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Methods: Frameworks for the study
Theoretical framework
A framework is essentially a research map for the study, a guide to how the study
should proceed. A single theoretical framework did not underpin this study, and the
study was not linked with any particular theory. Due to the broad and multifaceted
nature of the research question, a singular theoretical perspective would not have
been possible. However, Green (2014) argues that the epistemology on which a study
is based is a theoretical framework of sorts, as it provides an overarching philosophy
for the study, a belief system and theory to guide process. In this regard I would
agree with Green (2014) and present the constructivist epistemology described
earlier in this chapter as an appropriate theoretical framework guiding the study.
Conceptual framework
A conceptual framework draws on concepts from various theories and findings to
guide the research design, identifying worldview and the ontology and epistemology
of a study. I developed a conceptual model to illustrate this framework, and how the
various components of qualitative research work together to create knowledge. This
conceptual model was mostly based on previous work by Carter and Little (2007)
linking the importance of epistemology, methodology and methods in research, but
also influenced by Guba and Lincoln (1994) and Cresswell (2008), and is shown in
Figure 2.
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Figure 2. Conceptual model highlighting the relationships between ontology,
epistemology, methodology and methods and the production of new knowledge.
Operational framework
A strength of this study design lies in the operational framework. This framework
provides an overview of the entire study, maintaining coherence and focus on the
goals of the research study, it also demonstrates the important links between the
qualitative paradigm, ontology, epistemology, methodology and methods involved in
the research process as recommended by Carter and Little (2007) and shown in
Figure 3. The operational framework is broader than the conceptual framework and
considers many other elements influencing the research design, including ethical
considerations, reflexivity, rigour, transparency, context, sensitivity, coherence of the
research the quality of the product, and fit to empirical literature. The operational
framework illustrates the framework I developed to ensure consistency in the study
process and consideration of all the necessary components of high quality qualitative
research.
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Figure 3. Operational framework highlighting the interplay between the processes of
the current research study and the relationships between them to produce new
understandings that are highly relevant, rigourous, context sensitive and impactful to
clinical practice.
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Methods: Ensuring rigour in the study
In social research, validation cannot occur through subsequent replication, since
identical social situations cannot be recreated (Bloor, 1997). Instead, elements of a
study are viewed as being possibly generalisable across settings, or not generalisable
at all due to the research being in a truly particular setting (Bloor, 1997). It is up to
the reader of the research to determine to what extent the findings of a qualitative
study might apply to their own situation. The researcher can help the reader to make
this assessment by being transparent in all aspects of describing the sample, data
collection, data management and data analysis, as I have done in this chapter.
Qualitative research represents a distinctive paradigm, and as such, should not be
judged by conventional quantitative measures of validity, generalisability and
reliability (Mays & Pope, 2000). Instead, terms such as accuracy, confirmability,
transferability and trustworthiness apply in qualitative research (Lincoln & Guba,
1985). The aim is to discover patterns that exist. In using the ethnography
methodology and life history, no two researchers will elicit the same life story, and
no one researcher will ascertain the same life history on two occasions, the aim in
life history being to grasp unique experiences for what they tell us (Plummer, 2001).
Maintaining rigour in a study helps to safeguard the participant’s point of view, so
that researchers don’t construct a fictional, non-existent world (Fereday & MuirCochrane, 2006). There are strategies that can be employed by researchers to
establish and enhance rigour within a study. As Plummer (2001, p.155) suggests “the
closer I am to the phenomenon I want to understand, the closer I am to validity”. To
accomplish this, I transcribed my own interviews verbatim and regularly re-listened
to the original audiotapes to stay as connected to the original data as possible. By
doing this I was able to build up layers of understanding, gradually building up ideas
and concepts that eventually became themes and subthemes. Additionally,
approaching data analysis in a responsive, inductive, transparent and systematic way
has been reported to lead to openness and balancing quality, science and rigour
(Averill, 2014). I felt that selecting such a robust and systematic method in thematic
analysis, and using the method outlined by Braun and Clarke (2006, 2013) to analyse
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the study data, was crucial to maintaining rigour in the study. Table 3 demonstrates
elements of rigour and strategies employed during the study to support and maintain
each element.
Table 3. Elements of rigour identified and strategies employed during the study to
maintain rigour.
Element supporting rigour

Strategies employed to uphold rigour

Transparency

In depth discussion of chosen methodology and methods
Systematic and robust data analysis method with visible
and linked stages
Reflexive diary kept throughout study

Triangulation

As the primary researcher, I was responsible for the initial
coding and theme development and thematic framework
→ this was reviewed regularly by Supervisors for
congruence and fit

Credibility

Findings discussed extensively with Supervisors and
supported by both data and interpretative framework
Peer debriefing of themes with MS nurse experts for “fit”
of themes to clinical practice
Prolonged and deep engagement in the field of MS
The use of field notes to record impressions and describe
situations in depth
Participant quotes (raw data) provided as examples of
particular themes and relationships between themes

Transferability,

“Thick” and “rich” description

trustworthiness, authenticity Participant quotes (raw data) provided as examples of
particular themes and relationships between themes
Thematic framework of evidence of how the data builds
the interpretation
Comparison with research Interpretations and analyses compared with existing
literature

literature to confirm and expand study findings
Negative case analysis consideration and discussion
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Member checking
Member checking/ member validation is a common qualitative research method to
improve rigour in a study by providing the data transcriptions or findings back to the
study participant to review and comment on; aiming to validate findings by
demonstrating coherence between the researcher’s analysis and the feelings of the
participant (Bloor, 1997; Seale, 1999). However, it was not a viable option in this life
history study for several reasons. Firstly, in life history, participants can gain “new
horizons” or new ways of seeing things after the interview and discussion, impacting
on how they see things afterwards and often with a new perspective, which may then
change the view of the original life story (Plummer, 2001).
Secondly, Morse (2015) suggests that the findings in qualitative health research are
deeply analytical and abstract and are therefore not appropriate to give back to
participants, who may not understand the differences and reasoning between what
they disclosed in the interview and the researcher’s final analysis. Thirdly, there is
the question of what the researcher should do if there is a discrepancy with the
findings and how this would be handled (Braun & Clarke, 2013; Morse, 2015). The
concept of member checking is more appropriate for other approaches to research,
such as phenomenology, where the specific aim is to record an individual’s
perception as closely as possible in data analysis (Braun & Clarke, 2013).
The concept of truth telling in life history
The life story told at the time of the interview is taken to be the truth (Denzin, 1989;
de Chesnay & Fisher 2014). The guidelines of life history assume that no participants
are lying as they tell their stories, accepting the word of the individual and also being
aware that there is no such thing as absolute truth (Wiseman, 1974). Of course, some
stories are not always factual, but the researcher usually accepts the story of the
participant as true, even though they know that sometimes memory may be confused
or the story may be overdramatic for effect (Holloway & Freshwater, 2007b). It has
been suggested that storytellers in narratives rarely tell lies and even when not telling
the truth, consciously or not, they demonstrate their intentions and motivations
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(Holloway & Freshwater, 2007b). I accepted the life stories as presented by the study
participants as being honest accounts of their experiences.
Data Saturation
Essentially, data saturation is reached when the ability to obtain additional
information has been exhausted or when further coding is no longer feasible (Guest,
Bunce, & Johnson, 2006). Data saturation assumes that a circumscribed and total
amount of facts are available (and necessary) to be able to draw conclusions from
research (Malterud, Sierma, & Gusassora, 2016). This concept is not in alignment
with qualitative research and the epistemology of this study, which values the
individual voice; assuming multiple realities, of which only some can be known.
An exception to this in qualitative research is in grounded theory, which has an
inbuilt system of data saturation derived from data comparison, where every new
observation is compared with previous analysis to identify similarities and
differences (Glaser & Strauss, 2017; Malterud et al., 2016). In qualitative research in
general, it is better to think of data as being both “rich” (focusing on quality, being
layered, detailed and nuanced) and “thick” (focusing on quantity, a lot of data and
codes) rather than “saturated” (Fusch & Ness, 2015). However, there are some
general principles which indicate that enough data has been collected; these include
no new data arising, identifying no new coding categories, no new themes emerging
and collection of enough detail to replicate the study (Guest et al., 2006).
Additionally, if the interview questions are not structured and consistent for every
participant (as when using semi-structured or unstructured interviews), it is
impossible to achieve data saturation against a constantly moving target (Guest et al.,
2006).
Malterud et al. (2016) have proposed an alternative term to data saturation to guide
sample size in qualitative research called “information power”. The more
information the sample holds relevant to the study and answering the research
question, the lower the amount of participants needed. Assessing “information
power” involves a model considering the focus of the study (broad or narrow),
sample specificity (dense or sparse), and the quality of the dialogue (strong or weak);
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the model being particularly appropriate to individual interview studies such as life
history (Malterud et al., 2016). I felt that the current study consisted of diverse
informants who provided dense, specific and high quality insights; meeting the goals
of the study, answering the research question and providing excellent “information
power”. The quality of the interviews in the current study was excellent with the data
collected giving rise to over 2,000 individual codes. Although I had no new codes or
themes emerge after the eleventh interview, the final two interviews added a depth to
the existing data that was exceptional and both were integral to richness in the final
thematic analysis. As no new information was subsequently uncovered in the final
analysis, no new interviews were therefore scheduled and data collection was
deemed complete (Rubin & Rubin, 2011).

Methods: Ethical considerations
The concept of ethics is intrinsic to the constructivist epistemology because of the
inclusion of participant values in the research (Guba & Lincoln, 1985). More than a
checklist to simply tick off boxes, attending to ethical considerations is the moral
responsibility of all researchers (Ryen, 2016). It has been openly discussed in the
literature that ethical guidelines in general research are inadequate for qualitative
research, as they focus more on the needs and nuances of quantitative research and
clinical trials rather than the unique needs of qualitative study (Denzin & Lincoln
2000; Ryen, 2016). Denzin and Giardina (2016) explore these concepts further,
suggesting that the biomedical model of research ethics presumes a static, monolithic
view of the study participants. In life history research in particular, the subject and
researcher develop collaborative relationships, which are not captured in ethics
“rules” (Denzin & Giardina, 2016).
Despite these criticisms, the usual process for the ethical conduct of studies was
followed in line with Notre Dame University guidelines. However, in agreeing with
the concepts stated above, I decided to add additional considerations and precautions
into the research design to provide added support to the study participants. The
epistemological foundations of this study reflected my belief that the participants
were key informants and that we constructed the reality together. Successfully
completing the research study (for the sake of both of us) depended on the study
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participants feeling comfortable, supported and valued. Their needs and welfare were
critical to my study design.
Ethical approval
Ethical approval for the study was sought and granted by the Notre Dame University,
Australia, HREC, approval number: 016002S (see Appendix 1). Following the
recommendations of the Nuremberg code (1947), National Statement on Ethical
Conduct in Human Research (National Health & Research Council (NHMRC), 2007
and updated 2015) and the Australian Code for the Responsible Conduct of Research
(NHMRC, 2007), the study was subjected to a full ethical review, rather than
abbreviated low-risk review. This was primarily because I viewed the data collection
interviews as very likely to be sensitive in nature and potentially inducing
vulnerability in the participants. In addition to the above ethical considerations, the
four principles of medical ethics were honoured - autonomy, beneficence, nonmaleficence and justice (Gillon, 2015).
The full ethical review and approval included the approval of the HREC submission
form outlining the research design and study procedures, the Participant Information
Sheet and Consent Form (PICF)(Appendix 9), and a flyer for participant recruitment
(Appendix 2). As per the requirements for study approval, a PICF was provided to
each participant and signed prior to any study procedures taking place. The
participant and I signed two original copies and took one each for our files. As an
added protection for the participants, I ensured that they were able to read the PICF
at least a week prior to our meeting and interview date. This was to avoid the
situation where participants may have felt obligated to take part on the day we met
(if they were reading the PICF for the first time) because of the effort required by
both of us to attend the scheduled interview. This system also provided participants
the opportunity to ask questions, consult significant others and think about their
participation ahead of time. I also reminded the participants that on the day of the
interview they were free to withdraw from the study at any time, and for any reason.
The two specific areas that I identified at the beginning of the research process as
being potentially challenging to the ethical conduct of the study involved protecting
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participant confidentiality throughout all methods (transcriptions, coding, analysis)
and the possibility of exposing the participants to distress and/or vulnerability
discussing their experiences living with RRMS.
Confidentiality for the study participants was paramount, particularly as some stories
were distressing or involved family members, friends or HCPs directly (who did not
volunteer to be part of the study). Pseudonyms (false names) were assigned to each
participant to protect their identity and were mostly chosen by the participant
themselves, continuing the feeling of partnership in constructing the research
together. Still, two participants were adamant that their real names be retained.
However, after many discussions with the supervisory team for my study, I allocated
a pseudonym to protect them and their significant others from identification. In both
cases I felt their intention to keep their real name was for good reason and they
wanted the world to know their story, however, I believed there were issues they
didn’t consider which could be detrimental to them or their family if their identity
were revealed to the public. I also felt that I may inadvertently “hold back” on some
of their story to avoid revealing their identity, and their stories and messages were
too powerful to do this. I did discuss this with both of the participants after the
interviews were completed and they understood and supported the use of a
pseudonym with our further discussion.
The names of significant others, HCPs and friends were all deleted from the
transcripts, as well as potentially identifiable data such as birthplaces and
cities/towns of residence. Where important to the story, reference is made to living in
a rural town or community rather than to a specific region. Instead of using a
potentially identifiable occupation, I changed the position to a broader role to
continue the protection of the participant story as much as possible, without losing
the essence of the stories and the meaning that this occupation may have had for the
PwRRMS. Protecting the privacy of participants is a core tenet of research ethics
(Morse & Coulehan, 2015). I maintained privacy for the participants during the
interviews by speaking to them away from distractions in their homes or offices (in a
room, privately from other house members or colleagues) or in the case of two
interviews that were performed in public places, we inhabited a corner away from
noise or public traffic where we could not be overheard. All transcripts (audio and
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written) were immediately coded with pseudonym/study number with no reference to
real identity. Audio transcripts were deleted from the computer after written
transcription and kept on a de-identified SD card locked in a safe.
The possibility of my research causing distress or enhancing vulnerability in the
study participants was one of the areas I felt most strongly about, where I needed to
have a clear and workable plan in place in case additional assistance was needed to
cope by participants, particularly after the interviews were completed. I had no idea
exactly what the participants would tell me about the experiences, but my years of
clinical experience working in the field with people living with RRMS had shown
me that often patients could become emotional and distressed talking about things
that had happened to them previously in terms of their RRMS. I wanted to be well
prepared in case of distress during or after the interviews. The study design included
access to a psychologist experienced in MS care to be available to consult
participants if needed, as well as a flyer (Appendix 10) for the participant outlining
the procedure they could follow to contact me to institute this care (this information
was available in the PICF, but also given as a separate flyer for ease of accessibility).
At the end of every interview, participants were given the opportunity to ask more
questions. I contacted each participant after the interview to thank them for their
participation in the study and to ensure they were feeling healthy emotionally. No
study participant required additional care through the research process, and all
participants expressed gratitude and thanks for the positive experience the interviews
had provided them, to be heard, believed and listened to. I was also aware that
participants may reveal thoughts or feelings they never intended to reveal in an
interview, potentially making them feel even more vulnerable (Holloway &
Freshwater, 2007a) after their “confessional mode of discourse” (Atkinson &
Silverman, 1997). Making contact with participants after the interviews also gave
them the chance to advise if they wished to withdraw information from the study. No
study participant wished to take this option.
Annual reports were submitted to the HREC over the course of the study to continue
ongoing HREC approval. Study participants raised no points of concern during the
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course of the study and no incidents threatening the integrity of the ethical
considerations were made to the study Supervisors, the HREC or to myself.
Methods: Reflexivity
Reflexivity fits into the wider perspective of ontology and epistemology (Berger,
2015) examining the role of the researcher in the generation and construction of
knowledge and assisting the researcher to act without bias (Holloway & Galvin,
2016). Unlike quantitative research where an objective stance is necessary, in
qualitative research the active role of the researcher is valued and appreciated as an
important research tool (Braun & Clarke, 2013). However, it is important that the
researcher makes visible personal reflexivity as a form of quality control within the
research (Braun & Clarke, 2013), where the aim is for

“empathic neutrality”

(Ormston et al, 2014).
Personal reflexivity
In this particular study, it was important for me, as the researcher, to be specific
about my background and possible subjective viewpoints, and to identify early in the
research process both the potential strengths and limitations of these subjective
viewpoints. The key to performing a successful life history is to develop a trusting
relationship with the participant, developing the relationship through rapport
(Hagemaster, 1992). I committed to using all of my personal and professional skills
to develop and maintain trusting relationships with the study participants, and part of
this was my already existing professional background. The majority of study
participants had been cared for by an MS Nurse as part of their life journey with
RRMS, and had all valued the MS Nurse, their skills, knowledge and support.
Belonging to the “MS Nurse club” most likely held some definite benefits for me in
terms of rapport and trust and I felt that for many participants, this gained me instant
entry into their lifeworld. However, I was also aware that I could not automatically
take this for granted, and have expectations because of this role. First and foremost I
was a researcher, and my MS Nurse role was secondary to what we were there to
construct together. I was open and honest about my professional background, but I
didn’t dwell on it.
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My personal reflexive stance is that I am a middle aged, middle class, female,
Caucasian MS Nurse with 34 years of clinical nursing experience and 23 years of
(mostly quantitative) research experience, with the last 12 years of practice working
solely in MS. I am married and the mother of two children who are in the prime age
target of MS onset, in their mid-twenties. I am a spiritual person of a Roman
Catholic background. I do not live with RRMS, nor am I disabled, but I do live with
my own chronic illness of 26 years. I am a caring, empathic person and I
acknowledge that I tend to want to “fix” everything for others and help as much as
possible. I am not alone here, as a tendency to make suggestions and problem solve
is a common HCP limitation in research (Windle, 2011). Assessing this situation and
evaluating the possible effects of these characteristics on the research study was
challenging, but necessary. The picture of embodiment I presented to the participants
as an able bodied person inquiring about their world was also a consideration I had
going into every interview. I wore plain clothing and tried to physically blend into
the background as a conscious choice.
The positive impacts that my reflexive stance brought to the study were numerous.
Due to my clinical knowledge of the disease and experience as a registered nurse, I
was able to build rapport quickly with the study participants and to develop a trusting
environment. I felt I was able to make them comfortable, to feel free to discuss any
issue they wished and in any order they wished. As a consequence, I was able to
obtain data relating to sensitive issues, such as parenting, sexuality, relationships,
hopelessness, mental health, compromised care and fear. This enabled me to gain
new insights into living with RRMS that have been reported infrequently or have not
been reported at all in the specialty. I could also optimise my clinical experience in
the data analysis phase to see nuances in the data that may not have been discovered
by a researcher with no clinical MS experience. I understood the MS terminology
that participants used in their life history and I was able to situate it appropriately due
to my clinical knowledge; this was important as ethnography relies strongly on
naturally occurring language of the participants in the field (Holloway & Todres,
2003). Additionally, I was able to be mindful of when symptoms (particularly
participant fatigue) threatened to interrupt the integrity of the interview, and organise
breaks and rest when necessary.
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I specifically asked myself a set of questions before and after the life history
interviews as a way of being mentally and emotionally prepared to set aside my
personal opinions and put the study participants and their experience at the forefront
of the study (Appendix 11). Even though at this stage I was collecting data to prepare
for the later analysis, in qualitative research, analysis starts early and I needed to be
aware of things that could potentially later affect the findings.
I kept a reflexive journal (Braun & Clarke, 2013; Hinton & Kirk, 2017) throughout
the study process to capture times of indecision and times where I needed to work
through possible areas of limitation in the study, prompted by my own personal
views on data and findings. I also used the journal to chronicle how I was feeling at
various times during the study, such as if I was particularly emotionally affected by
the interviews, or aspects of the data analysis and literature review. An example of a
diary excerpt from the study is presented in Appendix 12. I also wondered at times if
many years of experience working as an MS Nurse in the field may have constituted
a form of fieldwork in ethnography, where extended participation and observation in
a culture occurs, but I decided that my experience did not meet the criteria of
fieldwork as my previous exposure was always in a structured, non-natural clinical
environment (a hospital clinic) with a different purpose (seeking healthcare and
advice). My mindset was that this was all going to be new to me.
Functional reflexivity
Functional reflexivity involves giving critical attention to the way research tools and
processes may have influenced the research findings (Braun & Clarke, 2013). I
regularly engaged in asking myself if I was limiting what could be found by having
such a broad research question (Willig & Stainton, 2008) and if the technique of
interviews was the best way to answer the research question. Using individual semistructured interviews provided a solid base to ask additional questions of interesting
data, to probe further when it was indicated and to enable the privacy for study
participants to talk about whatever they viewed as important, rather than being
overwhelmed by other participants in a focus group. During the study, I constantly
re-assessed if my methodological and method selection was serving the study well
and I was confident that no alteration was needed to the data collection methods and
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analytical methods as the study progressed. The more I practiced thematic analysis
and the more immersed in the entire process, the more natural the analysis became.
Reflexive Analysis
Reflexive analysis involves consideration of how the patterns and themes arose from
the data, it is up to the researcher to consider and explain exactly how this process
occurred (Srivastava & Hopwood, 2009). Thinking about this with a reflexive lens,
the patterns and themes I saw in the data certainly came about because they were
linked in some way to my extensive clinical experience working in the field of MS
and thousands of consultations with PwRRMS over the years, and the things I had
seen and heard. I was concerned that at times, my clinical mindset might overtake
my inductive qualitative research sensibility. To combat this, once every candidate
theme was developed, I went back to the original data - the transcripts and the codes,
to ensure that the themes were firmly embedded in the study data and not my own
thoughts and opinions. If a candidate theme could not be supported entirely by
participant quotes and stories, it was discarded, no matter how important I felt the
theme was personally. This ensured an inductive, data driven analysis.
Emotional reflexivity
At times, the interviews contained highly emotive content and I had difficulty
disengaging from the data, feeling emotional and vulnerable myself as I re-listened,
re-read and re-analysed times of sadness and distress in the lives of the study
participants. Some of the interviews were intense and the willingness of the
participants to share their lives with me, a stranger, was overwhelming. Several
participants had suffered neglected childhoods or had been subjected to horrendous
events and re-living these discussions invoked sad and heart-rending emotions. I paid
attention to nutrition and fitness and discussed my emotions with a few trusted
confidantes; debriefing with peers and having regular breaks from the work. These
measures improved the situation greatly. I read an article by Tanner (2009) exploring
her experiences listening to sad situations and the difficulties encountered during her
PhD work, which proved very helpful to me in facilitating this effective mental
health plan for myself during the study.
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There were several times during the interviews where the blurred roles between my
role as researcher and my clinical role intertwined and left me with a strong
emotional reaction, usually of anger. This was manageable, but there were several
times when participants were telling me stories of compromised care from other
HCPs that I became bothered and struggled to hide my feelings. Instead I opted to let
the participant see that I was affected by their story and I was interested and
listening, but not the full extent of my feelings. This situation usually involved other
HCPs not performing to duty of care or treating the participant badly, in a way that
was not harmonious with my values of nursing care. I wrote about these experiences
in my reflexive diary so I could come back afterward and look at my responses with
a reflexive stance to ensure that I was fulfilling my role as researcher and listener
first and foremost.

In summary
As the ontology, epistemology, methodology and methods, and the links between
them have been discussed and justified for the current study, the important
relationship between the methodology and the data analysis and study findings will
be presented in the following chapters. To introduce the study participants, the next
chapter will present a narrative of each individual study participant’s story.
Essentially chapter 5 will consist of a brief overview of the life story for each study
participant; their upbringing, families, friends, communities, events in their lives,
work, play, important life turning points and their story of RRMS. Chapter 5 will
provide context for each life story and important insights in order to gain deeper
understanding of, and appreciation for, the study themes presented in the following
chapters.
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CHAPTER 5: STUDY FINDINGS - THE LIFE STORIES
As comprehensively discussed in the previous chapter, Methodology and Methods,
the study participants share their life history, but the life stories are co-constructed by
the researcher (Plummer, 2001). The life histories told by the study participants
became the life stories co-constructed by me as the researcher, and formed the initial
part of the study findings. The life stories provide context and understanding to the
specific thematic findings in the following three chapters (chapters 6 to 8), as the
reader is able to gain perspective about the lives of the study participants. This helps
to appreciate each participant’s challenges, joys and life happenings; with each
narrative a unique story.
All participants were asked to choose their own pseudonym for the study, this
process involved much thought and care. It is for this reason that I have kept two
very similar names, Rudi (participant four) and Ruby (participant eight) in the study
findings and report. For these two participants, their chosen names meant so much to
them, having a great deal of personal significance. Two participants asked me to
choose a pseudonym for them. It is impossible to include all of the information
related to RRMS and other life happenings for the study participants within the word
limit confines of this thesis, but these stories have taken the most relevant
information from the history to represent a brief life story for each participant. I have
included a short summary of the DMT story, because for all study participants, the
DMT (or choice not to have a DMT) had some effect on their life journey, as told by
the participants. The life stories of all 13 study participants are presented below, in
chronological order of the interviews. I added an overarching phrase to each
pseudonym, a short title of sorts, to describe their journey and to provide a deeper
portrayal of their story with each pseudonym.

Participant number 1: Piper’s story
Pushed around from pillar to post
Piper was 42 years of age at the time of our interview and has lived her entire life in
the same rural town where she was born. Piper works casually as a volunteer,
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enjoying her time with people and a chance to do something with meaning. Part of a
very close migrant family, her extended family is a very important part of her life.
Married to her childhood sweetheart, Piper is the very proud mother of two busy and
spirited boys. Diagnosed with RRMS just over two years ago, Piper’s story is
interspersed with periods of mysterious illness of over 25 years duration, countless
visits to doctors and a strong sense of determination to find an explanation for her
unexplained symptoms.
Despite her bright and bubbly exterior, Piper’s life has been tormented intermittently
with unexplained physical and psychological symptoms, which at times have been
completely demoralising for her, leaving her feeling “like a fraud” and “like a
hypochondriac”. Piper attributes part of the challenge of understanding her various
symptoms to years of living in a rural community with a constant thoroughfare of
family doctors called General Practitioners (GPs), “always someone new…starting
again at the front end” and never getting to the bottom of her symptoms. Piper’s
earliest recollection of neurological symptoms occurred at the age of 13 when she
experienced the first of many severe headaches, wrapping around her face and
causing intense and unbearable pain. These types of pain episodes were to continue
on and off for many years.
Piper recalls “always being at the doctors” and having “all the tests under the sun” to
find the cause of her unexplained symptoms. From her mid twenties, she describes a
regular pattern of “getting checked and never finding anything wrong”. Piper
suffered a severe episode of depression after her marriage and was also diagnosed
with anxiety. She worked hard with a psychologist to turn her life around and change
her thought patterns and was also treated with medication for depression and anxiety.
Piper has since wondered if this episode might have been due to early RRMS, as
depression is a common co-morbidity. Despite the emotional pain, Piper describes
this time in her life as a major turning point for her and regards seeking help as “the
best thing I ever did...I didn’t realise til I was well that I was living half a life”.
Over the ensuing years, Piper was diagnosed with other illnesses (such as
underactive thyroid, Raynauds, low vitamin D) and also experienced significant back
pain from disc issues and also suffered years of infertility. The time leading up to
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Piper’s diagnosis of RRMS was an especially frustrating time in her journey.
Approximately 6 months prior to diagnosis, Piper was bedridden; suffering fatigue,
pins and needles, a loss of bladder control and poor memory. She describes this time
as feeling like she was “getting old really quickly…all of a sudden”. Piper recalls
saying to her husband “I think I really am going crazy, like the doctors think I am”.
After a few weeks these symptoms settled down and Piper decided to go on a holiday
to another state and saw a GP there whilst she was away. This GP performed a
neurolological examination, surprisingly, her first one ever. MS was suspected and
Piper was immediately sent for an MRI scan and then to see a neurologist in the
closest large city.
In quick succession, Piper was diagnosed with RRMS and commenced on a DMT,
the interferon beta1-b (Betaferon®) and she learnt to self-inject the medication every
second day. Piper recalls her overwhelming feeling at diagnosis as being “relieved
that I wasn’t going mad”. Unfortunately the DMT did not control the disease, and
she suffered further relapses. Piper has since commenced an oral DMT, dimethyl
fumarate (Tecfidera®) which has stabilised her relapses, but not her symptoms,
which continue to be a daily reminder to Piper of RRMS. She suffers greatly from
fatigue, nerve pain, insomnia and spasms but works through each day as best she
can; eating nutritiously, working casually, caring for her family, exercising regularly
and “walking through the pain” to be as healthy as possible. Piper’s extended family
have also been instrumental in providing support and encouragement, particularly
when she hasn’t felt well or has been experiencing a relapse. They have told Piper
that they are amazed at her tenacity and determination.
When recalling her diagnosis, Piper says she was “probably lucky…a lot of people
have to wait years and get pushed around from pillar to post”. The interesting thing
was, whilst listening to Piper’s story all I could think about was how Piper was
“pushed from pillar to post” around a medical system that wasn’t really listening to
her. In keeping with the new thought patterns she learnt from her therapy to
overcome depression, Piper has spent the last two years since diagnosis enjoying life
as much as possible. Piper is expanding her social circle (previously she kept to
herself and family a lot), travelling overseas at every opportunity and trying to
extract as much joy out of life as possible. Piper is making the most out of every day.
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Participant number 2: Margot’s story
Making the most of all I have and getting on with it
Margot, aged 57, at the time of our interview, moved to Australia with her parents
and sister when she was just a baby. Margot recalls her childhood being dominated
by multiculturalism, speaking, reading and writing English at school and then being
required to immerse herself in her original culture once back inside her home.
Margot went to university, worked in retail and customer service and eventually met
her husband with whom Margot has two sons. Margot was fortunate to maintain
good health until 16 years ago at the age of 41, when she suddenly tripped and fell
heavily, causing injuries to both her knees. She didn’t think much of it at the time,
but Margot developed numbness up to her hips in the ensuing days, alternating
constipation and diarrhea, and later numb hands. Totally perplexed, she arranged to
see her local GP who sent her for some investigations. Margot then saw a neurologist
and had a spinal MRI which revealed some “faded spots” on her spine. The
neurologist felt it was probably due to a virus. In retrospect Margot recalls feeling
like she was “patted on the head” on her way out as the neurologist said “there is
nothing wrong with you, off you go” and that “that was the end of that”.
As years went by, Margot noticed that she was tripping a bit more and reported to
her GP that the nagging numbness from years before had never really totally gone
away. She was referred to another neurologist who ordered both a spinal and brain
MRI. This led immediately to a diagnosis of RRMS. Margot was convinced until this
point that she had motor neuron disease (MND) and describes a feeling of “relief” on
hearing she had RRMS. Margot disclosed her new diagnosis to several family and
friends who were aware of recent events, however she made a conscious decision not
to tell her parents her diagnosis. Margot felt that their limited English, poor
understanding of MS, and her father’s tendency to “worry”, would cause too much
anguish and apprehension for them. Margot also elected not to disclose her diagnosis
to her workplace at this time.
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Margot commenced interferon beta1-b (Betaferon®), a medication she self injected
every second day until natalizumab (Tysabri®) was made available in Australia.
Margot then attended a monthly hospital visit for an infusion of natalizumab for
many years. She tolerated the medications well and was delighted to find when she
started natalizumab that she was paired up with other people with MS having the
same monthly infusions. This was the first time Margot came into contact with others
living with RRMS and found it “fantastic”, sharing tips and stories with others and
feeling a sense of camaraderie. Margot went on to fingolimod (Gilenya®) tablets
after a couple of years relapse free, which she remains on to this day.
Margot considers herself lucky in that she has not had many troublesome relapses
and has generally remained well, despite some accrual of disability in recent years.
She was working part-time until a few years ago when she decided to retire. Travel
has been important, Margot belonging to a tight knit group of friends who travel
together regularly.
Margot also sometimes uses a walking stick to help with stability on stairs and
uneven ground, mainly to alert others that “there is something wrong with her” and
to “be more careful around her”. Otherwise Margot is gently ambulant, walking
steadily, slowly and with a limp, but determinedly walking. She also enjoys looking
“romantic” when out with her husband as they hold hands to aid her stability. She
looks forward to more overseas travel with friends, conscious that she wants “to do
more travelling, before I can’t”.

Participant number 3: Kate’s story
I get knocked down but I get up again, you can’t beat me
Kate, a clever and engaging scientist, was aged 42 years at the time of our interview,
and has lived with RRMS for almost 20 years. She has recently retired from her
career; initially because her job was made redundant and later because her MS
symptoms have made returning to the workforce difficult. Kate’s husband of 25
years is supporting Kate through this momentous change in her life, which she
admits she has still not yet accepted.
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At the age of 23, and with a toddler son, Kate suddenly went blind in her left eye,
paving the way for several years of uncertainty as specialists struggled to work out
exactly what was happening to her. Kate was in the middle of studying part-time and
working full time when her episode of sudden blindness occurred. It gradually
resolved, only to be followed by several more episodes of unexplained blindness in
the following two years. She feared the worst, especially when the first doctor she
saw told her it could be a brain tumour. After a year or so, Kate was referred to a
neurologist who told her abruptly at their first meeting that she “probably had MS”.
Kate recalls that at the time she had no idea what this meant. He told her that she
“may end up in a wheelchair and you will probably be blind in five years”. Kate
recalls that she felt “a mess” and he prescribed her anti-depressants to, in the
neurologist’s words “get over it”.
During yet another baffling episode of unexplained blindness, Kate was referred to a
physician who immediately told her to throw out her antidepressants, which she
gladly did and immediately began to feel “a lot better”. This doctor was to become
one of Kate’s biggest supporters, treating her RRMS with some unusual but forwardthinking treatments at the time. He was always available for her to treat the
numerous relapses and symptoms she would go on to suffer. These years were
especially challenging as Kate juggled her family life, her full time job and her
studies toward a higher degree, always under the constant threat of another MS
relapse. Constant short courses of pulse steroids took their toll on Kate emotionally “
boy, I was angry…I would get fired up so quickly”, causing arguments with her
husband, as she struggled with the side effects from the various medications.
It wasn’t until a year after these episodes of blindness that the first brain lesions
appeared on an MRI, to confirm a diagnosis of RRMS. In keeping with diagnostic
guidelines at the time, it was still a “probable” diagnosis, but not a confirmed
diagnosis of RRMS that Kate had had to contend with. Kate commenced treatment
with the self injected interferon beta1-b (Betaferon®) every second day, struggling
with the side effects, feeling “totally miserable and really, really sick”. She
eventually relented and decided to stop DMTs for the next couple of years,
continuing to suffer relapses. As new medications became available in Australia,
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Kate eventually started on DMT again. She was commenced on glatiramer acetate
(Copaxone®). Kate recalls the struggle to find a suitable injection site, being “black
and blue around the tummy” from the daily injections. Kate later changed to the
three times weekly interferon beta1-a (Rebif®). A couple of years later, once again,
the interferon related side effects took their toll and Kate felt she needed to stop
treatment.
Up until this time Kate had managed to keep her diagnosis of RRMS secret from her
son, thinking “he’s a kid, there’s no need for him to know...I suppose it’s my idea of
keeping him safe”. When he started high school and she could no longer disguise the
side effects from the interferon, Kate felt ready to disclose her diagnosis of RRMS to
him. She felt like he took the news well, although “you can tell that he was really
upset”. About ten years after her RRMS diagnosis, Kate commenced the new
monthly infusible monoclonal DMT natalizumab, but suffered a serious side effect
which rendered her unable to have further treatment. Once again, there were no
options left for Kate, but her tenacious nature saw her enroll in a clinical trial for a
new medication. Today, Kate is being treated with oral DMT fingolimod (Gilenya®)
and also takes other medications to help with spasticity, her most painful and
unrelenting MS symptom.
Kate also weathered many storms through these years of living with RRMS, as her
extended family struggled with grief and illness in other family members. As part of
a migrant family, there was a sense of family commitment, with Kate vigilantly
maintaining all of her family responsibilities, despite her own significant health
issues. Kate also suffered significant injuries from a fall which has impacted her
mobility in recent years. Since her employment contract was not renewed and Kate
was forced to stop working in a job that she loved, she feels the great irony is that
now she has the time to do things she enjoys, but sadly her body cannot keep up to
do them.
Although Kate believes she is currently at a crossroads in her life, Kate remains a
fighter. Kate isn’t after a miracle cure, instead she just wants to stay the same and not
deteriorate further …“if I can stay like this I’ll be happy”. Kate left a lasting
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impression on me as an absolute powerhouse, as interested as she is in helping
herself, it is for the many others also suffering that she goes the extra mile.
Participant number 4: Rudi’s story
I’ve been through so much in my life, why more?
Rudi is married and the mother of four lively children and living in a country town,
close to the community where she was born. Rudy was aged 42 years at the time of
our interview and working part time in a local business, in a job that is “not very
stimulating”, but affords her reasonable hours and is mindful of the fact that she has
“bad days”.
Rudi recalls her childhood as difficult and sometimes it was very emotionally
painful. Early in the interview, Rudi commented that she wasn’t “going there”,
however Rudi opened up as the interview progressed, and this openness helped me
understand some of the childhood trauma she had been through. Rudi described
living her childhood with an absent father and a mother suffering from mental
illness. A self-declared rebellious teenager, Rudi left home at a young age, before
returning years later. Tragically, in later years Rudi was also to suffer the stillbirth of
her son, a time that she recalls as immensely painful…“not in my wildest dreams did
I think that would ever happen”, continuing to experience much emotional pain.
Rudi was diagnosed with RRMS about 11 years prior to our interview at the age of
31. Working out with a personal trainer one day, she suddenly experienced a facial
droop. Rudi immediately saw a doctor who wasn’t concerned about the symptom.
Nothing more happened until 4 years later when Rudi experienced an episode of
facial numbness, which quickly developed into slurring of speech and limb
weakness. She was rushed to hospital as it looked to others as if she had experienced
a stroke. The symptoms gradually resolved over the next week. A subsequent MRI
was performed and Rudi attended a visit to the neurologist for the very first time. She
was diagnosed with focal migraines. Rudi recovered, although never completely,
with some residual numbness down the left side of her body, she then sought a
referral to a city neurologist. Rudi was diagnosed with RRMS at this first visit to the
new neurologist. This diagnosis was based on Rudi’s clinical history, neurological
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examination and the MRI scans. Rudi commenced interferon beta1-b (Betaferon®)
injections every second day almost immediately.
Rudi recalls feeling “very angry” after the diagnosis, specifically saying that
“relief…I didn’t find that”. Rudi started treatment without wanting to learn more
about the disease. Rudi’s mother went to visit the local MS Society and brought
home brochures, which Rudi promptly threw in the bin. Within three months, Rudi
was in the intensive care unit suffering another severe relapse, this time losing her
speech completely. During this period in her life Rudi recalls “ I was sick for a very
long time” with numbness, weakness and balance issues. Rudi was immediately
escalated to the oral RRMS treatment fingolimod (Gilenya®). Rudi describes this
time as very stressful for her young family. Several severe relapses over the next
year and side effects from fingolimod saw another change in treatment to an oral
DMT, dimethyl fumarate (Tecfidera®). Although her neurologist has suggested more
efficacious DMTs such as natalizumab (Tysabri®) or alemtuzumab (Lemtrada®)
Rudi says she’s not interested. From Rudi’s perspective, the potential side effects are
just too dangerous with a young family.
Currently, Rudi looks forward to the future as her four children grow up and opening
the door for more travel. Living with RRMS has encouraged Rudi to take more trips
away, weekends with friends, and to start travelling more around the world… “I
dream of that and I dream of me walking in that”.

Participant number 5: Joy’s story
Overcoming adversity beyond comprehension and returning to faith
Joy has suffered through many crises and health issues in her 57 years to the time of
our interview, yet remains a strong, determined and courageous woman living with
RRMS, while simultaneously defying and astounding her current health care team.
Joy’s story invokes many feelings; sadness, shock, admiration and inspiration
amongst them.

136

Joy was born in a small country town and her childhood story is one of unbearable
pain and neglect, a time she sees as vital to making her the strong person she is
today. Joy had limited time playing with other children due to “excruciating” pain,
“I was so hypersensitive that she (mother) couldn’t even touch me, because with the
pain it was like razor blades…I would wake up in the morning and I’d feel like
someone had been beating me all night with a baseball bat”. She vividly recalls
nights of screaming out from leg pain, which nobody believed, or if they did, could
not put a name to. Joy recalls that her mother was labeled as having Munchausen’s
syndrome by the local doctors, eventually nobody believed that Joy was suffering
real pain, “they believed this is the child of the Munchausen’s mother, well of course
she’s going to be a hypochondriac”.
Things came to a head when Joy was 16 and she developed a complex form of
dyslexia overnight, not being about to read text type. Nobody believed Joy, and she
left school at 16 years of age despite been dux of the school the year before.
Unexpectedly becoming pregnant at the age of 17, Joy married, before developing
several complications during the pregnancy including a terrifying loss of vision with
no diagnosis. Joy suffered many other health care issues over the ensuing years and
eventually her husband left her as a single mother. Joy then experienced further
distressing and unexplained symptoms, including irregular periods of vision loss and
deafness. Joy recalls that when she visited the local doctors, none of them doctors
were interested in looking for a cause “they just didn’t believe me, I was a fruitloop…they thought I was crazy and they weren’t remotely interested”. Joy later
developed right-sided weakness, and reached a stage of utter despair when the
doctors still did not send her for any tests or investigations, recalling the feeling that
“it nearly broke me”.
Ten years after her first son was born, Joy gave birth to second little boy. Joy
enjoyed a period of good health during this time with no further attacks of blindness,
deafness or weakness. She continued to feel well until her second child was about
five years of age, when “the fatigue and the pain…was just indescribable,
sickening…my whole body screaming in pain, absolutely screaming”. The leg pain
Joy had experienced as a child returned and was to become an everyday occurrence.
Joy still had no explanation, diagnosis or a HCP who was interested in finding one.
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Several years later, Joy remarried and with support from her husband, was referred to
a neurologist. This neurologist subsequently diagnosed Joy with RRMS, Joy
recalling, “they were amazed that no-one ever bothered to test me before”. Joy
started on medication for the severe nerve pain and later glatiramer acetate
(Copaxone®) daily injections as a DMT to treat RRMS. Joy then recalls feeling
unwell and experiencing a “huge, huge reaction” where “I blew up to 3 times my
normal body size, just huge”. Joy suspected her husband was poisoning her “my
husband kept feeding me the medication (to treat nerve pain) and insisting…he
would put the tablets in my mouth and I would pretend to swallow them and then I’d
spit them out”. After about six weeks of pretending to take the medications, Joy
eventually started to feel better and drove herself to the hospital for assessment by a
doctor to find out for sure what was happening to her. Joy was diagnosed with
medication toxicity. Joy believes that “I don’t think he necessarily wanted me to
die…I will never know”. Joy stopped all medications at this point, including
injectable glatiramer acetate to treat her RRMS.
An onslaught of migraines in the year that followed led to a referral to a new
neurologist and more neurological testing. Joy was then diagnosed with complex
partial epilepsy. The neurologist told Joy that there was no way of knowing if her
previous symptoms throughout her life had been caused by RRMS, the epilepsy, or
both. As Joy recalls “she said…how have you had any sort of normal life…how did
you ever learn to walk and talk?”. Joy refused the offer of DMT to treat RRMS,
preferring to take her chances on no treatment at all and avoid any side effects.
In the meantime, Joy’s home life was deteriorating, she was feeling constantly
stressed, not allowed to take time off work when her MS symptoms were at their
worst. Then, Joy’s husband died suddenly. Joy recalls that her husband collapsed “on
top of me and squashed me so I couldn’t breathe”. This led to an intense few minutes
where Joy experienced a surge of “I must live…that adrenaline surge…that kicked in
because I was dying…I got myself out from underneath him, something…changed
something in my chemistry…I started to improve…I made a heartfelt decision that I
would get better…no matter what”.
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Gradually, Joy began to gain independence and returned to the faith she had with
God as a little girl. Joy believes she is currently enjoying life to the full, working full
time in an advocacy role to help others. Joy is a grandmother and remains very close
to both of her boys and their families. Looking to the future, Joy is not keen to take
any medications to treat RRMS, “if they can’t come up with a cure…I’m not going
to take anything that will make me sicker”. Joy’s message is that it is always possible
to change, to make an effort to overcome difficulties and that it is definitely worth
the effort.

Participant number 6 : Jane’s story
Losing what’s important to me, but looking on the brightside
Jane, aged 52 years at the time of our interview, has been living with RRMS for
about 15 years. She has always worked in the field of education, is single, and has
enjoyed travelling the world for both pleasure and work for most of her life. Jane
currently lives with her father and is currently working part-time, still in the field of
education, having recently attained a higher degree of which she is incredibly proud.
At the age of 37 years, Jane, who rarely saw a doctor, was troubled by a severe
headache and consulted a local GP. The GP ordered some scans but did not provide
Jane with a diagnosis. Not long afterwards, Jane suffered sudden vision loss when
she was cycling and it was recommended that she see a neurologist. After several
tests, the neurologist diagnosed Jane with RRMS. Jane recalls saying to her parents
at the time “don’t worry about it…it’s MS” after initially being terrified of having a
brain tumour. Jane elected not to take medication at this stage and decided to start
her adventures overseas where she worked for many years. Jane came back to
Australia regularly to see her family and to stay in touch with her neurologist.
Jane returned to Australia several years later following a severe relapse and began
self injecting interferon beta1-a (Rebif®) for the next few years, feeling
“disappointed” in starting therapy and beginning a time in her life which she recalls
as “really, really, really depressing…I don’t think people realise how bad it makes
you feel”. For about 4 years Jane didn’t do any exercise and stopped travelling as she
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felt “like a drug addict” carrying her supply of interferon beta1-a needles around
with her.
Finally, Jane was switched to the oral DMT fingolimod (Gilenya®) about two years
ago and says she now feels “much, much better”. The swap to an oral treatment has
opened up her travel options again and her horizons on life. Presently she is working
part-time on the advice of, and with the support of, her manager who is aware of her
RRMS diagnosis, a diagnosis which has not been disclosed to others in the
workplace because she is worried about losing her employment due to RRMS.
Support has been essential for managing her severe fatigue, by taking time off in the
working week to rest. Currently Jane’s symptoms include visual disturbances,
incontinence, hand weakness and balance issues.
Currently, Jane is planning for a future where she may need a wheelchair, but is not
dwelling on it, continuing to travel independently. She still worries about “not being
able to speak or read or write”; skills she needs to be able to do her job properly, but
for now, working part-time in a profession she loves “is phenomenal”.

Participant number 7: Paul’s story
I am not going down with RRMS, I’m just not
A 37 year old married father of three young children at the time of our interview,
Paul currently works in the travel industry. Paul greatly enjoys his working role it
allows him to work from home, travel often and participate in outdoor and adventure
sports whenever he can. Initially from a science background, Paul is interested in all
things to do with RRMS, often reading science and medical articles and taking a very
active role in his own care and treatment decision-making.
Paul recalls a trip to an ophthalmologist to investigate his initial symptom, blurred
vision, about eight years prior to our interview and was told that he probably had a
virus causing some inflammation and that his vision would go back to normal, which
it did. A few of years later Paul woke up with trouble breathing and chest pain.
Exhaustive tests were performed but no explanation was found. A further episode
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occurred a year afterward when Paul describes feeling “psychologically not right”, a
period of time where he recalls “literally a cloud…sitting in this cloud…I looked
around and there was this cloud”. With no medical explanation for this sensation he
was feeling, Paul was left wondering what was happening to him. Subsequently, his
GP referred him to a neurologist who spent two hours with Paul, exploring his
symptoms, conducting further tests and eventually diagnosing him with RRMS in
2014.
Paul recalls suffering significant anxiety in the immediate time following his
diagnosis. Before starting on a DMT, Paul was admitted to hospital and seen by a
second neurologist who unfortunately, negatively affected Paul’s life journey. Paul
felt pressured into a research study by this new neurologist investigating an MS
treatment. At that time Paul was feeling particularly vulnerable due to his recent
diagnosis of RRMS, his anxiety, a recent relapse and a course of intravenous high
dose steroids (which can affect mood and thinking). Despite his misgivings, Paul
completed the research study assessments because he wanted his negative
experiences at the beginning of his RRMS journey to count for something and to
help others. Shortly after this experience, Paul began care at a new MS Clinic where
he feels he has found great medical support, together with his local GP.
Paul has been discreet about disclosing his diagnosis, choosing to only tell his
immediate family, no friends and only one work colleague. Paul feels that he wants
to manage RRMS on his own terms and that disclosing to only a chosen and trusted
few, gives him the control of RRMS he craves.
Paul’s main RRMS symptoms currently are leg pain, which he describes as “walking
on ice in wet socks, crumpled wet socks”, and neuropathic pain that comes and goes.
Paul manages his symptoms mainly by grinning and bearing it, and generally gets on
with life each day. Although relatively stable on his current oral DMT fingolimod
(Gilenya®), Paul has recently acquired a new brain lesion on his last MRI scan. With
his science background, Paul voraciously reads science papers reporting on MS
therapies and wonders if now is the time for a DMT change to a higher efficacy
medication.
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Paul has tremendous hope for the future with RRMS, reasoning that science has
come along so far in medicine in recent years and that advances in other disease such
as cancer will also help in MS. He continues to research new advances in MS and
advocate for himself to receive the best care and DMT treatment that is possible. It is
impossible to come away from meeting Paul without feeling the same sense of hope.

Participant number 8: Ruby’s story
If I could turn back time, I’d do things differently for my children
At the time of our interview, Ruby was 38 years old, married, the mother of two
young children and currently the main wage earner in her household. Ruby’s
husband has taken time off to care for the family whilst Ruby works full-time.
Working in the field of education, Ruby is a passionate and finds great inspiration
and delight in her work. Part of a small but involved extended migrant family, Ruby
lives close-by to her relatives who provide much needed support as she works,
manages RRMS and looks after her family.
Troubled by some leg cramps on an overseas trip about 14 years prior to our
interview, Ruby didn’t think much of her early RRMS symptoms, and certainly did
not think they were significant at the time or the first presentation of RRMS. Further
neurological symptoms of leg weakness and clumsiness several years later saw Ruby
consult a neurologist and undergo tests, where she was informed that she had RRMS
but not offered treatment at the time. Instead, newly married Ruby was advised to
start her own family now and to come back after her family was complete to discuss
further management. Two years after her diagnosis when her first child was still a
baby, Ruby noticed pain and cramping in her arms, but put it down to physical work
that she was doing at the time. Her symptoms worsened and could no longer be
ignored. Ruby was subsequently seen by a new neurologist and started the DMT
Tysabri® shortly afterwards, but her RRMS continued to progress.
Although it was still early in her life journey with RRMS, by this time Ruby had
already gained significant disability, particularly in regards to mobilising and she
was only able to walk short distances without help. Adding to Ruby’s burden is that
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she remains troubled by a decision she made four years ago, when deciding on a
DMT after the birth of both her children. Due to concerns about safety and the
potential for significant side effects, Ruby decided to take more conventional DMT
rather than the more efficacious medication recommended by her Doctor.
Unfortunately Ruby has gained considerable disability over the last few years and
she feels as if the decision she made at that time, understandably based on fear, has
negatively influenced the progression of her RRMS. The drug is now registered in
Australia and Ruby has recently commenced the medication, alemtuzumab
(Lemtrada®). Ruby has great hope that she will improve and return to living the life
she wants, to be a more active mother to her little children.
Being diagnosed with RRMS has caused considerable heartache for Ruby. She
misses simple things like walking to the local shops with her children for icecream
without any planning or running around with them in the local park. Perhaps one of
her greatest disappointments with RRMS is the pressure she feels it places on her
husband, her children and on her extended family, “I just wish it wasn’t all about
me”. Ruby would much rather be in the shadows and not the focus of family life. She
still hopes that one day this may become a reality.

Participant number 9: Griff’s story
I’m a pretender to the throne
Griff was 62 years old at the time of our interview, and the married father of two
teenage boys. Griff describes himself as a “house husband” caring for the family and
home whilst his wife works full time in a demanding job. Initially trained in the
public service, Griff worked for many years in a government job and believes he did
very well in this position. Years later in his forties, he retrained and ran his own
business, only to suffer a serious relapse of MS which led to his eventual diagnosis.
This diagnosis and significant symptoms of fatigue, ultimately led to unemployment,
and loss of the business. Griff has not worked outside the home since that time.
After a childhood fraught with unrelated lung illnesses, Griff experienced what he
feels were the first symptoms of RRMS in his early twenties. He was hiking in the

143

snow and noticed that he had no sense of where his feet were in relation to his body
and experienced weakness in his hands. He decided not to disclose this to his partner
at the time and recovered over a few weeks. In retrospect, Griff feels he experienced
many more short relapses of MS over subsequent years but was not seen by a
neurologist or diagnosed with RRMS and until he was in his late forties. This was
mainly because Griff did not report his symptoms or seek help for them from his
family doctor.
A tumultuous few years followed Griff’s RRMS diagnosis. He was commenced on
the injectable therapy glatiramer acetate (Copaxone®) which he needed to administer
to himself every day. Griff recalls that this became more and more difficult, he
detested the injections and missed many doses. He later started on natalizumab
(Tysabri®) necessitating a half day stay in the hospital clinic. These were the most
stable years of Griff’s journey with RRMS, he suffered no relapses, felt well on the
medication and greatly enjoyed the clinic visits at the hospital. These hospital visits
were his major social outings and finally gave him the social contact that he was
craving. After several years Griff returned a positive JCV test which indicated that he
was at a higher risk of the serious side effect of PML if he continued taking
Tysabri®. Griff then transitioned to fingolimod (Gilenya®) and has remained on this
DMT ever since. Although he has remained relapse free, he is still hopeful of a better
and more effective treatment in the future.
Griff feels that RRMS has impacted greatly on his socialisation, largely due to not
working but also from the severe fatigue he suffers. As his two children have become
teenagers and require less help, Griff feels his days are “spent wastefully” and that he
has been a less than optimal role model to his children who see him resting and tired
most of the time. The second negative effect of RRMS on Griff’s life has been in the
area of sexual health. Griff discussed several times in the interview his
disappointment that there doesn’t appear to be the help available that he needs to deal
with sexual health issues related to his RRMS, despite several attempts to do so.
A key event occurred shortly after Griff’s diagnosis with RRMS, when he attended
an event at the MSL to learn more about his new diagnosis. At that stage Griff
showed no signs of physical disability and his major MS symptoms were all invisible
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to others. Griff recalls that the mother of a severely disabled young girl in the same
meeting “attacked” him, coming over to his group and yelling “What are you? You
haven’t got MS!” This confrontation left Griff shaken and upset, although he did feel
sorry for the mother in her situation. However, this experience has stayed with Griff
over the years and has led to him sometimes feeling like an imposter to the MS world
and a “pretender to the throne”.

Participant number 10: Will’s story
Fitting everything into life I possibly can…and then some
Will was born overseas and migrated to Australia in his late teens, before his
diagnosis of RRMS in his mid twenties. He was aged 35 years at the time of our
interview, and is the married father of two children, enjoying an active life with
plenty of team sports and individual exercise.
Will experienced a traumatic childhood, after his single mother died when Will was
in his teens, he was raised by his grandmother. After experiencing an episode of
optic neuritis at 17 years of age, Will had some tests but never attended follow-up
visits to find out results. Will travelled to Australia, where he started a new career. A
few years later, Will was hospitalised for a number of weeks as doctors battled to
diagnose his unusual neurological presentation. Will recalls feeling depressed during
this time. Eventually, after several months, Will was diagnosed with RRMS by a
neurologist who was consulted on his case. This neurologist continues to look after
Will and provide significant support.
Following his diagnosis, Will began treatment with interferon 1-a (Rebif®) and
things went along well for a short period of time, but not long afterwards, Will
recalls becoming depressed again. He recalls how he lost his focus, quit his job and
stopped attending his MS Clinic for follow-up. Very quickly things spiraled out of
control and Will had worries for his own mental health and for his future. He called
on his resilience from childhood and managed to stop the negative cycle he was in
without any medical intervention. He reconnected with his MS care team, started on
the monthly infusion natalizumab (Tysabri®) and began to enjoy good health, the
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relapses stopped and “I just felt great”. Will started going out socially after months
of staying at home, and started making a conscious effort to talk to others, he joined
various sporting teams, made new friends and reconnected with old friends. Will
then met his future wife and felt like he had true support, embracing positivity and a
healthy future.
Will’s continued on this journey to wellness, he was thriving on the new treatment,
enjoying his new level of fitness and remaining relapse free for several years. The
only thing Will did not enjoy about the hospital visits for his monthly infusions was
meeting with other RRMS patients having treatment at the same time. Rather than
bonding with them, Will kept a deliberate distance because he did not want to be
around those with RRMS who wished to talk about their disease. Unfortunately after
several years of disease stability, Will returned a positive JCV blood test which
indicated that the natalizumab treatment was no longer safe for him due to a higher
risk of PML, and so he stopped the treatment. Shortly afterwards Will commenced a
new medication alemtuzumab (Lemtrada®), given in two annual cycles as an
intravenous medication, also in a hospital setting. At the time of the interview Will
was about three months post his first treatment cycle and still not feeling “back to
normal”. However, Will is hopeful this new treatment will keep him healthy, active
and able to play sport with his two children. Appearing fit, healthy and strong to
others is very important to Will. In his words “I want to be able to tell my son (about
RRMS), I don’t want him to notice it first”.
Will’s main symptoms currently include headaches, fatigue and numbness in his
hands. He manages his symptoms and prefers not to discuss RRMS daily in his life.
He has worked out a system with his wife, as he doesn’t want to complain of his
symptoms all the time, he will only tell her sometimes. For Will, this works and helps
to keep RRMS in the background and happiness and positivity in the foreground.
This is how Will wants to live with RRMS.

Participant number 11: Susan’s story
Dreams really do come true, you just have to get through a lot first
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Susan, 40 years old at the time of our interview, is married and a busy mother of one
toddler. Susan works part-time in health care, a job she enjoys. Susan spends the rest
of her time nurturing her family. After many years of being single and worrying
about her future, Susan met her partner and married at the age of 37 years, she
describes her dreams coming true when she later gave birth to her cherished little
girl.
Susan began her journey with RRMS in her twenties when she suddenly experienced
sensory lower limb symptoms whilst at work. She initially blamed sleep deprivation
for her leg numbness, but soon realised that something more serious was happening.
Susan sought help from her GP who refused to refer her for assessment and testing,
even though Susan was a HCP herself and had specifically requested a referral to a
neurologist. Susan realised her symptoms were serious and neurological in nature.
Finding help elsewhere, after many tests, and several months of waiting, Susan was
eventually diagnosed with RRMS. Susan was living at home at the time and her
parents were devastated at her diagnosis, her father in particular blamed himself for
her illness with Susan suffering substantial grief watching him try to make sense of
what was happening. This led to several years of struggle where she sometimes felt
that she would never find a partner to share her life with. She believed it would take
a special type of person to accept her diagnosis of RRMS and the uncertainty that
goes along with it.
Starting with an injectable interferon 1a treatment soon after her diagnosis and later
glatirimer acetate (Copaxone®) daily injections, Susan managed her early DMT
years well. She suffered three relapses over the next ten years but recovered well
physically from each relapse. She gradually progressed to an oral DMT, dimethyl
fumarate (Tecfidera®) in later years and has been relapse free now for some time.
Susan had some issues with becoming pregnant and sought the help of a fertility
specialist, which resulted in the birth of her only child. She had to remain off DMT
for a period of time during the preparation for and during pregnancy, but remained
free of relapses.
After struggling emotionally for many years living with RRMS, Susan embarked on
a counseling course, which changed her life for the better. She learnt skills with a
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group of other people, not with MS but other mental health issues and illnesses,
which has transformed her approach to her own illness. Susan applied her new
learning and thought processes to her life with RRMS. This changed her mindset
from “struggling” to a “can-do” attitude and more confidence. Susan feels this
attitude helped bring her future partner into her life and saw the start of her dream to
be a wife and mother become a reality.
Currently Susan feels well, remains positive and is excited about her future. Susan
continues to work as a HCP and has embraced the learning she has from living with
RRMS to apply to her HCP practice, teaching people how to live better with chronic
illness. Susan also encourages and helps those newly diagnosed with RRMS by
speaking with PwRRMS experiencing difficulty. Susan advocates living healthily,
maintaining a nutritional diet, continuing exercise and paying attention to mental
health, Susan lives this by example.

Participant number 12: Davina’s story
A second chance at love, support and happiness
Davina was aged 55 years at the time of our interview and has worked as a HCP for
most of her life, a role she greatly enjoys. Davina was due to be married a few weeks
after our interview and she was very excited at the prospect of her future. Several
years prior, Davina had divorced the father of her four adult children, after a
tumultuous marriage that was marked by many years of little support, accentuated by
her husband’s lack of insight and understanding into RRMS.
Davina was diagnosed with RRMS shortly after her first marriage, when she was in
her very early twenties. Davina had just received news that she was accepted into a
course and was to embark on a new career. A few days later she developed her first
MS symptoms, sensory symptoms along her spine and leg weakness, and was taken
to the emergency room and admitted to hospital. After several days she was given
the news that she had RRMS and was devastated at the way she was told, by a
specialist at the end of the bed who told her that she “likely had MS” and “if children
were something you were thinking about, it’s better to be a disabled younger mother
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than an older one”. Davina was devastated, she withdrew from the course she had
dearly wanted to complete and sadly received little support from her husband
throughout the early years after diagnosis. Following the specialist’s comments about
starting a family, within a year, Davina had her first baby, then three more children.
Although these years living with RRMS and with four children were very
demanding, Davina recalled that being a mother gave her the wonderful feeling “that
I was finally good at something”.
Davina suffered occasional relapses during this time, but always recovered back to
her usual function. There were no DMTs available when Davina was first diagnosed,
but in later years she commenced an injectable interferon, interferon-1a (Avonex®)
as soon as it was registered in Australia, which she remained on for over a decade.
Only recently has Davina switched to her first oral DMT, fingolimod (Gilenya®).
This was a difficult decision for Davina, although she had felt miserable from side
effects self-injecting, she persisted for many years because she felt “safe” taking the
medication. The thought of new, oral tablets was attractive, but she was fearful of the
unknown side effects on her body and resisted changing therapies for a long time.
Although happy with her decision, she still is mindful that things could change at any
time. Davina has been relapse free now for several years but still suffers significant
fatigue and Uhthoff’s phenomenon (a temporary recurrence of earlier relapse
symptoms due to heat, infection or stress) from time to time.
Davina’s early years living with RRMS were also marred by her extended family
arguing over whose fault it was that Davina had developed RRMS. They searched
for a genetic link because Davina had a close relative with MS who had been
wheelchair bound and eventually was placed in a nursing home, the family refusing
to acknowledge that he had MS to others outside the family. This refusal to
acknowledge the disease left Davina feeling unsure and vulnerable within her own
family unit. Although Davina’s mother was very supportive, Davina’s husband and
father regularly contributed to her sense of low self esteem and loss of confidence,
often refusing to believe her invisible symptoms, such as severe fatigue. On one
occasion her husband ridiculed her in front of the children when she was extremely
tired, telling her “don’t play that MS card again”. Her husband never attended
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medical appointments with Davina and did not want to know anything about the
disease. Davina’s mother was her primary, and often sole, support and cheerleader.
After many years of struggling, meeting her new partner has instilled a great sense of
hope for Davina in her future. Davina was formally diagnosed with depression a
decade ago, but had resisted counselling and medication for her mood disturbances.
However, recently Davina has sought psychological counselling and feels she is
more positive in terms of both mood and attitude to life. Davina looks forward to the
future, has supportive, loving relationships with her adult children and believes that
she has a life partner who understands and supports RRMS. Davina is keen to do as
much as she can living with RRMS, whilst she can.

Participant number 13: Evie’s story
RRMS, you can run but you can’t hide, I’m coming to get you
Evie is a vibrant, strong and fit campaigner, acting as an advocate to others about her
life living with RRMS. At the time of our interview, Evie was 38 years old and living
with her partner, had never married nor had any children. Evie’s career has always
been very important to her. She works for a government agency and because of her
covert occupation, I have to be very careful about personal life details in this
narrative, and unfortunately have to leave out some relevant details because of this
situation.
Evie experienced a turbulent childhood, suffering various respiratory and allergic
conditions and she recalls being bullied at both school by classmates, and at home by
her father. Evie’s first MS symptoms started in her late teens just after she finished
school. Troubled by sensory symptoms in her hands, she then experienced changes to
her gait, which were noticeable to others and she was referred to a neurologist. Over
the next two years Evie had extensive testing, without a conclusion, but after another
relapse was subsequently diagnosed with RRMS. Despite her young age, Evie took
the diagnosis in her stride, understanding fully that she could do well with RRMS, or
“she could bomb”. Evie has had an extremely challenging journey with the disease,
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suffering well over a dozen relapses since her diagnosis, several of the relapses being
very serious and requiring hospitalization.
Eventually when it became available, Evie commenced on her first DMT, an
injectable interferon beta 1-b (Betaferon®). She describes it as a time which made
her unhappy due to this “God awful drug”. Evie stopped taking the medication,
preferring to be on no DMT for several years than to experience side effects, but
after several serious relapses she felt compelled to restart treatment. Evie was happy
when natizumab (Tysabri®) was introduced, attending a hospital infusion clinic
monthly for the treatment and being relapse free, and almost completely symptom
free, for many years. During this time, she was in the best physical condition she had
been in many years. However, after several years, natalizumab needed to be stopped
after a positive, high titre blood test for JCV revealed that Evie was at considerably
high risk for the side effect PML. Evie then progressed onto an oral therapy dimethy
fumarate (Tecfidera®), but she suffered a significant increase in disease burden in a
very short period of time. Subsequently Evie commenced the new monoclonal
antibody infusion alemtuzumab (Lemtrada®). Having recently completed the second
of the two annual cycles of alemtuzumab Evie is still waiting to see if the treatment
has been effective but is extremely positive about her condition and hopeful for the
future. Evie strongly believes a cure will happen.
Currently, Evie’s main symptoms are fatigue, Uhthoff’s phenomena, gait instability
and occasional episodes of motor weakness. Despite her many serious relapses, Evie
is grateful that her vision has remained relatively unaffected and so she has been able
to continue in her working role. To Evie, this is a saving grace of RRMS.
Despite her advocacy for MS, Evie still has times when she would prefer to be
known for other things she does than being someone who lives with RRMS. Evie is
passionate about showing the bright side of MS and regularly participates in sports
and riskier pursuits such as skydiving and rock climbing in order to prove that you
can do anything with RRMS. She wishes that these moments were the ones captured
and advertised for people living with MS rather than showing people in wheelchairs
or with significant disability. Evie is a strong believer in doing everything you can,
whilst you can, and has refused to be labeled as only a person with MS. Despite her
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significant disease burden, Evie participates in life to the full and is committed to
showing MS in the best light possible. Meeting Evie made me, and I am sure others,
feel the same.
Narratives and further findings
The life stories presented in this chapter highlight the diversity of the study
participants, and contextualise their individual suffering, their joys, their strength and
their resilience living with RRMS. Each story offers so much to MS Nurses to gain
insights into living with RRMS. Each story has a unique perspective about things
that have happened along the life journey, independent of RRMS, which may affect
the life lived with RRMS. Ultimately, the narratives display a sense of hope, despite
the many life challenges the participants have experienced.
The next two chapters will present and discuss the study findings as themes and
related subthemes. Each theme will be introduced individually and then be supported
with direct quotes and stories from the participants to support the analysis. This is
where the participant life stories presented in this chapter will support the more
formal study findings, allowing the reader to have some appreciation of the lives of
the participants and their journey, in order to better understand the themes abstracted
from the study data. Understanding the journey of the study participants also makes
the experience more personal and allows a more intimate connection with each story,
a concept very much in alignment with qualitative research methodology and with
the ontology and epistemology of the current study.
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CHAPTER 6 – STUDY FINDINGS: “WALKING THE LOW
ROAD”
Following on from the narratives in the previous chapter introducing the study
participants with their life stories, this chapter presents the first five of a total of eight
themes developed from the study data analysis and findings. The five themes
comprising this chapter titled “Walking the Low Road”, reflect the difficulty,
struggle, hardship and a redefinition of self following a diagnosis of RRMS.
Although this chapter is mostly a story of challenge, there are some key moments of
positivity, of finding hope and of moving forward with optimism and with
anticipation. Hints of what is yet to come. In the early years after diagnosis these
times of positivity seem to be frequently interwoven with times of struggle,
especially in the very early days after a diagnosis of RRMS. However, as the story
progresses, PwRRMS develop their own set of expert skills in managing RRMS and
work towards a better future living with RRMS. There are suggestions of this in
Chapter 6, but these skills really came to the fore in the following chapter “Finding
the High Road”, as study participants identified key ways in “Taming the Beast”, as
they shared their experiences living with RRMS.
This chapter Walking the Low Road, consists of five themes, each possessing its own
central organising concept, as suggested by Braun and Clarke (2006, 2013) to
succinctly outline the inclusions and boundaries of each theme. Themes have been
categorised into subthemes and sub-subthemes to further clarify and highlight
specific areas and concepts related to the overarching theme. A discussion of each
theme will follow, interwoven with what is known from the MS body of knowledge
to further introduce, explain or justify the concepts. Quotes from the participant
transcripts will demonstrate the grounding of the themes in the study data and
provide support to the theme development. The participant quotes are italicised and
will be documented by the line number the quote commenced in the transcript. If
data unrelated to the theme was then discussed within the quote, it will be left out
and be represented within the quote by three ellipses (…) in the transcript text. Often
participants would discuss a concept, go on to something else and then come back to
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the original thought. As the quotes are taken out of context, if any clarifications on
exactly what the participant is referring to are needed, they will be placed within
brackets in the quote. As per APA guidelines, each developed theme will only be in
“quotation marks” until explained. Table 4 demonstrates a summary of the themes,
subthemes and sub-subthemes comprising Walking the Low Road.
Table 4. Summary of themes one to five of the study findings; demonstrating central organising
concepts, subthemes and sub-subthemes developed from the study data.
Theme

Central organising

Subthemes

Sub-subthemes

concept summary
1. Piecing

Experiencing or dealing

What’s happening? Pieces

•

Seeking help

Together the

with the initial

start to form

•

“Brushed off”

Puzzle

neurological symptoms,

•

Exposure to vulnerability –as

seeking help for them,

the pieces form

undergoing tests and being
told the diagnosis of

Tests, tests, tests (the puzzle

RRMS

starts to come together)
The puzzle is complete (the

•

Vivid recall of the diagnosis

day my life changed forever)

•

Relief at the diagnosis

•

Disclosing to others

•

With-holding disclosure

2. (Re)

Making sense of the world

Getting acquainted with

defining Me

with a diagnosis of RRMS,

RRMS

Now That I

working out how to

Dare to compare

Have RRMS

manage life, family and

Negotiating normalcy,

•

I think I’m normal, aren’t I?

community, balancing the

disability and independence

•

How others see me

•

Maintaining independence

•

To be or not to be (a parent)

•

Breaking the news to

losses and the gains
Working out work
Parenting with RRMS

children
•

Impact of RRMS on
parenting

•

Parental losses

•

Joys of parenthood
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Balancing losses and gains

•

Battling losses

(my life plan (re)defined)

•

Accepting gains

Facing fears

•

Fear of symptoms/relapses

3. Battling

The battle of negative or

the Demons

difficult emotions that can

•

Fear of DMTs & side effects

get in the way of life

•

Fear of progression/disability

enjoyment, threaten

•

Fear of the wheelchair

•

Worry about being a burden

vulnerability and steal
away joy
Weary with worry and anxiety

Depression and despair

to family
•

Existing with Anxiety

•

Dealing with depression

•

Face to face with despair and
hopelessness

Struggling with the saboteurs
4. Surplus

Suffering over and above

Surplus Suffering inflicted by

Suffering

that imposed by the

HCPs in clinical care

•

Coping with uncertainty

•

I’m never free from RRMS

•

Social isolation

diagnosis and disease state
of RRMS and often

Surplus Suffering inflicted by

inflicted by others

“brush-off”
Surplus suffering inflicted by
HCPs in research care
Surplus Suffering inflicted by
family, friends and
community

5. High

The presence of invisible

Striving to make the invisible

•

Please see me

(In)Visibility

symptoms which cannot be

visible

•

Exposing the “secret one”

misunderstandings, but

When my RRMS isn’t

•

I’m not enough MS for you,

may also provide a refuge

enough- reverse stigma of

from chronic illness

RRMS

seen by others and cause
chaos and
devaluing the impact
•

A “pretender to the throne”

Invisibility as a welcome
cloak- the downside has an
upside
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Theme 1- “Piecing Together the Puzzle”
It’s silent, it’s dark
I try to sleep but the burning pain stops me
Where is this coming from?
This pain stopping me being able to see
Do I get some help or see what happens?
Risk sounding silly and complaining
Or hope it goes away
It goes away, there it goes, it settles again
I no longer have to worry
Hold on... back it comes
I’ll need a day off work again
They will wonder what’s wrong with me
The problem is…I don’t know
What you say, what is this?
It is MS, of that they now are sure
What does that mean, how will things be?
Regarding that, no-one can tell me
I don’t know what to expect
How to act, what to do
What’s going to happen, what’s true
But I’ll keep going, keep getting up
And hopefully I’ll get through
TB
The central organising concept for the theme “Piecing Together the Puzzle” is the
participant’s recall of experiencing initial neurological symptoms, seeking
professional help, undergoing multiple tests and finally being told that RRMS is the
most likely diagnosis. The theme is anchored by the notion that diagnosing RRMS is
essentially about putting together a puzzle piece by piece, as symptoms are initially
often vague and remitting in nature. After confirmation of the diagnosis, the theme
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then explores dealing with the immediate aftermath and impact of the disease. Often
the journey to diagnosis involves exposure to intense vulnerability, and for some,
involved long periods of waiting time before an answer was given. Most study
participants vividly recalled the day they were diagnosed formally with RRMS,
dealing with their own feelings and emotions and also negotiating disclosure of the
diagnosis to others. The theme of Piecing Together the Puzzle involves three distinct
subthemes as the puzzle starts to materialise and progress: “What’s happening?”
(pieces of the puzzle start to form), “Tests, tests, tests” (the puzzle comes together)
and “the puzzle is complete” (the day my life changed forever) the first and third
subthemes having several sub-subthemes to provide further clarity.
The time prior to a diagnosis of RRMS is often burdened with challenges, with
research suggesting that the period from the onset of symptoms, to when diagnosis is
delivered is a time where communication challenges between PwMS and HCPs are
particularly heightened (Thorne et al., 2004). This was certainly the case in the
current study, where almost all participants faced challenges communicating with
various HCPs, including family doctors [known in Australia as General Practitioners
(GPs)], along their journey to the diagnosis of RRMS. Participants were desperately
trying to make sense of strange and frightening symptoms, and often went on to seek
the help of a GP, who may or may not have been actively thinking about or aware of
the symptoms of, a diagnosis of MS. The diagnosis of MS is always challenging and
generally there may be poor awareness of MS by GPs (Hinton & Kirk, 2015).
The vagueness and intermittent nature of symptoms also plays havoc with the
diagnostic process, patients seeking help to legitimise their symptoms and the HCP
trying to piece together the puzzle, sometimes on very limited evidence. For several
of the participants in the current study, the process of being investigated for, and
diagnosed with RRMS, was viewed as traumatic and left a lasting impression.
During our interview, several participants cried or became distressed as they recalled
the time of diagnosis, and some participants were visibly distraught. For some of
these participants, the diagnosis was decades prior to the study interview, but they
recalled the event in fine detail and with much emotion.
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What’s happening? Pieces of the puzzle start to form
Recent research from Hinton and Kirk (2017) in the field of paediatric MS found the
process of diagnosing MS to be lengthy and frightening, with the involvement of
multiple HCPs, each giving conflicting opinions, different labels and expressing
professional uncertainty, further intensifying parental anxiety in the possibility of the
diagnosis. Uncertainty was a recurring theme, and similar to many participants in the
current study, making sense of being ill and experiencing symptoms without a
definitive diagnosis was difficult. Interestingly, previous work has also reported that
PwMS had trouble differentiating MS symptoms from routine ailments and found it
difficult to know exactly when to go to the GP for advice, regardless of the severity
of their disease (Moriya & Suzuki, 2011).
Pieces of the puzzle were the little clues that something was amiss, but usually in the
beginning never progressing to the thought that this could be a sign of a chronic
neurological disease. Usually, but not always, the initial symptoms (the first pieces
of the puzzle) were sudden in onset, were vague in nature, stayed around a little
while and then disappeared. They were not severe enough to prompt a visit to the
doctor or to seek help at that point, but nonetheless they caused some worry for many
participants as they described feeling “different”. At times, participants wondered if
they were imagining symptoms, self-diagnosing that they were sleep deprived, too
busy or too stressed at work. Sometimes symptoms were forgotten about, only to
resurface as memories at a later date when HCPs questioned directly about vague
and unexplained symptoms in the past. Participants such as Ruby suffered vague
symptoms at first, Ruby’s symptoms coming on after a plane trip which led to her
reasoning that the sensory leg symptoms she was experiencing were related to flying.
Ruby did not to seek medical help for some time after this first event.
One of my first symptoms…the calves got very tight and tingly and numb…that lasted
a couple of years…I thought it was just the flight…because it happened on the
flight…then when I got home I could walk fine, it was just uncomfortable…it must
have been a year…two years…the first sign that things aren’t going quite so well.
Ruby line 288
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Others experienced long periods of remission after the first symptoms disappeared,
times of silence and seemingly, no connection between the various symptoms. Paul
did not link any symptoms of the “funny” episodes he was experiencing, mainly
because they occurred several years apart. The medical staff Paul had consulted
along the way did not link the episodes together either.
I had L’hermitte’s (an electric shock-like sensation along the spine when moving the
neck forward)…it only lasted a couple of days…but it was a really funny feeling…a
bit odd…it lasted a couple of days and disappeared…a couple of years later I had
optic neuritis and it (my vision) just went completely white…I went to the
ophthalmologist and he gave me some prednisone…he said it was probably a virus.
Paul line 15
Susan described initially being a bit concerned with the sudden onset of her first
neurological symptoms, but made a self-diagnosis of sleep deprivation as she had
been working on night shifts.
I was at work one night and I thought my legs feel funny, it’s a bit numb at the
calf…maybe I just need to sleep…it went on for a few days. Susan line 151
For some, the background pieces of the puzzle, the symptoms, became harder to
disregard. For others, new symptoms, new puzzle pieces, appeared and could not be
ignored due to their intensity and severity. For many participants in the study, this
was the time that they decided they had to tell others about the symptoms they were
experiencing and to seek help. For many, the GP was the first port of call, and then
participants described the response as being “brushed off” by being ignored or the
symptoms minimalised, left in a holding pattern with recognition but no plan to
investigate further, or referred on to a neurologist.

Seeking help
Most participants were stalled at the start of their MS journey for varying periods of
time, but eventually found a HCP who recognised that RRMS might be a possibility
and referred them on appropriately. Very few study participants were fortunate to be
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referred on early to the appropriate professional and begin the journey to a RRMS
diagnosis promptly. After initially seeing her own GP who trivialised her symptoms,
Susan sought alternative help for her vague sensory symptoms from an
acupuncturist, who gave the help she needed. The acupuncturist (also a GP) realised
there something serious was happening, refused to treat her with acupuncture, but
referred her on to a neurologist. Piper had been unsuccessfully trying to have her
vague symptoms diagnosed for many years with local GPs in her country town, but
exasperated after yet another neurological event, sought advice from a HCP
girlfriend who immediately recognised what this could be.
(for help with sensory symptoms) I went to this acupuncturist, an old Chinese
man…he said I’m not going to touch you, I want you to go and see a specialist…a
neurologist…and I said “I’ve been going to my GP and he’s not listening to me, he
thinks nothing’s wrong with me”…the acupuncturist was also a doctor and referred
me on. Susan line 176
I called my girlfriend, she was a doctor…she straight away said…”it sounds like MS
to me…I can’t believe nobody has sent you for an MRI”…(she referred me to a
neurologist) and she (neurologist) diagnosed me straight away…I was probably
lucky…a lot of people have to wait years and get pushed around from pillar to post.
Piper line 556

“Brushed off”
“I was becoming more and more anxious, knowing there was something wrong but
people were just brushing me away”. Piper line 506
Almost half of the participants in the current study described being “brushed off” in
their initial encounters with HCPs, meaning that they presented and described their
symptoms, but weren’t taken seriously or investigated any further. The term “brushoff” is more formally defined as rejection or dismissal in which someone is treated as
unimportant (Oxford dictionary, 2017). For several participants, this was their first
encounter with the hospital/medical system and they simply did not have the health
literacy or the awareness to request and insist on investigative tests or a second
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opinion. Health literacy is a multidimensional concept referring to a person’s ability
to acquire, understand and use information about health and health services
(Batterham et al., 2016). Health literacy is important as people possessing health
literacy often have better health outcomes than people with low health literacy
(Berkman, Sheridan, Donahue, Halpern, & Crotty, 2011), a skill which could effect
the entire life journey living with a chronic illness such as RRMS. Participants in the
current study already possessing greater health literacy moved on quickly to other
HCPs after initially being brushed off, and were subsequently diagnosed with RRMS
not long afterwards. Other participants tried to help themselves when told nothing
was wrong by their HCP, by increasing or decreasing exercise, changing work hours,
reducing stress, anything to help the strange and unexplained symptoms they were
feeling.
Recent studies in adults exploring the diagnostic period and diagnosis delivery in
RRMS are lacking, although some recent paediatric studies exploring these themes
have shone much needed light on this topic. Hinton & Kirk (2015) explored the life
experience of children with MS and found that many early symptoms of MS are
misinterpreted, because they are vague and non-specific in nature. Parents began to
feel unease as symptoms returned and the realisation struck that something might be
wrong with their child. Communicating these concerns to HCPs was met with a
variety of responses, some meeting expectations to investigate symptoms further and
others not. Parents also expressed difficulty in communicating symptoms that were
intangible and without physical evidence (headache, sensory symptoms) and many
felt as if they were dismissed by the HCP. These findings present a very similar
pattern to some of the adult participants of the current study.
Piper suffered for many years struggling with her unexplained and undiagnosed
symptoms, her situation exacerbated by living in a small rural town where there was
a constant stream of GPs coming in and out for short periods of time, offering little
continuity of care. Piper describes being regularly brushed off by the GPs when she
presented with her symptoms and how it made her feel. At times she felt like she was
“going crazy” and spent many sleepless nights during a severe relapse just prior to
her RRMS diagnosis, worrying about what might be happening to her.
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You feel like a hypochondriac because you are always at the doctors and nothing
ever found. Piper line 251
The doctor said “there’s nothing wrong…you know, go away”…I went to a few
doctors actually…I feel like a fraud because I can feel these things…I’m not
dreaming it…I was really struggling to grip and turn…no strength and I was told it’s
cold, because this is winter go home and put some gloves on…it actually makes me
cranky because I’m not making it up…I know what’s normal. I said” I think there’s
something neurologically wrong with me” and she said “no there’s not, there’s
nothing wrong with you”...new doctors would come and do a 12 month stint and
move on…I feel like a fraud because I can feel these things…I’m not dreaming it.
Piper line 407
Susan, a HCP herself, consulted her long time family GP and requested a referral to a
neurologist on numerous occasions, but her GP ignored her symptoms and did not
provide the referral.
(My GP) he’s not listening to me, he thinks nothing’s wrong with me and I’ve asked
him “could you send me to a specialist because I think something’s wrong” but he
kept pushing it aside saying “no, you’re fine, you’re fine”. Susan line 184
Margot also felt like she was not listened to when seeking help for continuing vague
sensory symptoms in her legs. She had waited a long period of time, firstly for an
appointment with the neurologist, and then for an MRI scan. Margot was keen for
some answers to explain what was happening.
I saw him (neurologist) and he said “there are a couple of spots on the spine…so I
think it’s a virus”…in hindsight, as if he patted me on the head, well off you go,
nothing wrong with you, it’s only a virus. Margot line 309
Joy had experienced a childhood where her mother had taken her to the doctors
repeatedly for her many symptoms, but her mother was known in their small town as
a “Munchausen’s mother”, so Joy felt the backlash of that label as she tried to piece
together the puzzle of the mysterious symptoms plaguing her. She feared nobody
162

would ever take her seriously and investigate what was happening; in the end she
gave up and lived in silent agony for many years.
I was sick…and they just treated Mum like she was a Munchausen’s mother…they
thought she was crazy, so when I went to the doctor’s and said “I’m sick” they just
believed that this is the child of the Munchausen’s mother, well of course she’s going
to be a hypochondriac. Joy line 375
The form of brush-off discussed in Piecing Together the Puzzle relates only to the
time in the lead up to the RRMS diagnosis. The concept of feeling brushed off will
be explored again in a later theme “Surplus Suffering”.
Exposure to vulnerability as the pieces form
Previous studies in the adult population of PwMS have supported the theme of
vulnerability when dealing with MS, which was also experienced by many of the
participants in the current study. Isakkson et al. (2006) used content analysis to
investigate the illness experience of PwMS from onset of symptoms to diagnosis,
interviewing 61 PwMS (type not specified). Findings from the study revealed that
when initially diagnosed, most PwMS perceived disablement and death to be their
future with MS. The lack of efficacious MS DMTs available over a decade ago may
have strongly influenced this perception. Participants in that particular study also
reported that MS was a disease that no-one talked about after the diagnosis. It is
possible that the changed perception nowadays to openly discussing the disease is
because of current levels of patient education, internet availability of accurate and
up-to-date information and social media support. However, participants in Isakkson
et al.’s (2006) study did report that the period from symptom onset to diagnosis was
stressful, exposing them to immense vulnerability, as most of the participants in the
current study also experienced. It appears the concepts of a decreased time between
symptom recognition and the introduction of DMTs have not changed these feelings
in this population.
For several participants in the current study, the onset of symptoms provided the
PwRRMS their first experience in hospital or with specialists, and many were
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overwhelmed by this experience and felt intensely vulnerable. Participants felt anger
and mistrust when they felt they had not been taken seriously or brushed off with a
dismissal or a psychosocial explanation. However, other participants felt confidence
in the HCP when they were treated kindly and offered support through the process.
An earlier study found that many PwMS were treated for depression and emotional
issues prior to their diagnosis, and it was common for PwMS to feel like they were
“going crazy”, were hypochondriacs or that they were imagining the symptoms
(Russell, White, White, & Parker, 2006). For some participants, just the validation
that they weren’t “going crazy” and that something was physiologically wrong, was
all the support they needed.
The early days of unexplained and strange symptoms led to intense vulnerability as
several study participants struggled with whether to let anyone else into their world
and share the load of worry, or whether to just keep pressing on and hope things
would settle down. Periods of symptom remission often confused them and made it
hard to work out what to do, if anything. Alternatively, for participants such as Piper,
earlier visits to the doctor without any resolution had led them to feel that they
weren’t coping with life and the fault lay firmly within them.
I got to a point that I remember laying in bed one night…I was becoming more and
more anxious with it, knowing there was something wrong…and I said “I really think
I’m going crazy…I must be going crazy like the doctor’s think I am”…in the end I
gave up almost…they can’t find anything wrong. Piper line 506
Even with intense and dramatic symptoms, some participants reported that they kept
things to themselves, worried they would expose their vulnerability, not be believed
or not be able to explain their symptoms well enough to be understood. Participants
described how the symptoms could be frightening and scary, occur without warning
and leave most of them clueless as to what could be causing the symptoms. Trying to
pretend nothing was wrong and keep the symptoms secret from her work colleagues
failed for Davina, exposing her to intense vulnerability when the symptoms suddenly
took hold.
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So, a year to the day (after the first relapse) I was at work again and every time I
bent my head…I got this strange sensation down my back and in my feet…and I
ignored it…and I felt like I had a really tight belt on...it just got…worse…and they
had to put me in a wheelchair and take me to emergency. Davina line 410
After initially seeking help, the investigative phase also led to feelings of
vulnerability for participants, wondering what it could be, what was happening or
what they possibly did to cause the symptoms. Many participants recalled this period
in their lives, expressing emotional pain and distress, at being given no immediate
answers to quieten their minds. Susan, working as an HCP, intrinsically knew
something was wrong whilst she was undergoing nerve tests and feared the
symptoms were a result of something she had done, she wasn’t told the diagnosis for
several weeks after testing.
I got in and they said…well, something’s not right here…and they got a doctor to
come in…but they would not say anything to me, everything was hush hush and I
could tell something wasn’t right…and I thought…did I do something when I bunjee
jumped?...I was so scared. Susan line 219
Other participants put the symptoms aside as they remitted and forgot about them
and moved on with life, not sharing their experience with anyone else. At the age of
18, Will had some initial tests after some neurological symptoms but never went
back for follow-up after his first episode resolved and never told anyone else about
them. As a teenager with no parents and little close family around him, he felt
vulnerable and uncertain without close support of others.
I never went back for results…I forgot all about it…had I followed up back then
probably I would have been diagnosed much earlier…but just…young…naïve…there
was always something in the back of my mind that something was wrong…in my
early teens I could always run but if I stopped, I couldn’t run again…I am telling my
foot to do one thing but it’s not doing what I’m telling it to do…I never told anyone
about it. Will line 506
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For those lucky few participants (such as Jane) who were sent to an MS Specialist
neurologist early on in the journey through the medical system, there was mostly a
rapid diagnosis of RRMS made and a treatment plan commenced. For several
participants, specifically Rudi and Davina, being transferred to a specialist caused
further frustration as they were brushed off yet again, or sent on their way with no
real answers or guidance.
(the neurologist told me) “your symptoms sound like it might be MS…but it isn’t
conclusive…before we go any further, you’ve just married, have your family and
once you have children, come back and we will do the next phase”. Ruby, line 49
He (the neurologist) told me I was a textbook case of optic neuritis and a severe
one…he said he knew I would go home and look it up, and that it was a symptom of
MS…but I wasn’t to panic because I had no other indications of it. Davina, line 389

Tests, Test, Tests…the puzzle comes together
Although diagnosing MS earlier is advantageous (with efficacious DMT choices to
alter the course of the disease), it is more important to be correct in the diagnosis
(Giovannoni et al., 2016). Meticulous care should be taken to exclude the many
conditions that mimic MS, and this can take time and patience (Aliaga & Barkhof,
2014), which is hard to explain to a patient experiencing symptoms. What is now
emerging is that MS has a variable and sometimes long pre-symptomatic phase of
years, potentially decades, and this may include a significant amount of cognitive
deficit (such as issues with information processing and memory) (Giovannoni, 2016).
Possessing cognitive deficits could also hinder PwRRMS in coping emotionally with
the long and arduous diagnostic process because of these issues with information
processing. However, a frank discussion from the HCP and MS Nurse about the
reasons for the careful and thorough testing at the beginning of the journey could
potentially change the goals of the journey for PwRRMS and significantly lighten
their emotional load.
For some participants, the constant stream of tests and more tests was a trial in itself,
trying to find the elusive answer to what was happening. Many participants recalled
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this time as challenging and difficult as they played a game of test, wait, doctor,
another test, more waiting, another test, doctor again and hopefully, but not always,
an answer. Evie, Paul and Will describe the ongoing barrage of tests over extended
periods of time, which still did not always conclude in a definitive diagnosis.
My GP said…straight to a neurologist…go…then that led to two years worth of tests,
which are just the worst…lumbar punctures and electrode tests. Evie line 525
(I took myself off to the hospital to have it checked out) I ended up having an
angiogram, I had a colonoscopy, an endoscopy they did everything to find out what’s
going on…(with no answer), but I went back to the doctor and said “something’s not
right”…Paul line 63
I was in hospital for 4 weeks, I wasn’t recovering…I was having MRIs, tests…I was
diagnosed with sarcoidosis…nothing was happening…then I had test after
test…biopsies behind the eye…it was just so hard…I had a breakdown…I hid it from
everybody…I was released from hospital without a diagnosis. Will line 683
Piper describes having numerous tests done but they were not appropriate tests to
determine a diagnosis of MS. She had test upon test, but never once a simple
neurological examination, even though the majority of her symptoms were sensory in
nature.
I had all the tests under the sun. Piper 131
I’ve had everything and they can’t find anything wrong. Piper line 259
Because she (diagnosing GP) did a lot of the neurological things that the neurologist
would do…nobody had done any of that to me, nobody had checked for sensitivity.
Piper line 573
Other study participants suffered the opposite experience, with no investigations
what-so-ever. Joy pleaded for most of her life to be investigated, when she developed
new symptoms and when she experienced blindness and deafness, but to no avail.
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Finally, there was one participant, Rudi who had testing completed but the results
were either ignored or misunderstood by her HCP. Rudi recalls reading her MRI
report herself and noting the comment that it was likely demyelination given her age
and sex, and yet was diagnosed with migraines and sent away, only to be diagnosed
with RRMS years later after a relapse so severe she was admitted to intensive care.
They couldn’t work out what caused it (blindness) they didn’t really do a barrage of
tests, they couldn’t understand, again, they didn’t believe me. (and later on) they
weren’t really interested, they didn’t believe me...I was a fruit loop, they thought I
was crazy. Joy line 130
Even though the MRI report indicated that I had lesions, demyelination, consistent
with my age and female…the report was saying…he (neurologist) treated me for
focal migraines and I slowly got new symptoms. Rudi line 92

The puzzle is complete- the day my life changed forever
It was only about 30 years ago that it was discussed in the medical literature the
merits of even telling a patient that they had MS. In some cases it was advised that
this was not always a good idea, potentially causing unnecessary upset and stress in a
disease with no cure (Sencer, 1988). Two decades later, research into receiving a
diagnosis of MS reported that PwMS often felt intense feelings of abandonment and
isolation from their neurologist following their diagnosis of MS. Most often this was
likely because they were sent away with no plans for follow-up or treatment
(Johnson, 2003). This was not replicated in the current study, possibly because there
were no, or limited, treatments for RRMS in the years prior to the earlier study
reports and no need to be reviewed again by the neurologist, with family doctors and
community care taking over care in many cases. However, this has changed greatly
in recent years and now close follow-up care after diagnosis and commencement of a
DMT is expected by the Neurologist and MS Nurse, and crucial to ongoing
management (Giovannoni et al., 2016). Imparting a diagnosis of MS is the start of a
transition between HCP/MS team and the PwMS, which needs to provide
information, offer advice and continue support in an ongoing manner (Johnson,
2003).
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Vivid recall of the diagnosis
For several participants in the current study, recalling the day they formally received
their diagnosis of RRMS was fraught with emotional distress; for some it was the
method in which the diagnosis was delivered and for others it was recalling the lack
of support or information received afterwards. It has been reported that the day of
MS diagnosis can be recalled by PwMS vividly and with a great deal of emotion and
detail (Isaksson et al., 2006; Solari et al., 2007; Malcomson et al., 2008; Solari et al.,
2014). This highlights the importance of the conversation and the amount of effort
the HCP needs to invest in the consultation. As highlighted in previous sections of
this theme, sometimes PwMS have been waiting years (and occasionally decades) for
a diagnosis and most often the diagnosis will come from a Neurologist. The power of
this interaction and the potential impact on the future life of the PwMS cannot be
underestimated. PwMS have reported frustration with the vagueness of the diagnosis,
lack of commitment, and lasting negative impressions of the HCP (Malcomson et al.,
2008), themes strongly supported by several participants in the current study. An
honest, frank discussion from the Neurologist/HCP explaining the reasons for the
delays of making the diagnosis, the need to be certain of the diagnosis, the
difficulties in prognostication, together with the potential for hope and the power of
current research, could counteract much of this negativity and set the PwRRMS on a
more hopeful and positive path for the future.
All study participants recalled in detail the day (and the way) they were diagnosed
and given the news that the symptom cluster and diagnosis of RRMS was confirmed.
Participants recalled how they felt as the words “MS” were verbalised, sometimes
for the very first time. Some participants were alone when they received the news,
others had the support of others, but no matter the circumstance, the day is firmly
etched in their memory. Even though it was over 20 years ago, Evie recalled what
she believed were the exact words from her neurologist.
I remember the day I was diagnosed (20 years prior)…I remember the exact
wording…he said to me “ I think you have a mild case of MS”…and I went “Oh
OK”…I knew it wasn’t good, it could have been bad…”there is potential for it to be
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very bad”…I wasn’t scared, I wasn’t upset, I wasn’t angry…so OK…what do we do
about this? Evie line 567
Rudi recalls how she felt as the diagnosis was being delivered, as sensory symptoms
started to ascend in reaction to the stress she was feeling as the words she had feared
became reality.
And she (the neurologist) was starting…I knew where she was going and I could feel
the numbness coming in my face, I remember that vividly…and then…I had the
wheelchair in mind. Rudi line 1616
After months of waiting for a diagnosis, Will begged his neurologist to tell him the
diagnosis over the phone, and so he was in his car in a garage on the side of a major
freeway when he heard the news that he had RRMS.
(the neurologist rang and he wanted me to come in) I said “can you tell me now
because…it’s killing me…I’m waiting for your call”…so I pulled over to a garage
and he said “this is most likely what we’re going to have to…the route that we’ll
take”…I wanted him to tell me…he said “I can’t tell you over the phone…I cannot
have that conversation with you”…but I said” if you don’t…I’m not coming
in…what are you going to do?”. Will line 755
For many, having solved the puzzle and leading to a diagnosis of RRMS left them
deeply wounded by the revelation. They felt the covert message from the HCP was
this is your new life, accept it, move on, I’ve done my job now. This was
heartbreaking for some, and was the start of a difficult relationship with RRMS and
with their HCPs. The manner in which the diagnosis itself was delivered caused utter
devastation for both Kate and Davina, who can both clearly recall the encounters
over 20 years later.
The first thing he said to me was “you know what, I think you have MS”… I
said…”oh what does that mean”? Because I had no idea what MS was … and he
turns around “and you may end up in a wheelchair and you will probably be blind in
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five years time”… I said “I’m only going to be 27 and I’m going to be blind?”…and
I was a mess. Kate line 234
The consultant I wanted to see was away so the one I had (in hospital) stood at the
end of my bed and said “it’s 99% definitively MS because you fit the sex, the age,
your symptoms are very textbook…so I suggest to you that you think about your
future and perhaps if children were something you were looking forward to, it might
be something to think about now, because better to be a disabled young mother than
a disabled older mother” (starts to cry)…I was distraught. Davina line 467
Other participants felt resentment at the diagnosis and a sense of unfairness,
particularly Rudi who felt a sense of anger upon hearing the news.
Even though I read the report…after I was diagnosed I became very angry…
(another friend with MS) say’s it’s relief…but I didn’t find that, I wasn’t researching
anything…it didn’t come as a complete surprise...later Mum went down and got
some pamphlets…”Mum” I said “you can stick these up your arse, I don’t want to
know anything about it”, I was at that angry stage…I don’t want to know. Rudi line
777
Griff was grateful to have a diagnosis after many years of trying to find the cause of
his symptoms, but didn’t feel as happy as he thought he might in finding an answer.
Solving the puzzle was “cold comfort” for what lay ahead.
I feel like death warmed up…then I have a name to it…but it’s a cold comfort…
because the name comes along and all of a sudden, now I have “it”. Griff line 1312

Relief at the diagnosis
Although some participants felt devastated at their diagnosis of RRMS, and others
felt anger, some participants felt a sense of relief. Making downward comparisons is
very common, both in the lead up to diagnosis, and in the immediate period
afterwards (Taylor, 1983). Downward comparisons happen when patients compare
themselves favourably with the lives of others whom they believe to be worse off
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them themselves (Taylor, 1983). This was echoed on multiple occasions in the
current study as participants pieced together the puzzle themselves; fear of having a
brain tumour, cancer, motor neuron disease (MND) or permanent blindness were
common, and felt to be a far worse outcome than MS. Perhaps this was a coping
mechanism which assisted participants survive the period from symptom onset to
diagnosis, and beyond. For several participants, the day they were diagnosed with
RRMS was a day of relief and the puzzle was solved, and in their minds, solved in
their favour. The fact it was RRMS brought a lightening of their burden and
possibilities for the future. Piper, Margot and especially Joy had all imagined
illnesses they considered worse than RRMS and were grateful to have an answer
they considered to be less of a burden.
I said (to the neurologist) thank you…I was relieved…I was relieved that I wasn’t
going mad. Piper line 614
You go through every scenario…what could it be…could it be cancer…and I don’t
think MS came to mind really…I was thinking motor neuron disease…so I was really
quite worried…two to five years of expectancy…it was a relief…thank goodness it
wasn’t MND. Margot line 385
I said what have I got again?…and he said “MS”...and I said “is it going to kill
me?”…and he said “no”…and then I said “you’ve just given me my life back
again…I’m laughing yes, I’m not going to die from this”…I don’t have to line up
foster care for my son, I can finish raising him myself…I don’t have to live in fear
anymore. Joy line 1879

Disclosing to others
Piecing together the puzzle and confirming the diagnosis of RRMS was one thing,
however telling this story to loved ones was another, and often induced feelings of
dread and uncertainty. The journey wasn’t over with confirmation of the diagnosis,
in many ways it had really only just begun. Many participants struggled with sharing
their news, even though they may have been relieved themselves, they were still
mindful that they were about to change the lives of their loved ones forever. Telling
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someone they loved that they had an incurable neurological disease, of which no-one
could tell them where or when the next relapse would strike, how severe it would be,
if they would recover and that they would need to take a medication which could
make them feel worse, or do serious harm, was a mammoth task. They would often
have to put their own feelings aside so they could comfort others, and sometimes this
came at a high price for their own mental health.
Most participants were diagnosed between the age of 20 and 40 years and were
reluctant to tell their parents of their diagnosis for fear of worrying and upsetting
them, particularly if parents were elderly and would base their understanding of MS
on that of years ago, when wheelchair scenarios were common. This was especially
difficult for Susan, who had to halt her own intense feelings, to deal with the hurt and
responsibility her parents felt upon learning her diagnosis.
I think they (Mum and Dad) didn’t understand it…they were very emotional and
blaming themselves…how could this happen? It was very emotional (and Dad)
sobbed like a little boy…I didn’t show any emotion, I held it all in because I had to
be strong for them…that didn’t help me because it delayed my grieving and delayed
me dealing with it because I was trying to be strong for Mum and Dad. Susan line
374
This time was also difficult for Davina, whose diagnosis of RRMS caused a family
rift. Davina’s uncle, who was diagnosed with MS decades prior, had been hidden
away at home and denied the diagnosis of MS by his family, associating the disease
with shame.
I also had my two families…my father’s family and my mother’s bickering about
whose fault it was genetically…so that was a bit hard to deal with and I was in the
middle...and my mother was frightened…because on top of all of this I had an uncle
who had MS and was wheelchair bound…so that was a lot for my family…because
my grandmother used to tell everybody he had a head injury when he fell off a ladder
and he didn’t have MS. Davina line 568
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With-holding disclosure
Other participants held the diagnosis close and from diagnosis to retelling their story
to me, told only the bare minimum number of people they needed to. Paul had still
only told his wife, his parents, his brother and his work boss of his diagnosis, not one
other friend. Paul says he doesn’t need other people worrying about him, he does
enough of that himself.
Not many people know…I told my CEO…nobody else knows…I much prefer it that
way…no friends know…I just get enough canoodling from Mum, I don’t need any
more, that’s enough you know…I’m reminded enough of it as it is. Paul line 994

What next?
Now that the pieces of the puzzle have completed a picture of RRMS, it was time for
the study participants to work out the next step on the journey of living with RRMS.
However, just because the puzzle was solved for now didn’t mean that it was solved
forever. The unpredictable nature of living with RRMS ensured that new pieces of
the puzzle were very likely to form, at any given time in the future, and often
suddenly. The next theme, (Re)defining me now that I have RRMS, begins the story
of how PwRRMS make sense of their new diagnosis and how they move forward in
their lives.

Theme 2 :” (Re)defining Me now that I have RRMS”
Who is this new me I find in my old body?
How do I belong? Where do I belong?
Do I belong? Will I belong?
I didn’t choose to change, it choose me
Finding my way without warning is difficult
I struggle to be
The road isn’t sign posted and I cannot see the lights
Does the old me even exist anymore?
What fate awaits me?
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I need to be, I need to see
Let me try and find how to be me
TB
The first weeks, months and years after being diagnosed are critical for the PwRRMS
to define, or (re)define their identity now that they are living with RRMS. For some,
the confusion and devastation of the diagnosis of RRMS played heavily on their
minds and bodies and they struggled greatly, as discussed in the previous theme.
Others seemed to take the diagnosis in their stride and march on, eager to find out
more about the disease they had acquired and boldly declare that they are ruling it,
it’s not ruling them. How do PwRRMS make sense of the time after diagnosis and
move along on their life path, still the same person, but now different?
After the diagnosis of a chronic illness such as RRMS, people are confronted with
new situations that challenge their habitual coping strategies, strategies they may
have used in past illnesses or times of hardship, and now they must find new ways of
coping (Taylor & Aspinwall, 1996). It has been said that a diagnosis of RRMS opens
the door to uncertainty and variability and has specific challenges (Koopman &
Schweitzer, 1999) as well as extremely complex ones (Dennison et al., 2010).
Additionally, as RRMS occurs in the prime of life, it is likely to leave a strong
psychological imprint, with very real changes in values and beliefs in how the
PwRRMS views him or herself (Irvine, Davidson, Hoy, & Lowe-Strong, 2009).
Defining oneself, or (re)defining oneself, in the face of a newly diagnosed chronic
illness is always difficult, but the challenge is amplified in RRMS where the long
term prognosis of the illness is not known and the future is highly unpredictable.
The central organising concept of the theme “(Re)defining Me Now That I Have
RRMS” is about how the PwRRMS makes sense of the world with their new
diagnosis. This involves discovering more about the disease, working out how to
manage feelings relating to work and finances, relationships, parenting and finally
balancing the losses and gains of now living with RRMS. It is a mammoth task. Six
subthemes presented during the current study, each distinct but sharing the central
organising concept of defining a part of self or finding a part of self in their context
as a PwRRMS. The subthemes that are grouped under the theme (Re)defining Me
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Now That I Have RRMS are: getting acquainted with RRMS, dare share compare,
navigating normalcy, disability and independence, working out work, parenting with
MS and balancing losses and gains, each with further sub-subthemes to provide more
detail and clarity.
Getting acquainted with RRMS
“Diagnoses, especially those that relate to serious illness, mean much more to
patients than simply the identification of a particular disease state. Diagnoses are
permeated with cultural and personal meaning”
(Toombs 1995, p7)
In the time immediately following a RRMS diagnosis, the majority of study
participants were determined to find out as much as possible about their new
companion in life, RRMS. Of course, the uncertainty and unpredictability of RRMS
in general ensured that many questions remained unanswered. For several
participants, this was extremely difficult, as they were provided with minimal
information at diagnosis and received little follow-up care.
Prior to the 1990’s, the MS neurology consult was sometimes referred to as
“diagnose and adios” or “MRI and goodbye”, first coined by Neurologist Labe
Scheinberg at an MS meeting in 1986 (Pearce, 2004). Thankfully MS practice has
moved on since this time, mostly due to the introduction of DMTs. Now the primary
role of the neurologist and MS team is not just to diagnose an untreatable condition
and then say farewell, but to continually assess and monitor after the diagnosis for
the entire life journey with RRMS; to ensure DMT safety, to detect relapses and to
observe for signs of disease progression.
In order to (re)define self, many study participants set out to acquire knowledge of
what RRMS was and what was most likely to happen to them in the future. Most
PwMS find information on MS empowering (Malcomson et al., 2008), but
unfortunately for many, there is a lack of information given at the beginning of the
journey (Rintell & Melito, 2013). This reality applied to several participants in this
study. Kate, Ruby and Davina recall that they were provided with little information
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after diagnosis, no chance to ask questions and no health management plan. A
systematic review addressing the information provided to PwMS following diagnosis
reported that there is growing evidence that information provision can increase
disease related knowledge and may have a positive effect on decision making and
quality of life, with no negative effects noted (Kopke et al., 2014). Information for
PwMS needs to be given in a way that allows appropriate time, repetition, flexibility
and must be individualised according to needs (Krahn, 2014). HCPs also need to be
mindful that the information and resources are appropriate for the individual and take
into account factors such as education, occupation, financial status and social level.
If these factors are not considered, PwMS can be left feeling vulnerable and the
information rejected as useless (Sharifi et al., 2016). This was the case for Jane, who
literally threw the initial information booklet and resources straight into the rubbish
bin. Jane felt that the information provided and the method of delivery did not meet
her individual needs at the time.
Lode et al. (2007) revealed that almost half of their study participants (n=86) were
dissatisfied or very dissatisfied with the information provided to them at the time of
MS diagnosis. As optimising information delivery early in the disease course induces
coping styles that provide a better adaption to living with MS (Lode et al., 2009), MS
HCPs and MS Nurses need to manage this important process in a method which is
supportive of individual needs. A later study interviewed 61 PwMS at their first MS
clinic appointment regarding their on line MS research activity, and discovered that
82% of people in the study gathered medical information on line before their first
appointment, yet only 36% discussed what they found with the physician (Hay,
Strathmann, Lieber, Wick, & Giesser, 2008). This area needs further investigation so
HCPs can stay engaged and aware of information seeking habits of PwMS, to
provide guidance on appropriate, relevant and reputable websites and to truly partake
in shared decision making, based on the same shared information. Careful and
individualised education planning (incorporating written, verbal and electronic
methods) is needed in newly diagnosed PwRRMS, and with reassessment as
necessary along the disease trajectory.
Nowadays typing the words “Multiple Sclerosis” into a Google search results in
almost 29 million “hits” at your fingertips in less than a second. However, there are
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unfortunately no systems in place to advise what is factual and trustworthy
information, and what is not. For someone newly diagnosed with RRMS, possibly
medicated with high dose steroids and dealing with the suddenness and havoc of the
new diagnosis, trying to negotiate 29 million websites and work out what is helpful
must be almost impossible. Many study participants in the current study commented
that there was “a lot of junk” out there and that the sheer volume of information was
overwhelming. Other participants tended to wade though the minefield of
information and narrow down the websites that seemed to make sense to them. A
recent Australian study explored online information seeking in PwMS (n=51, type
not specified) using focus groups (Synnot et al., 2014). The study revealed that all
participants had used the internet for information at some stage of living with MS
and mostly indiscriminately soon after diagnosis. Many participants in this study also
described the dichotomy that exists for MS information; in that they felt there was
too much information in general, but too little information on what they really
needed (Synnot et al., 2014). Worry about parents or children obtaining information
on the internet about a family member with RRMS, particularly if there was a focus
on wheelchairs in MS, also concerned several study participants. This phenomenon
has not been supported by recent literature, however is worthy of further exploration.
There was a great deal of difference between participants in the current study
regarding how they acquired knowledge, depending on the decade they were
diagnosed. Participants such as Davina and Evie, who were diagnosed over 20 years
ago, had to rely on books, pamphlets and phone calls to receive information, others
diagnosed more recently such as Piper and Paul, were able to embrace the internet
immediately. Most participants were somewhere in between, relying on help from
the MSA for initial information, finding others with MS in their local community to
ask questions of, or receiving information from their MS Neurologist, MS Nurse and
local MS clinic, where these were functioning. However, information gathering is
not static, initial information at the start of the journey was sought, but in MS,
information needs are continual and all participants relied on the internet and
websites for their current updates and new information. Some participants such as
Kate, Paul and Will preferred highly scientific websites for their knowledge, but
others such as Ruby and Piper favoured more low-key blogs and real-life stories.
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I just have this…overwhelming…overwhelming thirst for trying to understand reality
I think…I mean there’s a lot of trash out there, but there’s a lot of good stuff as
well…I register with on line scientific journals…at night I don’t have very good
sleep…I get on my phone or my ipad and just read about all this stuff…for hours at
night, every night. Paul line 647
Absolutely yes (I go to the internet)…some of the stuff, I take with a grain of
salt…I’m registered with a couple of scientific journals, I get a bit from there as
well. I hate the MS Australia stuff because it’s all wheelchair shit you know…it’s all
worst case stuff. Paul line 693
Margot also realised that not everything on the internet was factual and helpful; and
was grateful because her elderly parents didn’t have a computer and wouldn’t be
exposed to that information to cause them further worry.
The good thing with elderly parents was that they didn’t have a computer and they
couldn’t look things up on the internet…but everything on the internet, just because
it’s on the internet doesn’t mean that its true…so I’ve kept that in my head… so you
don’t trail for all sorts of quick fixes and horrible stories. Margot line 532
Seminars and webinars seemed to be an effective way for PwRRMS to gain the
information they needed and also garner support to educate their family and friends.
Positives for some participants included the fact that the information was freely
available at a time when it was convenient for them, and in the case of webinars, that
they could do this in the privacy of their own home or office. Susan found MSA
helpful in her quest to learn more about many aspects of her new illness.
I always thought knowledge is power. I joined MS Society because I asked them what
to do, what do I need to do, where do I get my information…I used to go to a few
talks…whatever drug I was on at the time…how to live with MS…anything to help
me. Susan line 448
However, not all participants valued the sources of information in the same way.
Rather than turning towards the information available to them, some participants
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turned away. Not all study participants were ready to take on the wealth of
information in RRMS at the beginning of the journey. Rudi had definite views that
they would acquire information in their own time, when they were ready to do so.
This highlights the importance of gathering and providing information appropriate to
the individual at suitable times in their RRMS journey.
My Mum went down to the MS Society here and got pamphlets…I was sitting there
rolling my eyes and I said “Mum, you can shove these…I don’t want to know
anything about it…I’ve got MS, don’t talk to me about it, I don’t want to know. Rudi
line 797
Jane wished to keep a positive mindset from the beginning and didn’t want
information focusing on negative aspects of RRMS around her.
(after diagnosis) Mum gave me the book about MS…and you end up in a wheelchair
and incontinent…all the horrible things with this…it was a really old book…and I
just binned it. Jane line 105
Following diagnosis, many participants had some sort of contact with the MSA,
whether in person, by phone or internet. However, no participants mentioned any
contact during the diagnostic process. Ruby, Piper and Susan all gained value from
the help of MSA as a professional organisation in the early days of acquiring
knowledge, and Susan also took family and friends along to educate them directly.
The MS Society is brilliant…I used to love the blogs but I can’t handle
negative…(there is also) a facebook page that was a really good site to be on (for a
particular DMT)…I think on line there’s a fair bit but I use it quite discerningly and
I try not to look at too many blogs…there’s a few on there that whinge too much and
I can’t stand that, I know there’s a lot to whinge about, but when you’re feeling low
anyway, it doesn’t really help. Ruby line 995
I went and saw (our local MS Society representative) when I was first diagnosed to
find out whatever information she had. Piper 1793
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I’ve done a few webinars, I love those…just to be updated with anything that’s
new…there’s that much junk out there. Piper 1921
I took a couple of girlfriends and my Mum with me (to the MSA) just so they could
understand what was going on because…they see me as…as I’m OK, they don’t
know what’s going on inside…I wanted them to understand what MS is about. Susan
line 498
Dare to Compare
Another source of information to acquire knowledge to help (re)define self involved
daring to compare oneself to others also living with MS. For some study participants,
there was struggle in deciding whether to engage with the world of MS, or whether
to avoid the world of MS. This was reported by participants in Dennison et al.’s
(2010) study as whether to engage or avoid “the cripple club”. Engaging with other
PwMS and witnessing disability can potentially have three effects: helpful
interactions (support and advice, sharing tips), to be shown the spectre of what may
happen (dare to see) or to not relate at all (compare and not fit in) (Dennison et al.,
2010). Moreover, being with other PwMS can lead to empowerment in the peer
community and to shared resources, a mutual recognition of ability, social relations
and an environment that displays no “stereotyping shame” (Skar, Folkestad, Smedal,
& Grytten, 2014).
Following diagnosis, many study participants described how they needed to see what
RRMS looked like in others, but the participants differed greatly in their reasons for
doing so. Most initially knew very little about what RRMS meant, the little they did
know was through MS read-a-thons conducted in primary schools in Australia many
years previously. If they dared to compare they sought out MSA meetings where
they could meet others dealing with the same disease, or what they thought was the
same disease. Other participants tread more carefully and sought out individuals they
knew through others to gain access to the MS world. This subtheme is concerned
with several aspects: daring to see what was out there in the MS world and seeing
what they may become as a PwMS, comparing themselves on the MS severity scale
and also hopefully learning more about RRMS in the process.
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Whatever their motivation, attending MSA meetings was a common event for
participants to dare to compare in their journey. Some participants went to MSA
meetings solely to make downward comparisons, to prove to themselves that their
MS was less severe and that they compared more favourably than others. For Paul,
this marked an important line in the sand to make sure that he could cope with the
diagnosis. Paul harboured guilt, daring to compare himself against others with MS,
but mostly in the progressive state and not the RRMS type he was diagnosed with.
Paul did this early in his RRMS journey when he was relatively unaffected by
disability. He attended a meeting, knowing the meeting would attract people living
with progressive MS, and in a worse situation than himself. He felt as if he needed to
see the worst the disease could do, and found comfort in doing so. It was part of
daring to see what could happen and comparing himself more favourably against that
outcome. He utilised the information to actively do every thing he could possibly do
to stave off the same future, he (re)defined himself as someone with MS but not that
type of MS.
I don’t know if this is a little bit morbid…(MSA were running seminars)…and this is
the morbid bit…I wanted to see what other people with the condition were like…I
think people that have been more severely affected were probably more interested in
being there…I hope that was the case because it was pretty depressing actually…and
I don’t know if I was going there to be depressed…I was thinking…with everything
I’m reading, maybe this isn’t a very big deal…so I wanted to go and see… this
sounds really terrible, but it was a comfort thing…well, I’m alright. Paul line 1310
Jane also went to a meeting with people with progressive MS, but her experience
was very different, suffering reverse stigma about her own RRMS. Jane’s “dare to
compare” didn’t go as planned.
I did go to a few MS meetings…the first meeting I went to was really depressing and
these young kids who have the other type of MS…we were all just sitting there crying
and I thought…I don’t want to go back to this because this is just too
depressing…and it was like I was the lucky one in the room…it’s almost as
though…well, you’re lucky, it makes them feel even worse. Jane line 202
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Susan also went along to a group meeting, but what started out as an uneducated
glance at her possible future, ended with Susan acquiring new knowledge about
RRMS, which she used to empower herself and move forward. Margot sat back and
watched the reactions of others in her physiotherapy group, as a severely disabled
PwMS began therapy, and felt that everyone in the room was glad it wasn’t them.
The comparisons for them were favourable.
There were a few people in wheelchairs…really bad ones…that scared
me…confronting…I thought…that’s going to be me…that’s how I felt…but then,
doing more reading and research…that’s the worst of the worst…it doesn’t always
have to be like that…everyone’s different. Susan line 506
(on seeing patients in a wheelchair today) I feel OK because I know that I’m not
going to be like that…I’m better…I’m different because there’s all different MS’s.
Susan line 1239
(in my physio group) there’s people there a lot more disabled…they get driven by
community transport and they’re in wheelchairs…there’s a woman…and she has to
be wheeled in…I don’t think she can do much herself at all…there were a few people
with MS around…I just glanced at them…everybody was looking…I could imagine
in their mind, thinking “oh gosh, she’s worse than me, it could be worse”…they’re
probably all thinking “at least that’s not me, I’m better than her at this stage”.
Margot line 2204
Signing up for the nearest MSA meeting straight away was not for everyone and
some participants chose a more measured approach to joining the MS world. Will
avoided others with MS as much as possible, not wanting to compare with them.
When Will attended the day admission centre at the hospital for his monthly DMT
treatment, he carefully avoided PwRRMS, preferring the company of “cancer
patients” also attending the same centre for treatment, who he felt had a better and
happier disposition.
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I stay away from other people with MS …because I don’t want to hear bad stories
and I don’t want to know how other people cope with it, because I believe the way I
cope with it…works for me…I would purposively sit with the cancer patients because
you could have fun with them. Will line 289
Other participants such as Margot and Griff enjoyed their time receiving their
medication in the infusion centre at the hospital surrounded by others with RRMS.
They both expressed their sadness at the loss of their readymade social RRMS
network when their DMT infusions were stopped and they were switched to different
DMTs, demonstrating the experience as a helpful interaction.
Although the majority of study participants sought to dare and compare against
others with RRMS, several participants sought comparing with others who had
difficult life circumstances but were non-RRMS, in an effort to (re)define
themselves. Susan enrolled in a course to help with making positive life plans,
attended by people with mental health issues, loss of family members and other sad
events. Davina was directed to a church group by her Church Minister to help her
come to terms with her own diagnosis by appreciating and sharing the hardships of
others who had been in war zones and lost children. Both Susan and Davina were
able to spend time with people they considered to be worse off than themselves,
helping them to build positivity and to have hope in their own futures.
In that group course, I met lots of beautiful people who had lots of sad stories who
came there to learn, also how to be strong and cope with difficulties in life…people
had lost children or partners or also dealt with illnesses…it gave me a lot of
strength…also people didn’t understand what they were going through, weren’t
listening to them…it’s similar, it’s similar. Susan line 731
(as I struggled after my diagnosis, a Minister) got me in contact with women in the
church where they had been in some really bad situations overseas, where they had
lost children to diseases…older women… it made me stronger. Davina line 1178
Daring to compare for the PwRRMS is an important part of (re)defining self after
their diagnosis. PwMS organising their own network can function as a coping
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system, assisting with stigma and introducing role models who have accepted MS
into their lives and adjusted (Grytten & Maeside, 2006). However, as demonstrated
by participants in the current study, this needs to be the right group for the right
person, there is definitely no “one size fits all” approach. Mixing PwMS of different
types and stages can be disastrous to self-identity and image, as Jane discovered at
her first MSA meeting with progressive PwMS and no people living with RRMS.
Jane recalled how many in the group cried as they heard sad and demoralising stories
and how it left her feeling depressed afterwards. However, when Jane connected with
a group of people living only with RRMS, the situation was vastly different and she
gained much more out of the meeting and left feeling positive. It is important that
MS Nurses are able to assist, advise and educate PwRRMS on how to engage in
meaningful and appropriate social relationships with others living with MS, and how
to negotiate social contexts and comparisons of MS in a fair and realistic way.
Referrals to appropriate sources of support in this regard have the potential to be life
changing.

Negotiating Normalcy, Disability and Independence: what’s what and who’s who
Trying to (re)define self as a PwRRMS led to numerous participants struggling with
the idea of what being “normal” actually meant, against their existing perceptions of
disability. I feel normal, am I normal? What is normal? Am I disabled if I just have
numbness in my little finger? Do I need to be immobile to be disabled? Do you have
to see disability for it to be real?
One way to manage chronic illness is to construct and live a story of “life as
normal”, for people to think of themselves as living a normal life, just with a few
problems (Robinson, 1993). At the beginning of the RRMS journey this can be
particularly difficult, but is possible once the disease is under control, less active and
the PwRRMS has had time to process the changes and acquire knowledge about
living with the disease. Normalisation is a chiefly positive response to illness
acquisition and involves actively adapting to changes wrought by the illness,
allowing resumption of previous roles and responsibilities (Joachim & Acorn, 2000).
Returning to work, or usual daily activities, and minimising disruptions as soon as
possible after a relapse also provided opportunity to assume to live “a normal life”
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(Dennison et al., 2010). Kate demonstrated this repeatedly, suffering a relapse, going
to hospital for treatment, straight to work and home again without telling her family,
much preferring to keep things as normal as possible.
I think I’m normal, aren’t I?
The body of work by Charmaz (1983, 1987, 1990, 1999, 2006) in chronic illness
explains how living with a chronic illness implies feelings of living a restricted life
with loss of the former self image (Charmaz, 1983), sufferers striving to include the
illness in their daily lives and their identity (Charmaz, 2006). Several of the study
participants either still viewed themselves as normal, or tried to give the illusion of
being normal, either to themselves, or to others (or in most cases, both). Some
participants queried what normal was, particularly in terms of vague symptoms such
as fatigue and tiredness. To most study participants, looking and behaving normally
meant not looking disabled to others. Susan took a pragmatic view to negotiate her
symptoms and for Ruby and Kate, the appearance of normal was very important.
I get tired… but I work four days…they’re tough days…and I look after a house, my
husband, a little one who is full of beans…that’s normal…I’m just like a normal
everyday mother doing all the normal things a mother does…and she gets tired.
Susan line 1144
Just normal, I want a normal lifestyle, I want to be able to teach my kids to give…I
want them to be happy…I just don’t want to be in bed…or on the sofa…I want to be
moving. Ruby line 1575
I do make an effort every morning to have my shower, get dressed, put some make up
on…to get my nails done…so I can be a normal person. Kate line 1930
For Davina, the quest for normalcy was so central to her sense of self that it led her
to overachieve, to work harder to be accepted as normal. In contrast, just maintaining
the function of mobility constituted normal for Piper, and is her goal living with
RRMS.
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I would say that since I was diagnosed I have tried harder in everything to be
normal…I have not worked on a normal level, I’ve worked above target…now I am
exhausted because I’ve tried so hard to do that to make myself look normal. Davina
line 978
Being diagnosed has…now I can hopefully control it…I feel more confident…I do
envisage myself…hopefully…never being with a walking aid…so that’s what I’m
hoping for…I think you can live a normal life. Piper line 2017
How others see me - not being defined by my diagnosis
Even if the PwRRMS view themselves as normal and not disabled, ill or sick; if
others look at them differently or treat them as different, frustration and anger can
develop as PwRRMS are judged against their disease instead of themselves. In
essences, others judge them as a person with MS based on what they know about the
disease. Both Rudi and Ruby felt that RRMS had hindered them from appearing
normal to others.
I notice still to this day, that people treat me differently since my diagnosis…I’m fine,
just treat me like I’m normal! So I found that a bit condescending…they look at me
as a person with a disease now, which is a bit frustrating. Rudi line 1435
The hard thing is…when people look at you like a basket case and you lose your
identity…Oh…that’s MS. Ruby line 707
Not wanting to be seen as disabled, Will did not disclose his diagnosis to his
extended family for some time and only wanted to see them in person when he was
at his best and not as someone who appeared disabled.
I only went to see them (extended family) for the first time, two years ago…and I
think I know what it is…being seen, I don’t want to be seen as having a disability…I
think that’s the first time I’ve used that word today…I think that’s the first time I
have used it, ever. I want to be seen as Will, everyone knows Will as the big, strong
guy. Will line 1235
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Dealing with episodic disability presents further challenges for PwRRMS in
negotiating normalcy, possibly being disabled one week with a relapse and not the
next, and can prove a difficult concept to deal with. Most people with episodic
disability inhabit the space between illness and wellness, a space that is fluid,
dynamic and open to change at any time between sick and well, normal and disabled
(Vick, 2013). Thus, they can be living under the appearance of, and genuinely
feeling, normalcy for long periods of time. Additionally, invisibility of symptoms
encourages the belief that the PwRRMS is normal, especially if they look normal to
others and function well most for the time, challenging the notion of what it is to be
disabled (Vick, 2013). For those with episodic disability holding onto the appearance
of normalcy and being reluctant to disclose their diagnosis, stress and worry about
others uncovering their secret was ever-present. Several participants were determined
to present the persona of normalcy and not disclose their diagnosis (to be discussed
further in the next section), hiding their episodic disability and thereby proving to
themselves and to others, that they were functioning as normal. Success in this was
essentially proven if others around them did not notice any issues.
Maintaining independence
Maintaining some degree of independence was extremely important to many study
participants. If they could possibly manage to do a task, they certainly wanted to try.
Asking for help was simply not something that came easily to them. This may be a
reflection of wanting to appear normal to others or reinforcing normalcy to
themselves.
I have plenty of family, everybody’s here…so I’m lucky in that regard I don’t like to
ask people to do anything…I do it myself thanks if I can…I’ll do it myself…it’s only
when I’m really down and out with fatigue and I can’t do much…then I’ll ask for
help…but I will push on if I can. Piper line 1300
It’s hard to ask for assistance…it was hard to ask for help…I didn’t want to seem
needy, I guess. Margot line 1188
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(when I needed steroids) I would do things myself, I don’t really depend on
anybody…you can’t be seen as you’re moaning and groaning all the time…and half
the time (my husband) didn’t even know I’d just had steroids…I did things myself.
Kate line 946
It’s really tough when you go through a relapse and you’ve got to give up your
independence…the simplest thing…that was a big struggle…having to ask for help
for simple things like giving kids lifts and things…I know it’s no hassle because I do
it all the time for people…to do that and ask yourself was a big hill to climb. Rudy
line 1743

Working out Work
Part of (re)defining self for many participants involved negotiating employment and
what their work fututre might look like with their new diagnosis of RRMS. For some
study participants this was a positive experience, and for others a more negative
experience. This proved to be an issue at many times during the life trajectory (not
just in the post diagnostic period) and could be an issue for a different reason at a
different time. For example, a relapse could suddenly bring a new symptom (such as
loss of sensation in the hands) which impacted on work performance. Making the
decision to disclose a diagnosis of RRMS at work was a significant decision for
many participants. For a few participants, secrecy and non-disclosure ensured that
they could maintain control over who knew the diagnosis and allow them to try and
maintain normalcy at work. For others, disclosure meant they were able to secure the
help they needed at work to allow them to keep working and performing in their
position, albeit with some adjustments.
Most participants in the study were still working, part time or full time, only Kate
and Griff (not by choice) and Margot (by choice) were not currently employed. The
situation in regards to MS and employment in Australia appears to be improving,
with a recent longitudinal study of 1260 participants suggesting that employment
rates for PwMS (type of MS not specified) increased over the study time period 2010
- 2013 compared to the general population and was thought to be related to positive
organisational responses to work adjustments and work roles for PwMS (van Dijk,
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Kirk-Brown, Taylor, & van der Mei, 2016). However, the news was not as good for
men living with MS, as the data showed that male unemployment rates in MS remain
significantly lower than the general population (van Dijk et al., 2016).
Rudi needed over 2 years off work to recover from a severe MS relapse and recalls
her feelings from this time and how she turned it around into a positive (re)definition
of self.
When I lost my job I thought…I can be down and think that I’m unemployable, I
can’t work…or the path I chose to take was well, work’s always going to be forever,
the kids are going to grow up and I need to look at this as I’m lucky because I get to
spend this time with my children…whilst it was tough financially, we adapted. Rudi
line 944
It has been reported that fatigue, cognitive difficulties and mood disorders may have
an enormous impact on work ability for PwMS (Sterz et al., 2016). A recent study
exploring the meaning of work in the lives of PwRRMS found that becoming
familiar with the disease, adjusting expectations, having a supportive, realistic
manager and seeing work as meaningful, were all helpful in facilitating employment
(van Gorp et al., 2017). For several participants, they took the opportunity to
(re)define themselves in terms of work. Ruby enjoys her job, it gives her purpose,
and although ambulation is difficult, she can perform her role in education with
adaptations and has excellent support from work colleagues. Davina worked harder
to prove herself at work, and Susan was given an opportunity to change her work
environment to suit her new needs living with MS. For Rudi, whilst the work itself is
not interesting, she values that she can choose her days and hours to suit her lifestyle
and this is currently more important to her.
I’m really supported, I’ve got lots of friends there who check on me and I feel very
supported. I’m working full time but have asked next year to have part-time so
hopefully I will get a day off a week…to do a little gym…and I want a day with (my
daughter) at home. Ruby line 790

190

Workplace was good…I was very close to my boss and on a level of that first line
management…the rest of management didn’t know, where I worked was such a big
organisation that I was protected…I think I showed them that it didn’t worry my
ability to work. Davina line 946
(after my diagnosis, a manager I knew offered me a role)…so you don’t get as tired
and without shiftwork so you can stay healthy…I liked where I (already) worked, so I
decided to do half in both, two days and two days…they looked after me and they
understood, so I was very grateful and very blessed. Susan line 579
I’m now back working 12 hours a week I chose the hours and the days…this just
landed in my lap so I was lucky…whilst it’s not the most stimulating job, it’s a job,
this is good for now. Rudi line 955
The decision to disclose or to not disclose an MS diagnosis at work was one of the
most important and personal decisions for study participants. Protective disclosing is
a tactic used by many PwMS to successfully inform others the diagnosis of MS, in
their own words and in a way that is acceptable to them, as a form of information
control (Grytten & Maeside, 2006). This enables PwMS to protect themselves and
exert some control over who knows the diagnosis and exactly what they know, a
concept important in the workplace. Individuals with MS develop strategies and
utilise resources, identifying priorities, and planning, part of (re)defining themselves
not just as a PwRRMS, but also as an employee/ worker after diagnosis. Some
participants in the current study chose to fully disclose their diagnosis at work with
good outcomes (Piper, Evie, Ruby, Susan), others partially disclosed (Davina, Paul)
practicing information control, and others have never disclosed (Jane, Joy, Will)
because they don’t feel it is necessary. No study participants in the current study
expressed regret at their decision.
Several participants had chosen not to disclose their RRMS diagnosis in their
workplace and were committed to keeping the secret, for reasons of privacy, fear of
losing employment and/or fear of being stigmatised. Employment discrimination has
been reported in MS, primarily through not providing needed accommodations at
work, unfair working conditions, denial or delay of promotion and different
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standards of performance (Roessler et al., 2011). However, it has also been suggested
that early disclosure at work may help maintain employment, if disclosure is
followed by appropriate work adjustments (Frndak et al., 2015).
I still haven’t told my current workplace that I have MS…I don’t want to tell
them…I’m only on a year’s contract and they might not employ me full-time…better
if I don’t. Jane line 504
Not many people know…I told my CEO, he’s provided support in knowing…I got a
major promotion a few months ago…and he knew at that point…very supportive, but
nobody else knows, I much prefer to keep it that way. Paul line 994
(when I was being diagnosed) my workplace were being very difficult at the time
about the amount of time I took off and they actually put me on performance
management…it was really hard to hit my (work) target…and my manager was not
supportive, or the company…they didn’t give me any help at all. Will line 740
For Joy, who did not disclose her diagnosis at work, in hindsight losing her job gave
her the chance to recover fully from a previous relapse and allowed her the time to
rest and later to (re)define who she wanted to be and what she wanted to do. Joy
changing her area of employment to one which she enjoyed more and gained
fulfilment in.
I pushed and pushed and I just deteriorated, it was really hard and I was just trying
to hold down a job…I’m so sick and I can’t work (and my husband wouldn’t let me
leave my job)…I was just heartbroken…I lost my job…I wasn’t doing my job…but
not working gave me the reprieve…I could just sleep and heal. Joy line 853
(and now) I really do love my job, my job is to give other families’ hope…I teach
what I’ve learnt. Joy line 1851
Evie experienced an interesting situation at work, where a work colleague newly
diagnosed with RRMS became aware that Evie also had RRMS and started asking
her questions during work time. Eager to help in the beginning, Evie was soon
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overrun with questions and conversations from this person, which started to impact
her own work role in both time spent talking about RRMS (and therefore not
working) and in how others viewed her (always talking about RRMS). She had
previously disclosed discreetly at work to a selected few but Evie had not openly told
all of her colleagues, who were now aware of her diagnosis. Evie had preferred to
have a division in her life between RRMS and work, but that was now dissolved.
(the colleague with MS would constantly ask questions and advice at work) so, my
MS had now infiltrated my personal life and my work space…so I was forced to think
about that whilst I was at work too…I couldn’t get away from it. Evie line 1089
Re-establishing a new identity after the loss of the role as a worker has been
identified as often leaving a void in the life of the PwMS (Hunt, Nikopoulou-Smyrni,
& Reynolds, 2014). Griff has felt this most keenly as he has struggled with financial
dependence on his wife and maintaining any sort of social circle since leaving
employment due to his MS. For years he was reliant on attending his monthly
treatment infusions to provide social stimulation, and with a change in therapy and
no longer a need to attend the centre, he has struggled to maintain any social
interaction. Leaving the workforce has been reported as shrinking the social and
geographical worlds of PwMS, as lives are now hidden from view, particularly as
disease progression occurs (Dyck, 1995). For Griff, losing social contact was a major
casualty of not working.
No income, that’s a bit hard…all of a sudden I’m a dependent, financially dependent
and that’s never sat comfortable with me. Griff line 837
After working for 22 years…reality slaps me in the face…social contact is what
you’re trying to establish so people have a community to operate in…all those links
have gone…I don’t have those links anymore. Griff line 504
It has been reported that mourning the loss of a meaningful occupation is a real threat
for PwMS (Matuska & Erikson, 2008). In the current study, this was experienced
profoundly by Kate, who suffered greatly with the loss of her identity along with her
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employment, a world where she felt accepted and valued, moving to her new reality
of unemployment and struggling to make a meaningful contribution.
(losing my job last year) it was a bit of a nightmare at work…they wanted to shut
down my department…it didn’t make sense…I fought really hard, to the point where
I got sick…and I thought…I can’t do this…I‘ve done everything for them, and this is
the way they treat me…there was a lot of anger as well…I can’t cope with it, I’m a
real mess…there are times when…I’m lost…I’d rather work…I loved my job. Kate
line 1899
If new roles, identities and interests could be established, participants spoke of how
losses could be turned into gains with new hobbies and new opportunities. For both
Griff and Kate, they have still not recovered from the loss of the work role in their
lives, whilst others such as Piper, Margot and Rudi, have made the most of their
enforced time off work and have found new ways to enjoy their time, travelling,
exercising, maintaining wellness and expanding social circles.
The MS Nurse has an important role to play with support, education and guidance on
aspects of work and employment in living with RRMS. Early referrals for advice
from MS organisations to assist with work disclosure decisions and allied health
professionals such as occupational therapists for practical work management
solutions (Yu & Mathiowetz, 2014) can significantly impact the journey.
(Re)defining self in regards to employment is an important part of the life journey
with RRMS.

Parenting with RRMS
One of the most surprising revelations when analysing the current study findings was
realising what an enormous impact the role of parenting had on PwRRMS. As a
parent myself, I was always cognisant of the fact that the parental role was important
in chronic illness, yet I was completely unprepared for just how important this role is
to PwRRMS. It may be due to the unpredictability, which threatens to change the
parental role, or being at the mercy of a disease which could render disability at any
given time. It may be the heightened sense of value placed on parenthood living with
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a chronic illness. All but two of the participants in the current study were parents and
they all became visibly physically changed during the interviews when talking about
their children, their faces and voices softening, becoming animated and happily
discussing the positive aspects, and becoming sad and upset when discussing the
challenges of parenting as a PwRRMS.
To be or not to be (a parent)
Historically, women with MS were advised not to have children, and if pregnant, to
terminate the pregnancy (Smeltzer, 2002). This is currently not the case with
pregnancy reported to have some protective effects on the course of RRMS and on
disability progression (Pozzilli & Pugliatti, 2015). The impact of MS on family
planning was an issue for several participants in the study. Plans for more children in
families were curtailed as a direct result of the impact of RRMS, and also as a result
of unknown effects of some of the RRMS treatments. Ruby wanted a third child, but
understood that the bulk of the childcare would probably fall to her husband as she
was gaining disability and so elected not to contemplate further pregnancies. For
Kate, there were simply too many unknowns to consider a second pregnancy, and
coming from a science and medical background, she felt very strongly that this was
the right parenting decision for her and how she wanted to (re)define herself with
RRMS.
(with two kids) we were blessed…and now that my body is so worn…there is no way
that I can put that pressure (another baby) on him (my husband)…I would if I was
physically able to take care of the child…I think we’re very blessed to have the two
that we have, I can’t be too greedy. Ruby line 1320
And the decision not to have any more children…it was related to MS…I was scared,
thinking, what if I have another child, I get sicker, how am I going to bring up two
children? And I’ve got no idea what these drugs are doing to me and what they’re
going to do to a baby…I did make the right choice, I know that. Kate line 1377
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Breaking the news to children
Breaking the news of an MS diagnosis to children could be a daunting process. The
impact of MS on children has been shown to be a concern for parents with MS,
supported by research reporting that MS can have a negative effect on children
(Bogosian, Moss-Morris, & Hadwin, 2010) with most children having a poor
understanding of MS (Bostrom & Nilsagard, 2016). A recent studied identified that
children may also worry that their parent with MS would die, highlighting the
importance of support and communication to strengthen the child’s ability to cope
(Bostrom & Nilsagard, 2016). Rudi needed professional help for her daughter, who
experienced emotional trauma after witnessing Rudi suffering a severe relapse.
I had to get my 12 year old into therapy because she didn’t cope, she became quite
anxious and she thought I was going to die every time I got carted away by the
ambulance. Rudi line 600
At the time of diagnosis, more than half of the participants were already parents.
Rudi (four children under 12) and Paul (three children under the age of eight)
described how they set out to explain RRMS to their children.
You know what it’s like as a mother…you just get on with it, as hard as it is…I got
them (four kids) all together and explained as best I could to a child…they knew I
was sick, no hiding that…the youngest took off halfway through the conversation to
go play on the swing…it was hard…it was hard work. It’s been distressing,
especially my two young girls…I find that tougher than the physical side of things
sometimes. Rudi line 568
I really haven’t gone into too much…I have explained with…Dr Seuss’s book “Inside
Outside” and he (son aged seven) always goes “they’re yucky white blood
cells…you’ve got yucky ones”...and sometimes he asks me “how’s your brain today,
Dad?”. Paul line 980
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The impact of MS on parenting
Recent studies have shed light on the impact of MS on parenting, although most of
this literature has concentrated on mothers and MS; with a paucity of literature
exploring the experience of fathers and MS. An Italian study interviewed 16 female
PwMS, of varying types and stages, aiming to uncover the value of motherhood in
PwMS (Willson, Tetley, Lloyd, Messmer-Uccelli, & MacKian, 2017). The
researchers described how the participants strove to maintain control of their MS,
how they compared themselves to other mothers and how they frequently felt
different to other mothers (Willson et al., 2017). Several participants in the current
study echoed these concepts. Rudi, a mother of four, reported that she felt different
to other mothers because of what she could not do related to her RRMS.
My girls look at that (what I can’t do) and see that I’m not like other Mums and
that’s hard for them when I say “I just can’t go because I’m too sick”…and that,
that’s hard on them. Rudi 685
A study exploring the lived experience of mothers with MS (type not specified) has
reported that PwMS who are mothers of young children describe the experience as
physically challenging, yet highly rewarding (Plumb-Parlevliet, 2015). Mothers with
MS recognised that energy is limited, and this is often challenged by children,
causing the mother to regulate and limit activity (Payne & McPherson, 2010). Many
mothers have support networks in place to help them cope with MS and this includes
partners, family and friends (Payne & McPherson, 2010; Pakenham, Tilling, &
Cretchley, 2012). In the current study, Piper, Margot, Kate, Rudi, Davina and Ruby
all reported the importance and value of a close network to assist them in their
motherhood challenges with partners and family being particularly supportive.
My mother-in-law…if I tell her I’m crook she’ll be around in a heartbeat, so that’s
good. Piper line 1329
When we moved here, Mum and Dad bought around the corner, they knew that that
there was a potential diagnosis…I’m pretty close to my family, and my sister lives
close by…this has brought us closer together for sure. Ruby line 1122
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Parental losses
It has been reported that mothers also experience loss related to their ability to fully
engage/participate in their children’s lives due to MS (Willson et al., 2017). In the
current study this was expressed by a father, Griff, who struggles greatly with the
impact MS has made on him as a parent, his sons observing their father exhausted
with fatigue instead of playing with them and taking them to the park.
My kids have grown up with someone who struggles…when I should have been going
to the park, when I could have been kicking a ball… their primary role model was
probably somebody who fell asleep at 3 o’clock in the afternoon. Griff line 1323
As Ruby experienced a severe relapse shortly after delivery, she missed out on
crucial time with her first baby, those memories still haunting Ruby seven years
later.
(my new baby) it was hard not being able to take care of my baby…I couldn’t pick
him up, I just had no strength, I couldn’t get up to him, I couldn’t change
him…(cries)…it was so...hard…the kids have seen a lot…it’s hard on them as well
because it limits us from what we can do. Ruby line 430
The joys of parenthood
In the current study, all mothers and fathers valued their parenting role and several
participants felt that parenting with RRMS left them feeling empowered and bringing
out their best qualities. Being a mother may bring some beneficial psychosocial
effects to the life journey with MS, enriching lives and providing purpose (PlumbParlevliet, 2015) which may be important given the high rates of depression reported
in MS (Feinstein, 2011). Possible rewards from parenthood cannot be
underestimated, it has been reported that PwMS who are mothers have higher quality
of life and more social activities compared to childless women with MS (Twork et
al., 2007). Davina gained a sense of empowerment from motherhood and Will uses
his love of fatherhood to give himself hope for a future where he is active with his
children.
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I was desperate to have a third child…I was good…at least I was really good at
something…I really enjoyed being a mother and I felt I was quite successful at it…it
gave me a sense of empowerment. Davina line 675
I want to be able to play sport with my son and daughter…we are the best of
friends…we play netball and we play golf…I want to play football with my son and I
want to take him on the golf course! Will line 1488
The immense value of the role of a mother remains evident, regardless of the degree
of disability or whether the MS diagnosis or motherhood came first in the equation
(Willson et al., 2017). The fathers in the current study also expressed happiness and
delight in fatherhood, although it wasn’t always easy to keep up with the children.
Balancing both the challenges and the joys of parenthood takes skill, patience and
time. The MS Nurse has a vital role to provide guidance, education and support on
parenting issues at all stages of the life journey with RRMS.

Balancing losses and gains – my life plan (re)defined
Chronic illness has been described as a disorder that persists for an extended period,
affecting a person’s ability to function normally (de Ridder, Geenan, Kuijer, & van
Middendorp, 2008) and profoundly impacting day to day lives (Moss-Morris, 2013).
The presence of chronic illness has the potential to induce intense changes in a
person’s life and can result in negative effects on both their wellbeing and quality of
life (Sprangers, Hanneke, & Haes, 2000). However, chronic illness can also provide
the potential for individuals to find advantage in the situation and a positive effect on
lives, known as benefit finding (Pakenham 2005a, 2005b). Findings from the current
study to be discussed in this section demonstrated examples of both scenarios, and
sometimes both scenarios in the same person, at different times. Balancing these
losses and gains was an important part of (re)defining self and setting a new life plan
with RRMS.
It should also be noted that the onset of MS doesn’t necessarily bring into question a
person’s sense of self, rather it is the degrees to which symptoms impact on a
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person’s ability to fulfil roles important to their pre-MS self, that appear to have the
greatest re-defining impact (Mozo-Dutton, Simpson, & Boot, 2012). MS symptoms,
which have the power to threaten the PwMS’s perception of self, may also contribute
to emotional issues such as depression and anxiety (Mozo-Dutton et al., 2012). For
several participants in the current study, this was certainly the case. Kate’s
burgeoning career in academic study was grossly threatened by sudden blindness,
rendering her unable to read intermittently and leading to failure to complete a
course for the first time in her life. On treatment, Kate’s relapses lessened and she
gradually regained some control and resolution of her symptoms. Accepting this
particular symptom into her life story was not easy for Kate and involved years of
anguish. MS HCPs can apply this knowledge to their dealings with PwRRMS by
assessing patients and clients for symptoms which impact the most upon their life;
and not just the symptoms that HCP working within the medical model, believe to be
the most important.
Battling losses
Feelings of loss dominated the immediate post diagnostic period for several
participants and for some, this was repeated again at various times later on in the life
journey. The fact that RRMS could occur randomly and cause relapses at almost any
time could potentially lead to the loss of important life milestones. Piper believes she
lost the opportunity for a memorable wedding and honeymoon due to RRMS
symptoms, suffering continuously from severe headaches and facial nerve pain in the
weeks prior to and involving her wedding.
I’d be in tears with those headaches…I had this new bout just before I was
married…they don’t go away and they just wrap around my face…it’s just horrible.
Piper line 384
(my honeymoon) was a disaster actually…(and the) wedding day was a disaster…I
again had really severe, severe headaches…my wedding day was a blur…(and the
honeymoon) we actually came home early…and called the doctor. Piper line 361
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The onset of a new relapse and/or significant physical disability could induce
feelings of loss for the normal body, and loss of independence without warning. Rudi
keenly felt the loss of her normal life during a severe relapse and the degradation of
not being able to perform activities of daily living. Jane was an avid athlete who was
not able to go back to her usual level of competition after her diagnosis and
continues to feel this loss of physicality.
(with a severe relapse) it was degrading…have to be wheeled to the toilet...the
basics…and that was hard to cope with…things are just taken from you…that’s what
I find hard with MS, giving up simple things like not being able to go for a
walk…because that’s my time out and I enjoy doing it…and you don’t think it’s much
to ask. Rudi line 276
My balance and the way I hold a pen isn’t good…my balance isn’t good…I don’t
ride a bicycle any more…(MS) has curbed my lifestyle…not that I was ever a risk
taker, but I used to do a lot more…things like that are disappointing. Jane line 552
Margot had a difficult time dealing with her gradual loss of mobility. Her husband
began looking at wheelchairs as they enjoyed travelling and he felt it would be a
safer option, but he was met with stiff opposition from Margot who didn’t give in
easily.
It’s a real mental block…(crying)…it’s really hard to do that…it’s the elephant in
the room…it was a real mental block to sit in that (a wheelchair)…in public. Margot
line 1533
Accepting gains
Appreciating the gains that may occur in RRMS will be discussed more deeply in the
theme of positivity and hope, but for many participants, finding some benefit in their
new life with RRMS was crucial to them finding peace and courage to move on and
integrate RRMS into their life. Benefit finding is a specific type of coping strategy
whereby, despite adversity, individuals positively evaluate their circumstances and
report gains such as personal growth, improved relationships and changes in
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priorities and goals (Pakenham 2005a, 2005b). Research has shown that benefit
finding has been strongly and directly correlated with positive outcomes in MS
(Pakenham 2005a) and practicing benefit finding by valuing life and acknowledging
simple pleasures could be beneficial in MS (Irvine et al., 2009).
Benefit finding was a positive and active process for Rudi, who appreciated the
personal, family gains she found directly as a result of living with RRMS.
I got really angry (after my MS diagnosis), but by the end of it I actually think of it as
a gift because it’s made me live my life differently…it’s made me start to travel
whereas I would have put that off…I was heavily involved with my kids anyway…but
I just have a different outlook on life now, I tend to care less about things I don’t
have time for gossip, I’ve let all that go…so I view MS as a gift. Rudi line 835
Margot overcame her fear of the wheelchair to gain new awareness and opportunities
and find benefit in the things she had learnt.
I think I accept things a lot more…I think you become more patient, you tolerate a
lot more and you become…more accepting of people and maybe you develop a
thicker hide…overseas people are so good to people in wheelchairs…they were just
fantastic…and straight to the front of the queue…it was great…I thought, I can’t
believe I haven’t done this sooner, it was the best thing. Margot line 964
Enrolling in a course to help her cope with her new diagnosis, Susan gained so much
more and greatly valued the insights she learnt which improved other areas of her life
as well.
I had lots of fun and went on more holidays…I hadn’t had any relapses and I felt
better about myself and I was doing a course…in that group I met lots of beautiful
people…what I’ve learnt through this has made me a better person. Susan line 731
Balancing the losses and gains after a diagnosis of RRMS often led to constructing a
new life plan. Gathering new information, working out what is important to the self,
what doesn’t matter and what might matter in the future takes time and effort. How
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participants managed this, and how long this took, was highly individual, but always
involved a personal decision to move on and to embrace a new life, with changed
attitude and values. The majority of study participants had moments where they
made a decision to embrace the new self and move forward with purpose. It was as if
they reached a cross-road and actively chose to embrace their life living with RRMS.
I said, from that point, nothing’s going to stop me I’m sick of being…that guy that
just goes home…I never used to go out (following diagnosis)...I used to go home
from work, go to sleep…I just said I’m not going to go home and sulk on my
own…go to work and live in circles…so I joined a basketball team, I joined a
football team…I’d go and play poker with my friends…I just lived this active life.
Will line 1151
I thought well, I’ve got to try harder…to try and meet someone or do other
things…so I started up doing other hobbies and taking up different interests to try
and meet people…and also to learn other things to make myself feel better. Susan
line 697
So I got really angry and obviously went through the stages of grief, but by the end of
it I actually think of it as a gift because it’s made me live my life differently…it’s
made me start to travel whereas I would have put that off. Rudi line 835
I take each day as it happens, one day at a time. I don’t plan for the future, if things
happen, they happen...you’ve got to put things in little pigeon holes…with my studies
and my work I did not put too much emphasis (on relapses)…it was an
inconvenience…but it was not my biggest problem…you’re (RRMS) not going to beat
me. Kate line 2419
(I had an experience) where I said “fuck you body, you will do what I tell you to
do”…so I got my two walking sticks out and went for a six kilometre walk…and I
pushed hard and the more it hurt…you are not doing this anymore and I took
back…took back control of my own life…yes, the disease doesn’t control me, I
control my own body. Joy line 1090
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It is true that although MS does present complex challenges and signals a difficult
period of adjustment, the majority of PwMS do adjust successfully (Eeltink & Duffy,
2004), and we as HCPs can openly discuss this with PwRRMS early in the journey.
Pakenham (1999) has also shown that adjustment to MS improves as the time since
the onset of symptoms lengthens, meaning that for many PwRRMS, that time will
often be their friend. Time will heal emotional pain and time will help (re)define who
they are and where they fit in, not just within the MS world, but within their own
world and what is important to them as an individual. Adjusting to RRMS, like many
chronic illnesses, is a process that continues throughout the course of the life lived
with MS, and responds to changes in the illness status over that time (Sharpe &
Curran, 2006). In RRMS, these changes are likely to present many times and
particularly around times of relapse, new symptom onset, pregnancy, medication
change, and disease progression. A PwRRMS is likely to require many redefinitions
of self throughout their lifetime.
Participants described their losses, different for everyone depending on their
individual beliefs and values. As previously discussed, loss of employment was a
major concern for several participants, and for Griff and Kate, this continues to be a
major issue in their lives. Other losses, affecting the participants in the current study,
such as loss of independence, physicality and mental health have also been discussed
in this chapter (Clair, 2003; Courts et al., 2004). The sense of loss and regret for
PwMS who are parents knowing that children are observing the journey and possibly
missing out on life (Willson et al., 2017) was replicated in this study (by study
participants Rudi, Ruby, Griff and Davina). There is a paucity of recent literature on
the experience of being a PwMS and feelings of loss.
There have been several research studies identifying benefit finding in MS
acceptance and adjustment (Pakenham, 2005a, 2005b, 2009) and thereby impacting
positively on (re)defining self. A study exploring story making and living with MS
uncovered that for some, being diagnosed with MS was akin to MS being a saviour,
delivered to save them from the person they were becoming (Clair 2003). No study
participants in the current study expressed their feelings in this regard, although Rudi
discussed how she changed her “attitude to gratitude” after living with MS for a
while and recovering from her initial relapse. Most participants in the current study
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viewed MS as a partner, finding new ways of working with the disease rather than
against it.
Many PwMS change negative reactions (denial, concealment, loss of confidence)
into positive changes and outlooks, including an increased appreciation for life and
spirituality (Irvine et al., 2009). Most PwMS modified their lifestyle to do the things
they wanted to do and needed to do (Matuska & Erikson, 2011). This was also
demonstrated by several study participants, most notably Rudi, who described how if
she wants to “play hard” and enjoy activities and sports, then she also needs to “rest
hard” and nap regularly, even if it means missing out on other things.
Coming to terms with a new life plan may mean consequences to current lifestyle
for PwMS. These concepts will be discussed further in the following chapter but it is
important to recognise what these changes might be in terms of (re)defining the self
with MS. The amended life plan for many study participants meant changes to
family life, to relationships, to social lives, a new strategy of planning, changes to
workplace and employment, to new methods of stress management and to seeking
joy and happiness in their lives. Some looked at the balance scales of life and chose
to openly accept the gains (Joy, Evie), some chose to focus on the losses (Paul, Griff,
Kate), some participants accepted both (Piper, Rudi, Susan, Will). But, for all study
participants, the process was fluid and dynamic, it could change regularly and
swiftly, and signalled a new life trajectory. It became the nature of living with the
disease for many, part of who they were now, an identity that was constantly open to
change and (re)defining. It prepared participants for one of the next important steps
in their lives living with RRMS, to Taming the Beast and set up their life in a way
that they felt they were in control of RRMS. This will be discussed further in the
next chapter. Before this time however, many participants needed to embark on
“Battling the Demons” before they could regain some of this much needed control.
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Theme 3: “ Battling the Demons”
My Demons
Though quiet
Are never quite silenced
Calm as they may be
They wait patiently
For a reason to wake
Take an overdue breath
And crawl back to my ear
Sarah Boswell
For the purposes of this study, “demons” were conceptualised as negative emotions,
sometimes very strong emotions, which can threaten the livelihood of PwRRMS.
Demons can be subtle, creeping in every so often on a bad day and upsetting routine
and peace of mind, or they can be like a runaway freight train completely
annihilating all in its path. The end result is that PwRRMS are mostly never free,
even when clinically or physically things are in quiescence, there’s potentially
always something beneath the surface, where demons lay. For all participants in the
current study, a variety of demons threatened them at different times, and for
different reasons.
The central organising concept for Battling the Demons in this study encompasses
the experiences of confronting and living with the negative emotions that PwRRMS
may feel throughout the life course, the things that steal away joy from life. There
are many potential trigger points in an RRMS life journey to disrupt emotional
equilibrium and quality of life (Dennison et al., 2009), including the time of
diagnosis, the presence of new or chronic symptoms, with a relapse, change of DMT,
when meeting other PwMS, or with disease progression. MS has been described not
just as a journey of feelings, but a journey of feelings that change over time
(Lysandropoulos et al., 2015). Adding to the burden is that people with neurological
disability may be more likely to resort to ineffective ways of coping with emotions,
which adds additional strain (Gedik et al., 2017).
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Psychological problems in MS have been recognised for many years. A seminal
paper on common psychological problems in MS from Burnfield and Burnfield
(1978), described emotional reactions to MS as being inevitable, having serious
effects on both the patient and their family, and also recognising at this early stage
that they may be responsible for more disability in terms of suffering, than physical
effects of MS.
Too often in our busy clinics today, a patient’s emotional well being generally takes
a back seat to discussions about DMTs, medication side effects and physical
symptoms (Minden, Turner, Kalb, & Burke, 2014). Unfortunately, necessitated by
the highly efficacious, but also potentially dangerous medication armamentarium of
the modern day. The presence of these new, and longed for DMTs and earlier and
more rapid diagnosis clearly does not remove the emotional burden in PwRRMS. At
times it can be just the opposite, they can be the cause.
The theme of Battling the Demons comprises four intricate sub themes, which all fall
under the umbrella of demons, stealing away happiness and causing angst to the
PwRRMS. These subthemes are facing fears, weary with worry and anxiety,
depression and despair, and struggling with the saboteurs. Each of these subthemes
also contains additional sub-subthemes to provide deeper exploration.

Facing Fears
Fear can be best described as an unpleasant emotion caused by the threat of danger,
pain or harm (Oxford dictionary, 2017). This threat can be real or perceived, which is
an important point in RRMS as so much is unknown, and nothing can be guaranteed.
This means that some threats are connected to reality, but some may not be. For the
purposes of coding and analysis in this study, and to separate fear from some similar
emotions such as worry, stress and anxiety; fear was conceptualised as being
frightened to the point of terror, invoking physiological body changes such as body
heat, shaking, sweating and crying (Scheff, 2015). Some of these body changes I
witnessed when the participants talked about fear and what they were fearful of. This
reference to fear being a distressing emotion was essential in the initial coding for
this category. For example, during Paul’s interview, he started to turn red in the face
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and loosen his collar when talking about his fear of wheelchairs, he started to
perspire and needed to have a short break, his fear was intense and physiological.
It has been reported that for PwMS, the first two to three years after diagnosis can be
marred by distress and worry about the future, from being seen as healthy, normal
and able-bodied to sick, abnormal and disabled (Mortensen & Rasmussen, 2017). A
mixed methods study using both questionnaires and semi-structured interviews of 85
PwMS explored the theme of uncertainty in MS (Boeije & Janssens, 2004). The type
of MS was not specified, but many were on DMTs and had a low-moderate disability
score, suggesting a high proportion of RRMS participants. Uncertainty about future
disease progression was a predominant factor, for those with both low and high
perceptions of risk. Wheelchair dependence was perceived as a serious outcome,
primarily because of lack of independence and a shrinking social world (Boeije &
Janssens, 2004) and provides some understanding for the current study where so
many participants were fearful of the possibility of needing a wheelchair and disease
progression in the life journey, feeling like a burden to their family and worrying
constantly about the future and what might happen. One would have thought the
advent of higher efficacy medications to treat RRMS may have had some effect on
these emotions, but for many that is not the case, fear continues to be a constant
battle. It is a hard task for MS HCPs and MS Nurses today to change the
stereotypical

representation

of

PwMS

being

wheelchair

bound

and

misunderstandings surrounding what RRMS actually is and how the disease course
can be significantly altered with modern treatments abound.
Elements of facing fear expressed by the current study participants included the subsubthemes of fear of medication side effects, fear of symptoms/relapses, fear of
disease progression/disability and fear of the wheelchair.
Fear of symptoms/relapses
For PwMS, symptom changes can be overwhelming and almost feel akin to
receiving a diagnosis of MS all over again, facing an acutely uncertain future much
like an “emotional yo-yo” (Blundell-Jones, Walsh, & Isaac, 2014). Several study
participants voiced a fear of symptoms striking at any time and relapses occurring
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suddenly, blindness in particular. Rudi had a tendency to relapse rapidly and
severely, and as the mother of 4 young children, this induced fear of relapses, and
what her children may witness.
I can relapse very quickly…when the paralysis comes…it happens very
quickly…they’ve seen that happen and it’s been quite distressing, especially for my
two young girls…the other week I fell and lost my balance, I lost my speech. Rudi
line 582
For Joy, sudden blindness from optic neuritis (a common presentation of MS
involving demyelination of the optic nerve) induced deep fear and a second relapse
causing dyslexia left her terrified, again. For Susan, a hospital admission with a
severe relapse left her fearful of what may happen in the future and if she would
recover.
I was completely blind…for periods of time…terrifying, really terrifying and they
couldn’t work out what caused it…and it happened again and terrified…absolutely
terrified. Joy line 123
So I came into hospital and I stayed the night…I was very scared and I was crying…I
couldn’t sleep…I said to the nurse “I’m very, very scared, I don’t know what’s going
on”. Susan line 280
Fear of DMTs and side effects
The physiological look of fear on some of the faces of PwRRMS during the
interviews in relation to some DMT side effects has never left me. Once again, there
were strong physiological reactions talking about how dangerous they felt some of
the DMTs are, as well as possible unknown effects in the future. This concept will be
discussed in greater depth in theme 7, “The DMT Dance”, but also belongs as part of
the story of fear in this particular theme as well. The most dramatic of these fear
reactions were Piper and Joy, who had very strong feelings. After a relapse, Piper’s
neurologist wished to increase her treatment to a new DMT known to cause PML,
but she was adamant she was not having it, nor the new and experimental HSCT
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because of perceived high mortality. Joy was also equally adamant she wasn’t taking
a DMT which had recently been associated with deaths in others living with RRMS.
That PML thing keeps popping up …what does scare me with that is how do you
know it’s that or an MS symptom causing it?…I’d rather be in a wheelchair than
dead…Piper line 1362
(later when talking about HSCT) I think the risk is too great…I get that these people
are in a real state of bother…they’re struggling…but I just think I’d rather be, like I
said, I’d rather be in a wheelchair than dead, I just think the risk is too great. Piper
line 1960
(my neurologist) wanted me to go onto a drug that was about at the time…which had
only killed about three people…it had only killed three people! So I said “you’ve got
to be kidding”. Joy line 820
Ruby had been offered a stronger DMT after her disease had progressed rapidly, but
Ruby declined due to fear about the significant side effects. A couple of years later
during our interview, Ruby wished she had taken the opportunity earlier, crying as
she recalled her lost opportunity, lost to fear.
I really wish I’d listened to him (neurologist), I was just so scared, he said it could
lead to other autoimmune things…and I think it was just pure fear, pure
fear…going…I’ve got two young kids and the risk of cancers…I just didn’t know if it
was worth the risk…my fear of the PM…? What was it called, PML? That was
massive…like every time you have that injection, you just go…(sobbing). Ruby line
511
Fear of progressing/disability
Although this subtheme has similarities with fear of the wheelchair, it is more
general and involves disability in all forms, rather than the specific fear of a
wheelchair itself. Some study participants met others with more severe disability at
clinic visits or at MSA, and many became fearful that this might also be their future.
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Being lonely and isolated as a result of disability weighed heavily on their minds and
the possibility of a bleak future was ever strong, especially when confronted with the
reality of other PwMS.
Margot attended exercise sessions at the local MSA and observed people living with
progressive and more serious forms of MS on many occasions. She talked to them
and realised many were socially isolated, raising with her a fear deep inside that this
may one day happen to her as well.
A lot of them (people with progressive MS) I think are isolated and a lot of them are
lonely…it’s very isolating…people become very isolated which is a real shame
because then it’s hard to…how would you make friends if you’re isolated at home
with disability? who are you going to meet?...I think that would be very hard. Margot
line 2517
Griff was a family friend of a celebrity with progressive MS who featured in many
MSA fundraising campaigns for MS. As one of only a few people Griff knew with
MS at the time, he was fearful for his own future with disability.
(I knew) the picture boy for the MSS for years so I’d been exposed to MS for at least
15-20 years with him…so it was a pretty scary image to measure myself against
him…so I did have an understanding at least of how much damage it could do. Griff
line 511
Will had personal experience of what severe disability in MS looked like, and he
became immediately fearful at diagnosis that this could be his future with disability
as well.
A friend of mine’s stepfather has MS…he’s in a wheelchair and he’s flat ninety five
per cent of the day…the first thought in my mind when I was diagnosed was what
happened to him. Will line 16
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Fear of “the wheelchair”
When confronted with a diagnosis of RRMS, many study participants jumped
straight to imaging life in a wheelchair, an expectation which is common in the
community and based on the natural historical progress of the disease. Before
modern day DMTs and treatments, the risk of requiring a walking aid to walk half a
block was quoted as 50% at 15 years from MS onset (Weinshenker, 1994).
Nowadays the risk of needing assistance to ambulate in the future has not been
quantified, the common switching between medications and the heterogeneity of
RRMS making predicting future scenarios difficult. This fear of the wheelchair
commonly settles with education and guidance from MS trained neurologists and MS
Nurses, but for some participants in the current study, abject fear was the resulting
emotion, terrifying and paralysing in intensity. Fear of the wheelchair could strike at
any time, during relapses or with new symptoms, at the sight of another PwMS, or
sometimes, with no specific trigger at all.
Rudi considered her future and the possibility of being in a wheelchair during a
severe relapse, where she lost all motor function in her legs as well as the power of
speech. The episodic disability of this relapse induced fear that one day the
symptoms may be permanent.
The worst case scenario is I will be in a wheelchair…and that will be a very, very
black day for me, or a black time if it does happen…afterwards I thought how’s this
going to affect my life…I might be in a wheelchair next year…and those sorts of
thoughts…and that’s why I used to get down quite quickly with my relapses because
it’s almost like a little bit of a taste of what may be reality. Rudi line 856
Paul disliked the MSA education material and resources because he felt that there
was an undue focus on wheelchairs in MS, unnecessarily inducing fear in PwRRMS.
Paul became emotional as he recalled how he felt reading this information.
I hate the MSL stuff because it’s all wheelchair shit you know…it’s all worse case
stuff…I don’t want to be in a wheelchair. Paul line 880
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Susan’s fear of the wheelchair was directly related to the fact that she felt that level
of disability would take away any chance of her finding a partner to share her life
with. Susan was tearful as she recalled her feelings at that time.
I’m very, very scared…well if it’s MS am I going to be in a wheelchair, or what’s
going to happen…will I meet someone…who’s going to look after me…you know,
will I be a burden? Susan line 335
I always thought it (MS) was bad…that people would look…Oh no…I don’t want
to…to be with her cause she might end up in a wheelchair…I might have to look
after her or they’ll leave…that’s what I thought. Susan line 855
Davina was terrified at her diagnosis, because her uncle’s MS had rendered him
wheelchair dependant at a young age and was looked upon by the family with shame.
The family used to tell people he had a head injury from falling of a ladder, denying
MS. The fear of the reality of a wheelchair in MS was personal for Davina.
I felt terrified, absolutely terrified because I had no idea what was happening to
me…and my mother was frightened…because on top of all of this, I had an uncle
who had MS and who was wheelchair bound . Davina line 360
Post traumatic stress disorder (PTSD) is a disabling condition typically characterised
by the re-experiencing of a traumatic event and experiencing intense fear,
helplessness or horror (APA 2013, p. 467). The prevalence of PTSD in MS was first
postulated as being approximately 15% in a study sample of 58 participants
(Chalfant, Bryant, & Fulcher, 2004). However, this finding was not replicated in a
larger study of 232 participants where PTSD prevalence was reported as
approximately 5% (Ostacoli et al., 2013). Interestingly, there was no relationship
found between the presence of this mental health disorder and the severity of the
disease. There are some peculiarities in PTSD in MS, as it is not related to a single
event in the past but rather to the course of the degenerative condition, and the
intrusive PTSD symptoms are typically orientated to the future, such as fear of the
wheelchair, relapses and progression (Ostacoli et al., 2013). In the current study, no
participants were formally diagnosed with PTSD, however intense physiological
213

reactions to talking about fear of future disability and wheelchairs figured strongly
for Paul, Davina, Will and Susan.
The mere thought of MS can strike fear in people, even without any knowledge of
the disease (Lysandropolous et al., 2015). Previous studies have demonstrated fear as
an emotion central to the MS journey, but more recent studies on these specific
phenomena in RRMS are lacking. A qualitative study, which interviewed ten women
with SPMS, described how the women felt fear due to uncertainty about the future,
fear intruding as the participants felt they did not know what was happening to their
physical bodies (Olsson et al., 2008). A larger study interviewed 27 PwMS and used
IPA methodology to reveal that fear of the future was prominent for PwMS, and in
particular, fear of mobility loss, becoming a burden to family members and
placement in a nursing home (Finlayson, van Denend, & DalMonte, 2005). Although
the authors did not specify the type of MS in their inclusion criteria, participants
needed to have MS for more than 15 years and be aged over 55 years, suggesting
some elements of progressive MS and possibly influencing the fact that nursing
home placement figured in fear. This nursing home fear was not evident in the
present study, perhaps due to earlier disease stage of the participants or the presence
of more effective patient education and DMTs in the modern era.
Fear is often induced by the vagueness of symptoms pre-diagnosis, and the
uncertainty of the cause of MS post-diagnosis and the possible disease trajectory
(Thorne et al., 2004). A study from Thorne and colleagues (2004) used focus
groups/individual interviews and phenomenological methodology with a group of 12
PwMS and introduced the concept of “fear points” in the MS journey. “Fear points”
are modifiable moments where patients receive either support or obstruction to their
fear (Thorne et al., 2004). If timely, relevant and accurate information and validation
of their experience is provided at these vulnerable times, the MS HCP/MS Nurse can
modify these experiences significantly for PwMS (Thorne et al., 2004). “Fear points”
will be different for each individual, but if carefully looked for and assessed by MS
HCPs and MS Nurses, appropriate referrals may prevent future escalation of
emotions and improve QOL. For some participants in the current study, fear resolved
over time, but for others it never completely resolved. Fear sometimes turned to
more chronic worrying, or expressed itself in other ways such as anxiety and
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depression. Sometimes it was addressed with counselling and psychological
interventions and sometimes it was shelved temporarily only to resurface at a later
time. But fear in some form, at some time, featured in almost every participant’s life
story.
Theoretical foundations from fear studies can also help MS HCPs understand that
perhaps some degree of fear may be helpful in clinical care. Looking at a positive
aspect to the fear story, the seminal work of the “fear drive model” assumes that the
emotional response of fear can function as a drive to mediate belief change and
behaviour change (Leventhal, Meyer, & Nerenz, 1980). At times during the RRMS
journey, our patients need to change beliefs and to change behaviour in order to
adhere to evidence-based MS wellness prescriptions such as smoking cessation,
adherence to DMT regimes, adherence to safety monitoring programs and follow-up
appointments. A careful assessment by the MS HCP/MS Nurse is crucial in
determining the impact of fear on an individual patient and whether referral to
appropriate resources is required.

Weary from worry and anxiety
Worry is carrying tomorrow’s load with today’s strength
Carrying two days at once and moving tomorrow ahead of time
Worry does not empty tomorrow of its sorry
It empties today of its strength
Corrie ten Boom
Worry is negative thinking arising from anxiety; it is a longer-term feeling than fear
and has been described as an active anticipation of possible negative outcomes
(Vasey, Crnic, & Carter, 1994). For the purposes of coding clearly and consistently
for data analysis in this study, worry was conceptualised as different to fear and was
defined as both a noun and a verb “being troubled or feeling troubled over actual or
potential problems” (Oxford dictionary, 2017). Anxiety disorders are listed in the
Diagnostic and Statistical Manual of Mental Health disorders, fifth edition (DSM-V),
(APA, 2013) as a diagnosable mental health illness, of which I am not authorised to
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diagnose as an registered nurse. However, I do have the skills to assess for the
presence of anxiety and to refer to appropriate HCPs for further assessment and
advice. For the purposes of this study, anxiety was based on DSM-V descriptions;
challenging a person’s control, consisting of a mix of symptoms such as fatigue,
impaired concentration, irritability, difficulty sleeping and impacting on day to day
activities for a prolonged period of time, and conceptualised as excessive worry.
Previous studies have demonstrated high levels of worry in PwMS, and a link
between worry and anxiety, separate but unique related psychological constructs
(Bruce & Arnett, 2009). A quantitative survey based study of 50 patients (of mixed
RRMS and SPMS) demonstrated that 36% of participants experienced worry in the
elevated range and also that worry was associated with depression and anxiety
(Bruce & Arnett, 2009). The authors report that indeed, the very nature of MS
(uncertainty, symptoms, threat of relapse) may create an optimal environment for
excessive worry, supporting the findings in the present study where some degree of
worry interjected the lives of all participants at some time. The concept of worry in
MS as an independent construct certainly requires further exploration and research,
particularly as excessive uncontrollable worry can also progress to a more serious
generalised anxiety disorders (Bruce & Arnett, 2009) or other anxiety and depressive
disorders (Thornton, Tedman, Rigby, Bashorth, & Young, 2006).
In the current study worry took on several forms, and sometimes the participants
worried about themselves, but just as often they worried about their loved ones and
how RRMS was affecting the family unit as a whole. Almost all participants worried
about something directly related to MS at one time or another, with worry about
becoming a burden in the future a common worry. The chronic worriers could then
go on to feel anxiety, either acutely or more long term, and for this reason (as a
linked concept) anxiety has also been included in this sub theme.
In the midst of a severe motor function relapse, Rudi felt at her most vulnerable,
feeling anxiety herself, but also feeling that she was the cause of anxiety for her
young daughter. Rudi was worried about hurting her children if a relapse came on
suddenly whilst she was driving and caused an accident.
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I went through a really bad period with anxiety, to the point where I nearly gave up
driving…because it happens so quickly (relapse)…so I thought…I’m going to hurt
my children or I’m going to hurt someone else…I suppose it’s going to be always in
the back of your mind…I mean I was to the point where I used to drive with no-one
in the car and see how long it would take me to stop by pulling the handbrake
on…working on things to keep my children in the safest place possible. Rudi line 702
In the first year after his diagnosis, Paul spent hours at night researching on the
internet everything he could about MS, his GP suggesting that he might need some
professional help and counselling because the worrying and need for information
became excessive.
And you know at night …and this is why the GP sent me off to the psychologist, I
don’t have very good sleep at all, I sort of just lay there and I sort of get on the
phone or ipad and read all this stuff (on MS) for hours at night, every night…the first
year after diagnosis was very hard…I was…you know…anxiety…and you know, no
matter how you try, and rationalise it, you can’t, you just can’t beat the fact that
you’re a human being and that emotions are part of…you know, being alive. Paul
line 477
Davina was learning to cope with her new diagnosis of RRMS and became pregnant
shortly afterwards, causing her worry and anxiety over how she was going to balance
both the new disease and motherhood.
It was a huge shock and I was such an anxious person to start with, so dealing with a
diagnosis and then being a very young mother…I also had a very anxious pregnancy
because I didn’t know how. Davina line 539
Worry about being a burden to the family
Worry about being a burden, either in the present or in the future, and worrying
about what MS was threatening to do to their family unit and loved ones was
common to almost all participants at some point of their RRMS journey. This sub-
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subtheme also focuses on the participants worrying about family members being
worried about their RRMS.
It has been suggested that one of the greatest challenges for children whose parents
have MS is balancing caring for the parent with restraint in expressing their own
feelings to protect their parent and avoiding burdening them with their own sadness
of MS (Moberg, Larsen, & Brodsgaard, 2016). For Rudi, her children witnessing her
last severe relapse has been a constant cause of worry for her, sometimes much more
than the worry she has for herself physically. Rudi sought psychological counselling
for her daughter to help manage the anxiety her daughter feels.
(When my last relapse happened) the children were hysterical…the kids, so they
were in tears and so…so…that’s really tough…I find that tougher than the physical
side of things sometimes...they shouldn’t have to go through that at such a young
age…(my daughter) she takes too much of it on board. Rudi line 625
After a serious fall and fractures a few years before, Kate’s mother worried
constantly about Kate falling again and being on her own, sometimes frustrating
Kate as she struggled to get to one phone with limited mobility.
If I don’t answer the phone then she’ll ring the mobile and if I don’t get to that in
time, she’ll ring again and it’s whole panic stations, she thinks something’s
happened to me…I know she worries but it doesn’t help. Kate line 2398
Ruby worries for her sister, that her sister feels left out of the family unit as there is
so much fussing over Ruby. The situation of Ruby requiring frequent assistance with
home and childcare because of her significant MS symptoms also causes stress for
her retired parents as well.
MS has changed our family dynamics…I mean Mum and Dad were stressed about
me…I think my sister feels a bit left out (Ruby cries)…it would be nice if it wasn’t all
about me. Ruby line 1147
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Worry for PwMS regarding affording MS healthcare and medications has figured
prominently in an overseas study (Jones & Amtmann, 2014), however this theme did
not present in the current study. This could be due to the fact that the Australian
government has subsidised access for residents prescribed DMTs to treat RRMS,
providing them at a greatly reduced cost.
Existing with anxiety
As previously discussed in chapter 2, anxiety is more prevalent in the MS population
than in the general population (Wood et al., 2013; Feinstein et al., 2014) and has
been strongly associated with lower QOL scores across all levels of illness severity,
from mild impairment to severe (Ionescu et al.,

2012). Anxiety is also more

prevalent in females than males in PwMS (Theaudin et al., 2016). Several
participants in the current study reported feeling anxious at many stages of their
RRMS journey and often felt that they were left to cope with anxiety on their own.
High levels of anxiety have been associated with an emotional preoccupation of MS,
and focusing on the emotional consequences of the disease (Roy-Bellina et al.,
2010; Tan-Kristanto & Kiropoulos, 2015) rather than physical symptoms. Susan
demonstrated this in the present study when she described a time in her life when she
felt being completely mentally overtaken by MS, to the point where she couldn’t
concentrate anything else in her life, not her family, not her work and not her usual
sources of happiness. Paul described spending many nights lying awake, feeling
anxious and researching MS on the internet, despite having very little physical
disability at the time.
Interestingly, negative life events, problems in family life and social functioning can
also be significantly associated with anxiety (Liu et al., 2009). Stress in childhood
has been explored as potentially being a risk factor to developing MS in later life
(Nielson et al., 2014). Childhood stress was present in the life stories of Joy, Will,
Margot, Rudi, Davina, Evie, and Griff, for varying reasons including loss of parents,
divorce, alcoholism, moving to foreign countries and childhood illness. A nationwide
cohort study from Denmark found that there was an increased risk of MS amongst
persons exposed to stressful life events before the age of 18, especially long term
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stress (such as parental divorce) rather than acute events of significance (such as the
death of a parent or sibling) (Nielsen et al., 2014). Others have also found that
exposure to abuse and neglect in childhood increased MS risk (Spitzer et al., 2012).
In regards to stress influencing MS activity, there is substantial evidence that disease
activity is increased under stress (Saul et al., 2016), but this particular study looked
at stressful life events in the 12 months preceding diagnosis, not in earlier childhood.
A systematic review exploring predictors of anxiety found that positive
reinterpretation, social emotional support and humour predicted an improvement in
anxiety symptoms (Butler et al., 2016). In the current study this was demonstrated
repeatedly as study participants recounted stories of anxiety followed by seeking
assistance and at times, psychological help. Anxiety is most highly associated with
depression, low self efficacy, stress, emotion focused coping, pain, fatigue and QOL,
factors that may be amenable to intervention if identified and actioned by MS HCPs
(Butler et al., 2016). Furthermore, a prospective study has shown that depression can
strongly predict anxiety and anxiety can predict later depression (Brown et al., 2009),
continued revisiting of both of these issues by MS HCPs longitudinally could have
an immense impact in preventing future problems.

Depression and Despair
Depression…I knew what that felt like…there was nothing…it’s nothingness…a
feeling of nothingness…I know this sounds strange but it’s the only way I can
describe the feeling. Evie line 270
Dealing with depression
As already discussed in chapter 2, for people living with MS the lifetime prevalence
rate of a depressive disorder has been reported as greater than 50% (Hoang et al.,
2016). As with anxiety disorders, depressive disorders are a diagnosable mental
health illness under the DSM-V (APA, 2013), following listed criteria including
depressed mood, loss of interest and enjoyment in usual activities, reduced energy,
reduced self esteem and confidence, ideas of guilt and unworthiness, pessimistic
thoughts, disturbed sleep and appetite and ideas of self harm (APA, 2013). For the
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purposes of this study, depression was coded if it seemed reasonable in the
descriptors the participants used to express their feelings, or if the participants used
the term themselves (which occurred in the great majority of cases). “Feeling
depressed” is a common phrase people use to describe many emotions, but I only
included it in the coding if there was supporting evidence from the study participant
that it was more serious than a fleeting emotion (such as a formal diagnosis or a story
of prolonged depression with symptoms such as those described above). Despair was
defined as a noun, the complete loss or absence of hope; and as a verb, to be without
hope (Oxford dictionary, 2017). Both depression and despair have been
conceptualised under the same subtheme, as they often paired together in the
participant’s narratives. However, the accounts of the participant’s stories for
depression and despair will be kept separate.
A British study exploring patient’s feelings when transitioning from RRMS to
SPMS, used thematic analysis to interview nine PwMS and seven HCPs. The
researcher found that shock and devastation is common in response to being
reclassified as SPMS, and is a significant psychological blow (O’Loughlin, 2015).
Participants in the study emphasised the importance of being able to debrief with an
MS Nurse after discussions on this topic so that they have ample opportunity to ask
questions and reconfigure the news in a hopeful manner (O’Loughlin, 2015). In the
current study, this experience was shared by Davina who pinpoints the day she was
told that she would one day transition to SPMS, as the day her battle with depression
began. Davina was reviewed by a psychologist and diagnosed as being moderately
depressed, but failed to follow-up or seek further care, she had a fear that she would
be medicated and didn’t want that for herself following years of working in the
health system herself.
When something does happen it hits me like a steam train and I go down to the
depths of depression…like I won’t get back up again…I think I’m consistently just a
little bit depressed…I think it after I was told that it could convert to
progressive…and

then

the

interferons

would

make

that

feeling

of

desperateness…hopelessness…it would make it a hundred times worse. Davina line
1068
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Piper was formally diagnosed with depression at different stages of her life journey,
both before and after her RRMS diagnosis. Despite the negative impact depression
was having on her life, she was not keen to seek help until her husband demanded it.
I sort of probably had a bit…a bout of depression…I was treated with a
counsellor…in hindsight you could see a pattern from younger and it was only that
my husband said to me if you don’t do something about it…this marriage is
over…that it sort of pushed me. Piper line 279
Susan was single for many years, deeply concerned that she would not find a life
partner who would accept her RRMS. Living alone with RRMS at times of major life
events often triggered symptoms of what Susan termed as depression.
(Buying a house) was another turning point for me because I was
again…depressed…thinking I’m doing it on my own and what if something happens
again? Susan line 633
After her first MSA meeting, where she met several young people living with
significant disability and progressive MS, Jane refused to go to any more meetings
and to avoid the feelings of sadness she was experiencing, which Jane referred to in
her life history as depression.
We were just sitting there crying and I thought I don’t want to go back to this
because it’s just too depressing…because they don’t work, they don’t study, they’re
at home in a wheelchair and they’re not going anywhere…and it’s just too
depressing. Jane line 211
The interferon injections were also a constant source of what Jane refers to as
depression, not just the fact she was self injecting, but that she always felt so much
worse after the injections. Jane ceased treatment after a couple of years, finding it
preferable to be on no treatment and risk relapses rather than feel depressed.
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(being on Rebif®) you just had to inject all the time and it’s just depressing…I used
to hate it…and I thought I might as well just give up and do nothing…and it was just
really depressing. Jane line 372
After his neurologist sought special permission for compassionate use of an
expensive DMT so he could have it at no cost, Will was tormented about doing the
right thing and battling his feelings of depression. His life went into a downward
spiral for several months.
It’s probably the greatest thing anyone has ever done for me…but then I threw it all
back in his face…depression set in pretty bad…I just wasn’t feeling any better…I
didn’t contact them (MS team) so I went unmedicated…I quit my job…I hadn’t told
my family at this point about my diagnosis. Will line 880
Rudi felt that because she has been through so much in her life, from a troubled
childhood living with a single mother diagnosed with bipolar disorder to the stillbirth
of her third son, that it was time for life to be fair to her. Rudi often felt the demons
of depression and worked hard to fight them.
I do tend to crash and burn emotionally because things are just taken from you…I
suppose that’s when I get down cause I think it’s not fair…I think because I’ve been
through so much in the past that you know how hard I have to fight and you look at it
and you feel tired just thinking about it…when you’ve had to fight all of your life.
Rudi line 1690
Face to face with despair and hopelessness
It has been suggested in chronic illness literature that despair and hopelessness
actually help move towards hope for patients, as awareness of the future and
consequences become clearer (Morse & Penrod, 1999). It has also been suggested
that maintaining hope is a balancing act between hope, hopelessness and despair,
with patients often passing through despair when moving toward hope or
hopelessness in a study of living with another chronic illness, acquired immune
deficiency /human immunodeficiency syndrome (Kylma, 2005). Moore (2005) has
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placed hopelessness at the centre of despair, with despair occupying the bigger
picture and hopelessness one component of it. Threats to hope (and thereby openers
to hopelessness and despair) include pain and other uncontrolled symptoms, spiritual
distress, fatigue, anxiety, social isolation and loneliness (Fitzgerald Miller, 2007), all
potential threats when living with RRMS. Interestingly, perceptions of hopelessness
from those seen by the patient as “powerful”, such as HCPs and family, may also
threaten hope (Fitzgerald Miller, 2007).
Davina described times of feeling hopelessness and the angst she felt at never ending
darkness. For several years after her diagnosis, Susan struggled with managing her
feelings around RRMS, often taking two steps forward and one step back and never
feeling emotionally in control as life when on around her.
I’ve had times of hopelessness, people say to me you’re not your disease and I’m
not…but…sometimes it becomes my focus and I can’t think past it because hope to
me is looking to my future, that’s hope. Davina line 1523.
Hopelessness is dark and it’s lonely…and it’s never ending darkness and
misery…hopelessness feels like it’s never going to end, that nothing’s ever going to
fix it. Davina line 1539
I felt like I’m here but I’m not here…I felt numb…I thought I can’t feel like this…I
can’t think like this. Susan line 481
Joy suffered debilitating bouts of deafness and blindness, the aftermath of coping
with

sensory

loss

took

her

to

the

depths

of

despair.

It was horrific…it nearly broke me (tearing up)…and I went into a downhill spiral
emotionally…(and later)…I deteriorated from there…so the visual thing would come
and go it was just really, really hard and I’m trying to hold down a job and I’m
saying to my husband I’m so sick I have to, I have to give up work I’m so sick, I can’t
work and he was just like ‘absolutely not”…I was heartbroken. Joy line 855
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Choosing to keep thoughts of despair and hopelessness to themselves was sometimes
the chosen path, no matter how much support was around them at the time. Will
discussed his feelings, keeping his friends away from what was happening after the
diagnosis of RRMS was made. He made this conscious decision to distance his
friends from his diagnosis of MS because of a family friend who was wheelchair
bound and severely disabled.
I had a breakdown to be honest…and no-one saw it, not even my best friends, I hid it
from everybody…it was just the worst and again, looked back at my friends
stepfather…and that’s all I could think of. Will line 700
Depression, despair and loss of hope in MS can be serious and life threatening issues.
Loss in MS goes beyond loss of ambulation and function and also incorporates the
loss of future plans and dreams, pre-morbid roles and significant relationships (Gedik
et al., 2017). Thoughts of death and self-harm are prevalent in MS, with data
suggesting that over a quarter of PwMS (type not specified) contemplate suicide
(Feinstein et al., 2012) and that young males in the first five years of diagnosis are
the most at risk (Feinstein, 2011). A recent study of 3,823 MS patients used a
systematically collected questionnaire during routine clinic visits to capture the
frequency of thoughts of death in patients with epilepsy and MS (Dickstein et al.,
2015). A prevalence rate of 15% in the MS cohort was reported (slightly higher than
epilepsy), associated factors being depression, male and unmarried, medical comorbidities and poor QOL (Dickstein et al., 2015).
Exploring suicidal thinking in MS, researchers used questionnaires and semi
structured interviews to talk to 16 PwMS (type not specified) who all expressed
suicide ideation, but not suicidal intent (Gaskill, Foley, Kolzet, & Picone, 2011).
Fear of burdening their family was one of the most common reasons participants
gave for thinking about suicide as a way of reducing family tension. They also
identified issues of feeling a loss of control, loss of femininity/masculinity,
hopelessness, feeling lonely and symptoms of MS; all amplified if they were in
distress (acute symptoms, pain) exacerbating the feeling of being a burden (Gaskill et
al., 2011). Despite most participants in the current study expressing concerns about
burdening their families, no participants in the current study spoke directly about
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suicidal thoughts. Will discussed having several emotional “breakdowns” during the
course of his life journey living with RRMS, during his long diagnostic process and
hospitalisation and then again a few months following his diagnosis of RRMS.

Struggling with the saboteurs
A saboteur destroys, damages or obstructs (Oxford dictionary, 2017). Saboteurs are
the unwelcome demons that threaten happiness and downplay moments of joy for
PwRRMS. These saboteurs were different for each individual, but could have a
significant negative impact on living with RRMS. The saboteurs I identified as
subthemes were “Coping with uncertainty”, “I’m never free of MS” and “Social
isolation”.
Coping with uncertainty
When a person’s actual present and future is characterised by uncertainty, a person’s
sense of feeling whole is threatened (Olsson et al., 2008). Uncertainty in chronic
illness has been well recognised (Mishel & Braden, 1988; Mishel, 1990) and it is not
surprising that the uncertain and ambiguous nature of MS creates the “perfect setting
for uncertainty to thrive” (Tams, Prangnell, & Daisley, 2016). Uncertainty can take
several forms in MS, including symptom uncertainty, medical uncertainty and daily
living uncertainty (Gray & Arnett, 2014). This is further hampered by a lack of
pattern manifestation in terms of remission and relapses (McReynolds, Koch, &
Rumrill, 1999), so it becomes difficult to control and predict. Eventually being
diagnosed with MS and piecing together the puzzle doesn’t do away with the concept
of uncertainty, in many ways the uncertainty has only just begun.
Mishel (1990), a nurse researcher and theorist, spent many years studying
uncertainty in illness theory. Mishel (1990) defines illness uncertainty as being
multifactorial and encompassing doubts and unpredictability’s relating to symptoms,
diagnosis, treatments, relationships, prognosis and future planning. All of these
components are features in the RRMS journey and impact directly on PwRRMS,
sometimes on a daily basis and in multiple ways. Every participant in the current
study felt the wrath of unpredictability at some time in their life, with the inability to
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plan for a “normal” future, presenting as a constant stumbling block. Coming to
terms with uncertainty in MS and the inability for long term planning is problematic
for many PwMS (Finlayson et al., 2005) and, as previously explored, can lead to
other demons, such as anxiety, fear, despair and depression breaking through the
barriers to take control.
Of all the saboteurs, coping and living with the uncertainty of such an unpredictable
and incurable disease caused challenges for most of the study participants. They told
of stories about the uncertainty of where MS will target next, how bad a relapse
might be and how their individual disease may ultimately progress. Many found the
concept of being diagnosed with a disease with no definite prognosis difficult to live
with and coming to terms with uncertainty was a daily battle for them. Kate was the
mother of a two year old child when she was diagnosed and uncertainty caused some
challenges in planning life.
RRMS…is unpredictable…and scary…extremely scary because you don’t know
what’s going to happen…Kate line 24
I had a two and a half year old son at the time (of diagnosis)...it was scary…You
couldn’t plan your life because you were always worried about a relapse…going on
a holiday…I was scared and always at the back of my mind was what would
happen…what am I going to do? Kate line 1248
Knowing the DMTS could reduce relapses, but not stop them altogether impacted
both Jane and Piper, the uncertainty always a factor.
You just think it’s a very difficult disease because you never know what’s going to
happen…you can’t judge anything. Jane line 745
I’m still going to relapse at some point really…aren’t I…I could relapse more often
on one of them (medications)…you don’t know. Piper line 1393
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I’m never free of RRMS
Caring for chronic illness takes planning, time and motivation by the patient (Katon
et al., 2010) and can be hampered by constant intrusion to everyday lives (Larsen,
2016). Integrating illness into daily life includes skills of modifying lifestyle and
seeking normalcy through balancing activities and illness needs (Schulman-Green et
al., 2012). Some participants discussed how RRMS is always with them, which is
one of the realities of living with a chronic illness. This seemed to be most prevalent
in the time after diagnosis when thinking about MS took up so much time and
energy. Life enjoyment was sabotaged by the continuous preoccupation with RRMS,
and this could happen at any stage. For Paul, it was constantly on his mind, and he
felt that he didn’t need to share that burden with others.
There wasn’t a moment that would go by where I wasn’t thinking about MS…I’ve
always got it in the back of my mind…don’t get too comfortable and think that
everything’s going to be OK…be prepared. Paul line 852
(on non-disclosure to his close friends) I’m reminded enough of it as it is…I don’t
need to…other people to…I don’t need any more, that’s enough, you
know…everyday you don’t go without thinking about it…it’s impacted my life in that
way, in a big way. Paul line 1024
Between relapses, Rudi kept a lot of her symptoms to herself and frequently hid how
she was feeling, reluctant to let others know that RRMS is always with her, even
when she appears well and back to “normal”. Similarly, Will refused to be a burden
to his wife, he worried that he wouldn’t be seen as the strong man he wanted to be
seen as and often hid symptoms from his wife so that she won’t have cause for
worry. However, sensory loss in his hands and the loss of the feeling of intimacy
when holding hands with his wife, are reminders that he is never free of RRMS.
I don’t think (my husband) realises that I have something every day…because I don’t
tell people…oh I had pins and needles today…or I’m a bit tired today…I get sick of
talking about MS. Rudi line 1413
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I hid it from my family and I do it for the simple fact that…my wife’s pretty
fragile…we’ve got responsibilities…I need to be that strong person…I wouldn’t want
anybody to have to go through how I feel on a daily basis. Will line 64
I hide the aspirin packet so my wife doesn’t see it because I don’t want her worrying
about it…she’s got a baby to look after…I know how hard it is to deal with all of this
and all of that…My hands are very numb you know, things like having my wedding
ring on, I don’t know if I’ve got it on or not, I can’t feel it, which is sad…I’ve never
said this to my wife because my wife always wants to hold my hand and I don’t know
if I’m holding it or not. Will line 100
Social Isolation
Social isolation refers to the absence of social relationships and social networks
(Umberson & Montez, 2010) and has been reported to be a risk factor for suicide in
MS (Feinstein, 2002; Pompili, 2012). Seminal work in chronic illness suggests there
are health risks of social isolation and loneliness (Charmaz, 1983). There is a paucity
of literature exploring social isolation and MS, but there have been reports in health
policy literature, which suggest that both the quality and quantity of social
relationships affect mental health, health behaviours, physical health and mortality
risk (Umberson & Montez, 2010). Prospective studies of mortality have shown that
individuals with low levels of social relationships were more likely to die than those
with greater social relationships (House, Umberson, & Landis, 1988). In adults with
medical conditions, social relationships also reduce mortality risk, confirmed in a
study of coronary artery disease (Brummett et al., 2001).
The daily grind of social isolation could be a constant saboteur to mental health and
how the participants saw themselves. Griff became a stay at home father after losing
his job because of his MS symptoms and has never returned to the workforce. Now
that his children are older, he finds himself frequently alone and struggling with
social isolation.
The social consequences of social isolation…I was never allowed to be completely
“in” with the mothers groups, with the playgroups…the kids start high school and
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the first thing they tell you is we don’t want to see you…my days are spent
wastefully…social contact is what you’re trying to establish so people have…you
know, community to operate in…well I don’t have those links anymore...it’s not
going to be easy for me to return to the workforce…who’d want me anyway? Griff
line 707

Recognising the demons to battle
What we know about some of these demons (fear, anxiety, depression, PTSD) and
MS is that they can be fatal. Of course, MS and MS treatments can also be fatal, but
that situation is far less prevalent than demons such as depression, which can induce
suicide (Feinstein et al., 2014). The demons of fear, worry, anxiety, depression,
despair and social isolation can be interlinked in many ways, for example depression
and anxiety often go hand in hand to sabotage mental health, predictive of each other
in MS (Brown et al., 2009). Worry can lead to anxiety, anxiety can lead to panic and
depression can lead to despair and hopelessness. These negative emotions can then
also interfere with RRMS treatment, with people suffering mood and anxiety
disorders in RRMS being five times more likely to non-adhere to their DMT (Bruce
et al., 2010). MS Nurses have an important role to play in assessing and monitoring
for signs of these demons, as trusted confidantes by PwRRMS, they often can
discuss these issues and advocate for PwRRMS to ensure early referral to appropriate
services (Porten & Carrucan-Wood, 2017).
The following theme of “Surplus Suffering” explores a novel concept in MS care,
which may inadvertently contribute to some of the demons experienced by people
living with RRMS. The concept of Surplus Suffering is suffering over and above that
experienced by the disease of RRMS itself and represents an area of MS care with no
existing specific literature.

230

Theme 4: “ Surplus Suffering”
Only through the experience of trial and suffering can the soul be strengthened,
vision cleared, ambition inspired and success achieved.
The world is full of suffering; it is also full of overcoming it.
Helen Keller (1880-1968)
The central organising concept for the theme of “Surplus Suffering” is suffering
inflicted by others onto the PwRRMS over and above that imposed by the condition
itself.
Eric Cassell, a physician who has explored the concept of patient suffering in
medicine for decades, has defined suffering as “the distress that is brought about by
the actual or perceived impending threat to the integrity or continued existence of the
whole person” (Cassell, 1991, p. 4). Suffering affects the entire person, extending
past the physical to emotional, social, spiritual, existential and financial domains and
often not fitting neatly into current biomedical paradigms (Epstein & Back, 2015).
Many people living with chronic illness suffer as they experience their illness, but it
is the broader significance of the suffering beyond physical discomfort which can
cause the loss of self for many people with chronic illness (Charmaz, 1983). Indeed,
consequences of suffering spread and accumulate through one’s life and can prevent
patients moving forward into the present, stealing joy and limiting social worlds
(Charmaz, 1999). Suffering is important for MS HCPs to consider because it can
lead to some of the demons discussed in the previous chapter, especially isolation,
hopelessness and vulnerability (Reed, 2003) and involve a loss of dignity and
alienation (Coulehan, 2011).
It has been argued by Cassell and others that little attention or discussion has been
given to the problem of suffering and patient emotions in medical education,
research or practice despite the relief of suffering being considered one of the
primary ends of medicine by both patients and the general public (Cassell, 2004;
Kenny et al., 1997; Shapiro, 2011). Furthermore, suffering is ultimately highly
personal, the presence and degree of the suffering can only by known to the sufferer
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(Cassell, 2004). If suffering is not relieved, there is a threat to the person’s integrity
and a loss of part of that person as their suffering continues (Cassell, 2004). This
degree of suffering and loss to self was evident during the current study. Several
participants whose physical, mental and emotional suffering continued with them for
many years after the precipitating event, felt an intense impact on their present sense
of self and their life living with RRMS. This will be highlighted throughout the
remainder of this theme with the use of participant comments, crystallising their
experience of Surplus Suffering.
Medical models of suffering tend to concentrate on fixing, curing and eliminating
illness compared to the nursing perspective which tends to look at the broader
paradigm of the quality of a life lived (Ferrell & Coyle, 2008). As nurses play a
fundamental role in the caring of those who suffer, and are present for people as they
struggle through illness, the relief of suffering is at the core of nurse’s work (Ferrell
& Coyle, 2008). Suffering is a universal human experience and nurses commonly
encounter pain and suffering at all levels when caring for their patients (Davitz &
Pendleton, 1969; Reed et al., 2003). Nurse researcher Morse (2001) has identified
two stages of suffering: enduring suffering which occurs when the sufferer brackets
their emotions so that they continue on in everyday life, not expressing the negative
emotions and emotional suffering which is a distressing state where emotions are
unconstrained. Individuals can move between the two types of suffering depending
on their circumstances and context (Deal, 2011). Participants of the current study
reported experiences of both enduring and emotional suffering.
Surplus Suffering as a concept was first described by James and Clarke (2001) as
they explored the experience of Portuguese immigrant women adjusting to life in a
new country and the extra suffering inflicted on them as a result of seeking healing in
a western health care system where disagreement arose between their old culture and
the new health care system (James & Clarke, 2001). In that particular study, Surplus
Suffering was conceptualised as the women suffering over and above the signs and
symptoms that brought them to medical care in the first place (James & Clarke,
2001). Further work in Surplus Suffering by Clarke and Fletcher (2005) explored
experiences of parents when their child was living with cancer, interviewing 29
parents and discovering that “problems in the system” and carelessness, unkindness
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and mistakes led to increased suffering for children and their families. In this work,
the authors conceptualised Surplus Suffering as the extra, unnecessary suffering that
can result from the HCPs and the health care system, in addition to the inherent
physical suffering already resulting from cancer and its treatment (Clarke & Fletcher,
2005). Clarke went on to explore further themes of “Surplus Suffering” as a key
component in studies of people living with Asperger’s syndrome (Clarke & van
Amerom, 2007), parenting a child with mental health issues (Clarke, 2012) and
childhood mental health issues (Clarke, 2013).
Whilst listening to the stories of many of the participants I interviewed in the current
study, at times I was struck by the realisation that the medical/health system had let
these PwRRMS down in some way and induced additional distress on top of the
burden of living with RRMS. By this I mean suffering in addition to that caused by
disease onset, disease symptoms and disease related disability and in addition to the
considerable mental health and emotional burdens discussed in the previous theme,
Battling the Demons. Very sadly, the stories of additional distress experienced by the
participants in the current study sometimes involved compromised care from their
HCPs, neurologists and nurses, exacerbating the disease-related suffering these
PwRRMS were already experiencing. For other study participants, it was the
additional emotional pain inflicted by those they loved or trusted, such as family or
friends or sometimes by strangers. During the study interviews I was struggling to
find a way to describe some of the similar feelings and experiences I was hearing
from the participants (and later coding and analysing) that effectively described the
concept of what I initially termed “added distress” or “compromised care”. When I
unexpectedly came across the work of Clarke at a qualitative research conference in
May 2017, the concept of Surplus Suffering fit the data exceptionally well and truly
captured the essence of the stories I had been told. Unfortunately, I realised at that
moment that Surplus Suffering was alive and happening in the field of RRMS.
Surplus Suffering reminded me of the seminal work by Charmaz (1999, P.365) of
suffering and chronic illness:
“When in agony suffering is immediate and relentless. Suffering can also be
insidious. It steals in and it spreads out. It is of the self and it is social. As suffering
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spreads out it shapes social relations and limits social worlds. Such suffering means
work - for chronically ill people, caregivers and co-workers.”
The notion that suffering is dangerous, stealing in and spreading out and affecting
many others in its path was highlighted in the stories of study participants. Surplus
Suffering presented a risk to the health and livelihood of the affected study
participants until it was discussed, assessed and positively managed. The significance
of suffering in chronic illness has been well documented by nurse researchers (Morse
& Carter, 1996; Charmaz, 1999); suffering shapes stories and meaning and poses
existential problems of identity and self as one lives with chronic illness (Charmaz,
1999). Often MS Nurses will hear stories from patients of positive and negative
experiences they have had with other HCPs leading up to, and after, their diagnosis
of RRMS. Even if Surplus Suffering was not inflicted under their care, the MS Nurse
could possibly be dealing with the impact of previous Surplus Suffering on the
PwRRMS in current consultations. This could in turn influence learning and
education, adherence to medication/lifestyle recommendations, trust, loyalty and
likeliness to partner with us as HCPs in future care. It is something MS Nurses need
to explore and assess at the beginning of their professional healthcare journey with a
PwRRMS. Everyone’s journey is unique, not all PwRRMS will have stories of
Surplus Suffering to tell, but many may well.

Towards understanding and a definition of Surplus Suffering in RRMS
From the study participants’ interviews and stories, and from the literature on the
phenomena of suffering, I have adapted a definition of Surplus Suffering from the
work of James and Clarke (2001), Clarke and Fletcher (2005), Clarke & Amerom
(2007) and Clarke (2012, 2013) to fit a conceptual model of living with RRMS:
Surplus Suffering is suffering caused to PwRRMS over and above suffering from
the existing physical, emotional and mental burdens of the disease. Surplus
Suffering in RRMS is caused by the actions of others; including HCPs, the
healthcare system, family, friends or community.
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Surplus Suffering inflicted by HCPs in clinical care
The most moving story I listened to during the interviews was the multifaceted story
of Surplus Suffering incurred by Joy for most of her childhood and then continuing
into her adult life. As a small child Joy endured mysterious burning sensations which
interrupted her sleeping patterns and stopped from her enjoying play with other
children in her small country town. Joy’s Surplus Suffering began when her parents
never believed Joy’s pain and neither did doctors when her mother eventually took
her to be assessed. The Surplus Suffering lay in the emotional pain in this case of
being ignored, rather than the physical pain. Additionally, Joy’s mother had been
labelled as having Munchausen syndrome, a form of factitious disorder listed in the
DSM-V (APA, 2013) where people exaggerate or create symptoms to seek medical
attention and assume the patient role. Growing up in a small rural community this
was a difficult label for Joy to avoid. Her pleas for help were not taken seriously and
intense pain and sensory symptoms were not investigated further. Even when Joy
suffered a form of sudden dyslexia at age 16 and in just a few months plummeted
from an A level student to failing school, she was still not believed; not by parents,
not by teachers nor by HCPs. This pattern stayed with Joy into her adult life as she
suffered various neurological complaints over the years (such as blindness, deafness,
stroke-like symptoms) but was never investigated properly by her HCPs, often
refusing her requests for further specialist referrals or investigative testing.
The doctors really weren’t interested, they just didn’t believe me…they thought I was
a fruit loop, they thought I was crazy. Joy line 360
They just thought I was crazy and they weren’t remotely interested and it didn’t help
that my mother…they treated her like she was a Munchausen’s mother…they thought
she was crazy, so I went to the doctor and said “I’m sick”…they thought…they
believed this is the child of the Munchausen’s mother, well of course she’s going to
be a hypochondriac…I didn’t even get any tests or anything. Joy line 369
I went deaf and my right leg dropped and right arm…but again he wouldn’t send me
for tests to see if I’d had a stroke…and I thought you’re frigging joking! My right
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side had dropped and you’re not willing to do any tests on me? I just…despair…it
nearly broke me. Joy line 403
Kate, highly educated and with experience in the medical and scientific field, sought
neurological medical attention after sudden episodes of blindness could not be
explained. Over 25 years prior to our study interview, Kate recalled her first visit
with the neurologist when she was told her likely diagnosis was MS. Kate had no
knowledge of the disease at that point in time and struggled greatly with the abrupt
delivery of the diagnosis, leading to extreme Surplus Suffering in the many years
since. There was no follow-up education and no chance to ask more questions at that
consultation.
He says “you probably have MS”…he turns around and goes to me “and you may
end up in a wheelchair and you will probably be blind in five years time”…I looked
at him and thought, five years…I said I’m only going to be twenty seven and I’m
going to be blind? And I was a mess…he gave me antidepressants to get over it and I
thought…Oh, this can’t be happening to me. Kate, line 243
Davina’s experience of Surplus Suffering was also the result of the news of her
diagnosis when it was revealed to Davina at the foot of her bed in a full hospital
room shared by others. The doctor was presumably unaware of her family history.
Davina had an uncle who had been hidden away from family and society with his
MS, his physical disability instead explained to others as being the result of an
accident and head injury. Davina was left devastated with no offer of follow-up care
at that point and cried during the interview as she recalled this experience.
He stood at the end of the bed and said it’s probably 99 percent definitively MS
because you fit the age, your sex and your symptoms are very textbook…so I suggest
to you that you think of your future and perhaps if children was something you were
looking forward to, it might be something you think about now, because better to be
a disabled younger mother than a disabled older mother…I was distraught…there
was no-one to go to really. Davina line 471
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In the area of power, dominance and medical interaction, the doctor-patient
relationship has traditionally been viewed as an area where doctors exercise power
over patients (Pilnick & Dingwall, 2011). In recent years this has been addressed in
medical training programs, but research on whether there is a positive impact on a
more patient centred approach having a positive impact on health outcomes has not
been established (Jaen et al., 2010; Lee & Lin, 2010). One extreme model of the
doctor-patient relationship is paternalism, where the doctor makes all the decisions
without patient input (Goodyear-Smith & Buetow, 2001). In some ways, recent
advances in medicine (such as the introduction of the more efficacious RRMS DMTs
in the last decade) discards the whole person and concentrates on a list of scan results
and blood tests (Aitini et al., 2014). This feels especially true of RRMS where the
new DMTs dictate careful and prolonged scan and results monitoring, perhaps at the
expense of a closer doctor-patient relationship. MS HCPs must be mindful to
maintain a balanced, individualised and holistic approach. Relationships between
doctors and patients with MS are particularly complex (Burnfield, 1984).
However, more recently it has been suggested that proper disclosure with effective
communication requires discernment, tact, timing, flexibility, responsibility and
sustained attention to the particular needs of the patient as a person in their own,
unique context (Krahn, 2014). Studies have also shown that getting clear information
can help reduce patient anxiety and distress with suspected MS, at all stages of the
process (Heesen et al., 2004; Kopke et al., 2012). This means that the consultation
where a diagnosis of MS is revealed should be planned thoughtfully with adequate
time for preparation, a discussion of the likely diagnosis and planned treatment
options, sources of support for afterwards, time for questions from the patient and a
planned date for a follow-up appointment.
The paternalistic delivery of diagnosis and prognosis experienced by both Kate and
Davina affected them negatively for many years. Kate immediately decided not to
consult further with that particular neurologist and was fortunate to find a new
specialist she was able to talk to about her concerns, listen to her questions and
consider her feelings. However, she still felt anger and resentment for many years
after her encounter. A gentler approach with Kate that took into consideration her
specific context of being a 22 year old balancing terrifying symptoms, full time
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work, mothering and part time university study may have ameliorated many years of
Surplus Suffering and given Kate opportunities to manage her feelings. Davina still
retains the emotional scars of the day her diagnosis was revealed to her, crying and
emotional as she recalled the story from almost three decades ago. Similarly for
Davina, realisation from the doctor of her previous life experience with MS in a
close family member may have resulted in a gentler, more compassionate delivery of
her RRMS diagnosis.
Studies have shown the importance of the physician-patient relationship to patients
and the effect this relationship has on long-term adherence to therapies and lifestyle
prescriptions (Koudriavtseva et al., 2012). In a disease such as RRMS, regular and
consistent adherence to DMTs are essential to gain disease control and prevent future
disability (Bruce & Lynch, 2011). A recent study of 97 people with “mild” MS using
mixed methods of interviews and questionnaires, explored the physician-patient
relationship and determined that patients with MS sought a close relationship with
their doctor and more disease related information. On the other hand, sources of
dissatisfaction included poor management of diagnosis, unavailability and poor
accessibility, low levels of psychosocial support and a lack of information
(Koudriavtseva et al., 2012). Furthermore, Mead and Bower (2002) identified five
dimensions essential in a patient centred approach; a biopsychological perspective,
viewing the patient as a person, sharing power and responsibility, practicing
therapeutic alliance and also viewing the doctor as a person. Unfortunately, in the
stories of Joy, Kate, Davina and Paul, they all believed that their biopsychological
position was ignored, they were not viewed as individuals, they were given no power
or access to shared decision making and no exposure to therapeutic partnership.
Their care (in the stories discussed in this theme) was not patient centred and lacked
information and support.

Surplus Suffering inflicted by brush-off
The concept of brush-off was explored in the first theme Piecing Together the Puzzle
as study participants reported feeling ignored or dismissed by HCPs in the early days
of their quest to identify the cause of their symptoms, in the lead up to a diagnosis of
RRMS. As part of piecing together the puzzle, the concept of brush off was anchored
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strongly in that theme. However, it is definitely also a form of Surplus Suffering and
also belongs in this theme to tell a story of the emotional pain induced by the refusal
of HCPs to take symptoms seriously, to investigate symptoms further or to trivialise
symptoms. All of the participant stories and quotes from feeling brushed off as a part
of Piecing Together the Puzzle also belong here in Surplus Suffering. Rather than
repeat them, I will acknowledge their strong links as a form of Surplus Suffering, and
also add some other instances where brush off figured strongly in participant stories.
Participants Davina and Susan have both served long careers as HCPs, and were
impacted by Surplus Suffering directly from the nurses looking after them during
inpatient hospital stays during severe relapses of MS. Both of these cases happened
many years prior to the study interviews, but were still as real and distressing to
Davina and Susan when I interviewed them. They have never forgotten what they
felt as being abandoned by fellow health professionals when they needed them the
most, the Surplus Suffering exacerbated by the fact this was from a profession they
valued as caring and kind.
Davina worked at the same hospital where she was admitted as an inpatient and tells
how the nurses secluded her in the furthest room from the nurse’s station, causing
her to feel isolated and alone at a time of intense vulnerability. Recalling her
memories of what happened induced distress and she cried as she remembered how
she felt.
They put me in the end room and the nursing staff on the neurology ward avoided me
because I don’t think they wanted to face me, that was very, very obvious…how do
you treat someone who has just been given the worst news of their life...of which they
didn’t understand either. Davina line 511
When Susan was an inpatient following a severe relapse, she recalls feeling
desperate for support in the middle of the night but received no compassion or
guidance from the nurses looking after her.
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I was scared and I was crying…and the nurses kept coming in and doing obs…I
couldn’t sleep and I said to the nurse, I’m very, very scared…I don’t know what’s
going on”…there was no support. Susan, crying, line 280
As explored in Piecing Together the Puzzle, Susan’s GP would not refer her on for
tests or to see a specialist despite her neurological symptoms and requests. Although
the GP has since apologised to Susan, the impact of the Surplus Suffering from his
disbelief of her symptoms remained with her and were expressed during the study
interview.
To acknowledge what I was feeling that’s all I wanted…and I was angry when it all
started with my GP not listening to me…I accept his apology but he needs to listen to
his patients, people know their own body. Susan line 1008

Surplus suffering inflicted by HCPs in research care
Paul’s story has significant implications for poor clinical research conduct but also
for compromised care and Surplus Suffering. Paul had been carrying around the
emotional scars from a consultation encounter with a neurologist, not telling anyone
else about it until our interview, and carrying the burden of Surplus Suffering for
several years. At the time of the Surplus Suffering encounter, Paul was already under
the care of a neurologist he trusted and who had recently diagnosed him with RRMS
(after several years of Piecing Together the Puzzle) and was about to start his first
DMT in a few weeks. In the wait time before his next follow-up appointment he
suffered a further relapse and was admitted to the emergency room of a local
hospital. He then saw a different neurologist who provided emergency treatment and
advised a follow-up appointment to check Paul’s progress a week later. As Paul had
very little experience with the medical and hospital system, he was unsure of the
correct etiquette in this situation and agreed to attend the appointment. Upon arrival
to his consult with the emergency room neurologist, Paul was ushered through to
another room, unfortunately apart from his wife who had accompanied him. The
neurologist asked if he would like to begin a DMT soon, Paul answered that he
would, and within minutes Paul recalls that he was signed up to a new clinical drug
trial without explanation and without the chance for him to ask why. The neurologist
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told him that the nurse would explain it all to him later. Unfamiliar with MS clinical
care and procedures, Paul felt bullied into signing the papers and assumed that he
would be given better explanations later. However, this did not happen, leaving Paul
feeling angry and taken advantage of.
I said “what’s going to, what’s this all about? and he says “Oh well, we can go over
all of this later on but what I want to know is to see if you would like to start
treatment today or in the near future?”…and I said “well, you know, obviously I
want to get onto something, but what does that mean? ” And he says “Oh well, OK,
I’ll take you out to the nurse out the back and we’ll get you enrolled in this
trial”…and I’m thinking…what is this? what is this?...And so, ten minute consult
without anything…what the hell is going on?”…he stood up…he went and stood at
the door, just under ten minutes to usher me in and out…it was quite horrific in
hindsight. Paul line 250
Not once through that whole episode did he do any neurological test, you know,
tapping a knee and all that sort of stuff…and that would at least be baseline stuff that
you would be doing? …I was worried about what sort of results were coming out of
this thing…you’ve got to treat these things very seriously. Paul line 371
Despite his misgivings, Paul completed the twelve-month trial commitment as he
didn’t want his efforts and time already spent to be in vain. I asked Paul why he
continued in the trial and returned for follow-up visits when he felt so violated. Paul
recalled how his background in science encouraged him to complete the research
trial for altruistic reasons (for others rather than himself) and he was pleased that he
did so, despite the personal cost to his piece of mind continuing to be regularly
exposed to the neurologist who he believed was the cause of his Surplus Suffering.
This was made easier by the fact that Paul rarely ever came across him at research
visits; ancillary research staff seeing Paul for most of the trial assessments.
I wouldn’t have gone through it other than thinking you know…if I can help in some
way because bloody hell, I don’t want anyone else to…or I would want other people
to be helped as well. Paul line 408
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As a researcher in clinical trials for many years I was horrified by Paul’s story, but
more than that, I was affected by the degree of Surplus Suffering this act of disregard
for clinical guidelines had on Paul. He tensed up when discussing it, his fists became
small balls, he became red in the face and the anger surfaced as he became emotional
recalling the day the Surplus Suffering began. Paul’s basic right to autonomy was
violated, he was not provided with the appropriate information to make an informed
choice. In fact, all four of the general principles of international research ethics were
violated in some way: beneficence (the welfare of the patient comes first), nonmaleficence (do no harm), autonomy (independence, in charge of self) and justice
(fairness to patients).

What’s happening? Unravelling the cause of Surplus Suffering inflicted by
healthcare and preventing Surplus Suffering
All of these encounters have shown areas where HCPs have let their patients down in
some way and even though most likely (and hopefully) this has not been intentional,
the Surplus Suffering has been felt for years and sometimes decades afterwards. A
research study looked at the evidence for quality care encounters alleviating patient
suffering (Arman & Rehnsfeldt, 2007). The authors found, that similar to other
research, healthcare encounters may actually increase suffering rather than alleviate
it (Arman & Rehnsfeldt 2007; Clarke & Fletcher, 2005; Wiman & Wikblad, 2004).
Findings also showed that the basis for this suffering was essentially neglect; patients
were not seen as whole human beings and their suffering was not noticed by the
HCPs. The stories described above certainly fit this category and highlight situations
where kindness and compassion from medical and nursing staff could have
potentially changed the journey for these PwRRMS.
Compassion has been defined as understanding or being aware of another person’s
suffering and acting to end this suffering (Crawford et al., 2013) and has been
described as an important part of the ethos of nursing (Bradshaw, 2011).
Papadopoulos and Ali (2016) explored compassion in nurses and other HCPs in an
integrative review and found several overarching themes as the main components of
compassion These included being empathetic, recognising and ending suffering,
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being caring, communicating with patients, being competent, connecting to and
relating to patients, and involving the patient in their care.
Similarly, “turning toward” is a concept in medicine which involves recognising
suffering, becoming curious about the patient’s experience and intentionally
becoming more present and engaged (Epstein & Back, 2015). Turning toward is
about being authentic, emotionally available and engaged, intentionally tending to
the immediacy of the patients experience even when the suffering is horrific and
troubling. Expressing loyalty, honesty, shared humanness and non-abandonment to
patients can be shown through caring actions, taking an extra minute or two, calling a
worried relative, choosing words carefully and caring gestures (Epstein & Back,
2015) and can be long remembered by the patient after the visit.
Suffering occurs when an individual feels voiceless, when their suffering is unheard
or when they cannot give the words around an experience (Ferrell & Coyle, 2008).
When nurses ask questions and act as confidants for patients, they can aid relief from
suffering and reduce physical, emotional, social and spiritual distress (Ferrell &
Coyle, 2008). Several participants who recalled experiences of Surplus Suffering in
the study interviews contacted me afterwards to say that they felt better for having
told “secrets” about their previous care and that they now felt more optimistic about
the future. Paul told me that he could now “let go” and move on from his previous
bad experience of research in MS care (which he felt was now due to his “good”
research experience in the current study) and Joy was equally as happy to have been
able to tell her complete story to someone who listened and engaged. I feel humbled
that this research study was able to be a catalyst for such positive change. The degree
of (often silent) Surplus Suffering experienced by these individuals was distressing at
times to listen to, but helping participants to regain some optimism and trust in MS
HCPs is extremely fulfilling. I felt that the simple act of telling me their life history
and exploring their feelings helped each participant to move forward with positivity
and hope, despite this not being a specified aim of the study.
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Surplus Suffering inflicted by family, friends and community
In a seminal paper on the lived experience of RRMS, Miller (1997) reported a theme
of conflict arising as a result of RRMS in two ways; the first was conflict with HCPs,
particularly physicians regarding the diagnosis of RRMS or explaining the disease,
as described in the three subthemes discussed above. The second area of conflict
involved study participants reporting considerable conflict within their own family
(Miller, 1997), a concept that was also experienced by some of the participants in the
current study.
Joy continued to suffer greatly, not just from the Surplus Suffering from HCPs
already discussed, but also from people she loved. When she was 16 years old and
suddenly became blind to typed text (a form of dyslexia) she was not believed by her
family or teachers.
No-one believed me, my teachers didn’t believe me, my parents didn’t believe me, I
wasn’t taken to the doctor, no-one believed me, no-one cared, no-one did anything
about it, nothing…you are lazy, stupid, ridiculous. Joy line 57
Joy’s second husband worked in the healthcare sector, his championing her search
for a diagnosis and health care connections had been integral to Joy finally being
diagnosed with RRMS after decades of undiagnosed symptoms. However, he
showed no compassion in relation to Joy’s RRMS symptoms and disability. Joy
recalls him forcing her to take more medication when she was already showing signs
of drug toxicity, something she feels that he would have identified as a HCP. It took
Joy some time to realise what was making her feel so sick, finally getting herself to
hospital and being diagnosed with valproate toxicity (a drug used to treat epilepsy as
well as nerve pain) from overdosage.
Over a number of years I ended up going on Copaxone® injections as well as
Epilum…I ended up having this huge, huge reaction, I blew up to three times my
normal size…Epilum toxic and the Copaxone®. Joy line 694
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He did this twice during our marriage…but I figured out it had to be medication
induced…He would put the tablets in my mouth and I would pretend to swallow them
and then I’d spit them out…that’s what got me better and then I would drive myself
to the hospital…I don’t think he necessarily wanted me to die…I don’t know…I will
never know. Joy line 743
On a separate occasion Joy’s husband forced her to continue to work as she battled a
severe relapse, not allowing her to take sick leave (which would have been unpaid)
and pushing her to breaking point.
I’m so sick and I can’t work and he was…”absolutely not, you have to go to
work”…I was just heartbroken, I kept going but my legs went on me and I started
walking with a cane because I was really struggling to walk…and then I lost my job
because I wasn’t doing my job, so while my husband was screaming at me “you have
to go to work”, I lost my job, so I couldn’t go to work. Joy line 859
The impact of Surplus Suffering from Davina’s immediate and extended family
brought tears to her eyes as she recalled the unkindness inflicted by her family over
many years. This happened initially at diagnosis when her mother and father’s
families argued openly over whose fault it was genetically that she had developed
RRMS. This caused extra angst at a time when Davina desperately needed support.
Later, her (now ex) husband did not engage with Davina and she felt at the time that
there really wasn’t anyone else to go to or confide in. He treated Davina and her
RRMS symptoms with contempt and also encouraged their children to do the same.
Additionally, Davina’s sister-in-law accused her of taking away attention from other
family members because of her RRMS.
The problem is… because my husband didn’t want to know, he never shared it with
them (our children)…he never was supportive of me…so then it became them against
me…so if I lost it or I got really tired, I’ve got MS or whatever, don’t stress me so
much, they’d turn around and say “Oh, don’t pull that MS card again”…he would
never defend me, he’d never say “don’t you speak like that to your mother, she’s got
a condition”…and that went on for years. Davina line 1264
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She (my sister-in-law) said to me that you use your MS as a crutch and said your
parents give you so much more attention and provide far more to you then they do to
your brother…and out of that came the greatest reign of jealousy…how could
someone say that to me? Davina line 1778

MS Nurses managing Surplus Suffering
The three important questions that arise from this data and discussion are firstly, how
can MS Nurses ensure that they aren’t the perpetrator of Surplus Suffering?
Secondly, how can Surplus Suffering in the PwRRMS be managed in a way that may
lead to healing and enhanced nursing and medical care for the future? And thirdly,
how can MS Nurses educate others (HCPs and family/friends/community) on how to
avoid inflicting Surplus Suffering on PwRRMS?
Empathic nursing and “going the extra mile” may be the key to setting up better
outcomes for the PwMS in the future (Davies, 2014). The word empathy comes
from the Greek empatheia meaning physical affection or passion, but shares its roots
with pathos, which means suffering (Stueber, 2011). Unlike sympathy, empathy goes
beyond merely acknowledging suffering. When a nurse truly practices empathy with
a patient, they share the patient’s struggle and feel their pain (Davies, 2014),
allowing the nurse to interact on the same emotional level as the patient and helping
to establish trust (Ward, Cody, Schaal, & Hojat, 2012). Four components of empathy
have been conceptualised by Morse’s group in a model to provide insight into
developing and expressing empathy (Morse, Bottorff, Anderson, O’Brien, &
Solberg, 1992). This includes consideration of moral empathy (unconditional
acceptance of another human being when encountering their suffering), cognitive
empathy (sensing what another human is thinking), behavioural empathy (nonverbal
communication to convey understanding such as a smile or head nod) and emotive
empathy (perceiving and sharing the patient’s feelings) (Morse et al., 1992). These
empathic qualities should be mindfully considered by MS Nurses at every step of the
life journey for PwRRMS.
By embracing holistic care and practicing empathy with PwRRMS, the MS Nurse is
in the ideal position to establish a relationship of trust, taking into consideration the
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vulnerable state of the person who may have experienced Surplus Suffering in the
past and may continue to live with it. Discussing past hurts, past compromised care,
past disappointments and perceived let-downs can help build a bridge to the future
based on common goals and realistic expectations, improving care effectiveness.
This does not mean that the MS Nurse ridicules or supports past care or injustices,
but that they listen closely to the patient stories, reflect and validate the patient’s
feelings to enhance mutual respect and understanding. Patients can also find meaning
in suffering through personal growth (Pollack & Sands, 1997), if we, as engaged MS
Nurses are courageous enough to guide them.
The challenge for MS Nurses is to foster an atmosphere where patients realise that
finding meaning in their suffering is a possibility and they may gain skills to help
them in current and future situations (Pollack & Sands, 1997). MS Nurses cannot
always alleviate suffering, but can listen, support, show kindness and compassion
(Deal, 2011) and create a safe, empathetic environment in which patients can heal
and gain strength. As Helen Keller reminded us in the opening quote to this theme,
suffering can strengthen the soul, and as MS Nurses, part of our mission is to find
strength and lend strength until the patient finds their own. To help patients
understand the place of Surplus Suffering and to help them to heal.
The following theme of “High (In)Visibility” explores some of the reasons why
Surplus Suffering may have occurred in the first place; the occurrence of many
invisible symptoms in RRMS, symptoms which cannot be easily seen or understood.
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Theme 5:” High (In)Visibility”
But you look so well, are you sure that’s what you have?
Of course I’m sure, I didn’t make this up for attention
Attention I don’t want and don’t need
Maybe if I just hide in the corner and work hard you won’t notice
You’ll forget
And then I’ll never have to try and explain
I’ll never have to tell you I’m not the same
That I’m different to you
That I’m different to me
So I hide, I keep secrets
I hide symptoms I can’t really make clear
I pretend, I pretend I am the normal person you think I am
I am normal
But if I am normal, why do I feel so wretched
So strange, so unknown to me
I wish I could take you on a journey
A journey through my body
Through the sensations, the weird noises
The sharpness of pain and the prickles
The feeling of not being able to move even though I do move
Of looking normal to you but feeling like a log to me
Of fogginess and clouds
Of tiredness and misunderstandings
Not quite here, not quiet there
Not quite anywhere
TB
For the purposes of this study, I conceptualised invisible symptoms as symptoms
which cannot be seen by others. Invisible symptoms are very commonly experienced
by PwMS (Ben-Zacharia, 2011) and were experienced by all participants in the
current study at some time in their life journey with RRMS. Invisible symptoms in
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RRMS are numerous and include fatigue, mental health issues (including mild
depression and anxiety), sensory symptoms and pain (pins and needles, tingling,
burning), mild cognitive dysfunction (thinking and memory issues), mild sexual
dysfunction, mild bladder and bowel issues (urge incontinence, constipation) and
visual disturbances (blurred vision, colour loss). I have used the descriptor of “mild”
in some of these invisible symptoms, because there are more noticeable features by
others in the case of moderate to severe classifications. Additionally, invisible
symptoms represent an extra layer of invisibility and complexity because PwMS
reluctantly discuss them and MS HCPs may not enquire about them (Lysandropoulos
et al., 2015). This may be related to lack of time in a consultation, inability by the
patient to express the symptom or to understand its connection with RRMS, or
perceived inability to treat the invisible symptoms by the HCP.
The central organising concept of this theme is the presence of invisible symptoms
and their impact upon life with RRMS. Invisible symptoms may cause chaos with
activities of daily living and may also cause misunderstandings with others, but on
the other hand they can also provide a refuge from chronic illness and the struggles
that MS brings. The fact that invisible symptoms are invisible can have both
undesired and desired effects, sometimes leading to conflicting feelings in the same
person about the same or other invisible symptoms. Some study participants suffered
greatly from the effects of invisible symptoms in their lives, but other participants
held on to the welcome cloak of invisibility protecting them.
There are three subthemes to High (In)Visibility; striving to make the invisible
visible (please see me), reverse stigma (when my MS isn’t enough for you) and
invisibility as a welcome cloak (the downside has an upside). The subthemes are all
linked by concepts of invisibility but all had different effects on the lives of the study
participants, clarified further by sub-subthemes.

Understanding the impact of invisible symptoms
Invisible symptoms are not peculiar to RRMS, it is well documented that invisible
symptoms exist in many other chronic diseases, such as mental illness (Jackson,
2015), systemic lupus erythematous (Brennan, 2016), fibromyalgia (Cunningham &
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Jillings, 2006; Parsa et al., 2015), Parkinson’s disease (Hermanns et al., 2013) and
heart failure (Whitehead et al., 2017) to name but a few. It has been suggested that in
living with invisible symptoms, PwMS may feel that they are not being seen heard or
met properly in the social environment (Lohne et al., 2010). Most people would
identify a PwRRMS as someone who has significant overt disability and possibly
using a wheelchair to ambulate. The idea of a PwRRMS functioning at a high level
with no outward signs of disability at all, but claiming to have significant unseen
symptoms, may cause issues for the understanding of MS in the wider community.
In a German MS registry study report (involving over 18,000 PwMS of all MS types)
20% of PwMS lost work capacity due to invisible symptoms despite being able to
mobilise independently (Stuke et al., 2009). The impact of MS on quality of life is
also emphasised by the high number of persons in the registry who suffered from
invisible symptoms (notably fatigue, cognition difficulties and mood disorders), both
in the early and the late stages of MS (Stuke et al., 2009). The invisible symptoms of
MS, often combined with the difficulty in communicating these invisible symptoms
to others, can often cause inattention towards the disease and ignorance (Grytten &
Maeside, 2006). It must also be remembered by HCPs that invisible symptoms can
often be more distressing to PwMS than visible symptoms (White, White, & Russell,
2008), even if they are not brought up and discussed.
Study participants discussed both positive and negative qualities about living with
invisible symptoms, some aspects were complicated for them to understand and often
involved more than just the symptoms. For example, Kate was appreciative that she
could keep her symptoms of RRMS invisible at work where she had not widely
disclosed her diagnosis, but what she wasn’t counting on was the fact that her DMT
side effects were threatening to give the secret away. The side effects from her
interferon treatment, including flu like side effects, temperatures and fatigue led to
people at work wondering “why is she so sick all of the time?”. Kate couldn’t
explain to them the reasons why as she did not wish to disclose her diagnosis. Rudi
lamented that her husband didn’t realise that she suffered invisible symptoms
everyday and preferred to keep it to herself; she didn’t wish to talk about invisible
symptoms as she felt this gave them and her RRMS some sense of control. Paul gave
an example of an invisible symptom he found it difficult to explain to others, he
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didn’t really understand it himself, but he felt it everyday for months before the
symptom remitted.
It’s like a cloud…I was sitting on a cloud…I don’t understand…it’s really hard to
describe…a very, very weird feeling and I could sense there is something not right.
Paul line 78
Balancing whether to tell or not to tell others about invisible symptoms was
individual for each participant and each decision had consequences, either for telling,
or against telling. On the one hand, participants wished to have invisible symptoms
understood, but on the other hand, to disclose the invisible symptoms might mean
disclosing the diagnosis of RRMS as well, which was a big step for some. Others
disclosed the invisible symptoms but had their experiences devalued as their RRMS
was deemed to be not severe enough. Some participants were glad their RRMS
symptoms were (mostly) invisible as they could continue hiding their diagnosis
whilst getting on with life. The subthemes of High (In)Visibility will explore these
concepts in more detail.

Striving to make the invisible visible
Research into another autoimmune illness with predominantly invisible symptoms,
systemic lupus erythematosus (SLE or lupus), revealed that others were disbelieving
of the diagnosis because the participants looked so well and normal, leading to
feelings of psychological invalidation and loneliness for the person living with the
disease (Brennan & Creaven, 2016). The researchers also discovered that this lack of
meaningful sympathy extended past family and friends to include HCPs and GPs and
these experiences may then have deterred participants from disclosing their diagnosis
to others or from seeking support afterwards (Brennan and Creaven, 2016). As
discussed in the preceding two themes Battling the Demons and Surplus Suffering,
similar situations also applied to PwRRMS, with several participants in the current
study experiencing invalidation from HCPs and GPs, and for some participants such
as Piper and Joy, this was a repeated occurrence. Several participants in the current
study also experienced similar feelings of disbelief, invalidation and loneliness from
family, friends, work colleagues and the community.
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Please see me
Living with an invisible chronic illness raises questions of illness validity where no
evidence can be seen by others (Moore, 2013) and is challenged significantly if the
disclosure of the illness produces no visible support (Moss & Dyck, 2002). Doubts
regarding symptom severity can be raised by family, friends, work colleagues and
also by doctors and other HCPs, significantly impacting on identity and self for the
PwMS (Skar et al., 2014). In addition, the lack of proof for such invisible symptoms
as fatigue and sensory dysfunction can lead to others punishing the PwRRMS for
being lazy, malingering and lacking credibility (MacAllister et al., 2009). Many
participants in the current study were the recipient of doubts by others on the severity
of their invisible symptoms, were not believed or brushed off and felt unsupported in
their claims.
Struggling to come to terms with the diagnosis of RRMS diagnosis herself, Susan
wished her friends and family could better understand her invisible symptoms, so
that they could truly understand her difficulty. Susan took them along to her initial
education meetings at MSA, believing that if they attended and learnt about the
disease that they might be able to relate to her invisible symptoms such as severe
fatigue and sensory loss.
I took a couple of girlfriends and Mum…just so they could understand what was
going on because…they see me as I’m OK they don’t know what’s going on
inside…so I wanted them to understand. Susan line 498
Evie disclosed her diagnosis of RRMS in the workplace early on in her journey and
had worked with the same group of work colleagues in a senior role for many years.
She organised for someone else with RRMS to come into her workplace to talk about
what it was like to live with invisible symptoms in an attempt for her work
colleagues to appreciate the daily struggles she encountered. Evie felt it helped to
provide greater understanding of her situation in her workplace, and it was beneficial
that a stranger (rather than herself) did this introduction.
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I wanted them to see somebody else other than me. They see me, they see me well,
but they don’t see me, they’ve never seen me bad. I wanted them to see something
different to me…and they were absolutely floored…most of that I have suffered at
some point and some I go through on a daily basis. Evie line 26
Margot cleverly devised a way of protecting herself in crowds when she was affected
by invisible symptoms such as dizziness, finding a way to alert others to stay clear
and keep herself safe from being knocked over or falling.
People (in crowds) don’t know you might be a bit rocky, so you have to be very
careful…I take that (a walking stick) with me and it made such a difference, even
though I wasn’t using it to help me…people thought straight away, oh there’s
something wrong with her…I’ll be careful around her, which is great…that was a
very good tool…so even though it wasn’t assisting me walking, it let other people
know. Margot line 1969
For Davina, a constant struggle was having her invisible symptoms seen and
appreciated by others, she wished there was some outward physical sign to alert them
of her severe fatigue.
The hardest part for me is when I don’t feel a hundred percent…I wished I suddenly
developed little green spots or something would happen to me where people would
say “Oh, she’s not great”. Davina line 786
Exposing the “secret one”
Sexuality, in particular, is an invisible symptom which has been significantly
neglected in literature and is often neglected in MS consultations (Esmail, Munro &
Gibson, 2007). Griff openly discussed what he referred to as “the secret one”, the
invisible symptom “nobody wants to really talk about”, sexual dysfunction in MS.
Griff discussed how the concept of sexual dysfunction is hard for HCPs to hear, hard
to talk about by patients, hard to treat by doctors and leads to “hushed tones” in MS
circles and in Griff’s case, led to more questions than answers. Over the years Griff
had unsuccessfully sought out treatment and assessment for sexual dysfunction. Griff
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felt that but has been left to deal with it on his own, and felt that his neurologist was
not skilled in assisting with this symptom or referring him to the appropriate
resources and personnel to help.
Nobody ever wants to really deal with that (sexual dysfunction), not even me...I don’t
want to deal with it either, (doctors) don’t want to talk about it…a young fellow me
(a fellow person living with RRMS) at a meet and greet came up to and said “what
about sex?”…it’s all in hushed tones and it’s industry wide I think, nobody wants to
deal with this…how you express it to your partner, how you even tell yourself that
you’re not a bad person? Griff line 575
Sadly, Griff is not alone, prevalence reports indicate that 40-80% of PwMS report
changes in sexuality (Foley, 2010; McCabe, 2004; Redelman, 2009). Sexual
dysfunction has been found to be associated with depression and reduced QOL and
to have implications related to relationships, fertility, pregnancy and parenting
(Delaney & Donovan, 2017). Additionally, it has been suggested that MS HCPs
often wait for patients to initiate discussions about sexual dysfunction rather than
bringing up the issue themselves (Gromisch et al., 2016), perhaps restricted by time
in a consultation or by inability to actually help with the issue. This is an area that
needs immediate action by MS HCPs to improve assessment, reporting and treatment
of sexual dysfunction in MS. Interestingly, despite the reported high prevalence of
sexual dysfunction in males and females with MS, no other study participants
discussed sexual dysfunction in the study interviews. This may have been for several
reasons, such as time constraints, embarrassment at discussing sexual health with a
stranger, importance placed on other issues they wished to discuss first or the fact
that it was not a concern for them personally, or the fact that it is the “secret one”,
even in the arena of research.

When my MS isn’t enough: reverse stigma of RRMS
MS has been described as an “invisible employer who hides their needs as a patient”
and can lead to feelings of silence, belittling and ignorance (Lohne et al., 2010).
Many participants in the current study with predominantly invisible symptoms of MS
felt that their disabilities were less important than others with more obvious and
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disabling MS symptoms such as people using a wheelchair or with poor speech. And
yet they struggled each day, trying to lead a normal life whilst managing debilitating
invisible symptoms. The dichotomy about how the PwRRMS feels on the inside with
invisible symptoms, against how the PwRRMS appears on the outside as physically
normal, can be difficult to cope with.
One of the surprises to me investigating invisible symptoms with the study
participants, revolved around the concept of reverse stigma, the idea that as someone
with RRMS, their MS wasn’t severe enough to be considered legitimate or to secure
empathy and understanding from others. So, rather than suffering from the stigma of
a disabling disease, this was just the opposite, it was stigma in reverse. This could
happen for two reasons, being compared to progressive forms of MS and RRMS
being viewed as insignificant against it, or being “fobbed off” as unimportant when
trying to give insight into invisible symptoms to others, because they looked well and
healthy and not unwell and sick. Both reasons had the same effect, loss of confidence
and self esteem for the PwRRMS.
Seminal work from Goffman (1963) exploring stigma in illness, reports that
ignorance from others is an assimilative technique to establish sameness and
common identity amongst a group. In the case of participants in the current study, it
had the opposite effect and left them feeling vulnerable and isolated. Experiencing
others refusing to acknowledge MS is a violation of self and imposes alienation
(Grytten & Maeside, 2006). A previous study in RRMS has also reported that PwMS
have been discriminated against for being “too healthy” and have taken advantage of
the sick role to secure benefit for themselves (Miller, 1997).
I’m not enough of MS for you, devaluing the impact
There appeared to be two distinct sides to stigma in MS described by study
participants; one of being ignored, or the MS symptoms being devalued or
undervalued (“reverse stigma”) and the other of having MS over-emphasised and
over-acknowledged (Grytten & Maeside, 2006). Findings from the current study
support reverse stigma as being particularly applicable to RRMS, whereas the latter
possibly applies to more progressive forms of the disease displaying more overt
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disability, and was not reported by any participants in the current study. Grytten and
Maeside (2006) also reported that PwMS experienced minimalisation of their illness
by others, even amongst friends.
Margot struggled with the “filthy looks” people gave her as she parked in the
disabled car spot close to the local shopping centre and then proceeded to walk once
she disembarked from the car. For months Margot carefully avoided parking in the
disabled parking bay, she struggled with her invisible symptoms of fatigue and pain,
sometimes overwhelming her on shopping trips and making it difficult to walk long
distances, but she did persevere. One day Margot gave up the fight, put her disabled
parking sticker on the dashboard and parked in the disabled bay, only to be
confronted with looks from strangers that she felt conveyed a message to her of
“ fancy parking there, you’re not even disabled”. Margot went back to struggling
after that for some time, parking long distances away from the shops rather than risk
perceived judgement from strangers again. In recent times though, Margot has come
to terms with the situation and puts herself first.
Davina struggled with acceptance of her invisible symptoms from others, particularly
hurtful was that her husband and children often did not believe the severity of her
invisible MS symptoms and openly made fun of her. Davina just wanted to be seen,
believed and understood.
(I didn’t tell my four kids much) I didn’t want to burden them I suppose…but because
my husband didn’t want to know, he never shared it with them…never was
supportive of me…so then it became them against me… if I was…really tired…he
would never defend me and that went on for years…and then they’d make a joke of
me…he (ex husband) would undermine me. Davina line 1263
Recently one of Davina’s now adult children recently contacted her after watching a
documentary about MS on television. As Davina recalled the conversation, tears fell
down her cheeks as it meant such much to her that finally, her RRMS was visible to
at least one member of her immediate family.
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She (daughter) said…”I just watched this documentary on someone who’d just been
diagnosed with MS and I was unaware of what you must have gone through”…so it’s
been really hard…it meant that maybe she’d started thinking a little bit about it.
Davina line 1298
Interestingly, two participants, Susan and Davina, who reported lack of
understanding of invisible symptoms from close friends, both worked in the
healthcare profession, as did their friends who failed to understand the difficulties
they were under fighting invisible symptoms. Perhaps their exposure to more serious
conditions in healthcare desensitised them to the suffering of their friend, the
PwRRMS. Davina was particularly surprised that her HCP friends would question
her invisible symptoms and devalue her severe fatigue levels.
My (HCP) friends would turn around and say “Oh, what’s wrong with you, you can’t
keep up anymore, you’re getting old?”…and they do it til this day…how dare
they…and then they’ll try and make me feel better by saying “oh, everybody gets
tired”…but I said, I don’t get tired, it’s more than that and it can hit me really
suddenly and I go down like a pack of cards. Davina line 794
For Susan, although she felt that she has already educated her friends about the
invisible symptoms of RRMS, she felt they still didn’t fully understand the impact
that invisible symptoms of RRMS could have.
People, they don’t understand…they see you as you’re OK because mine’s only mild,
but inside…in here, it’s hard to accept and hard to make other people understand
how you’re feeling…it was hard to talk to friends about and if I did say anything,
they’d say “Susan, you’re OK, look at other people, you’re very lucky”…so I went
OK…but I was really sad and thought…well, what about me? Susan line 670
Jane was fundraising for MS awareness and research in an endurance bicycle event.
The riders were to cycle a long distance in extreme heat and the day prior to the
event Jane expressed her concern to the organisers that fatigue and Uhthoff’s
phenomenon (when the body overheats and old MS symptoms reappear from
previous nerve damage) would be a problem for those with MS in completing the
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course. Jane requested an earlier start time to avoid the midday heat for herself and
the fellow MS riders taking part, but this request was refused. Jane was then forced
to leave the ride without even starting it, causing her to lose the significant amount of
fundraising money she had been promised to take part in the event. Jane felt that she
had been shamed for speaking up and verbalising her issues, her invisible RRMS
symptoms. The irony of the situation is overwhelming, raising awareness of MS and
MS symptoms in a fundraising event, only to have her own invisible MS symptoms
overlooked and devalued by the very group that should have the greatest
understanding.
They thought I was being demanding…it was so disappointing…I said…I have
MS…I know what it’s like. I had to leave the trip early, it wasn’t possible to do…very
disappointing, people had sponsored me and I had to tell them I couldn’t do the ride
for these reasons…I raised a lot of money but I didn’t do the ride like I said I was
going to…it was so disappointing. Jane line 798
A “pretender to the throne”
Griff’s tale of reverse stigma is as poignant as it is astonishing. As a newly
diagnosed, vulnerable man diagnosed in his forties with RRMS, he was navigating
his first MSA meeting and getting to know more about MS and the invisible
symptoms he had been battling silently for many years. After the seminar there was a
chance to meet other PwMS. Griff was surprised when the mother of a severely
disabled and wheelchair bound young lady came over to Griff and verbally
“attacked” him, accusing him of not having MS and not being serious. This public
humiliation threatened his newfound confidence, and although he understood the
reasons behind the reverse stigma, the emotional scars are still borne by Griff today.
He felt like, and still feels like, a “pretender to the throne” of MS.
Compared to so many other people, I am light years ahead…which brings its own
problems in fact…I coin the phrase “pretender to the throne”…when I was at a
welcome to your disease meeting, there was a girl…probably early twenties…and in
one of those wheelchairs you never really get out of…her Mum’s with her and
absolutely distraught, saw me and maybe 3 other people chatting…we have much
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lower damage…and she came over and attacked us…I was upset at the time but I
wasn’t cranky at her…I’d hate to think what she was going through…(she) had a go
at me because “what are you? You haven’t got MS!”…that’s always been at the back
of my mind, that I’m a bit of a “pretender to the throne”. Griff line 532

Invisibility as a welcome cloak: the downside has an upside
Many people living with chronic illness don’t look so different from those healthy
people around them, and it can be a huge burden to make the invisible visible (Siouta
et al., 2016). Some PwRRMS decide to keep the diagnosis private and the invisibility
of many MS symptoms suits them very well. Previous studies regarding living with
MS have noted that PwMS often wish to deal with their disease privately (Clair,
2003) and this may be due to several reasons including stigma, embarrassment and
(perceived) career advancement. Several participants in the current study were able
to continue working and functioning at a pre-RRMS symptoms level and were able
to keep their diagnosis of RRMS hidden from those they did not wish to disclose to.
However, not disclosing their illness could also expose the PwRRMS to real threats
of physical and emotional well being rendering PwMS “damned if they do, damned
if they don’t” in regards to disease disclosure (Vickers, 1997). If they were not sure
what to do, participants in the current study tended to err on the side of caution by
withholding the diagnosis and practicing information control. For some participants
such as Kate, Paul and Jane, this was the great benefit of invisibility; there was
definitely an upside to the downside. Keeping a diagnosis of RRMS concealed from
a public that knows little about the disease of RRMS has been previously reported
(Miller, 1997) and this may help the PwRRMS retain the identity they wish others to
see and avoid being labelled.
The presence of invisible symptoms could also be seen as a blessing to some
participants. At times the invisibility of MS symptoms was an added bonus and seen
in a more positive light, especially when there was reluctance to disclose the MS
diagnosis to others, such as in the workplace or to extended family or friends. This is
a form of information control, not just in deciding disclosure just after diagnosis, but
continually along the life journey living with RRMS. The presence of invisible
symptoms allowed decision making by the PwRRMS, who received what
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information, how and when was then up to each individual. Will wished to control
what his family sees of the disease, especially his wife as she is caring for a new
baby. Piper also keeps her symptoms from her children, acting as she always has and
pushing herself to live and look as normally as possible.
The invisible stuff…I hide it from my family…my wife’s pretty fragile, we’ve got two
children, we’ve got responsibilities…I need to be that strong person. I don’t want her
worrying about it…she’ll see what’s going on…she just leaves it alone because she
knows that’s how I deal with it…I keep it to myself. Will line 64
My kids don’t see the impact of MS, I guess they don’t see it because I just…if
I…stopped every time there was something wrong I would do nothing basically and
I’m not like that…I’m a do-er…the kids I guess don’t see, a lot of people don’t see
it…all the symptoms anyway because of my way of day to day living…I will do it…I
will push myself and I will do it. Piper line 838
Not disclosing the diagnosis and not being “called out” on it led to feelings of
success in keeping MS hidden, success mainly due to the predominantly invisible
symptoms. Paul and Kate were both successful in controlling who knew about their
diagnosis of RRMS in the workplace; Paul also kept the diagnosis secret from his
many friends and extended family.
Nobody else knows, I much prefer to keep it that way…my wife’s parents don’t know,
only my Mum and Dad and my brother know…(I haven’t disclosed to any friends) I
doubt they would think they could catch it…but I don’t know. Paul line 1004
(I was offered a new job and the Boss knew I wasn’t well) but due to invisible
symptoms he said “no-one needs to know, you can do the job”…and I thought, why
not? I’d hide my relapses and treatment and it worked quite well. Kate line 590
MS Nurses can educate PwRRMS that it is helpful to have a few close confidants
they can talk to about their symptoms (invisible and visible) and how they are
feeling, openly and honestly. The confidant can also help advise on sensitive issues
such as disclosure and can provide a “sounding board” for feelings. Having a
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sounding board to practice with can also help improve communication skills and
provide systems to make it easier to explain invisible symptoms to others. This is
especially important at the beginning of the journey and many MS clinics will advise
new patients to bring someone trusted with them to the first few appointments for
this reason. Becoming skilled at explaining invisible symptoms will take time and
practice, but is possible with the right guidance.
MS Nurses also need to become skilled at assessing for invisible symptoms in
PwRRMS and providing opportunities for open discussion and education. Setting
time aside to discuss fatigue, cognition, pain and sensory symptoms, mental health
issues, sexual dysfunction, bladder and bowel issues are just as important to the
PwRRMS as scan results, DMT prescriptions and laboratory tests. Discussing
invisible symptoms provides the words, phrases and framework to talk to others
about the symptoms and the difficulties they face. PwRRMS then learn the
terminology and they discover that the symptoms are understood by others, there are
reasons for the symptoms and that they are considered genuine. This instils
confidence in managing the life journey with RRMS.
This final theme of High (In)Visibility concludes chapter 6 of the thesis, Walking the
Low Road. The skills that have been learnt and practiced by the study participants
and the things they have learnt about themselves and others along the life journey so
far has prepared them well as they embark on “Taming the Beast”, the next and
opening theme to the following chapter , “Finding the High Road”. This really marks
the start of a brighter future and a time of much personal growth and development.
This is the time when PwRRMS begin feel a sense of taking control of their lives,
living with RRMS, not living against RRMS.
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CHAPTER 7- “FINDING THE HIGH ROAD”
The following chapter “Finding the High Road” outlines the final three themes from
the data analysis and explores a distinctly different overall feeling from the previous
chapter Walking the Low Road, where despite some occasional glimpses of
brightness, there was more a sense of confusion, of negativity, of unanswered
questions and of battle. Finding the High Road feels exactly like the metaphor it is
taken from, taking a turn in the road for a higher path, to be able to reach higher
ground and look down on the muddy waters below. A journey of self-discovery, of
finding previously unknown talents and gifts, of packing a personal “toolkit” to live
the best life possible with RRMS. A time of immense personal growth and
achievement, sometimes noticed by others and sometimes not. But always active,
always engaging, are the choices in Finding the High Road.
The three themes making up Finding the High Road and their related subthemes and
sub-subthemes are listed below in Table 5. The only subtheme in this chapter
requiring elucidation is the sub-subtheme “decisions driven by fear” which is placed
under the main theme of “The DMT Dance”. This sub-subtheme also relates to the
concept of fear, which was introduced in the third theme Battling the Demons in the
previous chapter. However, I have included decisions driven by fear in this chapter
and theme because it is part of the negotiation of successfully completing The DMT
Dance and an important element of perhaps later reaching “decisions driven by
hope”. This sub-subtheme also forms an opposing force to decisions driven by hope
and for this reason I felt DMT decisions driven by fear and decisions driven by hope
belonged together for clarity and understanding, both being key components of The
DMT Dance.
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Table 7. Summary of themes six to eight of the study findings; demonstrating central
organising concepts, subthemes and sub-subthemes developed from the study data.
Theme

Central organising

Subtheme

Sub-subtheme

concept summary
6. Taming the

Finding tools and

Finding my North Star

Beast

packing a toolkit to live

Getting a handle on

with and manage

RRMS symptoms and

RRMS, the different

relapses

ways that PwRRMS

Maintaining physical and

regain control of their

mental health and

life

wellness
Choosing my medical ATeam
Harnessing support from
family, friends,
organisations and
workplaces
Riding high on resilience

7. The DMT

Negotiating and coping

The hardyards: making

Dance

with the medication

decisions about DMTs

fear (“I’d rather be in

therapies to treat RRMS

and adherence

a wheelchair than

•

decisions driven by

dead”)
•

decisions driven by
hope

Switching to a better life
8. Holding

Hope and positivity

Hands with
Hope

•

functional hope

about reaching happier

•

restorative hope

times and the beginnings

•

curative hope

(or totality) of

•

defiant hope

•

optimism and a

acceptance of RRMS

Hope in its many forms

Purposeful positivity

into life and how

positive outlook

looking to the future

•

searching for meaning

with hope brings its own

•

harnessing a sense of

peace and rewards

humour
•

faith, religion and
spirituality

•

giving back and being
involved
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Theme 6: “Taming the Beast”
Now I have arrived
Armed in my combat gear
I’m taking you on
Gone is my negativity, my fear
This time I’m ready
I’ve read the rules of the fight
This time I’ll take you
I’ll show you my might
I’ve gained so much
I’ve lived and I’ve learned
I’m a new person now
Full of positivity I’ve yearned
TB
The theme of “Taming the Beast” represents a turning point for PwRRMS, a time
where they start to conquer the demons they have battled since suffering their first
RRMS symptoms, a time where they have gained some experience living with the
disease and now have some knowledge about what RRMS actually is, and is not. It is
a time for positive change, for the beginnings of acceptance, sourcing the best
support, sharing tips, gaining confidence and for recognising the incredible things
they have achieved since Piecing Together the Puzzle, working on (Re)defining Me
now that I have RRMS, Battling the Demons, managing Surplus Suffering and
learning how to live with High (In)Visibility. Taming the Beast brings life firmly
into the foreground, working to be a person living with RRMS, not an RRMS person.
Evolution is key to this theme, as the nature of RRMS means that change is always
potentially around the corner and nothing is static. Adapting to change and living
with uncertainty has become a major life achievement.
The central organising concept for this theme is packing a metaphorical “toolkit” to
live with and manage RRMS, the different ways the study participants found to
regain control of their life. Taming the Beast comprises six subthemes: finding my
North Star, getting a handle on MS symptoms and relapses, maintaining physical and
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mental health and wellness, choosing my medical A-Team, harnessing support from
family, friends, organisations and workplaces, and riding high on resilience. Several
sub-subthemes will add further clarity and explanation to these subthemes.

Finding My North Star
This subtheme goes beyond the “getting acquainted with MS” subtheme of
(Re)defining Me now that I have MS discussed, in the second theme of the previous
chapter. Finding my North Star is after the settling in period, where the initial shock
or devastation of the diagnosis and the thirst for knowledge or running away from
knowledge has advanced into more of an acceptance of RRMS. This subtheme has a
positive feel, in recognition of the qualities this stage has invoked in the participants,
finding new meaning in life and finding a place where both the person and RRMS
can cohabit the same body. For some participants, these feelings of regaining control
were still very new and developing, and for others the sense of control had been well
established for years prior to the interviews, yet was always constantly evolving.
The North Star, or Polaris, is the brightest star in Ursula Minor. The North Star does
not appear to move in the sky to the naked eye, remaining fixed above the North Pole
to mark the way due North (Hirsch, Kett, & Trefil, 2002). The North Star in the sky
guiding and lighting the path due North captures the sense of PwRRMS finding their
inner light and a way to move forward in life living with RRMS. Even though RRMS
was ever changing, the study participants could find their way to their fixed point of
control, their North Star, to keep travelling in a positive direction.
The turmoil and upset explored and discussed in the earlier themes started to settle as
education and learning brought confidence, as symptom mysteries unravelled, DMTs
were commenced and disease control started to become a reality. Although a difficult
concept for MS Nurses to explain to patients, the simple notion of time assisting
assimilation with the disease is real. Study participants Paul and Davina describe
how time can be the friend PwRRMS need, how time helps PwRRMS to understand
that life can be about more than RRMS, especially with some tools.
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As time rolls on and nothing happens, you tend to become a little more complacent I
guess...I’m always a bit cautious, so just a little more planning involved with things.
Paul line 937
I’m comfortable in my own skin now, I think I’ve accepted wisdom that comes with
age rather than worrying…I have got a wonderful partner, best friend…we have our
own quietness. Davina line 1746
Research has identified that several key skills are beneficial to successfully adjusting
to life living with RRMS. These include positivity, perceived control over life
situations, self-efficacy in disease management, optimism, hope, benefit finding and
spirituality (Dennison et al., 2009). Additionally, patterns such as developing
strategies to combat difficulties, making extra time to manage daily needs and
avoiding making MS the life focus, begin to develop as confidence and experience
living with MS grows (Dennison et al., 2010). Several study participants
incorporated some of these skills into their new existence living with RRMS and
chose to change their feelings and attitudes about RRMS as a conscious and
deliberate choice. I conceptualised this as slowly progressing in Taming the Beast.
Joy contemplates how she chose to look at RRMS in a new light rather than being
bitter and angry about feeling different to others.
That was my gift…it actually was my gift at birth to be given this brain that didn’t
function the same as other people’s, so I just didn’t see the world the way other
people saw it…and it gave me something more to work with…I am blessed. Joy line
2009
Similarly, Rudi describes how she purposefully changed her attitude to see RRMS as
a gift in her life and a facilitator for positive change, the chance to finally travel and
see the world.
As a mother you just get on with it…as hard as it is. I got really angry and obviously
went through the stages of grief…but by the end of it I actually think of it as a gift
because it’s made me live my life differently…it’s made me start to travel whereas I
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would have put that off…I just have a different outlook on life…I tend to care less
about things now so I view it as a gift…MS is not such a bad thing. Rudi line 835
After initially struggling with what he termed depression for many months, and not
adhering to his DMT or treatment plan, Will realised he needed to actively make
some changes to his life to successfully live with RRMS. His life turned around as a
result and he learnt what he needed to do for himself to secure happiness, finding his
North Star.
From that point I just said nothing’s going to stop me, I’m sick of being that guy that
just goes home…I never used to go out I used to go home from work and go to
sleep…I just said I’m not going to go home and sulk on my own, get up and live in
circles…so I joined a sporting team, I’d go and play poker with my friends…I just
lived this active life. Will line 1151
A recent study explored the experiences of 10 PwMS after being diagnosed with MS
(unfortunately the MS subtype was not defined) and reappraising their lives
(Flensener & Rudolfsson, 2016). The authors explored feelings about changing from
a healthy, strong body before MS, to experiencing altered bodily functions and the
possibility of changes to life activity. Much like the concept of Finding my North
Star in the current study, Flesner and Rudofsson’s (2016) work revealed that PwMS
“learn to fly with broken wings” by getting to know their new foreign body and
“building a new living space” for the body to function. Building a new living space
took time, requiring adjustment, reappraising and creating new meaning in life, and
was sometimes uncomfortable. Many participants in the current study displayed
features of these themes as they partnered with RRMS in a new life, learning to fly
with broken wings over time.
Susan suffered greatly in the early years of her RRMS diagnosis, and being a HCP
herself, she was frustrated that she couldn’t seem to make sense of her new MS
world and make positive progress. For many years she was sad, lonely and deeply
fearful of what her future life was going to be. Being single, she felt intensely alone
and that nobody would want to partner her in life with RRMS. One day after a
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relapse that all changed, Susan decided enough was enough. It was time to find her
North Star.
What I was looking for was to help myself to be able to understand these little
demons…to then thinking you are good enough…don’t listen to them...to be strong
and I could also help others…to just accept it, to embrace it because it doesn’t mean
the end…that was a new beginning for me. Susan line 773
MS doesn’t make you the person…that’s not you, there were other things before that
and there’s going to be more things, that’s just there and you deal with it. Susan line
1299
Coming to terms with the occasional need for wheelchair assistance if her mobility
was impaired by a relapse or severe fatigue was a huge stumbling block for Margot,
steadfastly refusing her husband’s attempts to try a wheelchair so that she could still
enjoy outings and travel. But, once she tried it, she was amazed at the difference it
made to both their lives and how easy things became now that the stress and worry
about possible falls was taken out of the picture. Finding her North Star to include
the occasional use of the wheelchair or walking stick with relapses or severe fatigue
brought new perspectives for Margot.
It was a real mental block (tearing up)…it’s really hard to do…it’s the elephant in
the room. The thing is it was so stupid…you do become more accepting…but it was
fantastic. Margot line 1533
I thought I can’t believe I didn’t do this sooner, it was the best thing…it was the
initial embarrassment but once I sat the first time…this is fantastic…now I’ll take my
wheelchair and the girls will wheel me around shopping. Margot line 1701
Starting to see unexpected benefits from situations that previously caused angst can
be a positive catalyst for change as well. Rudi turned the dismay she felt at not being
able to work due to her severe MS relapses into a positive as she was able to spend
more time with her four young children.
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Whilst it (our lifestyle) may not be extravagant, I’m just doing a lot more and loving
it…loving it…I look at this as I’m lucky because I get to spend this time with my
children…whilst it was tough financially, we adapted, as you do. Rudi line 950
Evie took a different approach, yet one that firmly changed her future path to one of
positivity for not just herself, but for others with RRMS. She began talking to others
as an MS advocate and sharing her story to change public perceptions about RRMS,
improving her own outlook on MS along the way. Evie’s North Star was all about
others and less about herself.
If I’m going to have it I may as well do something with it…that was the way I saw
it…I want to help others and make a difference, I want people to see people who
aren’t disabled by MS…it’s not all doom and gloom. You shouldn’t focus on what
you can’t do, it’s what you can do, what you want to do…yeah it’s going to feel like
shit sometimes and you’re going to get angry and upset, but you need to pare that
back and take a different perspective. Evie line 1210
As study participants were able to look back on their journey with RRMS, their MS
experience generally gave them confidence about how they viewed the disease in the
future. As discussed in the literature, over time, PwMS tend to develop expectations
about their disease path, and often with minimal input from MS HCPs in regards to
prognosis (Dennison, McCloy-Smith, Bradbury, & Galea, 2016). As confidence
grows, PwMS begin to make more decisions, to make plans and to become more
actively engaged as their knowledge increases and they regain a sense of control over
what is happening (Clair, 2003). Taking on a more active role in treatment decisions
is something that PwMS tend to opt for as they become more educated and engaged
as the life journey with MS continues (Heesen et al., 2004). This prepares them for
new challenges on the life journey, guides them in finding their new North Star and
allows them to start building positivity and hope, which will be discussed in greater
depth in Theme 8, “Holding Hands with Hope”.
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Getting a handle on MS symptoms and relapses
The course of RRMS is characterised by unpredictable relapses interspersed with
periods of remission from disease activity (Halper, 2007a). Relapses can either be
mild and barely noticed by the PwRRMS, cause a myriad of sensory and motor
symptoms, or be catastrophic in their effect causing paralysis, blindness and gait
disturbances. Although most people living with RRMS usually recover from early
relapses, some residual effects can remain and over time, relapse recovery tends to
lessen (Mills, Mirza, & Mao-Drayer, 2017). To add to the mix of confusion and
unpredictability for people learning to live with RRMS, “pseudo” relapses which feel
like a new relapse coming on but are not inflammatory in nature, can occur in the
setting of infection or changes in body temperature (such as with exercise or
overheating) and can be very frightening to the PwRRMS (Mills et al., 2017).
Working out the difference between true relapses and “pseudo” relapses takes time
and experience, none of which are accessible to the patient in the early stages of
living with RRMS. For most participants in the current study, coming to terms with
various RRMS symptoms and managing relapses was initially difficult for them, but
as time passed and with education and experience, their confidence in managing MS
symptoms and relapses grew as they began Taming the Beast.
After initially being worried about new onset symptoms and not understanding the
meaning of them, Piper gradually set up a system of communication between her
local GP and her MS clinic, which was located several hours drive away from her
rural town. Relapses became a nuisance rather than the cause for deep concern,
which she had felt in the early days.
They’re just a nuisance…I get a build up of things…you go to the doctors…I do
converse with my neurologist which is really good and so between here and there,
they get this agreement…you just hope they are not as bad or severe as before. Piper
line 1240
Piper’s husband set up an excel spreadsheet for her, with separate columns to score
her symptoms daily in an attempt to help Piper try and work out what triggers her
symptoms, her bad days or high fatigue days and hopefully avoid those triggers in
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the future to improve her quality of life. It is his way of providing support and has
been key for Piper to uncover ways of managing her own MS symptoms and Taming
the Beast.
Everyday I fill out a spreadsheet with all my meds, and symptoms, give myself a pain
score, how many hours I’ve slept, exercise, diet…we’ve even got the weather…so the
idea is we’ll see a graph and there might be some pattern. Piper line 1522
Becoming experienced and educated in RRMS provided Kate with the plan she
needed to instil confidence that she could manage her relapses, whenever and
wherever they occurred, which was important as she planned to travel overseas. Kate
felt as if she had regained some control over RRMS.
Being relapse free for four years was fantastic because you could plan your life…I
felt a lot better and my doctor gave me his mobile number, steroids to take and told
me what to do…so I thought I felt a lot better knowing that I had a backup plan. Kate
line 1247
For study participants Rudi, Margot, and Joy, the initial (undiagnosed) relapses
became less of a worry for them once they knew that it was MS and not something
they viewed as more sinister such as a stroke or brain tumour. This was particularly
so for Rudi, who suffered rapid onset and serious relapses which often resulted in
admissions to hospital.
Everyone else got panicky around me but I know it’s the MS so I don’t…I don’t feel
highly stressed…I know I’m not dying, I’m not having a stroke…I tend to cope better
than everyone else around me. Rudi line 252
For Margot, letting go of household chores that worsened her MS symptoms has
made a positive impact on her general health and fatigue levels. This has been an
effective tactic in Taming the Beast.
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I’ve pulled back on domestic duties, I don’t do cleaning anymore…I think you just let
things go really, but it’s not that important…I accept things a lot more…I’ll walk
past dust in the hallway…it’s not important…I’ve become more patient with MS.
Margot line 952
Kate suffers terribly with pain from spasticity, a condition caused by nerve damage
from MS where her leg muscles become tight and painful. A new drug has recently
become available internationally, which has had good results reported in reducing
spasticity symptoms. Although she is yet to try the medication, Kate is on a crusade
to bring the new drug to Australia because no treatments she has tried so far have
given any relief. Kate is determined to bring this quality of life-sapping MS symptom
under control, even if it means organising her own treatment to engage in Taming the
Beast.
I need it, I desperately need it…I don’t need it in three years time I need it now…I’ve
called the PBS…this is the problem and I need to do something about it…you have to
be on everyone’s back…I put that on the backburner until next week when I get
another burst of energy. I really do feel like I have to be my own advocate. Kate line
2158
Rudi suffered from severe bouts of fatigue, particularly after relapses. Rudi had to
find a way to deal with this debilitating symptom so that she could reclaim her life as
a busy and engaged mother of four children. Balancing rest and life enabled Rudi to
get a handle on her MS symptoms and to take on Taming the Beast.
I do recover…when the symptoms disperse, it’s very draining…it’s like I’ve been hit
with a truck…very tired...I go straight to bed basically cause there’s nothing else I
can do, and I will sleep…usually I recover pretty well. Rudi line 1087
There’s periods where I would have to go to bed…because I feel like I’ve been hit
with a truck…I’ve learnt…I can play hard but I also have to rest hard…because I’ve
done it before where I just keep going and pushing and pushing and I crash and
burn…so I’ve found I just have to balance. Rudi line 1769
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Maintaining physical and mental health and wellness
MS poses challenges to both physical and mental health and wellbeing, and
increasing disability over the course of the disease is associated with increasing
burden and transformation of life plans (Rommer, Suhnel, Konig, & Zettl, 2017).
Indeed, the adjustment process in RRMS does not conclude when early stage
PwRRMS get used to their MS symptoms, it continues as future disease status
changes occur, as their life journey goes on (Dennison et al., 2010). Learning to
manage health and wellbeing is therefore an important part of the life journey with
RRMS and one which is in a constant state of flux depending on symptoms, relapses,
medication side effects, as well as general life, work and family commitments and
responsibilities. It has been reported that after diagnosis, PwMS often say they won’t
be able to cope in certain situations or with certain symptoms, but longitudinally as
life progresses and the changes happen, they do learn to cope and often very well
(Dennison et al., 2010). This pattern was displayed by most participants in the
current study, capturing the concepts of Taming the Beast, so vital not just to coping
with the disease, but for thriving with RRMS. Maintaining physical and mental
health and wellness is an important step in this process.
The “Shifting Models Perspective” (Paterson, 2001) believes that people choose to
have a predominant focus of either wellness or illness in the foreground of their lives
and that encounters and experiences are selected which will support their preferred
perspective. During the time of Piecing Together the Puzzle discussed in theme 1,
study participants demonstrated that a perspective of illness lay in the foreground
leading up to RRMS diagnosis, with the tests, many consultations, hospital visits and
uncertainty. As time progresses after diagnosis, symptoms dissipate, relapses come
under control and PwRRMS generally become more settled, their focus often starts
to shift from the initial illness in the foreground to one of wellness in the foreground.
Holding the burden of illness in the background sustains a sense of well being, and
many study participants concentrated on a wellness plan for physical and mental
health.
As mentioned in theme 2, (Re)defining Me Now That I Have RRMS in the subtheme
dare to compare, Will took the view that he wished to stay away from others with
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RRMS during his DMT treatment in the day admission ward of the hospital where he
underwent his monthly infusions. Will chose to look after his mental health and
commit to mental wellness, deliberately sitting with patients being treated for cancer,
rather than his fellow MS colleagues. Staying away from others with MS and out of
the so-called “cripple club” (Dennison et al., 2010) distanced Will from MS
stereotypes and helped him place his RRMS in the background. Will also chose not
to read up on RRMS or engage with education programs for the same reason.
I don’t want to read the bad sides of MS because I can’t influence them and I can’t
change the way they feel…I don’t need to hear it…I know some people are geared to
go out there and really advocate, be positive and speak about their problems…that
doesn’t work for me. Will line 301
Will’s attitude to others with MS was in the minority for the study participants, most
of whom embraced being with others with RRMS, talking with them, sharing tips in
Taming the Beast and looking forward to their treatment infusions for this reason.
Margot looked forward to the monthly infusions of her DMT in the hospital day
admission ward and was disappointed when her DMT changed to an oral medication
and she no longer spent time with people living with RRMS. It had become an
important part of her mental health wellness strategy.
In the hospital you met other people with MS, which was fantastic…because people
had little tips, they had stories…you’d exchange how long you’d been diagnosed,
what your reactions were…and there were people from all walks of life. Margot line
503
An important facilitator for resilience in MS is physical wellness including exercise,
stress reduction and energy management (Silverman, Molton, Alschuler, Ehde, &
Jensen, 2015). Studies have shown that continuing physical exercise behaviour over
time predicts a continuation of enhanced QOL for PwMS (Dennison et al., 2009).
The most dramatic turnaround from illness to health and wellness in the current
study was from Joy, who described how she felt in the aftermath of her husband’s
death when her RRMS symptoms were at their worst and she attended his funeral
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aided by two walking sticks, making a decision that day to reclaim wellness to the
forefront of her life and take back control.
At my husband’s funeral I made an absolute heartfelt decision that I would get better
no matter what…something switched on…when my husband died…I had to choose
life…this resurgence wants to do what I wanted it to do, there must be another
pathway…I started fighting for my own health…I felt like I had the power to control
my health…I made it true…I was suddenly aggressively and passionately seeking
wellness and I have done ever since…I took back control of my life…the disease
doesn’t control me, I control my body. Joy line 983
Making the active decision in Taming the Beast by becoming healthier physically
was more than just a decision to move forward for many of the study participants, it
was also an act of defiance, challenging the very essence of what RRMS takes away
in physicality and mental health to do the physical activity which is threatened by the
disease. Many study participants described how maintaining or commencing acts of
physical health, exercise and sports helped them to feel better, stronger and more
connected in both physical and mental wellbeing. Piper was proud that she pushed
through her symptoms to maintain her physical health.
Just get out there and do stuff while you can and I do that everyday, I like going for
walks or runs…I do it because I can…I’ve got my own gym…even when I am
fatigued with MS I still do it, I will still do my walk, it actually makes me feel
better…if you move you’ll be amazed at the difference. Piper line 990
Margot has recently started gym work and has already felt the benefit, feeling
stronger physically. Rudi and Evie have also found that physical activity has helped
regain control with specific symptoms, as well as being a mental health boost of
positivity for Evie.
Since I’ve finished work I haven’t had many falls at all because I’ve started going to
the gym. I had an assessment and program done and now I go twice a week which
has been the best thing…my legs are stronger. Margot line 1341
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I do regular yoga…I started playing team sports…I’m absolutely loving it, whilst I
could be more active, I have consistency…and I paddleboard to help with the
balance. Rudi line 993
I’ve gone back to gym now, my muscles needed it…keeping fit and healthy…just to
remind myself that I was being more defiant…you can knock me down but I’m going
to get up. Evie line 1358
Susan embraces the holistic view of improving both her physical and mental health
and also in educating others living with MS and sharing her tips to living life better
with RRMS.
I always tell others with MS just try and do all the good things like eating good food
and exercising…the whole wellness thing is what you need, MS medications are part
of that but exercising, eating well, rest, seeing friends…that’s what makes you
healthier in mind and body…you have to be healthier up here too. Susan line 1305

Choosing my medical A-Team
The subtheme of “Choosing my Medical A-Team” is all about the PwRRMS gaining
some control in Taming the Beast by selecting members of the health care team to be
on their side, to take charge of their own care, to engage with self-management
strategies and to make decisions about who makes them comfortable and who they
trust to manage living with RRMS. Often when symptoms first strike, patients are
referred for consults and tests to people they have never met before and they don’t
have choice in who they see, especially so if they are referred by GPs or present
through emergency rooms. After diagnosis and the settling in period however, it
appears important for PwMS to choose their A-Team for the long life journey ahead
with a chronic neurological condition. It has been reported that PwMS choosing their
own doctors and health care teams helps the PwMS to take charge, a concept which
is extremely important to moving forward and gaining some control (Clair, 2003).
Several participants described scenarios where their MS HCP, in particular the
neurologist or MS Nurse, went “over and above” what was required to advocate for
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them, securing trust and instilling confidence in the care they were receiving. Will
was unable to gain financial assistance from the government for the expensive DMT
he needed due to residency issues. The medication cost was almost the same amount
as his earnings at the time. Will became very emotional as he recalled the day his
neurologist advocated for him and sought compassionate use for the medication,
meaning it would be provided at no cost to him.
He said don’t worry about it, you focus on what you have to do and we’ll work out
the rest…since that day I still make sure I come to him because he’s just the best.
Will line 672
I broke down in front of him…I don’t know what to say…it’s probably the greatest
thing anyone has ever done for me. Will line 877
After many years and failed attempts to secure a diagnosis for his intermittent
symptoms while Piecing Together the Puzzle, Paul was referred to a neurologist who
gave him plenty of time, spending two hours with him on the first consult and finally
providing a diagnosis and treatment plan.
My neurologist was brilliant…he had a number of MS patients…he had a massive
checklist he was going through, the first consultation I had with him would have
been over two hours and he was wanting to solve this…he later retired but not before
sending me to the best MS Neurologist…he’s the one in Australia that you want to be
with and he organised all that for me…he was wonderful. Paul line 112
The family doctor or general practitioner (GP) can often be the first consult when
PwMS develop their first symptoms (Giovannoni et al., 2016) and an important part
of the health care team during the lifetime living with a chronic illness. A systematic
review has shown that being under the care of an empathic family doctor improves
patient adherence to medical advice, decreases anxiety and distress, improves clinical
outcomes and improves patient enablement (Derksen, Bensing, & Lagro-Janssen,
2013). Paul was also fortunate to secure a GP who supported him at every
opportunity, becoming an important member of his Medical A-Team.
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My GP, she’s another one who spends hours with you, she’s learning from me about
MS, so whenever she’s at conferences she tries to go up and find out a little bit more
with neurologists, she’s told me she’s loving having me because I’m the only one that
she’s got. Paul line 481
MS Nurses have been perceived by patients as being ideally situated to discuss
practical and emotional issues relating to MS (Dennison et al., 2016). MS Nurses
play an integral role in helping patients and families come to terms with diagnosis
(White, 2012) and across the entire disease trajectory providing expert information,
relapse intervention and decision support (Mynors, Bowen, & Doncaster, 2016). MS
Nurses cover many domains, including advocacy, empowerment, disease expertise
and education (Halper & Harris, 2016) and have an important role in preventing
unnecessary emergency and hospital admissions (Quinn et al., 2014). Rudi and Ruby
both valued the support of MS Nurses who advocated regularly for them and were
both interested and available as members of their A-Team.
I’ve got a great GP, she’s advocated on my behalf, I’ve had her great support and
the whole MS clinic has been great…if I ring and say I need to see someone, they
know I’m sick and they will get me in…the MS Nurse, the fact that I can ring her,
that’s awesome because you probably have more contact with them than you do with
the doctor and she can answer your questions. Rudi line 1871
My neurologist, he’s just beautiful, he loves what he does and the MS Nurse…she
takes the edge off going, I’ve never met a more efficient woman in my life…the
nurses are divine and it’s a comfortable environment. Ruby line 494

Harnessing support from family, friends, organisations and workplaces
Social support systems can vary greatly between countries and cultures but mostly
comprise of family, friends and HCPs (Rosland et al., 2013), as well as
organisations, societies and work places. Immediate family, significant others and
close friends also play an important role as the first line of support, especially true
for spouses of PwMS who are often sharing the burden of MS on a daily basis
(Aymerich, Guillamon, & Jovell, 2009). When appropriate support is provided it can
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be positive and affirmative for the PwMS, however, sometimes social isolation can
occur as family and friends may withdraw from the ill person, especially if they feel
there is nothing they can offer in terms of help (Reade, White, White, & Russell,
2012). As discussed in earlier themes, for Davina and Joy sadly this was the case
many times during their lives with RRMS as those dearest to them withdrew their
love and support, refusing to acknowledge the impact of RRMS in their lives.
However, for the majority of the participants in the current study, family and friend
support was present in abundance and became a welcome refuge from RRMS and an
important factor in Taming the Beast.
Ruby and Paul described how their immediate families rallied around and provided
support when they needed it the most.
My husband’s become a pro at managing it now, I’m very blessed…Mum and Dad
bought a house around the corner and my sister wants to move closer…Mum and
Dad are just there which is a godsend with the children and this has brought us
closer together for sure. Ruby line 1122
My family first and foremost got me through that first year…my parents are just out
of this world, but my wife is just the best. Paul line 861
I try and give my wife time off MS, let me look after the kids for a while, but she’s
like no, we’ll do everything as a family…I’m very, very lucky. Paul line 947
For Susan, after many years of worrying and searching for a partner who would
accept both her and RRMS into their life, she was fortunate to find someone who
was willing to partner wholly with her in living with RRMS.
He was beautiful…such a gentle soul and I told him about my MS and he was so
accepting of it and he said that doesn’t worry me, he was so loving, he was very
supportive…I’ll do it with you…and then I forgot about my MS, it wasn’t the focus
any more when I had been focusing on that for the last whatever many years before I
met him…I was more. Susan line 884
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Simply holding the belief that others will provide appropriate support has been
shown to increase patients perceived ability to cope with chronic illness and to lower
their stress levels (Uchino, Cacioppo, & Kiecolt-Glaser, 1996) and actually receiving
support from loved ones can be an integral part of the illness journey (Kiecolt-Glaser
& Newton, 2001). MS focused research has repeatedly demonstrated that greater
social support is associated with better mental health outcomes (Koelmel et al., 2016)
and that the presence of social support can protect against stress and improve the
sense of purpose for PwMS (Bambara, Turner, Williams, & Haselkorn, 2011;
Kirchner & Lara, 2011; Krokavcova et al., 2008). Additionally, social relationships
are known to play an important role in stress and coping (Wirth & Bussing, 2016),
factors that are absolutely vital for PwMS in the unpredictable RRMS journey ahead.
High quality social interactions have been shown to lead to higher levels of life
satisfaction and also lower levels of depression and anxiety in a study using a mixed
methods questionnaire in 103 PwMS, most of whom were living with RRMS (Reade
et al., 2012). Supporting these findings is a recent Iranian study which demonstrated
that increased social support for PwMS was also positively associated with more
effective coping strategies and also enhanced psychological well being, both so
important for quality of life living with MS (Farran, Anmar, & Darwish, 2016). In
order to be effective, it appears that social support needs to be of high quality,
worthwhile and appropriately applied to times of need for the PwMS. Examples of
social support that did not fit these categories in the current study included Jane’s
mother providing her with MS information at diagnosis which was well meaning, but
outdated and wheelchair-focused, and Paul’s mother “canoodling” him with worry
and over emphasising MS. However, the great majority of participants in the current
study described situations where family and friends provided much needed support
and encouragement at just the right time, were consistent in their support and greatly
assisted them in Taming the Beast. In Piper’s case, her social world widened
significantly after her diagnosis and she took every opportunity to participate in life,
laughing as she recalled the toll her new social life took on her.

280

I’ve met another girl and she’s become a good friend of mine…she was the one who
recommended the neurologist…we sort of catch up nearly every other week and have
coffee…her experience with MS has been different but it’s actually nice to have
someone who understands. Piper line 695
I’m probably doing more than ever…my social life is more than I can take…I’ve had
that many weekends away…I’m actually a little tired of it! Piper line 683
A study exploring stigma in MS found that PwMS were sometimes ignored in social
situations and interpersonal relationships, described as “polite inattention” towards
the illness (Grytten & Maseide, 2006). Kate felt a sense of losing friendships when
her friends learned of her diagnosis with RRMS. However, Kate also felt that the
worthwhile friendships were able to withstand her life with RRMS and she takes
comfort in the strength of these current friendships.
Your real friends stick by you…friends that I’ve come to learn were more like
acquaintances…the minute you get sick and you can’t do things that you used to
do…they are no longer your friends…you’re in the too-hard basket…good friends
make the effort, they make the effort to come and we have developed strong
friendships. Kate line 1994
Rudi felt the support from her country town environment, where everybody pitches
in to help those who need it.
I’m very lucky, I couldn’t have had more support and friends…in small towns people
are so willing to help…people that you’re friends with, but you don’t really associate
with…give me a call…I’ll pick kids up, can I cook you something? So, I’m very
fortunate. Rudi line 1721
MS Societies and organisations can be an important source of social and emotional
support and can be vital in strengthening morale for PwMS as they adapt to their
disease (Ebrahimi et al., 2017). Additionally, connecting with social support from
other PwMS is an important positive coping behaviour (Rommer et al., 2016).
Several participants in the current study reinforced the importance of sharing stories
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and being supported by others with RRMS, people who truly understood how they
were feeling and the battles they were facing. This could happen in organisations
such as MS Australia, or more informally at MS clinics and infusion centres where
PwRRMS tend to gather together at common times for consultations and treatments.
The MS Society is brilliant, I love them…I used to love the blogs but I can’t handle
the negative…I’m quite a positive person. Ruby line 995
Natalizumab (Tysabri®) is a DMT infusion that needs to be given regularly every
four weeks in a hospital clinic, usually for a period of several years if all progresses
well. Patients would often be scheduled to receive their next infusion on the same
day four weeks later, leading to meeting up with the same fellow patients regularly.
For some study participants such as Margot and Griff, this led to strong friendships
being forged and a sense of support from others living with RRMS and having the
same treatment. Griff also valued the chance to see other diseases he viewed as
worse off than his own, appreciating the perspective this brought to his life.
You had a common thing, MS…I made friends there and it was nice… different
experiences rather than just yourself, the Tysabri® days were fun and I still keep in
contact. Margot line 506
Tysabri® became my social world…it was a big part of my social life…one of the
great pleasures was actually keeping the disease in perspective, I’m sitting there
with people having their cancer drugs as well…you’ve got to just do it…it was such
a good social environment. Griff line 958
Work places and work colleagues can also provide support at difficult times,
providing understanding during sudden relapses or on “bad days” when MS
symptoms were overwhelming. Having the ability to choose to work days and hours
to assist with fatigue management was seen by several participants as being a great
advantage in Taming the Beast. Rudi was able to chose hours that suited her RRMS
symptoms best and allowed her a rest time in the afternoon prior to collecting
children from school.
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Now I’m back working twelve hours a week I chose the hours and the days…this just
landed in my lap so I was lucky and it was the right time… and while it’s not the
most stimulating job, it’s a job and this is good for now. Rudi line 955
For both Ruby and Susan, having their immediate work manager understand their
unique needs has led to them feeling supported at work and able to continue
balancing work and life with RRMS.
I’ve just asked next year to have part time reduced hours to have a day off in the
week…my body’s really craving to move…my boss has been really good so
far…work’s been really supportive, so I feel blessed to be in that work environment.
Ruby line 657
They looked after me and understood…I was very grateful, very blessed…two days
on, one day off, two days on…and I rested and felt healthy. Susan line 591

Riding High on Resilience
Resilience can be defined as the human capacity to persist, to bounce back and to
flourish when faced with stressors (Bonnano, 2004). More formally, resilience is the
capacity of an individual to successfully maintain or regain their mental health in the
face of significant adversity or risk (Stewart & Yuen, 2011). In disability and illness,
resilience has been identified as an important contributor to QOL (Terrill et al., 2014;
Silverman et al., 2015). Moreover, in the case of RRMS, the very nature of the
unpredictability of the disease can present unique challenges in resilience right
through the life trajectory (Silverman et al., 2017). For all of these reasons it is
imperative that MS HCPs are aware of the benefits of resilience for PwRRMS and
that they themselves acquire skills to enhance and develop resilience for patients
under their care.
After only the first few interviews in this life history series, I was humbled by the
stories of resilience I was hearing from the study participants. This pattern continued
throughout all of the interviews and was one of the study highlights for me
personally. I have consulted thousands of patients over the years of my nursing
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career, and even more intensely since working in the field of MS, but, I questioned
myself, have I ever asked a patient to talk to me about previous life difficulties and
how they overcame them? Had I ever asked a patient with MS to relate stories from
their life that told me about some of their life challenges and how they managed
them? To my great embarrassment I could not recall ever asking that particular
question. But very quickly during this research study I became acutely aware of how
important resilience was for PwRRMS to Tame the Beast and what an essential part
of the life journey with RRMS that resilience occupied.
The stories of past resilience in the lives of the study participants differed of course,
but the common thread they all had was overcoming difficulty and moving forward
in life, sometimes even managing to thrive along the way. Some stories were
incredibly sad, comprising of very harsh and neglected childhoods and family
situations. Will had endured a home situation of an absent father and a mother who
died from alcoholism when he was thirteen, Joy had overcome a lifetime of
abandonment and neglect to be thriving, and Davina and Evie had both survived
bullying during school years and traumatic home situations from their fathers.
Margot and Kate were the children of ethnic parents who moved to Australia,
without speaking English, and later becoming translators for their parents and taking
on family responsibility beyond their years. Ruby, Piper and Susan also suffered
issues with infertility, and Rudi was to suffer incredible grief as her full term son was
stillborn. Surviving these traumas provided a strong base and an individually
acquired skill set for their later battles with RRMS.
During a particularly dark time in her RRMS life journey, Joy was desperate to
reconnect with her old, happier self and spent time trying to recall a time when she
felt carefree and happy. She wanted to use these memories to conjure up a new
direction for herself and in the process, Joy provided an excellent example of
harnessing resilience and moving forward to conquer demons.
I thought about when I felt most alive and full of joy and it was when I was in my
twenties, I used to wear stilettos and I really enjoyed it…the joy part is around the
high heels I hadn’t worn them for years, I had to wear flat shoes (because of
instability walking from MS)…so I thought, well, let’s give this a try. So I bought
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four inch high heels…I felt amazing, I felt amazing…I was walking better and I was
much more conscious of the way I walked and carried myself…I adjusted my gait for
wearing the high heels and then I walked towards the mirror with confidence, I was
so empowered and I felt so strong, so joyful. I felt like I got my whole life back…I
would walk downtown, dance all night long…that was a special time. Joy line 1151
Although most of the study participants did not outwardly recognise their great
achievements in resilience, several participants did recognise that previous
challenges had helped them gain valuable life skills to help navigate life with RRMS.
Piper and Margot both did realise that their special challenges had given them
resilience to shape their lives today.
People don’t see all the symptoms because of my day to day living…even if I’m
having a bad day with MS I know now that I am in control of my thoughts and I can
change that thought process…I think I’ve become more resilient along the way.
Piper line 1772
I think having MS was the big thing that impacted on my life…I think growing up in
an ethnic background with parents who didn’t speak English for a long time…you
are growing up in two different cultures…I think it gave me resilience…and a bit
more empathy for people. Margot line 1424
Rudi also recognised that the hardships she has endured throughout her life have also
helped her to deal with life so far and this resilience will help with whatever the life
journey is going to bring for her.
We’ve been through a fair bit...I think so very much...and I look at that as a gift as
well…and you know people had it worse than me, but people had it better…it does
give you resilience, not that it’s any easier, but it gives you something to be able to
get through it and get back on track. Rudi line 1275
I had Max, not in my wildest dreams did I think that would ever happen (his
stillbirth)…so yeah, it’s been tough but…you obviously carry some sort of
strength…the death of my son changed everything. Rudi line 1320
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Resilience is a learnable behaviour (Manning, 2015) and interventions can be created
for patients to provide training in resilience enhancement, important for the entire
life trajectory with MS (Mealer et al., 2012). A recent study explored the impact of
resilience in chronic illness and on later life disability (Manning, 2015). This
research supported the observation that high levels of resilience can protect against
the negative impact of disability in later life and that teaching resilience from the
beginning of the journey can have a profound effect in protecting against chronic
illness and disability in a normal aging population (Manning, 2015). The message for
MS Nurses is to take every opportunity to develop resilience in PwRRMS, as the
benefits may be life long and may even lessen later disability.
It is also important for MS Nurses to be aware that resilience is dynamic, it is under
constant negotiation and is often contextual (Ferguson & Walker, 2014). A recent
three year longitudinal study of 31 adolescents with chronic illness found that a key
component of living with chronic illness was the desire to live life as “normally” as
possible, as highlighted in the second study theme (Re)defining Me Now That I Have
RRMS; even in the face of challenges, and to focus on opportunities and optimism
(Ferguson & Walker, 2014). Similarly, participants in the current study were keen to
focus on the positive aspects of the situations they found themselves in instead of
focusing on the negative, although this was sometimes a struggle for the participants
to remain positive as some hardships were particularly difficult to deal with (death of
a child, childhood parental neglect). Participants were able to describe how they
faced challenges, developed new ways of looking at the problems and continually
moved forward with the help of family, friends and community.
MS Nurses have an important role in helping families through both the diagnosis of
RRMS and living life with RRMS, being in a unique position to facilitate
normalising the response to extreme events (such as diagnosis and relapses or
medication changes), ideally by providing narratives of families in similar situations
(Chesla and Leonard, 2017). Talking about stories of how other families successfully
overcame difficult or challenging periods instils confidence and practical information
to consider for the PwMS and is an important educational role for MS HCPs. Of
course, no two families are exactly the same, but knowing others have survived such
challenges can be immensely helpful for those navigating difficult times and can also
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be helpful for novice clinicians and HCPs to enhance their own learning and
development (Chesla & Leonard, 2017).
Sharing experiences and narratives through reflection also helps to strengthen
resilience in people living with chronic illness, showing the possibility of mastery in
a situation and fostering connectedness between the HCP and the patient (Kralik,
Van Loon, & Visentin, 2006). However, it is important to remember that this is
contextual for the PwRRMS and is not a one-off discussion, and PwRRMS may need
additional resilience assessments and education at each clinic visit. It is important to
reassess scenarios with patients and not assume they are at the same level of
resilience as the last clinic visit. They may have shown high levels of resilience at the
last appointment, but the nature of living with a chronic and evolving illness such as
RRMS means that they may also have lost some momentum along the way with life
and may need a reminder of the importance of fostering and developing resilience.
Approaches MS Nurses can use to nurture and build resilience in their patients
include discussing the importance of maintaining social connections both within and
outside the MS community, using strategies such as using humour, discussing ways
to creating a normalcy in their life, the benefits of maintaining a positive outlook,
methods of practicing self compassion, and the importance of planning ahead and
managing commitments (Silverman et al., 2017). Almost all of the participants in the
current study reported using at least one of these techniques to help when Taming the
Beast and many participants used several techniques. Harnessing resilience is an
important and valuable skill in the life story of PwRRMS, and a skill that can be
developed with the help of the MS Nurse.
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Theme 7- “The DMT Dance”
Shall we dance?
The first dance of the night is with me
Alone and fragile
Scared about the first steps and where my feet shall go
Some lessons, some guidance, a show
I start to feel a little more confident
But still not ready
The waltz commences, regardless of me
Stepping on toes
Feeling clumsy I suppose
I start to learn the steps
I sail through the air
I continue my lessons, I practice, I step this way and that
Life has more in store than I imagine
I change my dancing partners
This one feels more comfortable
These steps I know
My confidence starts to show
I can salsa, I can two-step, I can sway
I am now a dancing master, but in my own way
TB
The central organising concept of “The DMT Dance” consists of negotiating and
coping with medication therapies to treat RRMS, the DMTs. There are two distinct
subthemes within this concept, the first subtheme “The hard yards: making decisions
about DMTs and adherence”, further subdivided into DMT decisions driven by fear
and DMT decisions driven by hope, and the second subtheme switching to a better
life.
Although the past 25 years has seen the development of the first effective treatments
for RRMS with DMTs, there is still no curative treatment for RRMS (Torkildsen,
Myhr, & Bo, 2016), meaning that relapses on therapy are still possible (Anderson &
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Philbrick, 2014). Nowadays it is widely accepted that early treatment with a DMT
will reduce both MS relapses and MRI activity, which will ultimately delay disease
progression (Smith, Cohen, & Hua, 2017; Comi et al., 2017). Whilst DMTs have
improved the disease course of RRMS dramatically, they have also added a layer of
complexity to RRMS care (Comi et al., 2017). Managing DMTs provides challenges
for both patients and MS HCPs and requires close communication to improve
clinical outcomes and QOL for PwRRMS (Tintore et al., 2017).
The current focus in RRMS care is on both early diagnosis and prompt
commencement of a DMT in order to modify the disease course and result in better
outcomes for PwRRMS (Kobelt, Eriksson, Phillips, & Berg, 2017). That seems
straightforward, but PwRRMS and their HCPs are faced with complex decisions
regarding which treatments will be most effective and appropriate for them
(Bottomley, Lloyd, Bennett, & Adlard, 2017). As discussed in previous themes, this
is often at a time when Piecing Together the Puzzle, (Re)Defining MS now that I
have RRMS and Battling the Demons have led to increased vulnerability and distress
for the PwRRMS, further impacting on DMT decision making. Assessing the relative
benefits and risks for individuals of each DMT can be confusing and complicated for
the PwRRMS. Additionally, potential side effects (risks) of some DMTs can be very
serious, adding further worry, stress and uncertainty about treatment decisions. These
serious side effects include progressive multifocal leukoencephalopathy (PML), an
incurable brain infection which has contributed to many deaths in PwRRMS
(Chataway & Miller, 2013) and also autoimmune blood and kidney conditions which
have also led to fatality in PwRRMS (Coles et al., 2012). There is also preparation
needed at the start of the DMT journey regarding family planning and pregnancy, as
most DMTs have pregnancy related risks and considerations (Wingerchuk & Carter,
2014). With many PwRRMS diagnosed and commencing treatment during their
child-bearing years, this is an important factor in The DMT Dance.
Evidence from clinical trials and from daily clinical practice has demonstrated that
not all patients respond satisfactorily to a given DMT, the response to medications
and their effects are highly individual (Comi et al., 2017). Switching between DMTs
is common in RRMS, particularly if the patient does not respond well to the
medication (e.g. experiences a relapse or has new lesions on the MRI) or experiences
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significant side effects (Costello, Thrower, & Giesser, 2015; Giovannoni et al.,
2016). This often leads to a PwRRMS experiencing several different DMTs during
their lifetime, all with their own particular set of risks and benefits. This scenario was
referred to by Ruby in the current study as starting “the wave of medicines ” (Ruby,
line 110).
In Australia, the first DMT to treat RRMS was Betaferon® and was registered in
1995 (Broadley et al., 2014b). This injectable interferon was followed in 1998 by
two more interferons (Avonex® and Rebif®) and in 1999 by another class of drug,
glatiramer acetate (Copaxone®) (Broadley et al., 2014b). All of these DMTs
required PwRRMS to learn how to self inject the medication at various intervals
ranging from daily to weekly administration. The first infusible (by intravenous
infusion or “drip”) medication was natalizumab (Tysabri®), being registered in 2006
and the first long awaited oral medication to treat the disease, fingolimod
(Gilenya®), was registered in Australia in 2011 (Broadley et al., 2014c). Fast
forward to 2018 and there are currently 12 DMT choices for PwRRMS registered
with the Therapeutic Goods Administration (TGA) in Australia. Currently, all of
these DMTs are available at a heavily government subsidised cost on the
Pharmaceutical Benefits Scheme (PBS).
There are variable modes of administration between the DMTs ranging from
subcutaneous injections just beneath the skin, to oral tablets to intravenous infusions
that need to be administered in a hospital or clinic setting. This results in truly
individualised MS care where the best drug can be selected for the right patient at the
right time, without having to consider step-wise approaches, insurance company
preferences or other ‘red-tape’ which may govern DMT prescribing in many other
countries. Australia is one of only a few of countries in the world with so many
effective treatments available first line and at a low cost to the patient (Broadley et
al., 2014c). Many other regions, such as some areas in Europe and the USA, can
have restricted access to DMTs or restricted government or company reimbursement
(Wilsdon, Barron, Mitchell-Heggs, & Ginoza, 2014; Comi et al., 2017), causing
DMTs to be out of reach financially for some PwRRMS. For example, some
insurance companies in the USA require a PwRRMS to experience treatment failure
on a DMT before being permitted to start a more highly efficacious drug (Owens,
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2013), thereby missing the early time in RRMS when the anti-inflammatory effects
of the drug may be the greatest (Hauser, Chan, & Oksenberg, 2013). In an ideal
world where the evidence points to the need for early and effective treatments in
RRMS, there would be DMT treatment access for all PwRRMS and the full range of
DMTs available to PwRRMS and supported by national bodies, regulatory
authorities and reimbursement agencies (Giovannoni et al., 2016).

The hard yards: making decisions about DMTS and understanding adherence
As the course of RRMS is heterogeneous, a confident prediction of long term
individual prognosis of RRMS on a particular DMT is not yet possible (Wingerchuk
& Carter, 2014). This can be frustrating and confusing for patients as they are faced
with making DMT decisions when the long term benefits are unclear and the degree
of side effects and risks they may experience are also uncertain. A recent UK study
found that most patients with RRMS wished to be part of the decision making
process regarding their DMT and that shared decision making underpinned effective
disease management, especially when supplemented by MS Nurse support (Colhoun,
Wilkinson, Izat, White, Pull, & Roberts, 2015). However, there is very little
literature available exploring how PwRRMS make decisions about the best DMT to
suit their situation, their beliefs, their values, their disease state and their lifestyle or
how they balance treatment risks and benefits. By taking into account factors such as
patient preferences, lifestyle, how patients view risks and benefits, personal
tolerance, acceptance of side effects and the time commitment required for treatment
and safety monitoring, shared decision making between the MS HCP team and the
PwRRMS can be made.
People living with a chronic medical illness must balance the probability of current
side effects with treatment with the probability of long-term benefits (Bruce et al.,
2016). For a disease such as RRMS where disease remission and return to baseline or
‘normal’ functioning occurs between relapses, it can be very difficult to reconcile the
side effects from DMTs that make patients feel unwell with the fact that they often
feel better without any treatment. Jarmolowicz et al. (2016) reports that side effects
can often make patients feel much worse in the present moment, causing the patient
to consider balancing their current QOL (reduced by the taking DMT now) with the
291

potential of reduced QOL in the future (reduced by not taking DMT now). Unlike
drugs such as analgesics where an immediate benefit may be felt, DMTs in chronic
disease are preventative medications to reduce the probability of negative future
effects with no immediate observable benefits (Jarmolowicz et al., 2016).
Additionally, DMTs do not typically improve acute symptoms in RRMS and so
PwRRMS do not usually experience observable improvement while taking the
medication (Bruce et al., 2016).
Adherence has been defined by the World Health Organisation (WHO) as “the extent
to which a person’s behaviour - taking medication, following a diet and/or executing
lifestyle changes - corresponds with agreed recommendations from the HCP” (WHO,
2003). Studies have shown that DMT adherence in RRMS is particularly
problematic, with up to 25% of PwRRMS non-adherent to their DMT (Devonshire et
al., 2011). No medication is going to be effective in controlling a disease if the
patient is non-adherent, as former US Surgeon General C.Evert Koop stated, “drugs
don’t work in people who don’t take them” (Osterberg & Blaschke, 2005).
Maintaining DMT adherence in MS has been described as comprising of three
actions: those of acceptance (the patient accepting that therapy is needed),
persistence (continuing to take the treatment over time) and compliance (taking the
treatment as prescribed at the right time and right dose) (Remington et al., 2013).
This subtheme will define adherence as taking the prescribed DMT as directed by the
MS HCP.
Recognising adherence and non-adherence to DMTs is a crucial part of the MS HCP
role (Costello et al., 2008). The Global Adherence Project (GAP) was a worldwide
study of 2,648 participants, the goal of which was to evaluate the degree to which
patients with RRMS adhered to dosing schedules for DMTs as outlined by their
neurologist (Devonshire et al., 2011). Several factors were found to relate to greater
DMT adherence: being female, the ease of administration, satisfaction with therapy,
treatment at a designated MS centre and the presence of family support. Of further
importance in the GAP study was that adherent patients reported higher QOL scores
than non-adherent patients. This finding is significant for MS HCPs, as it suggests
that by targeting strategies to improve DMT adherence, there may also be indirect
improvement in patient QOL.
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Adherence to DMTs in RRMS can be difficult to quantify and the specific
combination of factors influencing an individual patient’s likelihood to adhere to a
DMT can be difficult to determine (Remington et al., 2013). Patients who are nonadherent to DMTs usually follow one of two patterns; either missing doses and
taking the DMT less frequently than prescribed (Wicks et al., 2015) or by
abandoning therapy completely, usually within the first six months (Rio et al., 2005).
Adding to the complexity of adherence or non-adherence on DMTs, there may also
be a wide range of emotional and cognitive factors present which are specific to
RRMS (Wicks et al., 2010), with mood and anxiety disorders prevalent in the disease
(Feinstein, 2011; Feinstein et al., 2014).
Increasing the complexity of DMT decisions further for PwRRMS, is the fact that the
more highly efficacious (more effective) therapies have rare, but potentially serious
side effects and unfortunately, the safest therapies have much lower rates of efficacy
(are less effective) in controlling RRMS (Smith et al., 2017). Very little is known
about how patients decide between oral (tablet) therapies and parental (injection or
infusion) therapies, or how patients ‘trade off’ the convenience of oral therapies
against treatment frequencies or side effects of the other medications (Lynd et al.,
2016; Utz et al., 2014; Wilson et al., 2015). Additionally, not all patients respond
satisfactorily to DMTs and a ‘one-size fits all’ approach is not attainable in RRMS
(Comi et al., 2017). Ideally, the best treatment option would be the safest treatment
that eliminates disease activity (Hauser, 2013), but the identity of this DMT is not
known at the beginning of the RRMS journey. This is currently an area of intense
research interest and hopefully biomarkers (measures such as blood tests or scans
which can determine responses to a medication) will be able to shed light on this in
the future (Hegen, Auer, & Deisenhammer, 2016).
Understanding how the PwRRMS makes decisions about which DMT will suit them
best is vital for MS HCPs to understand, but there is limited literature to provide
guidance and support for MS HCPs in this regard. A recent study of 189 PwRRMS
in Canada used focus groups and individual interviews to determine attributes of
DMTs that were most important to patients. The researchers concluded that overall,
the most important attributes were the avoidance of side effects and the improvement
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of symptoms (Lynd et al., 2016). Unfortunately, both of these attributes cannot be
guaranteed for patients with the current DMTs. As the adherence data discussed
above has suggested, actually taking the DMT as prescribed is a particular problem
area in RRMS, and an area where the MS Nurse and other MS HCPs can target
understanding to enhance adherence in the future. Unravelling how these decisions
are affected by other factors is poorly understood, however participants in the current
study shed some light on how these decisions were driven, some decisions appeared
to be driven by fear and some decisions driven by hope.
DMT decisions driven by fear: “I’d rather be in a wheelchair than dead”
As discussed briefly in theme 3 Battling the Demons under the subthemes of facing
fear and weary with worry; fear and worry can be major barriers contributing to
adherence issues in RRMS, especially fear of medication administration and
worrying about potential side effects (Anderson & Philbrick, 2014). This fear and
worry can be further impacted by mental health issues in RRMS (for example
depression and anxiety) leading to negative cycles that threaten DMT adherence
(Anderson & Philbrick, 2014). Indeed, fear and worry can sometimes influence a
patient’s decision to take any form of DMT, with some PwRRMS preferring to stay
unmedicated and take the risk of further relapses and possible disease progression
over what they perceive as unacceptable potential side effects. A one percent risk of
a serious side effect can reduce patient preference for a particular DMT fivefold
(Wilson et al., 2015).
A recent study using focus groups in PwRRMS found that patients who opted out of
DMT entirely felt that this was mainly due to side effects they experienced, feeling
that their present QOL was more important to them than future disease progression
(Mortensen & Rasmussen, 2017). In the current study, this was the case for Joy, who
adamantly refused to take the advice of her neurologist and commence a DMT. Joy
suffered greatly from side effects on earlier DMTs, at one stage needing
hospitalisation from medication toxicity. This experience made Joy reluctant to try a
new DMT, preferring to feel well in the present moment and take a risk with possible
disease progression in the future.
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I don’t see any point on going on a drug that could potentially kill me…I don’t see
any point on going on a drug that’s not going to cure me and when it doesn’t really
alleviate the symptoms. Joy line 1651
I don’t believe that medication is the answer for me…if they can’t come up with a
cure then, really…I’m not going to take something that may make me sicker. Joy line
1687
The Health Belief Model (HBM) looks at anticipated gains and losses balancing
present and future QOL (Rosenstock, Strecher, & Becker, 1988). Using the HBM,
health behaviour can be determined by personal perceptions about the perceived
susceptibility and seriousness of a disease together with the perceived threat and
benefits from a given behaviour, that is, in order for an individual to take a certain
medicine, potential gains must be considered greater than losses (Mortensen &
Rasmussen, 2017). Adding complexity to this theory in RRMS is the uncertainty of
the disease and the lack of prognosticative ability in the future (Wilson et al., 2015)
and if the chosen DMT will have the desired effect at all. On a background of fear
and worry, there is no definitive answer that can be given to a patient on what their
individual risk might be for a given DMT, and for some, the fear is too great. Piper
had researched the newer DMTs in preparation for a change to a DMT with
improved effectiveness, but was unconvinced this was the right move for her. She
preferred to take her chances with the disease than mindfully expose her body to
potential fatal side effects.
With the newer, unproven medications, I just think the risk is too great…I get that
these people are in a real state of bother, they’re probably prepared to give anything
a go...but I just think I’d rather be in a wheelchair than dead…I just think the risk is
too great. Piper line 1960
The list of reasons to be fearful about starting a DMT, often outlined in great detail
by MS neurologists and MS Nurses when considering DMTs (and supported by
product brochures and internet research) can sometimes be more frightening for the
PwRRMS than the disease itself. This is particularly so in recent years with the
advent of more efficacious (effective) therapies with more potent side effect profiles
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and where deaths have been reported in PwRRMS receiving the various DMTs. The
introduction in Australia in 2006 of the monthly intravenous infusion natalizumab
(referred to in the interviews by patients as the trade named Tysabri®) was exciting
because at that time it was the most highly effective treatment for RRMS and showed
long term benefit (Smith, Cohen, & Hua, 2017). However the occurrence of a
potentially life threatening brain infection called PML (Chataway & Miller, 2013)
forced the drug off the market shortly afterward. Natalizumab was reintroduced to
the market a year later, with a safety warning about PML which necessitated special
safety monitoring when using the drug. As of December 2017, there had been 756
reports worldwide of PML associated with natalizumab therapy, with 25% of the
cases being fatal (Biogen, 2018).
In more recent years, PML has also been associated with some of the other DMTs
(fingolimod and dimethyl fumarate), although not in numbers as high and as
predictable as with natalizumab (Faulkner, 2015). Several participants in the current
study openly discussed PML as a great fear for their current and future treatment.
Piper was adamant in choosing possible disease worsening from RRMS over
potential death from PML.
And that PML keeps popping up and I don’t like the sound of that…and what does
scare me about it is how do you know it’s PML or an MS symptom? And it’s not
curable. Piper line 1362
A blood test called the JCV test can measure for a specific antibody and give an
indication of whether a PwRRMS has a higher risk of contracting PML on
natalizumab treatment (Torkildsen et al., 2016). For Rudi, knowing that she was JCV
positive influenced her decision to refuse treatment with natalizumab (referred to by
Rudi as Tysabri®) and to risk further disease progression on her current oral DMT,
which had so far been not been able to control her relapses.
One medication they’re considering is Tysabri and I refuse to go on because I carry
the JC virus, they tested me for that and I’m just not willing to (take that risk). Rudi
line 501
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Participants also experienced fear when changing treatments after many years on the
same DMT, even if it was perceived by the MS HCP as a change for “good”; such as
changing from an injectable therapy to an oral therapy. This was the case for Davina,
after many years of struggling with the side effects of a weekly self-administered
intramuscular injection, to contemplating a daily oral medication. The fact that it was
a change at all was frightening for Davina, even if there were benefits expected from
the treatment switch by her MS HCP.
Changing treatments…that was really hard, I’m not good with change…so to change
a medical treatment was really scary because I’m going on the hearsay of someone
who knows more about it…but hasn’t actually received it…so I had to think a lot
about that…it’s a bit of an unknown, I don’t know if I’m going to have problems in
the future. Davina line 1423
Having a son before her diagnosis of RRMS, Kate made the decision not to expand
her family and have another child after her diagnosis, even though she did once wish
to have more children. From a science background, Kate was deeply concerned about
the possible effects of the DMTs she had previously taken on a foetus, especially as
Kate had needed less conventional and more toxic treatment options in the time
before many of the modern DMTs had become available.
Being on all of these drugs, I thought…I’m not going to have a child that’s going to
turn out to be sick. I’ve got no idea what these drugs are doing to me…and what
they’re going to do to a baby. Kate line 1393
There are very few qualitative studies addressing patient perspectives in regards to
preferences in selecting a DMT in RRMS. However, a recent study explored patient
perspectives on DMT choice by interviewing ten PwRRMS and using hermeneutical
phenomenological methodology to analyse the findings (van Capelle et al., 2017).
Researchers found themes of “constant confrontation with the disease” voiced by
study participants who felt frightened at the prospect of having to use medication
with possible side effects for the rest of their lives, reflecting similar themes of
participants in the current study. Emotional fear as a theme was also described by
van Capelle (2017), including a fear of injections and the act of injecting oneself
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making the patients feel ‘different’ to others. These themes were also supported by
current study participants, most notably Jane, who felt that her need to self inject her
interferon DMT curtailed her ability to travel freely with the medications to remote
countries (as she loved to do) and left her feeling disappointed and ‘different’ to
others.
I can’t do this now…you have to inject three times a week and it’s just a pain, you’re
travelling with syringes and everyone thinks you’re a drug addict, and I absolutely
hated it…it was really, really depressing…I thought I may as well just give up and do
nothing. Jane line 338
DMT decisions driven by hope
For other study participants, their choice of DMT, and indeed their choice to remain
adherent to the medication, was driven more by a positive sense of hope for future
good health rather than by fear of DMTs or potential side effects. Adhering to one’s
DMT is also an important way that PwRRMS can take control of their disease (Settle
et al., 2016). This appeared to be a conscious choice for Paul in the current study,
who performed considerable scientific research to decide on the DMT he thought
would give him the best result in the long term.
I was happy to go on Gilenya because at the time there was going to be some
neuroprotective effect and it looked like a better option than 2 pills and possibly
being sick all day…I was happy going on Gilenya at that point. Paul line 635
A little later on in his life story, Paul suffered a further MRI relapse with a new
lesion in a delicate area of the brain, of which he was considerably fearful. With a
science and physics background, Paul introduced the concept of “front end loading”
which I had never heard applied to DMT decision making before our study
interview. “Front end loading” is an industry or economic term involving developing
strategic information to address risk and to make decisions to commit resources early
in a project in order to maximise the potential for success (Merrow, 2012). In Paul’s
case, he was using the term to describe how he preferred to use one of the newer high
efficacy DMTs now before he deteriorated, rather than continuing the moderate
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efficacy DMT he was currently prescribed and risking further disease progress. His
neurologist did not agree to change treatments at this time and preferred that he stay
on his current therapy with close supervision. Paul argued that with an unpredictable
disease such as RRMS it was better to “front load” and possibly stop the disease and
he was willing to risk the potential serious side effects, which he felt were
manageable with his level of education and understanding of what they meant. With
a young family, an exciting new job and a love of the outdoors, Paul argued that he
had a lot to lose not escalating his DMT to a higher level and would continue to seek
out support to change therapies with another neurologist.
I’ve developed a new MS brain lesion and I’m not real happy about that. My
thoughts on how I want to proceed with all this are…front load risk, I would much
prefer to have it out and discuss with my neurologist again. I don’t want to be at a
stage where it is something they think about, you know, around the world at the
moment they’re using it as a front line…I’m aware that there’s lots of therapies.
Paul line 522
The best drug on the market is alemtuzumab, I mean, it does come with a lot of risks,
but they’re even more manageable than MS is…so if I take a thyroid medication for
the rest of my life, that’s great…a better outcome. Paul line 600
After experiencing significant deterioration in her physical condition over a short
period of time, Ruby placed hope in her new DMT (alemtuzumab, also known as
Lemtrada®) to be able to improve her mobility and prevent further decline so that
she could enjoy her two small children and participate more actively in family life.
I hope from the alemtuzumab (the DMT) to be able to walk…I don’t feel so weak…I
hope so…this time last week I couldn’t even strengthen my own body to come up so
this week I woke up and I can actually get up by myself…it’s no marathon, but for me
it’s pretty good, so fingers crossed. Ruby line 598
I was really excited about Lemtrada®…so hopefully it will start working and I’ll be
really happy. Ruby line 868
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Several participants in the current study described nursing support as an integral part
of successfully managing their DMT and a reason for their DMT adherence at
various stages of undergoing DMT therapy (such as complying with blood tests and
other safety monitoring). This was particularly so for those study participants
diagnosed for longer than ten years, who only had access to the self-injectable
medications in the beginning of their treatment journey and relied on nursing support
to teach them the injection techniques and injection site management. Margot had an
MS Nurse visit her to introduce her to the injectable DMT in the comfort of her own
home and surroundings.
A nurse actually came out and showed me how to do the injections which was
fantastic, she showed me how to do it and she made it so easy. Margot line 475
Hope in a DMT refers to more than just statistics of how well a DMT works to
control RRMS, hope also refers to feeling positive and confident about adhering to
treatment, with family and nursing support being an important factor in commencing,
continuing or changing DMT (van Capelle 2017). In the current climate of so much
choice, complicated therapies, monitoring programs, and evidence for using early,
effective DMTs, MS Nurses are more integral than ever to managing RRMS by
implementing patient-centric programmes and supporting PwRRMS (Giovannoni et
al., 2016).

Switching to a better life
Almost all of the study participants had stories to tell about past unhappiness on
earlier DMTs, particularly as two thirds of the participants had previously been
taking interferons or glatirimer acetate injections before the newer oral and infusible
medications were introduced. For these study participants, they were switched to
newer therapies as soon as they became available. Difficulties for patients with the
early injectable medications are well documented, particularly in terms of PwRRMS
suffering from skin reactions, injection site reactions, flu like symptoms and feelings
of depression as side effects (Costello et al., 2008). As these side effects and patient
experiences are already well documented (Miller & Jezewski 2001; Miller &
Jezewski 2006), only a selection of participant comments will be presented here.
300

These participant stories also have a role to play for the MS HCP to consider the
resilience shown by PwRRMS in overcoming challenges, as discussed in the
previous theme of Taming the Beast. These insights from Davina, Will, Evie, Griff
and Kate also give some background for the MS Nurse to understand why adhering
to DMTs can be difficult, and how the effects can infiltrate all areas of life.
When I started on the interferon…that feeling of desperateness, hopelessness…so if I
felt like that on the day I had the injection, it would make it a hundred times worse.
Davina line 1083
My symptoms were getting worse, depression set in pretty bad and I became noncompliant…I went unmedicated and I quit my job. Will line 884
I went onto the interferon Rebif®, God awful drug…I don’t have a problem with
needles, it was the reactions…site reactions made me look like a red and white
checkerboard and the cold and flu symptoms, the headaches, the pains, the
fevers…you just wanted to curl up basically…I didn’t take the treatment properly…I
wanted to do it…but…I feel fine, so I stopped it. Evie line 835
(Injecting glatirimer acetate) I hit a vein once, or a capillary and straight into my
bloodstream and I thought I was going to die…it scared the shit out of me, it knocked
me flat…and I had limited sites it was getting to the stage where I was hitting scar
lines…(as a consequence) my compliance was getting sloppier…because it was
fucked, I hated it and the thought of having to wake up everyday and do it again.
Griff line 892
I was on the Betaferon® which I really couldn’t tolerate, it was just like getting the
worst flu…I just couldn’t function…I’d have my injection and the next day I’d be
totally miserable and really sick…and going to work people would just be thinking
…well, why is she sick all of the time? And you just couldn’t explain it to them. I’ve
always been quite vocal about how I feel and I said to the Neurologist “I don’t like
this, it’s making me sick, it’s not making me better and I don’t want it. Kate line 743
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Several of the non-adherence scenarios described above were first reported to the MS
Nurse rather than to the neurologist. Physicians have been found to miss indicators of
poor adherence in patients (Osterberg & Blaschke, 2005), possibly due to the subject
not being brought up in clinic encounters and MS patients not being keen to report
non adherence to their physician themselves (Schwartz et al., 2017). Implications for
HCP practice include the need to check at every clinic visit and care encounter
(email, text, phone) on the status of adherence for DMTs. Often adherence is difficult
when patients are faced with intolerable side effects, especially when mental health
is also affected (Costello et al., 2008). The value of the MS Nurse as someone the
patient can confide in about true DMT adherence and also to discuss issues they are
having to maintain adherence are important aspects of the MS Nurse role (Burke et
al., 2011).
It is rare that the more serious side effects reported with the use of RRMS DMTs
actually do happen in clinical practice but when they do, the consequences can be
horrific. Kate suffered one of the first reported anaphylactic (allergic) reactions to
natalizumab (referred to by Kate as Tysabri®) and recalls the horror of that day
when hope in her new DMT suddenly was taken away. After this event, Kate was
switched to one of the new oral treatments and has thankfully remained well since
that time.
This Tysabri® was a nightmare, after three months it was stopped, it was working
really well and I was quite excited about the whole thing…I went back on it and I
had an anaphylactic reaction…that was horrible…I think I was the only case at the
time…that was absolutely horrific…I felt my back was itchy but before I could even
finish saying anything my face swelled up and the doctor’s trying to get a thing down
my throat…I was just terrified. Kate line 1076
For some study participants, specifically Griff, Margot and Susan, moving on to a
new DMT after suffering at the hands of their first treatments led to improvements in
their quality of life. Additionally, for both Griff and Margot, starting natalizumab
(referred to by the participants as Tysabri®) widened their social circles as an
unexpected benefit of a DMT change as they spent a half-day at their local hospital
day admission unit for the DMT infusion with other PwRRMS. These feelings about
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natalizumab were in stark contrast to those study participants who had earlier refused
to consider natalizumab because of the potential side effect of PML in the first
subtheme decisions driven by fear. Life just felt better on this DMT for these
participants, despite the reported risks.
On Tysabri®, I just felt flat afterward and then 36 hours later it was gone and I had
the rest of the month to myself, it was a joy and it was a big part of my social scene.
Griff line 954
I had Tysabri® for four years, that was actually really good. When I went to have the
Tysabri®, you met other people with MS which was fantastic…it was sort of like a
day out really. Margot line 494
For the first time in years Susan felt “normal” taking tablets rather than self injecting
her DMT.
I feel more relaxed…it’s just a little tablet, I take it, I don’t have to get up, it doesn’t
hurt…the injections were hurting. It’s improved, I don’t have to take injections with
me, to find a freezer or to have a letter on the plane about why I have syringes, so
now I feel normal taking tablets, I feel better and I feel positive. Susan line 1179
Oral treatments, especially when taken once daily, have been widely reported as
being preferred by the majority of patients with RRMS over injections and
intravenous infusions (Utz et al., 2014; Thach et al., 2016; Mortensen & Rasmussen,
2017). A recent study in adolescents with RRMS found higher levels of DMT
adherence since the introduction of oral therapies in this population than in past
studies (Schwartz et al., 2017). Over half of the participants in the current study were
now taking an oral DMT and were happy with the change in terms of lifestyle and
ease of administration.
To enable a DMT to have the maximum impact on the course of RRMS, adherence
to the prescribed regime is essential. Maintaining adherence involves developing
strategies to manage side effects, successful and safe DMT commencement and
monitoring safety and drug tolerance as vital aspects of the role of the MS Nurse.
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When The DMT Dance moves elegantly, controlling the disease with minimal side
effects, with the engagement of an educated empowered patient, a reliable support
network and an approachable invested HCP team, the results can be outstanding.
Switching to a better life is achievable. The treatment goal with RRMS is clear, early
and effective DMTs in a shared decision making environment (Giovannoni et al.,
2016), performing The DMT Dance. Although some decisions are initially decisions
based on fear, that doesn’t mean they will always remain so. At times, another
relapse, a severe relapse or progression of disease (either by EDSS disability
assessment, by reduced mobility or by MRI progression) may prompt a PwRRMS to
reconsider their past DMT decisions, and the basis for these, and change their
thought process and direction. As demonstrated within this theme, a major part of
this revolves around decisions based on hope and switching to a better life, and
merges well into the final theme from the study findings, theme 8, which is all about
Holding Hands with Hope and developing purposeful positivity.

Theme 8: “ Holding Hands with Hope”
Hope summons, hope heals
Hope can see me, hope can share
Hope understands, hope feels
Hope teaches, it helps me to bear
Hope wakes with me each bright new day
Hope teaches me to think in brand new way
Hope, stay with me
Hope, help me to be
TB
Linda Morgante passed away in 2007. Linda was based in New York and was an
exceptional MS Nurse researcher, author, clinician, teacher and leader (Halper,
2007b) who became well known for her belief in the concept of hope being an
essential component of living well with MS. As a noted speaker and writer in MS
nursing, Linda inspired and encouraged nurses from all over the world to instil hope
in MS care, both in their patients and in themselves. Linda Morgante wrote, spoke,
taught, lived and breathed hope.
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“Hope is an essential element of life - it embodies our vision of the future, our
opinion of ourselves and others, and our sense of control over the events and
direction of our lives. The presence of hope for someone experiencing an illness can
provide the energy necessary to promote health and well-being.” (Morgante, 2000,
p.9)
Looking back over the transcripts again in preparation to explore themes of hope and
positivity revealed a startling, yet irrefutable, pattern. Almost every interview with
participants in this research study commenced with stories of worry, of uncertainty,
of the uninvited guest of RRMS invading lives and causing havoc in many forms,
and almost all interviews ended with stories of hope, of some form of acceptance, of
resolve and a will to do well in the future. This should not have been wholly
unexpected by me, as the participants all volunteered to be part of the study and to
share their stories (suggesting a purpose to help others and an essence of positivity).
Nonetheless, it was a striking feature of the study and I was left astounded.
This theme of “Holding Hands with Hope” encompasses ideas of hope, positivity,
defiance, and spirituality, giving back to others and sharing stories. I also felt a sense
of determination, where PwRRMS held on tightly to their newfound peace and
positivity, often borne after many years of struggle. Holding Hands with Hope also
reflects the way fingers intertwine to provide support, not by a single finger, but by
many fingers and a thumb working together to link perfectly inside one another. It
reflects touch and sensitivity and it reflects hard work to get there. These hands are
not soft and protected; they are often calloused and tough. PwRRMS hold many
hopes and dreams in them, for themselves, but also for others living with RRMS and
progressive forms of MS, and also for the people working in the field of MS as well.
The central organising concept of this theme is hope and positivity, it is all about
reaching happier times, of the beginnings (or totality) of acceptance of RRMS into
life and how looking to the future with hope brings its own peace and rewards.
Expressions of hope differed greatly between participants of course, but the essence
of hope remained remarkably similar. It was palpable and it was present in every
study participant I interviewed. It often left me leaving the interviews smiling and
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happy, reflecting on the remarkable achievements of my informants, even if there
were tears and sadness interspersed regularly during the interviews. This theme is
divided into two subthemes and several sub-subthemes to provide additional clarity.
The two subthemes, “hope in its many forms” (including the sub-subthemes of
functional, restorative, curative and defiant hope) and “purposeful positivity”
(including the sub-subthemes of optimism and a positive outlook, searching for
meaning, harnessing a sense of humour, faith, religion and spirituality and giving
back and being involved) provide exploration of the role of hope in the lives of
PwRRMS and the various ways PwRRMS express this hope and positivity.
Despite the anguish, ambiguity and suffering that appears to be part of the life
journey with RRMS discussed in the earlier themes, participants often lingered after
the end of the interview to ensure I understood the entire story. The fact that
happiness and hope were a very important part of that story, even if it took years for
some participants to feel hope, or even if it was more of a temporary or fleeting
feeling. It was still present and it was overwhelming in intensity. As the MS Nurse is
a pivotal part of the team in ensuring the PwRRMS maintains a sense of hope
throughout the lifetime living with the disease, understanding the role of hope in the
disease is critical for MS Nurses (Morgante, 2000). I have never felt, or believed this
more, than after hearing the stories of these study participants.

What is hope? Why hope?
Defining hope for this particular theme was difficult, primarily because there are so
many different variations of the concept of hope, with literature spanning many,
many decades. Haase and colleagues (1992, p.143) sought to clarify the concept of
hope for nurses, reviewing the available hope literature at the time and defining hope
as:
“Hope is an energised mental state involving feelings of uneasiness or uncertainty
and characterised by a cognitive action-orientated expectation that a positive future
goal or outcome is possible”.
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Noted hope researcher and writer, Snyder (2002) also embraced the concept of goals
as an important component of hope and emphasised the active role needed to achieve
these goals. Snyder (2002, p.249) defined hope as:
“Hope is defined as the perceived capability to derive pathways to desired goals,
and motivate oneself via agency thinking to use those pathways”.
As a complex concept to describe, Clarke (2003, p.164) resonated strongly with my
own feelings, noting that:
“We know hope when we see it, feel it intensely when it is gone. But it is hard to
describe”.
The literature surrounding hope in both chronic illness and nursing care in general is
substantial and stretches back for decades. Less common is literature specifically
exploring hope and MS, although recent years have seen studies emerging,
particularly in areas of allied health and MS (Soundy et al., 2012; Soundy et al.,
2013; Soundy et al., 2016). Herrestad and colleagues (2014) have suggested that
instead of generalist work in hope, what is needed to understand hope more deeply,
are in-depth and context specific hope studies. As this theme developed and the data
evidence to support hope as a theme was extensive, I was keen to explore and define
hope in a way that captured the very essence of hope in this specific population.
Even in the absence of supporting literature, the data from the participants
demonstrated that hope is important to PwRRMS, and as MS Nurses, we have an
obligation to at least try and form some sort of understanding of what hope might
mean for patients under our care. If we make this effort, then we can recognise hope,
we can facilitate hope and also introduce strategies to inspire and coach hope in
others. We can take the beginnings of hope and help mould them into achievable
goals and aims and strategise pathways to reach these goals. We can partner with our
patients to make hope an important, active and achievable part of their health care
plan.
Dialectic relations between hope and despair have been referred to as the existential
paradox of chronic illness (Barnard, 1995). The line between hope and hopelessness
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can often be very fine and sometimes blurred. Several study participants spoke about
hope and hopelessness in the same sentence, feeling that talking about one
necessitated mentioning the other. Living the paradox means those suffering chronic
illness simultaneously confront their limitations and losses at the same time as
leaning towards hope and possibility. The concept of therapeutic hope in MS was
explored by Slater and Yearwood (1980). The need for a positive, affirmative mental
attitude in MS management by HCPs was proposed to counteract the natural
tendency toward negativity in PwMS (Slater & Yearwood, 1980). We, as nurses in
general, have a responsibility to notice, acknowledge, understand and verbalise the
possibilities, the abilities and the skills to live with chronic illness and to develop
strategies with patients to do this successfully (Chesla, 2005).
In healthcare, hope is of special interest because of the disruptive nature of illness
that requires considerable healing resources for recovery to occur (Tutton, Seers, &
Langstaff, 2009). For MS Nurses, understanding hope may also help to understand
the individual’s experience of the recovery process and identify effective support
strategies. In the field of MS, hope has been described as an essential element of the
life journey, and the very presence of hope may help a patient to continue
functioning more successfully or to remain independent for longer, bolstering self
esteem and well-being (Morgante, 2000). Every person has a perceived future and in
this dimension of existence, hope lives (Cassell, 2004).

Hope research and hope theory
“In studying hope I observed the spectre of human strength. This reminds me of the
rainbow that is frequently used as a symbol of hope. A rainbow is a prism that sends
shards of multicoloured light in various directions. It lifts our spirits and makes us
think of what is possible. Hope is the same – a personal rainbow of the mind.”
(Snyder 2002, p.269)
Stepping back from the enormity of the hope literature in academia, exploring hope
theory and its origins is necessary to give insight into how our thinking about hope
has evolved over the years and how hope fits into life with RRMS. Early general
hope literature recognised the desire to seek goals as part of hope (Cantril, 1964;
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Frank, 1975) and the concept of hope as a way of thinking, as a cognitive process,
was beginning to be recognised (Snyder, Irving, & Anderson, 1991). This led to hope
being defined as “a positive motivational state based on an interactively derived
sense of successful agency (goal directed energy) and pathways (planning to meet
goals) ” (Snyder et al., 1991, p.287).
In the following years, Snyder became a leading theorist on hope, believing that
having a goal is the cognitive component anchoring hope theory (Snyder, 1994), the
goal providing the targets of mental action sequences (Snyder, 2002). The means to
achieve goals Snyder refers to as “pathways” (Snyder, 2002); what we would
recognise as actions, the plan of what we would do to achieve a goal. An important
part of hope theory also rests with the motivation to reach these goals, the “agency
thinking” to achieve them. Hopeful thinking necessitates both “pathways” and
“agency thought”, and they often feed off each other (Snyder, 2002). Thus, for
PwRRMS, hope can be inspired and sustained by developing goals, making plans on
how to achieve these goals, discussing contingency plans in case of obstacles, and
maintaining the motivation to see the goals through to achievement.
Snyder’s theory of hope conceptualises hope as a cognitive-motivational
construction, which relies on the perception that goals can indeed be met (Snyder,
1989) and therefore, realistic. Further research by Snyder and colleagues (2006,
2014) suggests that people with high-hope (thinking characterised by specific and
clear goals) are more successful at harnessing the resources needed to achieve their
goals and at negotiating alternatives when obstacles appear. In contrast, people with
low-hope (characterised by vague goals) tend to ruminate and rely on avoidance, and
repeat cycles of goal blockage, escape and failure (Snyder, 2002).
The MS Nurse is in an ideal position to assess the hope status of the PwRRMS.
Identifying exactly where the PwRRMS is positioned in terms of low and high hope
potential could prove helpful to the life journey as early intervention and guidance
can provide the PwRRMS with both tools and resources to successfully self-manage
the condition. When considering an unpredictable disease such as RRMS, with many
losses along the way, with relapses, with an uncertain prognosis and with no cure, it
is easy to see how easily a lack of hope can penetrate the thinking processes for
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PwRRMS, block goals and impact on goal attainment. Indeed, RRMS can erode
well-being and interfere with goal pursuits on many levels (Madan & Pakenham,
2014) for example, interfering with cognition, mood and energy levels. However, if
hope related pathways and agency thinking can be engaged and supported by MS
HCPs, adjustment to RRMS may be improved, despite the losses (Madan &
Pakenham, 2014). If MS Nurses have a basic understanding of hope theory and the
importance of goals, they can help PwRRMS develop goals, articulate aspirations
and strategise pathways to goal achievement and also discuss alternative routes
(pathways) in the event of upheaval along the way. Additionally, as hope theory
suggests that hope is a cognitive process, the high rates of cognitive deficits seen in
RRMS (Chiaravolloti & DeLuca, 2008) may also have an impact on the ability of the
PwRRMS to set up goals, and the agency thinking and pathways skills needed to
achieve their goals. The MS Nurse can assess, intervene and help the PwRRMS in
the case of issues with cognition with both goal setting and strategies to achieve
goals, promoting both agency thinking and pathways.
There are very few studies investigating hope specifically in MS, however a recent
Australian study surveyed 296 PwMS (two thirds with RRMS) using various hope
scales in an attempt to explore concepts of MS disease adjustment and hope (Madan
& Pakenham, 2014). Findings from the study suggested that greater hope was
associated with better adjustment to MS. Greater hope scores also predicted better
life satisfaction, positive states of mind and lower depression, consistent with the
earlier work of others (Foote et al., 1990; Lynch, Kroencke, & Denney, 2001). It is
interesting that even though there were several decades between the studies, they
showed similar results, despite the introduction of DMTs in the interim. This
suggests that concepts of hope are just as important in the present time, even though
treatments and prognosis have greatly improved, essentially leading to greater levels
of hope. Hope has also been identified as a potent protective resource for coping with
MS (Madan & Pakenham, 2014), and a resource that the MS Nurse is perfectly
positioned in the health care team to recognise and assist with (Morgante, 2000).
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Hope in the nursing literature
“Hope is central to life and specifically is an essential dimension for successfully
dealing with illness”(Fitzgerald Miller, 2007, p.12)
Various conceptualisations of hope have also been posed in the nursing literature. As
difficult as it is to conceptualise hope into a simple and neat definition, it is an
important model for nurses to understand as it underpins our views about strategies
to use with patients, especially during different stages of health and illness
(Fitzgerald Miller, 2007). Hope has been described in theoretical terms for decades,
but recognition of hope as a concept in nursing is a more recent development (Herth,
1990), which continues to grow (Cutcliffe & Herth, 2002). Before any inductive
nursing studies were undertaken, Miller (1985) explored the empirical literature on
hope and identified elements of hope that can be demonstrated and taught to patients
and families by nurses. These elements included radiating hope, expanding the
patient’s coping skills, teaching reality surveillance, helping with setting and
obtaining goals and helping to renew spirituality (Miller, 1985).
In the 1980’s, the first inductive nursing studies of hope were performed, looking at
the role of hope in specific groups such as adolescents and those suffering cancer
(Hinds, 1984; Owen, 1989). Hind’s study used grounded theory methodology to
define hope as the degree to which an adolescent believes that tomorrow exists
(Hinds, 1984). The research in cancer also used grounded theory methodology to
develop a conceptual model of hope, resulting in six themes: goal setting, positive
personal attributes, future redirection, meaning in life, peace and energy (Owen,
1989). Indeed many of the key elements and themes of hope as expressed by Miller,
and later by Owen, were also important for participants in the current study and will
be discussed at length in the two subthemes to follow.
Further work in the following two decades built upon these theories and concepts of
hope with Stephenson (1991) reviewing over 50 papers to develop conceptual
attributes of hope. These attributes included viewing hope as a basic human
experience, providing meaning in life, being fluid in nature and not static, being
multidimensional and being associated with nursing (Stephenson, 1991). All of these
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attributes could be applied to the current study participants and particularly the
concept of hope being fluid and not static. This has deep connections to the variable
disease course of RRMS, with unpredictability and periods of remission. Several
years later Morse & Doberneck (1995) reported the concept of hope as being poorly
understood, despite the growing nursing research, and proceeded to interview
patients themselves to gain a deeper understanding of hope. This resulted in seven
universal components of hope being identified: a realistic initial assessment of the
threat, envisioning alternatives and the setting of goals, bracing for negative
outcomes, a realistic assessment of personal and external resources, socially mutually
supportive relationships, continuous evaluation for signs to reinforce goals and a
determination to endure. Whilst all of these hope components were seen in most of
the current study participants, a determination to endure was also present in all of
them.
There is a paucity of hope related nursing research specifically in MS. However
nurse researchers in other areas of chronic illness have found that patients showing
signs of higher hope (characterised by specific and clear goals) have been associated
with better adjustment in spinal cord injuries (Elliott et al., 1991; Lohne, 2001) and
breast cancer (Stanton, Danoffburg, & Huggins, 2002). A nursing study of hope
which fits well with the life story of MS is from a study exploring hope and its
meaning in patients with spinal cord injuries (Lohne, 2001). In this study of 10
people one year after their initial injury, Lohne (2001) found that every participant in
the study had hope, although for some it was sometimes silent hope, which was left
unexpressed. Hope was described as intensely personal, as giving inner strength and
as being a motivational spark (Lohne, 2001). Lohne developed this concept of hope
in later years, describing hope further as a universal and dynamic concept, which is
personally significant (Lohne & Severinsson, 2006). Similarly to how Lohne
described hope in spinal cord injuries, hope appears to be universal, dynamic,
motivational and personally significant in RRMS as well.
Morgante (1996) provided the first insights into hope, PwMS and the role of the MS
Nurse. MS Nurses can be a healing presence in the lives of their patients due to their
nurturing care, empathy and support of PwRRMS (Morgante, 1996). Additionally,
nurses who care for PwRRMS and their families can provide resources to inspire
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hope and prevent hopelessness (Morgante, 2000), often maintaining hope whilst
untangling a web of false hope (Morgante, 1996). MS Nurses are in an ideal position
to develop strategies with their patients to explore personal goals, to utilise support
and resources and to formulate care plans to enhance the likelihood of goal
achievement, which has been demonstrated to be a vital component of hope. Hope
may also help a patient with MS to continue functioning more successfully, remain
independent for longer and may also have a synergistic effect on medical therapies
(Morgante, 2000).
The overarching theme of Holding Hands with Hope can be further developed into
two subthemes to explore these concepts in greater depth - hope in its many forms
(how hope is expressed by PwRRMS and different types of hope) and purposeful
positivity (actively seeking out positivity to express hope).

Hope in its many forms
Our personal ideas of hope will be shaped considerably by our own personal
experiences, and no two life experiences will be exactly the same. During the
interviews with participants for the current research study, I was struck at times by
the different types of hope people fostered, although during the interviewing phase I
had difficulty in defining exactly what these types of hope were, and how hope fit
into

the

wider

model

of

MS

care.

A

recent

study

from

the

physiotherapy/rehabilitation specialty in neurological diseases and injuries has shed
some light on several different types of hope that PwMS may possess and use in their
MS journey, including concrete hope, hope in possibility, active hope and
transcendent hope (Soundy et al., 2013). Further work by Soundy and colleagues
(2016) used thematic synthesis to examine 47 studies of MS to identify expressions
of hope in MS patients as hope for a cure, hope for improvement, hope for normality
and hope to cope. I did not recognise all of these elements of hope in the current
study participants, possibly because Soundy et.al’s. 2013 study primarily focused on
spinal cord injuries and stroke, and to a lesser extent on MS. However, all of these
concepts of hope helped me build a clearer picture of the types of hope I was being
informed about by the participants. I was guided in some of my hope descriptors on
concepts from Soundy and colleagues (2012, 2013, 2016) research work in hope, but
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also extended them to be more inclusive of the personal stories I was hearing and
types of hope that have not previously been reported in this population.
Previous qualitative nursing research on the experience of living with RRMS
reported that PwRRMS hoped to manage and maintain function as part of their future
(Miller, 1997). As Miller’s study (1997) was conducted prior to the introduction of
DMTs to control RRMS, it was interesting to explore if hope to maintain function
would still be as important to PwRRMS today now that disability outcomes have
greatly improved. The answer was a resounding yes, it was extremely important for
many of the current study participants, and in several different ways, which will be
discussed in further detail below.
The specific types of hope I developed from the study participants during the
interviews included the following: functional hope (wanting to retain functional
ability, especially the ability to walk unaided), restorative hope (to be returned to
their previous state of health), curative hope (hope for a cure) and defiant hope
(challenging and resisting RRMS). To a smaller degree, realistic hope (acceptance at
the current situation and a good understanding of the possibilities ahead) also had a
place in almost every story, but was more inferred in their storytelling and overview
of their condition rather than discussed openly as a form of hope. In addition, I
believe that every participant harboured personal/secret hopes which live inside of
them, mostly unsaid and perhaps never truly examined, shared and explored. I felt
this because I witnessed the looks of longing, the pensiveness in conversation, the
struggling to grasp something when discussing hope and put it into words. I am
unsure of why this may be. Perhaps the participants were frightened to share their
feelings of hope in case they are not shared by others and therefore may be
extinguished, resulting in devastation. Or perhaps, speaking them out loud takes
away some of the mystery and reveals too much of their soul. Or perhaps, these
secret hopes are simply too complicated to summarise into words and feelings. In a
study of hope in spinal cord injuries, the researcher felt that every participant in the
study had hope, although for some it was “silent hope”, remaining unexpressed when
physical progress stagnated, but requiring courage and endurance (Lohne, 2001).
Perhaps a similar concept could also apply to PwRRMS, hope remaining even in
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times of distress or crisis, just remaining unexpressed at that particular time. But not
far from the surface.
Hope has also been identified as both an active process and as a more passive one
(Soundy et al., 2013). Active hope can be seen in patients who can identify and act
on a goal, possessing connectedness and demonstrating optimism (I see this as being
aligned with Snyder’s version of high-hope) as opposed to those patients
demonstrating more passive hope where they may have a vision of hope but cannot
use that vision to move forward, often kept back by fears (I see this as being aligned
with Snyder’s (2002) version of low-hope) (Soundy et al., 2013). Most of the types
of hope uncovered in the current research study are quite active in their character,
perhaps participants did not express more passive hope in keeping with the nature of
the concept. Being able to identify different types of hope in patients enables MS
Nurses to be able to engage more deeply, to gain more from interactions with
patients and perhaps most importantly, to be able to help patients in adjusting to
RRMS and to ensure the best possible outcomes, assisting with realistic goal setting,
pathways management and goal achievement.
Functional hope
Functional hope captures the hope of retaining functional capacity, the ability to
perform activities of daily living such as walking, showering and getting dressed.
Functional hope aligns somewhat with Soundy et al.’s (2013) description of adaptive
hope, which centres on the hope to manage and retain functional ability in
neurological conditions. However, functional hope in the current study appeared
more urgent, more determined and more centred on keeping function rather than
adapting (as shown in the quote from Paul below). Expressions of functional hope
were very common in the interviews and pertained mainly to ambulation and the
ability to walk. Functional hope was expressed by the study participants in one of
either two ways; to stay out of a wheelchair/walking aids or to be actively walking
and ambulant. Two sides of essentially the same hope, to retain walking function.
Optimistic, goal directed cognitions are aimed at distancing a person from negative
outcomes (Gillham et al., 1995), which is slightly different to hope theory where the
person aims for future positive goals and the methods to achieve them (Snyder,
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2002). In the current research study, the participants most often expressed this as an
overt wish to stay away from anything to do with wheelchairs and ambulation aids
such as walking sticks and canes. Thinking optimistically to distance from negative
outcomes, this would be a desire to not be wheelchair bound or requiring a walking
stick. Thinking in terms of hope theory, it would be a desire to stay fully ambulant,
to be walking “as normal” and the methods to achieve this state, such as participating
in yoga classes, taking DMTs as directed or seeing a physiotherapist for an exercise
prescription.
As discussed in an earlier theme, (Re)defining Me now that I have RRMS, under the
subtheme dare to compare, Paul expressed determination to stay out of a wheelchair
in the future, having glimpsed a little of what that type of life could entail during his
unhappy, early visits to MSA meetings not long after his diagnosis (he refused to
attend these meeting again). What he witnessed there made him determined to avoid
the “wheelchair scenario”, demonstrating optimistic goal directed cognition. This
was also Paul’s reasoning in the theme The DMT Dance with his wanting to front
end load and have a higher efficacy DMT despite the side effect risks. Paul did not
want to end up in a wheelchair as a result of RRMS, his functional hope active and
determined. Paul’s quote is breathtaking, almost childlike in its simplicity about
camping being the other option to a wheelchair.
I don’t want to be in a wheelchair, I want to be able to go camping. Paul line 727
For Rudi, Margot, Ruby and Piper, the physical act of walking holds personal
importance for them, and their hope for the future involves being ambulant and
functional, and the reason they pay such close attention to their own health, fitness
and well-being.
I see life being good and I hope to continue to travel and do the things I want…I see
my future as I am today…I dream of me walking in that. Rudi line 1707
So the future I see…I hope that I don’t get to the stage where I need a wheelchair all
the time…but hopefully…I think, use it or lose it…I make myself do things. Margot
line 2459
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I’m going to walk…to do things with my husband…let’s go do this, let’s go do
that…my son really wants to go to Hawaii, so I hope my legs can work enough to
take him. Ruby line 1560
If I wasn’t being treated it might be a slippery slope downwards…I feel more
confident knowing that a lot of these drugs are showing positive results…I do
envisage myself hopefully never being with a walking aid, purely because of the
medications…that’s what I’m hoping for. Piper line 2021
Restorative hope
Similar to functional hope, restorative hope is mainly about retaining function, but
differs from functional hope in that it is more of a hope to be returned to previous
levels of function, before the onset of RRMS. This would have been considered
impossible even a decade ago, but some of the newer DMTs have been reported to
improve function and reduce disability, for the first time in MS care (Coles et al.,
2012).
For study participant Ruby, recently completing a course of the DMT alemtuzumab
encouraged her to be hopeful for a complete recovery and return to earlier function,
of restorative hope. Rudi had experienced bouts of hopelessness after several severe,
debilitating attacks, but also gained confidence from her neurologist that the newer
DMTs may restore her to better health.
I don’t feel so weak…I was walking yesterday, it’s no marathon but for me it was
pretty good…so fingers crossed I really hope so, I want the function back…I used to
be able to walk with the kids everyday when we first moved here…so I want that sort
of function back. Ruby line 629
Normal, I just want a very normal lifestyle…I just don’t want to be in bed or on the
sofa…I want to be moving…just a very simple life…and not all about me, it would be
nice if it wasn’t all about me. Ruby line 1575
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(The neurologist said) with treatment we don’t hope to keep you where you are at,
we hope to keep you better…so I think…I had a bit of confidence in her…great. Rudi
line 1635
Curative hope
Of course, hope for a cure in the future was also very common in this group, fuelled
by recent advances in DMT development and in new therapies. For many
participants, they felt lucky to be diagnosed in a time where a cure could be possible,
and this was expressed as a form of hope. Will and Susan feel certain that a cure for
MS is imminent. Evie was also hopeful of a cure, but not in her lifetime, perhaps also
exercising a form of realistic hope.
In this small amount of time we’re only getting better, we’re getting more efficient at
what we do…it’s only a matter of time…a cure is going to happen so I know for me
it’s not going to be an issue, but now I need to make sure I keep on top of myself.
Will line 374
I believe that some type of drug…will be a permanent solution. I believe there will be
something. Will line 1507
I feel very positive about the future and with all the new medications, all the support
out there…a cure…and with all the research and new medications, there’s a lot there
to help people to lead a normal life. Susan line 1047
All of this research happening, one day they’ll find a cure and I might be dead by
that point, but it’s going to happen…you need to be optimistic about it, the future
and what you can do…there’s a lot of good people doing good work. Evie line 1458
Defiant hope
I really don’t do things by halves…getting back to gym so soon after treatment was
very important to me…I was being more defiant…it helps…you know what, MS? You
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can knock me down, but I’m going to get up, and then you bounce back, kinda
defiant. Evie line 1299
Defiance has also been referred to as a “fighting spirit” as the PwMS shows
determination to battle MS (Reynolds & Prior, 2003), demonstrated succinctly by
Evie in the quote above. One of the hardest aspects to accept for patients can be the
drastic change to their identity brought about by MS, often hoping to return to their
pre-diagnosis identity (Soundy et al., 2012). A recent study of 11 PwMS, five of
whom had RRMS, used content analysis and thematic analysis to explore patients
expressions of hope in a rehabilitation setting (Soundy et al., 2012). Some study
participants set themselves a challenge to overcome, to defy MS and the expectations
and passiveness that other patients or clinicians had towards MS, by taking action
they were doing something to progress hope (Soundy et al., 2012). After several
interviews in the current study, I identified this type of defiant attitude as a direct
expression of hope, almost at its most bold and daring and key to the participants in
their hope journey. Defiant hope provided a way to challenge the expected prognosis
and progression of MS. Defiance didn’t come easily for most study participants and
involved more than positive thoughts and an optimistic outlook; defiance needed
deliberate action, clear goals, and to be supported with plans, resources and active
engagement. The majority of the participants in the current study openly challenged
their RRMS, issuing a resistance that at times captured the very essence of defiance.
After twenty years of living with RRMS, Evie still offers resistance to RRMS and
remains positive about the future, regularly challenging her physicality and
expressing defiance as a means to show others that RRMS doesn’t stop her doing
anything.
I did go bungee jumping six months later (after MS diagnosis) just because I
could…trying to prove a point and now I’m almost 40 and I still do those things just
to prove a point…I went indoor rock climbing a few weeks ago…you’re not going to
get me, it’s not going to happen…sky diving, same thing. Evie line 657
Piper tries to live each day issuing resistance to MS, becoming even more defiant
when she is troubled by debilitating symptoms of MS such as fatigue and nerve pain.
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OK…just get out there and do stuff while you can…and I do that everyday. I like
going for my walks and runs…people say to me “why do you do that to yourself?”
and I say “well, I do it because I can…because I know what it’s like to not be able to
walk”…Even when I’m feeling lousy and I’m feeling fatigued with the MS in
particular, I will do it, I will push myself and I will do it. Piper line 990
Kate was working full time, mothering, looking after sick parents and studying for a
higher degree when she experienced many debilitating relapses. Although many
would have reduced their workload at such a busy time, for Kate, studying was her
lifeline, her turning point against the disease. Kate describes achieving her higher
degree as her greatest life accomplishment and representing active defiant hope
against RRMS.
MS would just pop up it’s ugly head but I didn’t make it important…I tried not to. I
did not place too much emphasis, it was an inconvenience yeah, but it was not my
biggest problem…I thought…you’re not going to beat me, I’m going to do what I
want. Kate line 1777
Joy was confined to wearing sensible, flat shoes due to her significant gait issues and
depended on a local shoe shop in her small rural town to order her supplies. Trying
to recapture positive and happier times, Joy decided she wanted to try high heels. Of
course, the shop assistant used to Joy’s usual symptoms didn’t think this was a good
idea and questioned her choice, but Joy was determined. This simple act of defiance
led to a simple, yet remarkable turnaround.
So I took a deep breath and I stood up in these high heels…so I stood up, adjusted
my gait and then I walked towards the mirror…I walked with my head held high,
with confidence…I was so empowered, I felt so strong…I felt like I got my whole life
back…it was really special. Joy line 1291
The study participants seemed to garner more hope with their defiance, perhaps
because this meant that they were actively taking a stand and actively taking control,
rather than MS taking control. Defiance gave a certain sense of purpose, a reason to
get up in the morning, a reason to exercise, a reason to take DMTs even when the
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going gets tough. Defiance is a form of hope and an expression of being hopeful, of
belief in oneself. MS Nurses can foster defiance in patients by helping them to
understand their current capabilities (not just their disabilities), to resist comparisons
with others and to concentrate on the resources and value that they already have and
which can be developed even further.
Nurses have been identified as having a crucial role in facilitating hope in patients
and their families (Tutton, Seers, & Langstaff, 2009). It has been suggested that
nurses are an important source of hope for people that are vulnerable and ill (Herth,
1990; Herth, 1996; Cutcliffe & Gant, 2001) due to their constant and prolonged
contact with those who are suffering, forming close connections and being in an ideal
position to influence feelings of hope (Travelbee, 1971). Nursing strategies to inspire
hope involve the presence of another human who demonstrates unconditional
acceptance, tolerance and understanding (Cutcliffe & Herth, 2002). Other hope
promoting strategies include fostering interpersonal connectedness with others,
assisting with attainable aims and goals, encouraging spiritual practice in those who
value spirituality, encouraging personal attributes such as a sense of humour and
affirming the worth of a person (Herth, 1990), benefit finding, expanding coping
skills and sustaining caring, therapeutic relationships (Miller, 1991), functions all at
the heart of the MS Nurse’s role. Communicating one’s own sense of hope is also an
important strategy for inspiring hope in others (Fitzgerald Miller, 2007), and for the
modern day MS Nurse, this is a somewhat easier task than in years gone by, with so
many new, proven, efficacious DMTs and many promising treatments on the
horizon. As demonstrated by the forms of hope discussed above, for PwRRMS
today, hope burns brightly as the possibilities for the future, for treatments and for
the Holy Grail, a cure, are for the first time very real.

Purposeful positivity
I think there’s a measure of optimism, I think it’s not even control, I think you can
decide what path you’re going to take…if you’re being negative all the time it’s
going to be bad for your MS, if it’s negative, it’s down, it’s feeling awful, woe is
me…it’s getting out of that perpetual cycle of negativity, it’s being optimistic about
the future, about looking forward to something going well. Evie line 1435
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Throughout the interviews I detected a sense of purpose for many participants when
they were discussing hope and remaining positive through their journey, a process
where they actively engaged with being positive, which I later termed “purposeful
positivity” to capture this intention. It didn’t seem to just happen randomly, as
highlighted by Evie in the quote above, purposeful positivity was a very active
process which was more conducive to living well and happily with RRMS for the
study participants. Examples of purposeful positivity included choosing and
sustaining optimism, benefit finding, searching for meaning, harnessing a sense of
humour, expressing spirituality, and giving back to the MS community.
Perhaps one of the most poignant examples of purposeful positivity came from Joy,
whose obese husband suffered a sudden fatal heart attack, falling on top on her and
crushing her beneath him. She managed to crawl out from underneath him and
survive, the incident starting a new path for Joy where positivity became key to
regaining control.
That instant (my husband died unexpectedly) was beyond devastating…but that surge
of whatever it was when he fell on top of me…that choosing life…whatever it was
that surged through me at that point did something in my chemistry…at his funeral I
was battling into the church to walk…but I started to improve, in fact I made an
absolute heart felt decision that I would get better no matter what…something
switched on, I chose life…if my body won’t do what I want it to do…there’s got to be
another road…I started fighting for it…I felt like I had the power to control my
health…it may or may not have been true, but I made it true. Joy line 969
Optimism and a positive outlook
Being diagnosed with RRMS in the current climate of breakthroughs in scientific
research and newer, more efficacious DMTs gives rise to the possibility of greater
positivity and optimism. Additionally, the huge variability in possible RRMS
symptoms and disease severity can also inspire confidence. A recent study exploring
parents’ experiences of their child living with RRMS, interviewed 31 parents in
semi-structured interviews and used grounded theory to analyse the results (Hinton
& Kirk, 2017). One of the important findings identified in managing the uncertainty
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of MS was “optimistic thinking”, hoping for a future where their child would be
minimally affected and lead a “normal life”, the huge variability of RRMS by its
very nature aiding optimism in this regard (Hinton & Kirk, 2017). Although this was
the viewpoint of the parents and not the PwRRMS, the concept of the latitude for
hope and positivity in an uncertain disease is an important one, and also has
applicability to adults living with RRMS. As MS Nurses, the unknown disease
variability forms the basis of many consultations with our patients and allows
positivity and hope to always have a place in our care.
Often the diagnosis of RRMS can cause negative reactions in the PwRRMS, as
explored by the earlier themes of this study in chapter 6. Over time however, many
PwMS report positive changes in terms of values and outlooks, as well as an
increased appreciation for life (Irvine et al., 2009). It has been reported that thoughts
are effective tools in garnering the motivation necessary to commit to behavioural
change and that positive thinking may benefit motivation in MS (Hall-McMaster,
Treharne, & Smith, 2016). Positive thinking is an active behaviour and entails having
a goal in mind, being self sufficient, letting go of the past and reinforcing positive
actions by doing something good (Hall-McMaster et al., 2016). Once again, as with
hope theory, it is postulated that positivity takes deliberate cognitive action and
working out what is necessary to reach goals, of possessing determination (HallMcMaster et al., 2016). Traumatic events challenge beliefs, with the result that
humans make active efforts to restore, or to enhance their beliefs and exercising
positivity is a way to cope with adversity (Taylor & Armor, 1996). Dennison’s
model of adjustment to MS suggests that those who adjust more successfully to the
diagnosis use the following resources: positive reappraisal, optimism, hope, benefit
finding and spirituality (Dennison et al., 2009).
Strategies to sustain optimism include avoiding being around those with negative
views who challenge (sometimes fragile) hope (Hinton & Kirk, 2017). Staying away
from negativity in others could involve distancing from family members, friends,
work colleagues and sometimes MS organisations in some cases. In the current
study, participants Will, Paul and Jane elected not to become involved with the local
MSA meeting groups to avoid being reminded of the negative aspects that MS could
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bring and to maintain and instead to nurture optimism and positivity from their own
family and friends.
Patient attitude has been identified as a major influence on overall disability burden
in MS in a large, cross sectional Belgian study of 1372 participants living with
RRMS (D’Hooghe et al., 2013). This study reported that those patients who scored
higher on health promoting behaviour (such as physical activity, spiritual growth)
were significantly less likely to reach a level of disability where they needed
assistance to ambulate (a single walking stick) (D’Hooghe et al., 2013). As patient
attitude is an area of possible control for the PwMS, educating patients about the
importance of a positive attitude could significantly contribute to better and more
positive outcomes (Lysandropoulos et al., 2015).
Both Piper and Griff exercise the power of positivity, of being in control of the
disease and verbalising a better future. A sense of control appears to resonate heavily
with a sense of hope and positivity. Piper has had extensive counselling so that she
can feel in control of MS and enjoys the challenge of keeping the disease in check.
This leads to hopeful feelings for her future health. Griff, ever the optimist, simply
regards himself as lucky and is pragmatic about what may happen in the future.
Even if I’m having a bad day with MS I know that I’m in control of my thoughts and I
can think whatever I want…I can change that thought process. Piper line 1772
I think I live almost day by day…I can’t picture what it’s going to be like…if I look to
a future with MS I do believe that I’ll be dead and buried before my MS puts me in a
wheelchair…I just don’t think it’s going to happen. I’m lucky. Griff line 1367
Susan, unhappy with the way RRMS was controlling her emotions and keeping her
from her dreams, embarked on a counselling course so she could learn to take back
control of her life, and understand herself better in the process. Susan regards this
course as a life-changing event for her, finally enabling her to enjoy life, help others
in her role as a HCP, exude positivity and put years of despair firmly behind her.
Susan uses the skills she learnt during the course now as a new mother with RRMS
and fatigue, to see things differently and remain optimistic and positive.
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Accept it, embrace it, because it doesn’t mean the end…and then I looked at it…that
it was a new beginning for me…I did look after myself more with what I ate and I
exercised. Susan line 806
You always have to hold on to your dreams because that’s what keeps you
going…what you are striving for…you have that to help you get up each day and get
on with life and make yourself a better person and stronger to help others around
you. Susan line 1128
I feel positive about the future and people being diagnosed with MS now…this
medication will be able to help them…there’s a lot that’s happened. Susan line 1202
MS Nurses can foster positive thinking in patients by encouraging a focus on
positive aspects of their life and by using positive self talk (Roger et al., 2014). MS
Nurses can also remind patients that cultivating optimism and hope will assist with
self confidence and regaining control of their lives, and taking part in programs such
as intensive wellness programs can also improve self efficacy and positivity (Ng et
al., 2013). As a positive attitude helps with regaining control over MS and more
positive outcomes overall (Lysandropoulous et al., 2015), providing education on the
importance of positivity and methods of achieving a positive state of mind can
potentially have a significant impact on the future for the PwRRMS.
Searching for meaning
Searching for meaning is another expression of positivity and has been described as a
cognitive process to find order and purpose in illness (Sharpe & Curran, 2006).
Creating meaning in life for PwMS can involve participating in meaningful
activities, developing new interests, and engaging in life with more purpose. This
concept was captured in a recent study where participants learning to live with MS
were likened to “learning to fly with broken wings” (Flesner & Rudolfsson, 2016).
Several of the participants in the current study expressed feelings of gladness that
things changed in their life, sometimes for the better, as a result of MS. Rudi
described the time where she couldn’t work due to recurrent severe relapses leaving
her with residual neurological dysfunction for several years. At the time she was
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raising four young children and really needed the money to support the family.
However, she chose to look at the situation differently and saw meaning in the illness
as giving her time to spend with her family during some very important years.
When I lost my job, I thought I can be down and think I’m unemployable…I can’t
work…the path I chose to take was that work’s always going to be there forever, the
kids are going to grow up and I need to look at this as I’m lucky because I get to
spend this time with my children…whilst it was tough financially, we adapted. Rudi
line 944
Choosing to rise above the possibilities of the diagnosis and concentrate on a life
well lived with MS is a conscious, positive choice. Kate looked inward to find her
life meaning and Rudi changed her perspective on money to live life to the full and
uncover new meaning. By seeing RRMS as something she lives with, but not the
entire story, Evie makes a choice to find meaning in all she can do rather than what
she cannot do.
It gave me strength to think, whatever this is, I want to get over it…I’ve got things to
do…more important things…and that’s the way I was driven. Kate line 388
Finances play a big role with anyone and I had lost my full time job (because of
RRMS) but you know, stuff it, it’s just money, so we went to Fiji last year…I’m just
doing a lot more and loving it…you change perspective. Rudi line 910
MS is not the main life…it doesn’t define who I am, yes I have it, but it isn’t who I
am…I do not let it define me, I have it, it bothers me, it drives me insane and it makes
me angry, but it is not the core of who I am as a person. Evie line 1184
It’s not all doom and gloom like people might think…if I ever go rock climbing again
I want some photos because I want to upload to MS Society so people can see that
you can do these things…you shouldn’t focus on what you can’t do, it’s what you can
do, it’s what you want to do. Evie line 1232

326

Harnessing a Sense of Humour
Another strategy to maintain a positive sense of self whilst living with a neurological
condition is to use humour (Roger et al., 2014). A qualitative study interviewed 27
women with MS and used interpretative phenomenological analysis to investigate the
results, finding that positive thinking and finding “jewels” in their situation were
important themes when living with MS (Reynolds & Prior, 2003). Participants were
found to consciously value special and positive moments, actively looking for
benefits, maintaining social relationships and enjoying fun and humour (Reynolds &
Prior, 2003). Similarly, an earlier study reported exercising a sense of humour, along
with maintaining a positive attitude, as important tools to living a life well with MS
(Gulick, 2001). Several study participants demonstrated a healthy sense of humour
during our interviews, at times telling me poignant or distressing stories but laced
with laughter, giggles and the ability to have a laugh at their own expense. It has
been reported that humour is a way to maintain a positive sense of oneself and play
down the challenges in life, playing an important role in encouraging positivity in
neurological diseases (Roger et al., 2014). Kate and Margot in particular, perhaps the
two most physically disabled participants in the study, recalled sad stories at times,
but quickly focused on humour to see the funny and bright side.
Kate was describing to me a time when she had to do a presentation but was crippled
by severe spasticity which affected her gait. Recalling the situation, which could
have also been portrayed with torment, Kate laughed and re-enacted the walking
motion in front of me.
I can’t bend my knees…and when I walk, I walk like, you know, the Tinman!
(laughing) in the midst of all this I had to give this lovely presentation (giggles). Kate
line 1343
Margot, who initially experienced so much angst thinking about the possibility of a
wheelchair as her mobility gradually and intermittently deteriorated, saw the funny
side of a wheelchair mishap on holidays with her husband overseas.
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We unwrapped the wheelchair…it was all bubble wrapped that’s got fragile all over
it…everything was chucked on top…and one of the struts on the side was bent, so
(husband) is manoeuvring it (laughs boisterously) and he ended up breaking it (more
laughing)…and broke the strut…so off we go…(bouncing on) cobblestones all
through (the town) (giggles). Margot line 1633
Margot also told a story of rising from her wheelchair in a shop to shock the shop
assistant, walking slowly away from the wheelchair and proclaiming at the
assistant’s puzzled look “I know, it’s a miracle!”. For some, a touch of humour (at
the appropriate time) can be a more comfortable way to address some of the more
uncomfortable aspects of living with RRMS. MS Nurses can also support and
encourage PwRRMS in the value of humour in their life journey.
I did wonder if Kate and Margot laughed at the time of the incidents, or if time
allowed them the luxury of being able to look back on an initially emotionally
painful event with a new sense of humour. But, getting to know Kate and Margot
through the life history interviews, I suspect they both did feel the brighter side of the
situation at the time.
Faith, religion and spirituality
Improving the health and well-being of the whole person, mentally, physically and
spirituality has been at the forefront of nursing since inception (Nightingale &
Skretkowicz, 1992; Reinert & Koenig, 2013), therefore considering the impact of
spirituality in the life journey of RMMS is essential. For the purpose of this study,
concepts of faith, religion and spirituality will be viewed as not just as traditional
religious faith, but as belief or belonging to any sort of higher being or spirit and will
collectively be referred to as “spirituality”.
It has been suggested that spirituality is related to better adjustment to illness,
providing a sense of coherence and meaning, purpose and the courage to endure
suffering (George, Larsen, Koening, & McCullough, 2000). However, there are very
few studies exploring spirituality in MS and those that have been published have
somewhat contradictory messages regarding the importance of spirituality in MS. An
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early study in Australia surveyed a group of 101 participants with MS (phenotype
not specified) and reported that those PwMS who derived high levels of meaning
from personal belief systems also experienced high levels of quality of life and
psychological well-being, as well as lower levels of depression and anxiety (Makros
& McCabe, 2003). A small study of seven PwMS (type not specified) found that
PwMS did have an increased appreciation for spirituality in their lives (Irvine et al.,
2009), which has also been supported by others suggesting that spirituality may be a
helpful resource to cope with chronic disease in general (Bussing et al., 2009;
Bussing et al., 2013; Levine, Aviv, Yoo, Ewing, & Au, 2009).
However, contrasting with this work are early empirical findings in larger studies
which have suggested that PwMS may be less engaged in spirituality when compared
to patients living with other chronic diseases (Bussing et al., 2005). A more recent
study of 213 participants, half of whom identified as RRMS, found relatively low
levels of faith importance in the study sample, with only 10% of participants
reporting reliance on faith to carry them whilst living with MS, most participants
citing family or themselves as their source of support in the MS journey (Wirth &
Bussing, 2016). It is worth noting however, that this particular study enrolled
younger participants between the ages of 25 and 40 years, possibly influencing the
results as it has been suggested that age is also positively related to higher measures
of spirituality (Bussing et al., 2005).
In the current study, Joy expressed positivity from actively practicing spirituality,
when she recalled stories about the disciples of Jesus healing a cripple, which is how
she used to see herself. She used this story to inspire positivity in herself and a belief
that miracles could happen.
I was reading my bible one day and I read this passage that talked about the
disciples and there was a beggar there crippled from birth…they said “in the name
of Jesus Christ rise up and walk” and then the cripple stood up...walking and
leaping and praising God…and this really impacted me…suddenly I could relate to
it…if that kind of miracle is possible, what does walking, leaping and praising God
look like in my life? And I pushed my body to walk. Joy line 1120
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In western religious thought, individuals strive to maintain an idea of self that is in
harmony with the universe and God and suffering has a purpose and provides a way
for humankind to enter a divine relationship with God (Goodrick-Clarke, 2008). It is
important for the MS Nurse to have an awareness of the cultural/spiritual beliefs of
the patient, as it is helpful to form the basis of individualised and patient-centred
care, and can be incorporated into the nursing care plan.
When things aren’t going so well in life, spirituality can provide an avenue of
support that adds another element to purposeful positivity. For Evie, this was an
important support in her hour of need, for Joy as a child it was the only real support
she had, and for Davina, re-engaging with spirituality during a dark time gave her
new insights, although she started off angry and disbelieving.
It doesn’t scare me because I think there’s more…there’s more…I have always
believed there’s more…call it God, or whatever religious faith, I don’t particularly
hold any, I consider myself very spiritual…you have to turn to your faith when life
isn’t so great. Evie line 683
Faith was really the only thing I had growing up as support. I took myself to church
from age six…faith is a huge part for me…in spite of everything around me…I
couldn’t explain that to people…it was my faith that kept me going especially when I
lost my ability to comprehend (when Joy became dyslexic). Joy line 1819
The other thing I got back that’s really helped me…I got my faith back…after I was
diagnosed with MS I went back to church…but I went back really angry. Davina line
1152
The minister helped me I was this screaming possessed woman and he turned my life
around, got me in contact with women in the church who had been in really bad
situations overseas, older women...having my faith back actually made me a bit
stronger, it has helped me tremendously…I feel a bit more supported. Davina line
1176
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Expressions of spirituality were not confined to participants in the current study. At
times, spirituality was an important coping mechanism for their loved ones as well.
Susan’s family engaged in regular prayer groups after her diagnosis, drawing
strength from others in the group, whilst Susan elected not to become involved.
Kate’s mother was deeply religious and although Kate herself was absolutely
terrified of her symptoms, her mother was convinced from her spiritual beliefs that
RRMS was going to go away. Because of the natural relapsing and remitting
evolution of the disease, this may have enhanced this aspect of hope for families as
symptoms disappeared and their loved one regained usual function, possibly as a
result of their faith.
Giving back and being involved
Another strategy to inspire hope and positivity demonstrated by the participants was
a willingness to become involved in the fight against MS and to give back to the MS
community in some way. Kate expressed one of the most incredible stories of
selflessly giving back to the MS community. Kate had experienced a miserable time
on an interferon DMT and eventually ceased it due to intolerable side effects, despite
persevering for some time. Kate was keen to help medical science and “give back”
and sought information on a new clinical drug trial. Kate made enquiries and was
disappointed to find that the trial involved being randomised (randomly allocated) to
one of two medications - a new oral medication that she was keen on trying and the
older DMT she had suffered greatly with. Kate elected to participate in the trial and
was randomised to the old interferon DMT. Not only did Kate administer the DMT
again for another year, suffering significant side effects, Kate also completed all of
the trial requirements, demonstrating both persistence and altruism.
Evie acts as a mentor for newly diagnosed PwRRMS and also as a speaker and
advocate in the MS community, regularly participating in MS events and raising
awareness of the disease and the impact of RRMS. Evie is adamant that she wants to
show the world the positive side of RRMS and what can be achieved, to be more
positive in the message.
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I want to believe in other people, that’s why (I advocate for MS), so I want to make a
difference and I figured that I can talk to people, I can write really well…if I’m going
to have it, I may as well do something with it…I want people to see people who
aren’t disabled by MS. Evie line 1205
Other participants such as Griff helped out by educating newly diagnosed PwRRMS
or those that are new to infusion treatments by performing a meet and greet role at
the local MS infusion centre, especially being available to help young men during
this challenging time. It was an important way of displaying positivity to others by
demonstrating living positively with the disease by example.
Raising money for MS research was an important display of positivity for Susan
after her diagnosis, becoming involved in fundraising bike rides even though she had
never ridden a bike before. Susan also made herself readily available to help others
newly diagnosed if they needed someone experienced to talk to, enhancing positivity
for others as well.
I thought well, OK, I can do something for myself…so I started entering the
charities…the MS bike rides…and I raised money. Susan line 538
My friends would ask me…can you talk to so and so…people who have been newly
diagnosed…and encourage them and give them ways that they can help
themselves…so they feel more positive and not to think that you’ll end up in a
wheelchair. Susan line 1225
Of course, by way of volunteering in the current research study, being willing to tell
their stories and give up time for others in the hope of contributing to MS research,
demonstrates being involved and giving back to the MS community for every
participant involved in the current research study.

Towards a definition of hope in RRMS
After researching the hope stories of the study participants, the evolution of hope
theory, hope nursing literature, MS specific hope literature and considering the
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thousands of MS patient consultations I have performed over the last 15 years, I have
come to my own beginnings of a definition of hope in the context of RRMS for MS
Nurses. I say beginnings, because the hope story has such a long way to go in
RRMS, and is likely to change as our understanding of hope deepens and as new
research adds certainty to current uncertainty in RRMS. In addition, further diseasespecific hope research is greatly needed in all aspects of MS, in both RRMS and in
progressive forms of the disease, before we can truly understand its significance.
My current definition: The experience of hope is a future inspired phenomenon,
remarkable for its elements of promise, possibility and positivity. Hope is essential
to human life, can be inspired, sustained and coached in others and is contagious
in nature. Hope is tangible and a very important aspect of living well with RRMS.
The MS Nurse can be, and often is, a beacon of positivity and potential for
PwRRMS, providing inspiration and hope in words and in actions.

A final word on hope
In order to assess, recognise and to inspire hope in others, MS Nurses need to feel
hopeful themselves. This has been aided tremendously in recent years as the first
DMTs have been developed to halt progression of the disease and prevent future
disability, with MS Nurses often administering the medications and monitoring
progress and therefore at the forefront of positive change in RRMS. However, in
order to inspire and sustain hope, it has been well reported that MS Nurses need to
strategise self-care within themselves (Morgante, 2000). As workload increases
dramatically, patient numbers grow and as DMT monitoring becomes more time
consuming and critical due to potential life threatening side effects, self-care
becomes even more important than ever before. Networking with peers, exercising
regularly and eating nutritiously, using confidantes, nurturing supportive
relationships, expanding knowledge bases, sharing expertise, taking holidays and
stress reduction are all methods the MS Nurse can use to nurture self care (Morgante,
2000). Feeling hopeful themselves is also a way that MS Nurses inspire hope in
others (Morgante, 1996). This should be a priority for MS Nurses, not just for
themselves and their own health, but because it will shine through and inspire in all
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interactions with PwRRMS, their loved ones and other HCPs working in the
speciality.
Take one's adversity
Learn from their misfortune
Learn from their pain
Believe in something
Believe in yourself
Turn adversity into ambition
Now blossom into wealth
Emily Dickinson
This theme concludes Chapter 7, Finding the High Road, and the thematic and
poetical findings of the current study. Following along the lines of hope and
positivity which completed the formal study findings, the next chapter will discuss
the study themes in relation to the life journey of RRMS. How the ebbs and flows of
life and the life history methodology fits together with the study findings to further
enhance the participant stories and bring the key concepts of the lived experience of
RRMS alive.
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CHAPTER 8: THE LIFE JOURNEY – EBBS AND FLOWS OF
LIVING WITH RRMS
I have many faces, I am never still
Today I am here, tomorrow I am gone
I haunt you for days and then I leave
You can never work out what to believe
Darting in and darting out
I cause havoc and play games with your mind
I cause you to second guess yourself, to self-doubt
And before you know it I’m in and I’m out
My face tomorrow looks completely new
I can still creep up, I can still surprise you
But then you change, you get better at this
You learn, you discover, you realise what I am
You start to beat me down and tell me I’m a sham
I’ve now met a considerable foe, you’re ready for a fight
We’ll face up against each other and you’ll show me your might
TB
The life journey of RRMS takes many twists and turns; it is never a linear journey,
but rather one of continual flux, which is mainly due to the innate unpredictability
and uncertainty that comes with the diagnosis of RRMS. I have been surprised many
times in my clinical work by the stability of a patient’s condition at a routine
appointment, only to see things change dramatically and seriously, within a matter of
days. Nothing is set in concrete in this disease. The great advantage of the life history
approach is that it reflects the entire life journey; with and without RRMS. By using
this process I was able to uncover many aspects of each participant’s life, which had
an impact on their later journey with RRMS. In particular, many participants
described events in childhood, which gave rise to the development of resilience, such
as childhood neglect, illness and migration from non-English speaking countries.
This resilience was then to serve the study participants well in later life, drawing on
coping skills to help them through the difficult and challenging times of RRMS. In
their narratives, I was able to uncover details about the participants which profoundly
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affected their RRMS story, even if they were unaware of it or of any connection
between other life events and their personal development and understanding of
RRMS. Even the process of telling the life history helped the participants to
understand where they came from and where they were situated now. They
recognised their achievements, revelled in their joys and respected their lows.
Although presented theme by theme in a logical succession, the eight themes
presented in these study findings do not always follow in sequence and definitely do
not always “end” with hope and positivity. Instead, the themes intermingle with each
other to reflect the ebb and flow of life. They tell the story of possible stops along the
life journey with RRMS and the constant moving backwards and forwards. For
example, a newly diagnosed PwRRMS might go through various aspects of the first
three themes in fairly quick succession, Piecing Together the Puzzle, (Re)defining
Me Now That I have RRMS and Battling the Demons, then encounter theme seven,
The DMT Dance with an attitude of theme eight’s Holding Hands with Hope. Then
an unexpected pregnancy throws everything into chaos. The PwRRMS is right back
to Piecing Together the Puzzle, (Re)defining Me, Battling Demons and having to
face difficult decisions about whether to proceed with the pregnancy considering
their exposure to medications known to cause foetal harm. Putting together a medical
team to help support and solve this problem will form part of Taming the Beast and
then (hopefully) using skills from Holding Hands with Hope to move forward.
Thereafter may be a year of stability and quiescence living with RRMS, with perhaps
the occasional Battling the Demons making an appearance on days of significant
fatigue or with the occurrence of a bladder infection. Then the uncertainty presents
again with the development of a severe motor relapse just days before a big work
event. A hospital admission and many tests follow, unleashing Piecing Together the
Puzzle and Battling the Demons (worry, anxiety, despair) as their perceived world
falls apart. The DMT Dance is set to start again as the specialist highly recommends
changing to a new, higher efficacy DMT, with several potentially life threatening
side effects. Whilst trying to use the skills learnt in Taming the Beast, the PwRRMS
is unable to see past the side effect profile and Battling the Demons threatens to take
over all they have learnt so far. Will I walk again? Will my Boss want to sack me?
What about the mortgage? Maybe this is my life now? Will my husband want to
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leave me now he can see what is possible with RRMS? I’ve always been unlucky,
surely I will get that side effect that kills…and there starts the long road back to
Taming the Beast, The DMT Dance and Holding Hands with Hope to reign in
positivity and belief about the future. As symptoms subside, the new DMT starts to
take effect, work allows time off to recover and life starts to settle again, Holding
Hands with Hope moves back into the foreground of life. Until a year later when a
work opportunity means a move to another town without an MS Specialist…and the
possibility of either Battling the Demons, or Taming the Beast arises. It could go
either way.
Using ethnography methodology, and the life history method in particular, to
uncover the study themes works in skilfully with the life trajectory of RRMS. The
most effective way to demonstrate the linking of the life trajectory, life history
methodology and the themes uncovered by this research study, is to illustrate the life
course of several study participants and the interlinking of the study theme findings
with their individual stories. The true value of the life history methodology can then
be clearly seen as the themes overlay their life lived with RRMS. The ebbs and flows
are shown below in four examples of life stories and recurring themes of Susan
(Table 6), Will (Table 7), Griff (Table 8) and Piper (Table 9). These participants
have been selected to represent a cross section of male and female experiences, short
and long term diagnoses, a range of other health issues and a range of disease
severity living with RRMS. Similar tables for the remaining nine study participants
have also been completed and can be located in Appendix 13.
Susan’s life story instilled in me a sense of resilience acquired by many years of
suffering, mostly in silence. Susan absorbed much of her parents’ grief and blame
when she was diagnosed with RRMS and remained strong as those around her
crumbled. It wasn’t until many years later that Susan realised she was dormant in her
journey; she wasn’t able to move forward. Working as a HCP, Susan was well aware
of the journeys of others with chronic illness, further complicating her view of self
and how she was progressing compared to others. Determined to change, Susan
began a counselling course, which set her on a new path (finding her North Star) and
life gradually began to change for the better. Today Susan is thrilled with her family
and totally in love with life, despite continued hardships along the way.
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Table 6: Susan’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life

•

Child of a migrant family

events and clues to resilience

•

Severe illness of glandular fever as a child

•

Physically

and

emotionally

demanding

employment

Onset of first symptoms

•

Working in healthcare

•

Living and working overseas

Piecing Together the Puzzle
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)

Symptoms worsen

Piecing Together the Puzzle (what’s happening?)
Surplus Suffering (brushed off)
Piecing Together the Puzzle (tests, tests, tests)
Battling the Demons (fear, worry & anxiety)

Hospitalised, it could be MS

Surplus Suffering (inflicted by clinical care)
Battling the Demons (fear, worry & anxiety)
Holding Hands with Hope (purposeful positivity)

Confirmed

diagnosis

RRMS

of Piecing Together the Puzzle (the day my life
changed forever)
Re(defining) Me now that I have RRMS (getting
acquainted)
Battling the Demons (fear of burden)
Holding Hands with Hope (faith)

Learning to live with RRMS

Re(defining) Me now that I have RRMS (getting
acquainted, dare to compare)
Battling the Demons (fear, worry & anxiety,
despair)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on
hope)
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Battling the Demons (fear of the wheelchair)
Sharing journey with family Re(defining) Me now that I have RRMS (getting
and friends

acquainted, reverse stigma, normalcy)
Taming the Beast (support from family, friends and
community)

Relapse

Piecing Together the Puzzle (what’s happening?)
Battling the Demons (fear, worry & anxiety)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on
fear and hope)

Completes

life

counselling Taming the Beast (support from family, friends and

course to better understand community)
self and illness
Re(defining) Me now that I have RRMS (getting
acquainted, dare to compare)
Relapse

Piecing Together the Puzzle (what’s happening?)
The DMT Dance (decisions based on fear and
hope)
Re(defining) Me now that I have RRMS (working
out work, normalcy)

Living with RRMS alone

Battling the Demons (fear, worry & anxiety)
Holding Hands with Hope (purposeful positivity,
defiant hope, functional hope, search for meaning)

New beginnings

Re(defining) Me now that I have RRMS (normalcy)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my
North Star, maintaining health & wellness, finding
my A-Team)
Holding Hands with Hope (purposeful positivity,
defiant hope)

Searching for a life partner

Battling the Demons (fear of being a burden)
Holding Hands with Hope (purposeful positivity,
defiant hope)
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Relapse

Battling the Demons (all fears, worry & anxiety)
The DMT Dance (hardyards: decisions based on
fear and hope)

Meeting

husband

beginning relationship

and Taming the Beast (support from family, friends and
community)
Holding Hands with Hope (purposeful positivity)

Infertility issues

The DMT Dance (hardyards: decisions based on
fear)
Taming the Beast (resilience)
Re(defining) Me now that I have RRMS (balancing
losses & gains, parenting with RRMS)

Pregnancy achieved

Holding Hands with Hope (purposeful positivity,
optimism)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my
North Star, maintaining health & wellness, finding
my A-Team)
Battling the Demons (fear of being a burden)

Life parenting with RRMS

Taming the Beast (support from family, friends and
community)
Holding Hands with Hope (purposeful positivity,
optimism)
Battling the Demons (fear of being a burden)
Re(defining) Me now that I have RRMS (balancing
losses & gains, parenting with RRMS)

Change of DMT

The DMT Dance (decisions based on fear & hope)
Holding Hands with Hope (purposeful positivity,
optimism)
Re(defining) Me now that I have RRMS (getting
acquainted)

Serious illness for husband

Battling the Demons (fear, worry & anxiety)
Holding Hands with Hope (purposeful positivity,
optimism, defiant hope)
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Taming the Beast (support from family, friends and
community, resilience)
Life

settles

with

RRMS- Holding Hands with Hope (giving back and getting

current status quo

involved)
Taming the Beast (support from family, friends and
community, maintaining health & wellness)

Will’s life story also reflected several years of hardship as he battled depression after
his diagnosis and fought his way back to a happier life, determined to live life to the
full. One of his most difficult challenges came about when the DMT that was
successful in controlling his relapses, natalizumab, needed to cease due to an
unexpected high-level JCV result, which put him at higher risk for the serious and
potentially fatal side effect, PML. Will had experienced many years of disease
stability up until this time and this came as a shock. However, as his life journey
reflected, this time when challenge presented itself, his life circumstances were
different to earlier in his journey, and he now had the close support and love of his
wife helping him in Taming the Beast.
Table 7: Will’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life

•

Fractured family life, childhood neglect

events and clues to resilience

•

Death of mother when he was 13 years old

•

Experience of MS from a close friend who
suffered progressive MS and was severely
disabled and blind

Onset of first symptoms at 17

Piecing Together the Puzzle (what’s happening?)

(with no follow-up)

Battling the Demons (fear)
High (In)visibility (welcome cloak, hide)

Living well, no symptoms

Battling the Demons (fear, worry & anxiety)
Taming the Beast (maintaining health & wellness)
Piecing Together the Puzzle (tests, tests, tests)

Travelling overseas, working Taming the Beast (maintaining health & wellness)
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hard
High (In)visibility (welcome cloak, hide)
Onset

blindness

unexplained

and Battling the Demons (fear, worry & anxiety)

neurological

symptoms, hospitalised with
no diagnosis for weeks
Piecing Together the Puzzle (what’s happening?,
tests,tests,tests)
Surplus Suffering (misdiagnosis)
High (In)visibility (welcome cloak, hide)
Diagnosis of RRMS

Piecing Together the Puzzle (the day my life
changed forever)
Re(defining) Me now that I have RRMS (getting
acquainted, working out work, non-disclosure)
Battling the Demons (fear of burden, worry &
anxiety, saboteurs, uncertainty)
Holding Hands with Hope (purposeful positivity,
optimism)

Learning to live with RRMS

Re(defining) Me now that I have RRMS (getting
acquainted, dare to compare)
Battling the Demons (fear, worry & anxiety,
depression & despair, uncertainty)
High (In)visibility (welcome cloak, hide)
The DMT Dance (decisions based on hope)
Holding Hands with Hope (defiant hope)
Taming the Beast (Finding my North Star, choosing
my A-Team)

Battling depression

Piecing Together the Puzzle (what’s happening?)
Taming the Beast (support from family, friends and
community)
The DMT Dance (hardyards: decisions based on
fear)
Battling the Demons (depression & despair, I’m
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never free, social isolation)
High (In)visibility (welcome cloak, hide)
The DMT Dance (hardyards: decisions based on
fear and hope)
Taming the Beast (Finding my North Star, choosing
my A-Team)
Recovering from depression Holding Hands with Hope (purposeful positivity,
and living well with RRMS

defiant hope, functional hope, searching for
meaning, harnessing a sense of humour)
The DMT Dance (hardyards: decisions based on
hope, switching to a better life)
Re(defining) Me now that I have RRMS (working
out work, balancing losses & gains)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my
North

Star,

maintaining

health

&

wellness,

choosing my A-Team)
High (In)visibility (welcome cloak, hide)
Well and relapse free on The DMT Dance (hardyards: decisions based on
natalizumab

hope, switching to a better life)
Taming the Beast (support from family, friends and
community, finding my North Star, resilience)
Holding Hands with Hope (purposeful positivity,
optimism)
Re(defining) Me now that I have RRMS (balancing
losses & gains, dare to compare, normalcy, working
out work)

Meeting

life

starting a family

partner

and Taming the Beast (support from family, friends and
community, finding my North Star)
Re(defining)

Me

now

that

I

have

RRMS

(normalcy, parenting with RRMS)
Holding Hands with Hope (purposeful positivity,
optimism, searching for meaning)
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Missed JCV blood test and The DMT Dance (decisions based on fear)
then a positive high titre
result-

immediately

cease

natalizumab
Battling the Demons (fear, worry & anxiety)
Taming the Beast (support from family, friends and
community, resilience)
Re(defining) Me now that I have RRMS (balancing
losses & gains)
Decision to start alemtuzumab

Taming the Beast (support from family, friends and
community)
The DMT Dance (the hardyards: decisions based on
hope)
Holding Hands with Hope (purposeful positivity,
optimism, restorative hope)

Living with RRMS, finding Taming the Beast (support from family, friends and
life balance

community, getting a handle on RRMS, finding my
North

Star,

maintaining

health

&

wellness,

choosing my A-Team)
Holding Hands with Hope (purposeful positivity,
optimism, curative hope)
Re(defining) Me now that I have RRMS (normalcy,
working out work, balancing losses and gains,
parenting with RRMS, disclosure)
High (In)visibility (welcome cloak, hide)

Griff feels that he has lived for many decades with RRMS, despite not being
diagnosed until his late forties. He recalls symptoms he covered up in his twenties
and thirties that indicate he may have been living with RRMS for much longer than
15 years. This situation gives Griff confidence to view the future as bright, knowing
he is (relatively) mildly physically disabled by RRMS after so many years of living
with the disease. However, there is a flip side to this scenario, one where this
confidence was severely impacted. This was discussed in Chapter 6, when Griff
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attended an MSA meeting and was confronted by the mother of a severely disabled
young lady with MS. To this day Griff often feels he isn’t as worthy as others to have
the diagnosis of RRMS. This is because he feels he doesn’t have the added suffering
and disability that more severe MS entails.
Table 8: Griff’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life

•

events and clues to resilience

Severe illness as a child and young adultmultiple

respiratory

conditions,

hospitalisations
•

Working in government agency

•

Death of parents

•

Several long term relationships

•

Marriage separation

Onset of first symptoms in Piecing Together the Puzzle (what’s happening?)
early twenties
High (In)visibility (welcome cloak)
Battling the Demons (fear, worry)
Intermittent

symptoms Piecing Together the Puzzle (what’s happening?)

continue for next 20 years on
and off
Battling the Demons (fear, worry)
Diagnosed with Guillian Barre Piecing Together the Puzzle (what’s happening,
12 years prior to RRMS tests, tests, tests)
diagnosis
Battling the Demons (fear, worry)
Surplus Suffering (misdiagnosis)
Personal relationship issues Battling the Demons (fear, worry)
with partner, separation
Holding Hands with Hope (purposeful positivity)
Relationship
through

strengthens Taming the Beast (support from family, friends and

separation,

back community)
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together, children
Holding Hands with Hope (purposeful positivity)
Severe relapse at work

Piecing Together the Puzzle (what’s happening,
tests, tests, tests)
Battling the Demons (fear, worry)

Confirmed

diagnosis

RRMS

of Piecing Together the Puzzle (the day my life
changed forever)
Re(defining) Me now that I have RRMS (getting
acquainted, disclosure, working out work)
Battling the Demons (fear of burden)
Holding Hands with Hope (purposeful positivity,
optimism)

Learning to live with RRMS

Re(defining) Me now that I have RRMS (getting
acquainted, dare to compare)
Battling the Demons (all fears, worry & anxiety,
saboteurs, social isolation)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on
hope)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my
North

Star,

maintaining

health

&

wellness,

choosing my A-Team)
Comparing self with friend Re(defining) Me now that I have RRMS (getting
with progressive MS

acquainted, dare to compare)
Battling the Demons (fear, worry & anxiety)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS)

Unemployment and role as High (In)visibility (strive to be visible)
“house husband”
Battling the Demons (fear, worry & anxiety,
saboteurs, uncertainty, social isolation)
Re(defining) Me now that I have RRMS (working
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out work, dare to compare, parenting with RRMS,
losses & gains)
Holding Hands with Hope (purposeful positivity,
optimism, searching for meaning)
Confrontation at MSL meeting Re(defining) Me now that I have RRMS (getting
with mother of a severely acquainted, dare to compare, parenting with RRMS,
disabled girl

normalcy)
Battling the Demons (fear, saboteurs, uncertainty,
social isolation)
Surplus Suffering (inflicted by community)
High (In)visibility (strive to be visible)

Sexual health dysfunction

Piecing Together the Puzzle (what’s happening?,
tests, tests, tests)
Re(defining) Me now that I have RRMS (losses &
gains, normalcy)
Battling the Demons (fear, worry & anxiety)

Struggling

with

glatiramer acetate

DMT The DMT Dance (hardyards: decisions based on
hope)
Battling the Demons (fear, worry & anxiety)
Re(defining) Me now that I have RRMS (losses &
gains)
Taming the Beast (getting a handle on RRMS,
finding my North Star, maintaining health &
wellness, choosing my A-Team)

Treatment
natalizumab

change

to Holding Hands with Hope (purposeful positivity,
defiant hope, restorative hope, functional hope)
The DMT Dance (switching to a better life)
Battling the Demons (worry)
Taming the Beast (support from family, friends and
community)

Struggling with severe fatigue Battling the Demons (fear of burden, worry,
/feeling a poor role model to despair, saboteurs, social isolation)
his children

347

Re(defining) Me now that I have RRMS (losses &
gains, parenting with RRMS, normalcy, dare to
compare)
Holding Hands with Hope (purposeful positivity)
Taming

the

Beast

(resilience,

North

Star,

maintaining health & wellness)
High (In)visibility (strive to be visible)
Thriving on natalizumab with Taming the Beast (support from family, friends and
social

interactions

hospital,

mentoring

at

the community)

others

with RRMS
Holding Hands with Hope (purposeful positivity,
optimism, giving back and being involved)
Re(defining) Me now that I have RRMS (balancing
losses & gains, negotiating normalcy)
The DMT Dance (hardyards: decisions based on
hope, switching to a better life)
Missed blood test for JCV, Battling the Demons (fear of burden, worry,
then high titre JCV blood test despair, saboteurs, uncertainty, social isolation)
positive - ceased natalizumab
immediately
The DMT Dance (hardyards: decisions based on
fear)
Re(defining) Me now that I have RRMS (dare to
compare, normalcy, losses & gains)
Taming the Beast (support from family, friends and
community,

maintaining

health

&

wellness,

resileince)
Commencing new treatment Holding Hands with Hope (optimism, restorative
fingolimod

and

refusing hope)

alemtuzumab
Taming the Beast (maintaining health & wellness,
North Star)
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The DMT Dance (hardyards: decisions based on
fear, switching to a better life)
Battling the Demons (uncertainty, social isolation)
Moving forward, living well Taming the Beast (maintaining health & wellness,
with RRMS

North Star, support from family, friends and
community, resilience)
Holding Hands with Hope (optimism, restorative
hope, searching for meaning, giving back & getting
involved)
Re(defining) Me now that I have RRMS (normalcy,
losses & gains)

The final life story presented in this section is Piper’s story, reflecting a shorter life
span living with RRMS than the previous three participants presented, but still an
abundance of applied themes and subthemes to her story. Piper’s life journey has
been marred by many years of Surplus Suffering due to constant brush-offs of her
symptoms by HCPs in her small rural community. However, her fierce determination
to not be defined by the disease and to live her best life possible is completely
overwhelming in intensity. Piper starts every day believing she is capable of Taming
the Beast and is constantly on the lookout to do so. Although disappointed by her
many years of struggle, she is in no way bitter about it, she still views many other
PwRRMS as going through worse scenarios and is grateful that she was eventually
diagnosed correctly.
Table 9: Piper’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life

•

Child of a migrant family

events and clues to resilience

•

Debilitating headaches and nerve pain as
an early teen through to adulthood

•
Onset of first symptoms

Small rural community upbringing

Piecing Together the Puzzle (what’s happening?)
High (In)visibility (strive to be visible)
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Surplus Suffering (brushed off)- repeated
Symptoms worsen- come and Piecing Together the Puzzle (what’s happening?)go over many years

repeated
Surplus Suffering (brushed off)- repeated
Piecing Together the Puzzle (tests, tests, tests)repeated
Battling the Demons (fear, worry & anxiety,
depression & despair)
High (In)visibility (strive to be visible)

Depression

Battling the Demons (depression)
Taming the Beast (support from family, friends and
community)
Surplus Suffering (brushed off)- repeated

Recovery from depression

Holding Hands with Hope (purposeful positivity)
Taming the Beast (support from family, friends and
community)

Infertility

Piecing Together the Puzzle (tests, tests, tests)
Taming the Beast (resilience)
Battling the Demons (fear, worry & anxiety)

Significant relapse with new Piecing Together the Puzzle (what’s happening,
symptoms

tests, tests, tests)
Taming the Beast (choosing my A-Team)
Battling the Demons (fear, worry & anxiety)
High (In)visibility (strive to be visible)

Confirmed
RRMS

diagnosis

of Piecing Together the Puzzle (the day my life
changed forever)
Re(defining) Me now that I have RRMS (getting
acquainted, normalcy)
Battling the Demons (fear of burden, worry &
anxiety, fear of the wheelchair)
Holding Hands with Hope (restorative hope,
purposeful positivity- searching for meaning)
The DMT Dance (hardyards: decisions based on
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hope)
Learning to live with RRMS

Re(defining) Me now that I have RRMS (dare to
compare, parenting with RRMS, normalcy)
Battling the Demons (fear, worry & anxiety,
despair, uncertainty)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on
hope)
Battling the Demons (fear of the wheelchair)
Taming the Beast (finding my North Star,
maintaining health & wellness, getting a handle,
resilience)

Sharing journey with family Re(defining) Me now that I have RRMS (getting
and friends

acquainted, normalcy, dare to compare)
Taming the Beast (support from family, friends and
community, getting a handle)
Battling the Demons (fear)

Side

effects

from

DMT Piecing Together the Puzzle (what’s happening?)

interferon
Holding Hands with Hope (defiant hope, functional
hope, search for meaning)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on
fear and hope)
Commence

new

DMT The DMT Dance (switching to a better life)

dimethyl fumarate
Re(defining) Me now that I have RRMS (getting
acquainted)
Battling the Demons (all fears, worry & anxiety,
saboteurs)
First travel overseas

Holding Hands with Hope (purposeful positivity,
defiant hope, search for meaning)
Taming the Beast (support from family, friends and
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community, finding my North Star)
High (In)visibility (a welcome cloak)
New relapse

Piecing Together the Puzzle (what’s happening?)
Battling the Demons (fear, worry & anxiety,
saboteurs)
Re(defining) Me now that I have RRMS (normalcy)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my
North

Star,

maintaining

health

&

wellness,

choosing my A-Team)
Living with RRMS

High (In)visibility (strive to be visible)
Holding Hands with Hope (purposeful positivity,
defiant hope, search for meaning, sense of humour)
Taming the Beast (support from family, friends and
community, maintaining health & wellness )
Re(defining) Me now that I have RRMS (dare to
compare, normalcy, parenting with RRMS, losses
& gains)

Sister

has

a

neurological Battling the Demons (fear, worry & anxiety,

episode

saboteurs)
Taming the Beast (support from family, friends and
community)
Holding Hands with Hope (purposeful positivity)

Relapse at Christmas

Re(defining) Me now that I have RRMS (balancing
losses & gains, parenting with RRMS)
The DMT Dance (hardyards: decisions based on
fear)
Taming the Beast (getting a handle, support from
family, friends & community, resilience)
Battling the Demons (fear of being a burden)
Holding Hands with Hope (purposeful positivity,
functional hope, restorative hope)

Moving forward with RRMS

Taming the Beast (support from family, friends and
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community,

maintaining

health

&

wellness,

resilience)
Holding Hands with Hope (purposeful positivity,
optimism, giving back and getting involved)
Re(defining) Me now that I have RRMS (getting
acquainted, parenting with RRMS, normalcy)
As noted life history author Plummer (2001, p.7) reflects “life is in fluctual praxis,
always in flow and ever messy.” As I began the task of linking each individual’s life
events with the themes and subthemes, the process, although “messy”, felt incredibly
straightforward despite being very time consuming. This process flowed organically
and seemed to fit together very neatly, participant after participant as I worked
manually through each transcript. I was surprised at first at the ease in which the
themes and life events all fit together so well. I then realised that this organic flow
was demonstrating to me that the themes fit back with the data well, and that this was
a reflection of good coding and theme development. As Braun and Clarke (2013)
suggest, to be able to invoke the original data just by reading the code or theme is the
result of capturing the both latent and salient features well, and is a fundamental aim
of the coding process. The further inclusion of specific subthemes within each theme
category in the life trajectory tables gave the added ability to “drill down” even
further into each theme, to identify a feature of the theme that was more descriptive
of the life event, but still fell under the same central organising concept of the
overarching theme.
Life history gives voice to the ordinary members of a culture as they cope on a daily
basis with the joys and challenges of life (de Chesnay & Fisher, 2014), and was
embraced and welcomed by every participant in the current study. The use of
focused ethnographic life history methodology worked cleverly with the ebbs and
flows of living with a chronic illness such as RRMS to reveal themes and subthemes
exploring the lived experience of RRMS. As RRMS is most commonly diagnosed in
young adults and is usually not life threatening (Compston & Coles, 2008), it
represents a long period of time to live with a chronic illness. Hopes, dreams, school,
study, sport, work, relationships, marriages, pregnancies, children, friends,
relationship breakdowns, grieving, set-backs, loss, pride, happiness, contentment;
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these are some of life’s typical challenges and joys, occurring with or without the
presence of RRMS. Using the life history approach generated rich and detailed data
about the experiences of living with RRMS and unearthed some extraordinary
insights, which have been outlined throughout the study findings chapters and will be
given deep clinical relevance in the following, concluding chapter.
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CHAPTER 9 - CONCLUSIONS AND RECOMMENDATIONS
FOR PRACTICE

The final chapter of this thesis will re-examine the aims and findings of the research
study and discuss how the research question is answered by attributing meaning and
understanding to the lived experience of RRMS. This chapter will also link the study
findings

to

recommendations

for

MS

clinical

practice.

These

clinical

recommendations will concentrate particularly on MS nursing care, however, they
will also be applicable in varying ways for all HCPs involved in the management of
MS.

Introduction
This research study posed the question “What is the experience of living with
RRMS?”. The aim of this research study was to explore the experiences of people
living with RRMS, in order to gain insights and understanding of the lived
experience. It is anticipated greater understanding will positively impact on the care
provided by MS Nurses in particular, but also for all MS HCPs in general. The
purpose of these insights and understandings is to be able to provide improved
clinical care, to offer patient-centred support in patient-focused areas, and to
ultimately improve the quality of life and nursing care for PwRRMS. This life
history study revealed the meaning of the lived experience of 13 people as they met
the daily challenges and joys of life, living with RRMS. This understanding of their
lived experience was accomplished initially by co-creating a life history, through the
telling and ordering of the life history by the participant to me as the researcher, and
further co-created by my questions and reactions as this interview took place.
Mishler (1995, p.90) suggests this model of narrative analysis is “reconstructing the
told from the telling” and highlights the active role of the researcher in this process.
Importantly, the co-construction of the data also supported the epistemological basis
of the study, a constructivist approach, where the participant and research co-create
knowledge together.
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The second part of the research process centred on revealing meaning in my
interpretation and ordering of the life history into a life story, and the subsequent
development of themes and subthemes to reflect this meaning. A third step in the
process will occur, and is indeed occurring now, as readers of this thesis and future
journal articles, and the listeners of future presentations and workshops, will develop
further meaning from the stories and themes as they are presented.
Alongside these meanings, the study participants also reported a deeper
understanding of themselves throughout the process. The act of reflecting on their
lives allowed both introspection and benefit finding. Throughout all phases of the
research, I too, deepened my understanding of not just PwRRMS, but also of myself
as an MS Nurse, a mother, a wife, a friend, a patient and a carer.
Throughout the research process, new meaning constantly evolved as the participants
merged their experiences of RRMS between the past and the present, often moving
backwards and forwards through the life history. Although at times recalling their
life history could be uncomfortable or distressing, all study participants concluded
their life history interview interpreting their experiences with RRMS in a mostly
positive light. This constantly amazed me; mainly because many of the participants
had suffered significant hardship during their life with RRMS, however they
constantly moved adversity aside to bring in positivity and end on an optimistic note.
There was a real sense of moving RRMS into the background of life and keeping
positivity, hope, family, friends, health and wellness in the foreground. This was
mostly achieved by employing the elements of one of the major study themes,
Taming the Beast. The elements identified in the study findings included finding my
North Star, getting a handle on RRMS symptoms and relapses, maintaining physical
and mental health and wellness, choosing my medical A-Team, harnessing support
from family, friends, organisations and workplaces and riding high on resilience. For
the study participants, these components all added up to one overwhelming factorregaining as much control as possible over a disease with no cure, no predictability
and no certainty. It was all about finding ways to once again be in charge of their
life after their diagnosis of RRMS.
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However, as Chapter 8 explored, this is not always a “done deal” or something that
automatically happens once a checklist is completed or a DMT is commenced. Any
number of negative experiences could threaten to take away the gains made by the
PwRRMS, at any stage and at any time in the life journey. These were the forces
explored in Battling the Demons; dealing with fear of disability and fear of losing
mobility and becoming dependant on a wheelchair, fear of DMTs and potentially life
threatening side effects, and living with the constant fear of relapse. Living with this
fear presented, in some participants, as sheer terror, especially when thinking about
the possibility of using a wheelchair in the future. However, although initially fearful
of the consequences of RRMS, others who previously thought they would be unable
to cope with physical disability adapted over time and came to respect and appreciate
the advantages that a walking stick or wheelchair gave them, especially during a
severe relapse. But the road to this point could be frequently fraught with high
emotion.
Participants in the study also highlighted a “push/pull” relationship with their RRMS,
part of them did not want to see what RRMS could develop into (as SPMS) in years
to come and deliberately avoided gatherings such as MSA meetings and education
seminars where it was expected to meet others living with MS. However, they would
find themselves engaging in internet searches and reading to find out more
information about what progression might look like. The main difference was they
could do this in the privacy and safety of their own home. A slightly different
variation on this push/pull relationship was the scenario of a PwRRMS attending an
MSA meeting (often with people living with progressive MS) in order to prove to
themselves that their RRMS was “better”, or that their MS was going to be different
to that lived by others with the disease. These examples of the push/pull relationship
reveal the PwRRMS once again trying to regain some control over the disease, of
being “in charge” and wanting to look at the future, but in small doses that they
could attempt to control. Being aware of the intracies of this “push-pull” relationship
could help MS Nurses and other HCPs in assisting adjustment to the diagnosis of
RRMS and in times of relapse, disease progression, symptom change or other life
events impacting on RRMS.
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I believe that one of the most shocking revelations of the current study findings was
the abundance of Surplus Suffering for many PwRRMS. This suffering over and
above that caused by living with RRMS, was frequently caused by HCPs, and mostly
(and hopefully) unknowingly. Unequal power relationships between doctors and
patients led to many of the scenarios described by study participants, scenarios which
could have been easily diffused if the doctor had taken the time to explain things
more carefully and to realise the impact of a diagnosis of RRMS on a person. It has
been suggested from previous research that the day of diagnosis for a PwMS is a day
they remember clearly with very strong memories (Solari et al., 2007), for many
study participants these memories and feelings came flooding back in great detail
during our interview. Surplus Suffering was often caused by HCPs brushing off
PwRRMS. This sense of being brushed off stemmed from not understanding the
symptoms, not believing the symptoms existed, relying too heavily on previous
patient assessments or simply not being aware of RRMS and the need to quickly
refer on for treatment early in the disease process because this leads to the best
clinical outcomes (Giovannoni et al., 2016).
Understanding what has led to Surplus Suffering is key to unravelling the causes.
Other specialities have reported difficulties and stress in nurses looking after diseases
which are incurable or unpredictable, such as in cancer (Corner, 2002; Lange, Thom,
& Kline, 2008) and myeloma (Cormican & Dowling, 2016), an area which is inderresearched in MS care. The area of Surplus Suffering in MS deserves further
exploration to try and understand why it is occurring in the first place; understanding
the underlying causes of Surplus Suffering is the only way it can be prevented in the
future, rather than simply managed by nurses and other HCPs.
The invisibility of many common symptoms of RRMS had some interesting flow-on
effects for those living with the disease. For some, invisibility was seen as a welcome
component of the diagnosis, the fact that others could not always see the symptoms
and know the diagnosis gave a positive slant to the disease. These participants felt
this invisibility allowed them to avoid the stigma of a chronic and poorly understood
illness. For others, they desperately wanted their condition to be seen, they wanted to
“out” the invisible symptoms and earn understanding from others as to how difficult
and challenging it is to live with debilitating symptoms which were difficult to
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explain to others. These symptoms in particular were fatigue, cognition issues and
the “hushed one”, sexual dysfunction. Interestingly, these invisible symptoms are
also amongst the most difficult to effectively treat, further compounding their
invisibility. For MS Nurses and other HCPs, being aware of the challenges of
verbalising and discussing these symptoms in an important step forward to guiding
patients to negotiate MS jargon and language in a way that helps them explain the
complexities and difficulties of these invisible and difficult to describe symptoms.
Although the role of Piecing Together the Puzzle began the sequence of themes in
the findings, this concept actually lasts a lifetime of living with RRMS. Due to the
unpredictability of the next relapse (in terms of the exact area of demyelination in the
CNS), RRMS can be a constantly surprising disease to live with. Often each new
relapse brings a host of new symptoms. Building experience to learn exactly what a
new relapse is often proves difficult, as one relapse may involve visual symptoms
and the next motor weakness and the next a bout of severe fatigue or cognitive
difficulty. It is all unpredictable. Thus, life is a constant act of defining and
(re)defining self as RRMS changes and morphs. Comparing oneself against others
can also be difficult as every case of RRMS is different, however this also gives the
PwRRMS an advantage, a chance to define, or (re)define themselves.
On the other hand, completing the study themes with Holding Hands with Hope,
exploring the different types of hope and purposeful positivity, doesn’t mean that the
life journey ends neatly there either. Life with RRMS is constantly in flux and
although the role of hope will always weave into the RRMS life in some way, it will
be more present at certain times and it will be harder to find at others. As a disease
with no current cure, hope represents an integral part of the “toolkit of living well
with RRMS” of both the MS Nurse and the PwRRMS.

Summary of the key findings and recommendations for clinical practice
This study set out to explore and capture a rich, thick and comprehensive
examination of diverse experiences of living with RRMS. Using focused
ethnography and a life history approach, the study gained insight into many key areas
of living with this unpredictable autoimmune, neurological disease over the life
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trajectory. This knowledge, partly supporting previous research further and partly
innovative, develops the body of literature that is available to enhance nursing
practice in MS care.
Several previous studies (Beshears, 2010; Clair, 2003; Courts et al., 2006; Miller,
1997) were identified in Chapter 3 as being the most similar in terms of study aims to
the current study, exploring the lived experience of MS. However, only Miller
(1997) and Beshears (2010) specifically stated that their research involved only
PwRRMS, not PwMS in general. Examples of themes, subthemes and subsubthemes from the current study supporting the previous literature identified in
chapter 3 include: harnessing social support, concepts of hope and hopelessness,
getting acquainted with RRMS, conflict with HCPs, facing fears, coping with
uncertainty and disclosure (Miller, 1997; Beshears, 2010); concepts of MS as an
adversary and of a saviour (Clair, 2003); concepts of brush-off, symptom
devastation, regaining control and self advocacy (Courts et la; 2004) and feelings of
living with uncertainty and RRMS always being in the backdrop of life (Beshears,
2010).
There are subtle elements of previous qualitative studies in all of the current study
themes, some stronger than others. For example, themes such as MS as an adversary
(inspiring to overcome obstacles) (Clair, 2003) are not semantically linked to the
current study, but may integrate more latently with the themes of purposeful
positivity and searching for meaning. Other themes such as getting acquainted with
MS in the current study explore the difficulties in navigating communication and
information resources, representative of changing times and new outlooks, as we
learn more about the disease process, symptom management and treatments.
Information access has become easier for patients in recent times with the internet,
but more challenging in terms of understanding the content and which information is
accurate and secure. Although a different process nowadays, these current themes
integrate back to Miller’s (1997) earlier themes of getting to know MS and the
importance of correct information, locating appropriate resources and observing
others with MS.
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There are many novel findings from the current study findings. The most significant
of these include Surplus Suffering (novel to reporting in RRMS), the push/pull
relationship with comparing to others with RRMS, finding my North Star, choosing
my medical A-Team, feeling a pretender to the throne (involving elements of reverse
stigma), the welcome cloak of invisibility, giving back and getting involved and The
DMT Dance - the hardyards: decisions based on fear and decisions based on hope.
The new study findings provide the opportunity for review of current MS nursing
practices and also the opportunity to make changes based on the new knowledge.
These new findings will be woven throughout the clinical recommendations to
follow.
In addition to the thematic findings outlined in Chapters 6, 7 and 8, there are
numerous clinical practice recommendations that have been developed from the
study findings. I have kept these clinical practice recommendations linked to the
theme they pertain to, for consistency in the story and for clarity of the context of the
recommendation. Although applicable and practical for all HCPs involved in MS or
chronic illness care, these recommendations particularly honour the unique role of
nursing and support patient focused nursing care of the PwRRMS.

Piecing Together the Puzzle
•

During the investigative phase for a diagnosis of RRMS, there may be
important points at which HCP intervention can assist each patient
considerably. Consideration should be made to providing information for the
patient detailing the multiple diagnostic tests, the reasons why they are
necessary and a discussion about the difficulties and intricacies in an MS
diagnosis. Consider support from MSA during the pre-diagnostic period if
MS is strongly suspected and it is appropriate and sought by the patient.

•

MS Nurses should take particular note of the past experiences and HCP
encounters that PwRRMS bring to their initial appointments and be mindful
that the path to the MS Clinic/Neurologist may not have been an easy one.
There may have been much suffering in the years prior, undiagnosed or
diagnosed as RRMS; being ignored by HCPs, having symptoms dismissed or
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trivialised and some made to feel like they “are going mad”. The MS Nurse
can discuss with PwRRMS how they came to be diagnosed and goals for the
path forward to build their confidence and trust. Asking about prior
experiences in healthcare and what their expectations are of RRMS care can
enable effective communication and goal setting for the future, and a
mutually acceptable, and achievable, nursing care plan.

•

The day of diagnosis is vividly remembered by many PwRRMS. Often HCPs
can be distracted, tired and busy managing multiple patients and situations at
the one time in a clinical setting. It is vital to be aware of just how influential
the day of diagnosis is for the PwRRMS and the considerable impact
kindness and compassion at this time can have on the life journey ahead. The
involvement of an MS Nurse at the time of diagnosis delivery would be an
optimal situation.

•

MS Nurses are in an ideal position to implement the need for flexibility,
repetition, time and understanding when delivering a diagnosis of RRMS.
The approach should be tailored to individual patients in a format that is
straightforward for them to understand. The involvement of families and
significant others can also assist engagement with information and improve
communication within the family and significant other networks.

(Re)Defining Me Now That I have RRMS
•

Individual education and information needs at the time of diagnosis for
PwRRMS differ greatly. MS Nurses should personalise disease education and
information at a time when the PwRRMS is ready to accept the information,
taking into account their preferred method of learning and also including
family members or friends (where this is desired by the PwRRMS).

•

Early referrals should be made for psychological assistance when the
PwRRMS seems to be struggling with adjusting to the diagnosis and
maintaining a positive sense of self. This should also be revisited regularly at
routine clinic visits, even when things appear to be going well from a clinical
point of view.
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•

MS Nurses can share with the PwRRMS the perspective that “time can be
their friend”, and that many people dealing with similar issues after an RRMS
diagnosis, do adjust successfully in time. Discuss openly with PwRRMS the
particular challenges of dealing with the unpredictability and uncertainty of
the disease and how challenging this can be. Discuss the value of maintaining
a positive attitude and investing in skills which promote personal coping.
These include resources such as managing stress, faith and spirituality, and
cultivating optimism.

•

MS Nurses are ideally positioned to enquire as to which MS symptoms are
affecting a PwRRMS’s life to the greatest extent, and thereby potentially
threatening identity, at any given time. These symptoms may be different to
the symptoms HCPs pay the most attention to, but may be impacting the
patient’s QOL significantly. Care should be taken to provide advice for these
symptoms in order to safeguard mental health and wellbeing.

•

MS Nurses can skilfully provide information on the benefits and the
disadvantages regarding disease disclosure in the workplace. Employment,
and maintaining employment, provides a sense of personal fulfilment,
socialisation and empowerment to many PwRRMS. Such discussions should
be highly individualised and take into account personal needs as well as the
workplace environment. Referral to an Occupational Therapist skilled in
workplace adjustments may be helpful. Adjustments can enable work to
continue to be an important part of life and socialisation for the PwRRMS.

•

MS Nurses can enhance awareness of the significant impact of RRMS on
parenting; the joys and the challenges, and offer support and guidance to the
PwRRMS. This concept should be revisited regularly over the course of the
disease, and particularly with events such as relapse or disease progression,
which could present new challenges to parenting with RRMS at different
stages of the family life trajectory.

•
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Battling the Demons
•

MS Nurses are ideally positioned to ask about childhood illnesses and life
challenges at the beginning of the RRMS journey. Look for clues about prior
displays of resilience, which may be helpful the PwRRMS in their current
battle. This will also provide information for the MS Nurse to assess coping
styles and the need for psychological referrals. It is also beneficial to build
confidence for the PwRRMS on their journey, reminding them of their
strengths and what they are capable of overcoming.

•

Signs of depression and anxiety need to be assessed for and addressed early,
and often. As depression and anxiety both strongly correlate with a lower
quality of life, it is important for MS Nurses to recognise anxiety and make
appropriate referrals early on. Similarly, accessing social support can reduce
anxiety and the need for this should be regularly assessed. Anxious patients
may also have distorted perceptions of the availability of support, so gentle
guidance from the MS Nurse may also be required. Social support systems
also assist with managing depression.

•

It is important for MS Nurses to understand that the uncertainty of RRMS can
be a source of concern, regardless of the individual’s degree of symptoms or
stage of RRMS. During clinical appointments, emotional well-being can
often be overlooked by more pressing physical symptoms, discussions on
DMTs, MRI results and medication side effects. MS Nurses and HCPs need
to ensure emotional well-being is assessed thoroughly at every routine clinic
visit. Emotional illness can be just as fatal as physical/DMT issues, just
sometimes much quieter.

•

It is vital for MS Nurses to be aware of “fear points” on the RRMS life
journey where even the most seemingly well-adjusted PwRRMS may
experience upheaval and require assistance to navigate the life journey. These
fear points include times of relapse, reports of MRI progression, new
symptom onset, pregnancy, change to personal circumstances, loss or change
in employment, DMT medication change or DMT risk factor change.
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•

MS Nurses are ideally positioned to assess for the possibility of PTSD in all
PwRRMS, and be familiar with possible signs of PTSD such as nightmares,
flashbacks, emotional detachment and avoidance of social situations. If signs
of PTSD are identified, urgent referral to a psychologist/psychiatrist is
indicated.

Surplus Suffering
•

The MS Nurse is perfectly positioned to lead the MS health care team by
example, practicing holistic care, empathetic nursing, “turning toward” and
demonstrating compassion. MS Nurses can also support and educate the
loved ones, work colleagues and friends of PwRRMS regarding appropriate
resources to help them partner with the PwRRMS on their life journey.

•

Patients undergoing testing or assessment for RRMS should be treated with
dignity, respect and recognised as a holistic human being in a unique and
challenging context, rather than a diagnosis or potential diagnosis. An extra
minute or two, an opportunity for questions, a gesture, eye contact and nods
of understanding can significantly influence a health care encounter and can
go a long way to providing a positive experience, despite what the eventual
diagnosis and prognosis might be.

•

A new patient under care, no matter what stage of the RRMS journey they are
at or how many years they have been diagnosed with RRMS, may benefit
from a frank discussion on their previous healthcare and any issues that may
have come up in the past. This can provide opportunities for discussion about
past encounters with HCPs but also provides an opportunity to discuss
current expectations. Goals for future RRMS care to improve care
effectiveness and HCP relationships can also be discussed.

•

Every patient is an expert in his/her own body and feelings. Acknowledging
this and using the patient’s knowledge is an important part of individualised
and holistic care. Connecting with, engaging with, and preserving the dignity
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of patients as human beings are fundamental not just to MS nursing care, but
and to all HCPs caring for PwMS.

•

A critical function of the MS Nurse is to lend strength, until the PwRRMS
recovers their own. Not taking over, not racing ahead, not leaving behind.
Lending

strength

can

be

conceptualised

as

nurses

providing

information/education, guidance, emotional support and advice. This is also a
key function of all MS HCPs in the healthcare team and MS support
organisations in the community.
High (In)Visibility
•

MS Nurses provide education and guidance for PwRRMS suffering invisible
symptoms about specific symptom management. Open discussion from an
early stage of the MS life journey on the high probability of invisible
symptoms (at least at some stage of the disease) can facilitate honest and
frank conversations in the future and possibly earlier detection and treatment
if and when they do arise. This will also assist PwRRMS to understand the
reasons and challenges behind invisible symptoms and how symptoms can be
treated and managed, thereby aiding confidence and self-efficacy.

•

Discussion of invisible symptoms should be a regular part of MS
consultations from the outset of the MS life journey so that the PwRRMS will
feel more comfortable discussing the more socially taboo subjects, such as
sexual health issues, cognition and bowel and bladder issues, if and when
they do arise. Early detection and treatment is key.

•

MS Nurses can provide guidance on managing invisible symptoms with
family, friends and work colleagues, and advise the PwRRMS how to explain
invisible symptoms to others and how to ask for support. Educational
materials can also be supplied to assist in discussions and adaptations that
may be needed. If the PwRRMS feels secure in understanding their own
invisible symptoms, they will be more confident explaining to others.
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Taming the Beast
•

To feel comfortable with an MS Nurse or other HCP, to be provided with
individualised information/education, to have confidence in their RRMS
management and to understand treatment plans and goals are all important
factors to consider for PwRRMS. MS Nurses in particular can encourage
PwRRMS to develop a supportive MS care team around them which meets
their individual needs – choosing my A-Team. MS Nurses should be
particularly mindful of PwRRMS living in isolated situations or rural
communities, facilitating effective communication with local health care
teams and to have plans in place in the event of relapse or other crisis.

•

Asking for help from others can be difficult for many PwRRMS. MS Nurses
are in an excellent position to provide guidance and advice for PwRRMS on
how to ask families, friends and organisations for assistance and to pinpoint
times when they may need special help, such as during a relapse, for the
duration of post partum care and during times of co-morbid illness.

•

MS Nurses can help build and enhance resilience in PwRRMS by providing
reflections and narratives on how other PwRRMS have managed similar
problems and moved forward. By being aware of strategies to enhance
resilience and encouraging these strategies in PwRRMS, MS Nurses and
HCPs can assist in confidence building and later overcoming difficulties
during the life trajectory with RRMS. The issue of resilience should be
assessed and discussed regularly and skills continually enhanced.

•

MS Nurses can assist families and friends of the PwRRMS to understand the
challenging nature of the disease, the invisible symptoms and the difficulties
that the PwRRMS may experience. MS Nurses in particular can provide
guidance and support as the loved ones of PwRRMS also come to terms with
what RRMS means and the many ways that they can help on the life journey.
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The DMT Dance
•

MS Nurses need to develop effective tools to improve communication and
support for PwRRMS in learning more about the disease and the specific role
of DMTs within their disease management. Being educated and engaged will
encourage active participation in DMT decision-making and help PwRRMS
to become more effective self-advocates.

•

There is no cure or one size fits all approach for treatment in RRMS.
Sometimes DMTs need to be trialled to assess their effectiveness and
compatibility on a PwRRMS. As perceived lack of efficacy can be an
important barrier against medication adherence, MS Nurses are ideally suited
to ensure PwRRMS have realistic expectations from their prescribed DMT
and also provide written information, which can be referred to at anytime.

•

Adherence to treatment regimes is essential to ensure PwRRMS receive the
maximum benefit from their treatment and also to ensure that the treatment is
cost-effective. Adherence to the DMT plan should be assessed at every MS
Nurse encounter, whether in the clinic or by text, internet based consultation,
phone or email.

•

PwRRMS should be informed of DMT options, the potential benefits and
risks of each treatment and the importance of adherence, using an approach
which suits their style of learning and their level of health literacy. Allowing
an active role for PwRRMS in treatment decisions may also give a sense of
empowerment and provide motivation to continue DMT when things don’t go
according to plan.

•

MS Nurses can provide guidance and support for PwRRMS to build their
own support network to assist with adherence. This can take the form of
education regarding the possible avenues of company support with the chosen
DMT, the importance of the support of family and friends, or by providing
information on how to access clinic, local medical and community support.
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Holding Hands with Hope
•

Hope is never static; it is always dynamic and changing form, requiring
constant supervision by the MS Nurse during the entire life journey with
RRMS.

•

Being at the forefront of care in RRMS, the MS Nurse is in a unique position
of trust to be able to observe and assess all aspects of emotional and spiritual
health. The MS Nurse can inspire, demonstrate, nurture, coach, educate about
and sustain of forms of hope for the PwRRMS.

•

Tools for the MS Nurse to inspire and sustain hope include regular hope
assessments, education, storytelling, advocacy, counselling and referrals
where necessary. Educating the PwRRMS about the importance of
maintaining optimism, a positive outlook, searching for constructive
meaning, maintaining a sense of humour, considering faith and spirituality,
where appropriate, and possible avenues to “give back” and be involved in
the MS community. These are examples of purposeful positivity, an
important component of the MS Nurse role.

•

MS Nurses build particularly strong therapeutic relationships with their
patients, often built on respect, caring, empathy, invested time and their
strong knowledge base. Being a symbol of hope is also an important part of
this relationship, leading by example and inspiring hope by living with hope
and positivity themselves. This requires self awareness, insight and self-care
by the MS Nurse. Living hope teaches hope.

Limitations of the study
There are some limitations to this research study. As a qualitative study this data
draws on a relatively small number of participants, however the information rich
informants gave the study powerful information. Additionally, the study was
confined to participants living in the state of NSW, Australia and the themes may not
be transferable to other geographic regions and countries.
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My role as an MS Nurse in clinical practice invariably influenced the data
interpretations in the study. I did my best to disclose and to be acutely aware of these
possible influences, not just during the interviews but also at all stages of the data
analysis process. However, despite these safeguards, it is likely that my MS Nurse
role has influenced the research findings in some way and may in fact have brought
greater depth to the study.

Directions for future research
This life history study has explored the lived experience of RRMS in the state of
NSW, Australia. Further research is required to explore the experiences of PwRRMS
in other contexts, in other regions, in other countries. Many previous studies have
purposively or inadvertently enrolled mainly women in their research, and the lived
experience of men with RRMS is also grossly under-researched and requires further
attention. Additionally, similar research to the current study needs to be performed in
currently overlooked areas of living with RRMS - in both children/adolescents and in
the aged population living with RRMS, interestingly both ends of the life trajectory.
There also exists little research on the lived experiences of carers of PwRRMS and
also on the lived experience of MS Nurses other MS HCPs.
Surplus Suffering in RRMS care emerged as a key, novel finding for this particular
population and would be the ideal concept to form the basis of further research work
in RRMS. Not just in recognising and managing Surplus Suffering, but in truly
understanding the underlying causes of the phenomena. Additionally, the concepts of
parenting with RRMS, comparisons with others with MS, invisibility as a welcome
cloak, harnessing resilience, the experiences of reverse stigma, worry and fear in
RRMS all warrant further exploration to better understand their basis and their
direction. Moreover, all aspects of hope and purposeful positivity could be examined
in further detail for further support and evidence on how the MS Nurse can best
assist and promote this important function.
This thesis explores and discusses how PwRRMS are active in Taming the Beast, but
just as importantly, the study highlights the importance of Holding Hands with Hope.
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In a time of great scientific and biomedical progress into RRMS, this situation
requires careful observation and monitoring so that knowledge of the patient
experience does not get left behind the rapidly changing and expanding medical
knowledge.

The life history method, the study findings and me
As a researcher, choosing the life history method proved to be an absolute privilege
for me, gaining so much more from the data than I had ever dared imagine. The
depth of emotions and information the participants shared with me still profoundly
affects me. I feel eternally grateful to the study participants for sharing their deepest
despair and their most rising joy, and amongst it all telling me about all of the other
facets of life that we so rarely have time to ask about in the roles of MS Nurse and
patient. It was these facets of life that ultimately helped me build up a picture of
hope, resilience and overcoming adversity that I had never really thought too much
about. My previous understanding was generated by the perspective of a perpetually
exhausted, task-orientated, problem solving MS Nurse. Perhaps I was a little
frightened to ask more questions because it might just open a “Pandora’s box” that
we didn’t have time to explore in a time-limited and already rushed clinical
appointment.
The life history methodology gave the study much more emotion and insight than
would have been achieved by simply asking pre-determined interview questions in a
structured format, or by presenting the participants with a survey or questionnaire of
things that I felt were important. Instead, life histories flowed naturally for the study
participants, forming stories and presenting a wide range of themes. These were
stories that sometimes broke my heart, and sometimes healed it, but always affected
my heart and understanding in some way.
Within a life trajectory it is possible to identify critical life events working through
central life themes such as love, work and play (Plummer, 2001). For PwRRMS,
these components make up their daily life living with the disease and how they get
through them, survive and thrive is what we, as MS Nurses and MS HCPs need to
understand more about in order to provide optimal care and education. It is not just
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about the exact moment of the person living with RRMS sitting in a consultation.
Patients cope and live with a lifetime of experiences which could ultimately be
affecting the present. Whilst it is impossible to assemble a life history for every
patient, it is possible to ask the right questions to bring together important details
which may affect current and future consultations, and have a significant impact on
their life journey with RRMS.
This thesis explored the experiences of 13 people living with RRMS, and has
outlined important areas of reflection for MS Nurses and provided recommendations
for clinical MS nursing care. The reason for this is to generate insights of the lived
experience of PwRRMS so that nurses have a deeper understanding of the RRMS
experience in order to plan nursing care accordingly. A critical role of the MS Nurse
is to lend strength whilst we repair and support Piecing Together the Puzzle, we
guide (Re)defining self, we assess, act and refer on when Battling the Demons, we
repair and prevent Surplus Suffering, we advocate for High (In)Visibility, we teach
skills in Taming the Beast, we educate and monitor The DMT Dance, we
acknowledge and inspire Holding Hands with Hope. In short, we, as MS Nurses, act
in the capacity of strength for our patients through the life journey of RRMS. From
Eric Cassell (2004, p.43):
“Recovery from suffering often involves borrowing the strength of others as though
persons who have lost parts of themselves can be sustained by the personhood of
others until their own recovers”.
As MS Nurses, we lend strength so very well. My hope is that through the new
knowledge gained into the life journey of RRMS in the current study, and by
generating future research, we can enhance and build upon this even further.
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Appendix 1 HREC correspondence
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Therese Burke
69 Grove St Lilyfield 2040 NSW

22

nd

February 2016

Dr Natalie Giles
Research Ethics Officer
Research Office
The University of Notre Dame Australia
Fremantle Campus
Dear Natalie,
Reference Number: 016002S
Project Title: “What is the experience of living with RRMS?”

The table below outlines the conditions/issues raised by the HREC and the researcher's
response summary, including the location of the required amendment in the full application.
Condition / Issue Raised

Researcher Response

Storage plans for data

A copy of the data collected will be stored in the School of

collected

Nursing, Darlinghurst Campus, to comply with university policy:

during

the

research

Code of conduct for research. This is now amended in the
original submission section 6.2b and 6.2c and a copy of the
electronic form with this addition clearly marked is attached.

Addition of UNDA logo to

The UNDA logo has been added and the subject recruitment

subject

advertisement/flyer is now known as version 2, dated 22

recruitment

advertisement/flyer

nd

February 2016. The new advertisement is attached.

I hope this addresses the concerns raised by the HREC. I look forward to hearing from you.
Yours sincerely,
Therese Burke (Student)
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Appendix 2: Recruitment flyer

ARE YOU LIVING WITH RELAPSING REMITTING MULTIPLE
SCLEROSIS?
A research study is being undertaken to explore the life experiences of
people living with Relapsing Remitting Multiple Sclerosis (RRMS). To be
eligible for inclusion in this study, you need to meet the following
criteria:
! to have been diagnosed with RRMS
! aged 18 years or over
! be able to read and understand English
! be able to walk unassisted
! To be available for an individual interview with the researcher at
a mutually agreed location in Sydney

If you are interested in finding out more information, please
contact the Principal Researcher, Therese Burke, by mobile
telephone on 0412 365 667 or by email on
therese.burke2@my.nd.edu.au

There is no obligation to participate in the research by making an
enquiry.
This research study has been approved by the Human Research Ethics
Committee of the University of Notre Dame, Australia.
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Appendix 3: Reflection questions
Reflection questions prior to interview
These are some reflection questions you might like to think about before the
interview, to help organise your thoughts and give you an opportunity to give
consideration to important things or personal events of significance that may have
happened in your life.
What have been the major events in your life so far?
What have been the major turning points in your life?
In what ways has the diagnosis of relapsing remitting multiple sclerosis (RRMS)
changed or altered your life plan/s?
When were you first diagnosed with RRMS and what was happening in your life at
that time?
What symptoms did you have leading up to the diagnosis of RRMS?
How did you feel waiting for the diagnosis?
How did you feel when the diagnosis was confirmed?
What effect have the relapses had on your life?
Has RRMS affected your relationships, and if so, who with, and in what ways?
Has RRMS affected your work life or employment, and if so, in what ways?
How have the new medications to treat RRMS impacted on your life?
What impact has RRMS had on your life generally?
What other health issues have you experienced and what impact have they had on
your life?
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Appendix 4:Safety checklist
Safety checklist prior to participant interviews
HDR project TB/ “What is the experience of living with RRMS?”
Where possible, perform the interview during the day.
Information on name, address and contact number of the participant should be
provided to the nominated Supervisor on the day of the interview (TM or JP
depending on their lecturing schedule).
Have Supervisor numbers pre-programmed into mobile phone, as well as emergency
number (000) and ensure the phone is charged and in working order for every
interview.
Phone questions PRIOR to interview to assess safety risks:
Are the premises a unit, house or place of business?
Are the premises easily accessible from the street?
Are there any stairs to gain entry?
Are there fences around the premises?
Is it likely that there will be anyone else home at the time of the interview? If so,
who?
Are their any pets on the premises? If yes, what sort and are they aggressive?
Are there any other safety issues that I need to be aware of?
On arrival:
Contact nominated Supervisor (TM/JP) with time of entry and expected time of
departure.
Assess the premises for the presence of safety risks, weapons, the influence of drugs
or alcohol.
Leave the premises immediately if any safety risk is identified or observed.
Keep mobile phone and keys with me at all times.
After the interview:
Contact nominated Supervisor (TM/JP) to advise of interview completion and
leaving the premises.
Version 1 dated 31st March 2016
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Appendix 5: Interview policy
SUBJECT INTERVIEW POLICY

HDR study: “What is the experience of living with RRMS?”
Subject interviews will take place at a mutually agreed location between subject
and Interviewer (Therese Burke). Ideal locations for the interview include:

•

UNDA interview rooms at Broadway

•

UNDA interview rooms at Darlinghurst

•

Library interview rooms (public libraries in Sydney)

•

Subject homes if preferred by subject

•

Interview room at Westmead Education Centre (under Westmead Hospital
research and education network) – this is not a clinical area

Therese will contact Tracey Moroney and Joanna Patching (Supervisors) to let them
know she has an interview planned and where and when the interview will take
place.
Therese will check in by phone and/or email on arrival to the interview and also at
interview completion so that all parties are aware of proceedings and safety is
monitored.
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Appendix 6: Field notes
TB HDR STUDY: FIELDNOTES FOR EACH SUBJECT INTERVIEWED
Interview name:
Date of Interview:
Time of interview:
Time on and off:
Breaks:
__________________________________________________________________
General demeanour (mood/dress etc):
Periods of Distress:
Periods of Joy:
Difficulties encountered during life :
Things which went well during life:
Themes/areas that came up during the interview:
Overall feelings after interview:
Things I could work on/do differently next time:
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Appendix 7: Code development
Examples of the development of semantic and latent codes from raw study data
Study participant and line: Rudi, line 276
Quote: “It was degrading that time because I had to be wheeled to the toilet and so
that sort of stuff was hard to cope with…and so I do tend to crash and burn
emotionally as most people probably tend to do because things are just taken from
you”
Semantic data codes: feelings of degradation, hard to cope, crash and burn
emotionally, RRMS takes from you
Latent data codes: Losses from RRMS, despair, negotiating normalcy and disability,
fear of progression/disability, seeds of resilience

Study participant and line: Susan line 788
Quote:” I remember how I was trying to be strong…that I think it didn’t help me
because it delayed my grieving…it delayed me dealing with it because I was trying
to be strong for Mum and Dad…just you know, accept it, embrace it, because it
doesn’t mean the end…and I then looked at it, you know, it was a new beginning for
me and how I had to look at it.
Semantic data: trying to be strong for others, delayed grieving, accepting the
diagnosis, new beginnings
Latent data: how others see me, maintaining independence, impact of RRMS on
parenting, accepting gains, worry about being a burden to family, purposeful
positivity, optimism, searching for meaning
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Appendix 8 : Thematic map
Thematic map development
Theme example 1: Searching for answers (original title when still a candidate theme,
later became Piecing Together the Puzzle)
What’s going on

Lead up symptoms what could it be?

➜

↕
I need an answer
↕
Seeing doctors ➜ brushed off, go away, nothing’s wrong with you
↕
More doctors ➜ brushed off
↕
Tests
↕
More tests ➜ No answers ➜ I need an answer
➜Answers
↕
Whose fault?
➷
I have a diagnosis
↕
What now?
➷
Is MS causing what I feel?
➷
Triggers, reasons
Who do I tell? And how?
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Theme example 2: Imposter to the throne (original title when still a candidate theme,
later became High Invisibility)

Quest to be normal
This is good
No-one can see, no-one suspects
I don’t want to look disabled to others
↕
Benefits- what’s good about invisible symptoms?
Disclosure, keep secrets
Normal- I look normal
I can fit in better
I’m in charge
↕
Imposter to the throne
Invisible symptoms
Things you can’t see
↕
The push/pull of symptoms- the good and the bad
↕
What’s bad about invisible symptoms?
Frustration
Lack of understanding
Relationship tolls
Family burdens
Hard to explain
Brush-offs
Centre of attention
“imposter”
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Appendix 9:PICF

PARTICIPANT INFORMATION SHEET
What is the Experience of Living with Relapsing Remitting Multiple
Sclerosis?
Dear
You are invited to participate in the research project described below.
What is the project about?
This research project will explore your experiences of living with Relapsing Remitting
Multiple Sclerosis (RRMS) in today’s world. There have been many recent advances in
RRMS treatment and science over the last decade, but very little information for Multiple
Sclerosis (MS) Nurses and other health care professionals (HCPs) working in the field of MS,
about what the experience of living with MS is like for the patient. This research study aims
to understand your experiences and the impact that RRMS has on your life, with the
ultimate goal of providing more individualised, holistic, patient focused care to people
diagnosed with RRMS.
By sharing your experiences of living with RRMS, you may be helping people working in MS
care to have a richer understanding of what it feels like to be living with this condition.
Who is undertaking the project?
This project is being conducted by Therese Burke and will form the basis for a higher degree
by research at The University of Notre Dame Australia, under the supervision of Associate
Professor Tracey Moroney and Associate Professor Joanna Patching in the School of
Nursing, Sydney, NSW.
What will I be asked to do?
If you consent to take part in this research study, it is important that you understand the
purpose of the study and the tasks you will be asked to complete. Please make sure that
you ask any questions you may have, and that all your questions have been answered to
your satisfaction before you agree to participate.
You will be asked to participate in a one-on-one interview with the researcher, and possibly
further follow-up interviews or telephone interviews, if they are needed and if you are
happy to participate further. One interview may provide enough information. The
interview/s will be audio taped to assist the researcher with capturing all of the important
information you provide and will not be used for any other purpose. It is anticipated that
the interview/s will take approximately 1-2 hours and will take place at a mutually
convenient location.
The question you will be asked to respond to will revolve around the experiences you have
had in your life in relation to living with RRMS – “What is the Experience of Living with
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Relapsing Remitting Multiple Sclerosis?” You will be provided with some reflection
questions prior to the interview to think about and you may or may not choose to use them
to help you get your thoughts in order prior to the interview.
There will be no reimbursement to you for taking part in the research study.
Are there any risks associated with participating in this project?
It is possible that you may experience some level of anxiety or distress during the session as
a result of talking about your experiences of living with RRMS. You will be monitored closely
during the interview and you are free to withdraw at any time during the session, or to stop
the session to have a break at any time you need to. If these feelings persist after the
completion of the session, arrangements will be made for you to access support from an
experienced counselor at no expense to you.
What are the benefits of the research project?
There may be no immediate benefits to you by taking part in this research project. General
benefits to the wider MS community are not yet known, but may possibly include an
improved understanding of the experiences of people living with RRMS to others in the MS
community.
What if I change my mind?
Participation in this study is completely voluntary. Even if you agree to participate, you can
withdraw from the study at any time without discrimination or prejudice. If you withdraw,
all information you have provided will be erased and removed from the study findings
where possible. You may stop or suspend the interview at any time and for any reason.
Withdrawal from the study will not affect your ongoing treatment with your MS medical
team or any potential future care from the researchers.
Will anyone else know the results of the project?
Information gathered about you will be held in strict confidence. This confidence will only
be broken if required by law. Only the researchers will have access to your data, which will
be coded after the interview to remove your real name in order to protect your identity. All
data related to you will be known by a pseudonym (a pretend name) and special features
about your case that may identify you (such as suburb, specific occupation and the like) will
be generalised so that you cannot be individually identified. The audiotapes and the written
data (transcripts) will be stored securely and electronic data will be stored on a passwordprotected computer with all identifying information removed (“de-identified”).
Once the study is completed, the data collected from you will remain de-identified and
stored securely with the researcher for at least a period of fifteen years, as directed by
current NSW laws. The results of the study will be published as a thesis, and for the
purposes of education, may be presented in the form of journal articles and presentations
at medical and nursing educational meetings in Australia and overseas. Your privacy will be
protected by continuing use of the pseudonym and protection of your case features
throughout these various publications and presentations.
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Will I be able to find out the results of the project?
Once we have analysed the information from this study, the researcher, Therese Burke, will
contact you by mail or email with a summary of the study findings. You can expect to
receive this feedback in about 1-2 years. If you do not wish to receive information about
the study findings, please let the researcher know.
Who do I contact if I have questions about the project?
If you have any questions about this project please feel free to contact either the
researcher, Therese Burke on phone number 0412 365 667 or email:
therese.burke2@my.nd.edu.au or the study Supervisors, Associate Professor Tracey
Moroney, on email tracey.moroney@nd.edu.au or Associate Professor Joanna Patching on
email joanna.patching@nd.edu.au. The researcher and Supervisors are happy to discuss
with you any concerns you may have about this study.
What if I have a concern or complaint?
The study has been approved by the Human Research Ethics Committee at The University
of Notre Dame Australia (approval number 016002S). If you have a concern or complaint
regarding the ethical conduct of this research project and would like to speak to an
independent person, please contact Notre Dame’s Ethics Officer at (+61 8) 9433 0943 or
research@nd.edu.au. Any complaint or concern will be treated in confidence and fully
investigated. You will be informed of the outcome.
How do I sign up to participate?
If you are happy to participate, please sign both copies of the consent form, keep one for
yourself and mail the other to the researcher in the envelope provided. The researcher will
then contact you to organise further details.
Thank you for your time. This sheet is for you to keep.
Yours sincerely,

Therese Burke RN CNC MSCN

Associate Professor Tracey Moroney

Associate Professor Joanna Patching
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CONSENT FORM
What is the Experience of Living with Relapsing Remitting Multiple
Sclerosis?
• I agree to take part in this research project.
• I have read the Information Sheet provided and been given a full explanation
of the purpose of this study, the procedures involved and of what is expected
of me.
• I understand that I will be asked to attend an interview/s with the
researcher, Therese Burke, and I will be asked questions about my
experience living with RRMS. The interview will be audio-taped only for the
purpose of the researcher transcribing the interview to analyse my
responses to better understand my experiences.
• The researcher has answered all my questions and has explained possible
problems that may arise as a result of my participation in this study.
• I understand that I may withdraw from participating in the project at any
time without prejudice.
• I understand that all information provided by me is treated as confidential
and will not be released by the researcher to a third party unless required to
do so by law.
• I agree that any research data gathered for the study may be published
provided my name or other identifying information is not disclosed.
• I understand that research data gathered may be used for future research but
Name of participant
Signature of
participant

Date

my name and other identifying information will be removed.
• I confirm that I have provided the Information Sheet concerning this research
project to the above participant, explained what participating involves and
have answered all questions asked of me.
Signature of
Researcher

Date
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Appendix 10:Post interview care

POST INTERVIEW CARE
If you feel any distress after we finish the
interview and you would like to talk to someone
else about it, please let me know on the contact
details listed below. I can put you in touch with a
counsellor who is experienced in MS care or refer
you to a psychologist for further management.
Alternatively you can see your GP to discuss
further and they can assess to see if you would
benefit from a mental health care plan.
Therese Burke
Mobile: 0412 365 667
Email: therese.burke@sydney.edu.au

If you feel suicidal or extreme distress, please
present to your closest emergency department for
access to a mental health emergency team.
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Appendix 11:Personal questions

Questions to ask myself and comments to remind myself of, prior to
each interview
Before interviews:
1. How am I presenting myself physically to the study participants?
2. I need to be aware of my tendency to problem solve, and instead,
just listen and let the study participant direct the interview.
Probe when necessary to obtain more information or to delve
deeper about living with RRMS.
3. I am not the clinical MS Nurse in this situation. I am a researcher
listening to a PwRRMS describe their experiences and then asking
questions to better understand the lived experience of RRMS.
That’s it. No clinical care.
4. These participants are not my friends and not my children. I am
empathic, but I don’t have to take their struggles on as my own. I
need to “feel” the data but not have it overtake my analysis
emotionally. I need to firmly ground in the data. I have an
important job to do for the participant here.
5. Don’t assume anything, always ask for clarification and further
explanation (if and when appropriate).
After interviews:
1. How did the interview proceed? Was there a natural flow? Did I
overtake the conversation too much?
2. Was I able to step away from my clinical role and fulfill the
position of researcher/listener?
3. What can I do better in next time?
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Appendix 12 : Diary excerpt
Diary excerpt from reflexive journal: Participant interview/feelings related
Date: 27th May 2016, home NSW
Context: I had just completed the interview and writing the field notes for participant
number 3, Kate.
Quote from diary: I had lots of feelings after this interview, which I just discussed
with JP (Supervisor). I felt changed forever. I am not sure if this was in recognition
of Kate’s work as a scientist and my “fan-like” view of her achievements or as a
fellow mother with her absolute dedication to her career whilst still having a strong
bond with her child. I felt I learnt life lessons from her in resilience, reaching for
your dreams and pushing on.
I felt sorry that she was clearly pushed out of her job when she had significant things
to contribute. Did they base this decision on her physical disabilities and assume her
mind was following? Did she display some cognitive signs not apparent to her, but to
others? (I am recalling the literature and how PwRRMS may not read facial cues etc)
Were there other, unrelated reasons?
Diary excerpt from reflexive journal: Methodology/method related
Date: 23rd June 2017, Balmoral NSW
Context: Pondering nursing core values
Quote from diary: “What is the essence of nursing? What makes us nurses? What
makes us a “good” nurse and is a “good” nurse defined differently by other nurses
than a patient would define a “good nurse”?
What makes patient insights and understandings more valuable?
Why should people care what a nurse thinks?
Do patients care what we, as nurses, think?
I downloaded 8-10 articles to review, looking at nursing, core values, social justice
and the like to help me come up with a statement that I could use in my Methodology
chapter- under nurses and ethnography/qualitative research.
“This study is inspired by patient focused, holistic care and is rooted in the nursing
values/core beliefs of honesty, empathy and understanding”.
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Appendix 13:Life journey and themes
13a. Margot’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

Child of a migrant family fleeing revolution

and clues to resilience

Multicultural issues
University graduate
Two children

Onset of first symptoms prior to

Piecing Together the Puzzle (what’s happening?)

diagnosis- injury from sudden fall
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)
Symptoms remain and reinvestigated

Piecing Together the Puzzle (what’s happening?, tests, tests,

by GP

tests)
Battling the Demons (fear, worry & anxiety)
Taming the Beast (support from family, friends and
community)

High (In)visibility (strive to be visible)

Taming the Beast (support from family, friends and
community)
Confirmed diagnosis of RRMS

Piecing Together the Puzzle (the day my life changed forever,
vivid recall, relief, disclosing, with-holding disclosure)
Holding Hands with Hope (purposeful positivity, optimism)
Taming the Beast (support from family, friends and
community, resilience)
Battling the Demons (fear, worry & anxiety)
Re(defining) Me now that I have RRMS (getting acquainted,
normalcy, working out work, losses & gains, parenting with
RRMS)

Commenced Betaferon®

The DMT Dance (hardyards: decisions based on hope)
Taming the Beast (support from family, friends and
community)
Re(defining) Me now that I have RRMS (getting acquainted)

Stopped

Betaferon®

commenced

The DMT Dance (hardyards: decisions based on hope)

Tysabri®
Taming the Beast (support from family, friends and
community)
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Re(defining) Me now that I have RRMS (getting acquainted,
dare to compare)
Holding Hands with Hope (restorative hope, purposeful
positivity, searching for meaning)
Learning to live with RRMS

Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, negotiating normalcy)
Battling the Demons (all fears, worry & anxiety, uncertainty)
Piecing Together the Puzzle (with-holding disclosure)
Battling the Demons (fear of the wheelchair)

Travelling around the world

Taming the Beast (finding my North Star, maintaining health
& wellness, getting a handle, resilience)
Re(defining) Me now that I have RRMS (normalcy)
Battling the Demons (fear of the wheelchair)

Keeping RRMS secret from parents

Piecing Together the Puzzle (with-holding disclosure)
Battling the Demons (fear of the wheelchair)
Holding Hands with Hope (defiant hope, functional hope,
search for meaning)
High (In)visibility (welcome cloak)

Disclosing to parents

Piecing Together the Puzzle (disclosure)
Holding Hands with Hope (defiant hope, functional hope,
search for meaning)
Re(defining) Me now that I have RRMS (normalcy)
Battling the Demons (fear, worry, saboteurs, uncertainty)

Struggling with disability and loss of

Re(defining) Me now that I have RRMS (normalcy, dare to

mobility, carpark stories

compare, losses & gains)
Battling the Demons (fear of the wheelchair, worry, saboteurs,
uncertainty, I’m never free, social isolation)
High (In)visibility (strive to be visible, reverse stigma)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness)

Retiring from work

Re(defining) Me now that I have RRMS (normalcy, working
out work, losses & gains)
Holding Hands with Hope (purposeful positivity, functional
hope, search for meaning, sense of humour)

Life gets busy living with RRMS

Re(defining) Me now that I have RRMS (normalcy, losses &
gains, parenting with RRMS)
Holding Hands with Hope (purposeful positivity, defiant
hope, search for meaning, sense of humour)
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Surrendering to wheelchair when

Re(defining) Me now that I have RRMS (dare to compare,

travelling or fatigued

normalcy, losses & gains)
Taming the Beast (support from family, friends and
community, maintaining health & wellness, resileince)
Holding Hands with Hope (purposeful positivity, functional
hope, search for meaning, sense of humour)

Moving forward with RRMS

Taming the Beast (support from family, friends and
community, maintaining health & wellness, resilience)
Re(defining) Me now that I have RRMS (getting acquainted,
normalcy)
Holding Hands with Hope (, purposeful positivity, optimism,
sense of humour, giving back and getting involved)

13b. Kate’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

Child of a migrant family

and clues to resilience

Studying forensic work
Working with sick children
Married with a baby, working full time and studying

Onset of first symptoms – sudden

Piecing Together the Puzzle (what’s happening? Tests tests

blindness

tests)
High (In)visibility (strive to be visible)

Told it could be a brain tumour

Battling the Demons (fear, worry & anxiety, uncertainty)
Taming the Beast (support from family, friends and
community)

Not a brain tumour, but no other

Battling the Demons (fear, worry & anxiety, despair,

diagnosis

uncertainty)

-

symptoms

worsen-

repeated episodes of blindness come
and go over several years
Piecing Together the Puzzle (what’s happening?)-repeated
Surplus Suffering (brushed off)- repeated
Piecing Together the Puzzle (tests, tests, tests)- repeated
High (In)visibility (strive to be visible)
Consults a neurologist- it may be MS

Piecing Together the Puzzle (the day my life changed forever)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Taming the Beast (support from family, friends and
community)
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Surplus Suffering inflicted by clinical care and by brush-off
Prescribed antidepressants “to get

Battling the Demons (worry & anxiety, depression & despair,

over it”

fear of disability and the wheelchair)
Surplus Suffering inflicted by clinical care and by brush-off

New specialist- works out possible

Piecing Together the Puzzle (what’s happening? Tests tests

connection between scar infection

tests)

and symptoms- stop antidepressants,
start treatment, still no confirmed
diagnosis
High (In)visibility (strive to be visible)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Taming the Beast (getting a handle, choosing my A-Team,
resilience)
Holding Hands with Hope (restorative hope, purposeful
positivity, optimism, faith from mother)
Infection scar extracted, thereafter a

Taming the Beast (finding my North Star, maintaining health

long period of remission

& wellness, getting a handle, resilience)
Holding Hands with Hope (defiant hope, functional hope,
search for meaning)

Continuing to study, work, parent

Battling the Demons (all fears, worry, uncertainty)
Taming the Beast (finding my North Star, maintaining health
& wellness, getting a handle, resilience)

Symptoms return, start methotrexate
(unconventional

treatment

The DMT Dance (hardyards: decisions based on hope)

to

suppress immune system) and many
courses of steroids
Holding Hands with Hope (restorative hope, purposeful
positivity, optimism)
Battling the Demons (all fears, worry & anxiety, uncertainty)

First MRI to show active lesions,

Piecing Together the Puzzle (the day my life changed forever,

now confirmed diagnosis of RRMS,

with-holding disclosure)

nondisclosure to son
Re(defining) Me now that I have RRMS (getting acquainted,
negotiating normalcy, parenting with RRMS)
Battling the Demons (fear of burden, worry & anxiety, fear of
the wheelchair)
Holding Hands with Hope (restorative hope, purposeful
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positivity- searching for meaning)
The DMT Dance (hardyards: decisions based on hope)
Learning to live with RRMS

Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, negotiating normalcy)
Battling the Demons (all fears, worry & anxiety, despair,
uncertainty)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on hope)
Battling the Demons (fear of the wheelchair)
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, getting a handle, resilience)

Chance opportunity to meet initial

High (In)visibility (strive to be visible)

neurologist and cause of Surplus
Suffering
Holding Hands with Hope (defiant hope, search for meaning)
Re(defining) Me now that I have RRMS (getting acquainted)
Taming the Beast (finding my North Star)
Battling the Demons (fear, despair, saboteurs)
Commence new DMT Betaferon®

The DMT Dance (hardyards: decisions based on hope,

when it comes onto the Australian

switching to a better life)

market
Re(defining) Me now that I have RRMS (getting acquainted)
Holding Hands with Hope (purposeful positivity, restorative
hope, functional hope, defiant hope, search for meaning)
Taming the Beast (getting a handle on RRMS, finding my
North Star, maintaining health & wellness, choosing my ATeam)
Struggling

with

side

effects

Piecing Together the Puzzle (what’s happening?)

Betaferon®
Holding Hands with Hope (defiant hope, functional hope,
search for meaning)
High (In)visibility (strive to be visible)
Decision to stop all DMT

Taming the Beast (getting a handle on RRMS, finding my
North Star, maintaining health & wellness, choosing my ATeam)
Battling the Demons (despair, uncertainty, social isolation,
I’m never free)
Holding Hands with Hope (defiant hope, search for meaning)
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Referral

to

new

neurologist,

commence Copaxone®

The DMT Dance (hardyards: decisions based on hope,
switching to a better life)
Holding Hands with Hope (purposeful positivity, restorative
hope, functional hope, defiant hope, search for meaning)
Battling the Demons (uncertainty, I’m never free)

Still relapsing regularly on treatment

Battling the Demons (all fears, worry & anxiety, despair, I’m
never free, uncertainty)
Taming the Beast (getting a handle on RRMS, maintaining
health & wellness)

Change to Rebif® when it comes

The DMT Dance (hardyards: decisions based on hope,

onto the Australian market

switching to a better life)
Holding Hands with Hope (purposeful positivity, restorative
hope, functional hope, defiant hope, search for meaning)

Rebif® side effects unbearable but

Battling the Demons (uncertainty, I’m never free)

continues treatment and tries to hide
symptoms
High (In)visibility (welcome cloak)
Holding Hands with Hope (purposeful positivity, optimism)
Re(defining) Me now that I have RRMS (balancing losses &
gains, parenting with RRMS)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness)
Decision to stop Rebif®

Battling the Demons (all fears, worry & anxiety, saboteurs)
Re(defining) Me now that I have RRMS (normalcy, parenting
with RRMS, losses & gains)

Tysabri® opportunity

Holding Hands with Hope (purposeful positivity, optimism,
restorative hope, functional hope)
Re(defining) Me now that I have RRMS (normalcy, parenting
with RRMS, losses & gains)
Taming the Beast (getting a handle on RRMS, finding my
North Star)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)

Anaphylaxis to Tysabri®

Battling the Demons (all fears, worry & anxiety, despair, I’m
never free)
Re(defining) Me now that I have RRMS (normalcy, losses &
gains)

Volunteers for research trial- back to

Holding Hands with Hope (purposeful positivity, defiant
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interferon treatment Betaferon®

hope, search for meaning, giving back & getting involved)
Taming the Beast (support from family, friends and
community, finding my North Star, choosing my A-Team)

Remission from relapses for four

Holding Hands with Hope (purposeful positivity, defiant

years

hope)
Re(defining) Me now that I have RRMS (normalcy, parenting
with RRMS, losses & gains)

Fall and injury: mobility affected

Battling the Demons (all fears, worry & anxiety, despair, I’m
never free)
Re(defining) Me now that I have RRMS (normalcy, losses &
gains)
Taming the Beast (support from family, friends and
community, finding my North Star)

Faces losing career & employment:

Taming the Beast (support from family, friends and

symptoms from fall and MS make

community, getting a handle on RRMS, finding my North

work difficult and then employer

Star, maintaining health & wellness)

makes

the

decision

and

stops

funding
Re(defining) Me now that I have RRMS (dare to compare,
normalcy, losses & gains)
Battling the Demons (all fears, worry, despair, I’m never free,
uncertainty, social isolation)
Living in forced retirement and

Holding Hands with Hope (purposeful positivity, defiant

coping

hope, search for meaning, sense of humour)

with

RRMS,

now

on

Gilenya® as DMT
Re(defining) Me now that I have RRMS (dare to compare,
normalcy, parenting with RRMS, losses & gains)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, choosing my A-Team)
Advocates for others with MS

Holding Hands with Hope (purposeful positivity, defiant
hope, search for meaning, sense of humour, giving back &
getting involved)
Taming the Beast (finding my North Star)
Re(defining) Me now that I have RRMS (dare to compare,
normalcy, losses & gains)

13c. Rudi’s life journey reflecting the study themes and subthemes
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Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

•

Tumultuous childhood

and clues to resilience

•

Mother lives with bipolar disorder

•

Rebellious teens

•

Small rural community upbringing

•

Stillbirth of her third son at full-term

Onset of first symptoms

Piecing Together the Puzzle (what’s happening?)
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)

Symptoms worsen

Piecing Together the Puzzle (what’s happening?)
Surplus Suffering (brushed off, misdiagnosis)
Piecing Together the Puzzle (tests, tests, tests)
Battling the Demons (fear, worry & anxiety)
Holding Hands with Hope (purposeful positivity)

Hospitalised into intensive care

Battling the Demons (all fears, worry & anxiety, despair,
uncertainty)
Piecing Together the Puzzle (what’s happening? tests, tests,
tests)

Confirmed diagnosis of RRMS after

Piecing Together the Puzzle (the day my life changed forever)

waiting for several weeks
Re(defining) Me now that I have RRMS (getting acquainted)
Battling the Demons (fear of burden, worry & anxiety)
Learning to live with RRMS

Re(defining) Me now that I have RRMS (getting acquainted,
dare to compare, normalcy)
Battling the Demons (all fears, worry & anxiety, despair)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on hope)
Battling the Demons (fear of the wheelchair)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, search for meaning)
Taming the Beast (support from family, friends and
community, resilience, choosing my A-Team, finding my
North Star)

Severe relapse

Piecing Together the Puzzle (what’s happening?)
Battling the Demons (fear, worry & anxiety, saboteurs: social
isolation, uncertainty)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on fear and
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hope)
Recovery from relapse

Taming the Beast (support from family, friends and
community, resilience)
Re(defining) Me now that I have RRMS (getting acquainted,
dare to compare)

Relapse

Piecing Together the Puzzle (what’s happening?)
Battling the Demons (all fears, worry & anxiety, uncertainty,
parenting with RRMS)
The DMT Dance (decisions based on fear and hope)
Re(defining) Me now that I have RRMS (working out work)

Anxiety

in

children,

especially

daughter

Battling the Demons (all fears, worry & anxiety, uncertainty,
parenting with RRMS)
Taming the Beast (support from family, friends and
community, resilience, choosing my A-Team)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, search for meaning)

MS condition worsens and advised

Re(defining) Me now that I have RRMS (working out work,

to stop working to recover

normalcy, balancing losses & gains)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, finding my A-Team)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, restorative hope)
Battling the Demons (fear of being a burden, fear of the
wheelchair)
The DMT Dance (hardyards: decisions based on fear and
hope)

Start Gilenya®

The DMT Dance: switching to a better life)
Taming the Beast (resilience)

Stop Gilenya® due to skin cancers

The DMT Dance (hardyards: decisions based on fear)

developing
Holding Hands with Hope (purposeful positivity)
The DMT Dance (decisions based on fear)
Taming the Beast (resilience, maintaining health & wellness)
Re(defining) Me now that I have RRMS (balancing losses &
gains)
Battling the Demons (fear, worry, I’m never free)
Starts travelling, trips away, playing

Taming the Beast (resilience, maintaining health & wellness,

sport

finding my North Star)
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Holding Hands with Hope (purposeful positivity, optimism)
Life parenting with RRMS

Taming the Beast (support from family, friends and
community)
Holding Hands with Hope (purposeful positivity, optimism,
harnessing sense of humour)
Battling the Demons (fear of being a burden, worry)
Re(defining) Me now that I have RRMS (balancing losses &
gains, parenting with RRMS, working out work)

Change of DMT to Tecfidera®

The DMT Dance (hardyards: decisions based on fear & hope)
Holding Hands with Hope (purposeful positivity, optimism)
Re(defining) Me now that I have RRMS (getting acquainted)

Further severe relapse

Piecing Together the Puzzle (what’s happening? tests, tests,
tests)
Battling the Demons (fear of being a burden, worry, I’m never
free, uncertainty)
Taming the Beast (support from family, friends and
community, maintaining health & wellness)
The DMT Dance (hardyards: decisions based on fear & hope)

Trying to regain a sense of self

Holding Hands with Hope (purposeful positivity, optimism,
giving back & getting involved, functional hope, restorative
hope, defiant hope)
Taming the Beast (support from family, friends and
community, maintaining health & wellness, resilience)

13d. Joy’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

•

Neglect as a child

and clues to resilience

•

Constant illness and pain as a child and teen

•

Married and baby at 18 years of age

•

Divorced twice, two children

•

Multiple life challenges

•

Raised in a small rural town

Onset of first neurological symptoms

Piecing Together the Puzzle (what’s happening?)

– dyslexia at age 16
High (In)visibility (strive to be visible)
Ignored, brushed off by family and

Battling the Demons (fear, worry, despair uncertainty)

school
Piecing Together the Puzzle (what’s happening?)-repeated
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Surplus Suffering (brushed off)- repeated
High (In)visibility (strive to be visible)
Holding Hands with Hope (restorative hope, purposeful
positivity, optimism, faith)
Drop out from school, pregnant the

Surplus Suffering (brushed off)

next year, married at age 18
Battling the Demons (fear, worry, despair uncertainty)
High Invisibility (strive to be visible)
Sudden

episode

of

intermittent

Battling the Demons (fear, worry, despair uncertainty)

blindness
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)
Piecing Together the Puzzle (what’s happening?)-repeated
Difficult birth, further symptoms not

Surplus Suffering (brushed off)

investigated
High (In)visibility (strive to be visible)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Taming the Beast (resilience)
(Non related to RRMS) post partum

Battling the Demons (fear, worry & anxiety, despair,

complications

uncertainty)

Sudden onset deafness

Surplus Suffering (brushed off)
High (In)visibility (strive to be visible)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Piecing Together the Puzzle (what’s happening?)-repeated

Sudden onset leg weakness

Surplus Suffering (brushed off)
High (In)visibility (strive to be visible)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)

Marriage breakdown

Battling the Demons (worry, despair, uncertainty, social
isolation)

New relationship begins, intermittent

Holding Hands with Hope (restorative hope, purposeful

neurological symptoms persist

positivity, optimism, faith from mother)
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)
Taming the Beast (support from family, friends and
community, resilience)
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Second child arrives, breakdown of

Battling the Demons (fear, worry & anxiety, despair,

relationship ensues

uncertainty)
Holding Hands with Hope (restorative hope, purposeful
positivity, optimism, faith)

Remission

from

neurological

Taming the Beast (getting a handle, resilience)

symptoms, only fatigue remained
Holding Hands with Hope (purposeful positivity, optimism,
faith)
Battling the Demons (uncertainty)
Symptoms, nerve pain returns with a

Piecing Together the Puzzle (what’s happening?)-repeated

vengeance
High (In)visibility (strive to be visible)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Begins relationship with and marries

Piecing Together the Puzzle (what’s happening; tests, tests,

a HCP who organises referral to a

tests)

neurologist
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Diagnosed formally with RRMS

Piecing Together the Puzzle (the day my life changes forever;
relief at the diagnosis, vivid recall)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Re(defining) Me now that I have RRMS (getting acquainted,
normalcy, parenting with RRMS, losses & gains, working out
work)

Begins treatment for nerve pain and

Holding Hands with Hope (restorative hope, purposeful

also DMT glatiramer acetate

positivity, optimism, faith)
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, getting a handle, resilience)
High (In)visibility (strive to be visible)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty, I’m never free)
The DMT Dance (hardyards: decisions based on hope)

Husband becomes abusive, won’t

Battling the Demons (fear, worry, despair, uncertainty, I’m

allow sick-leave with relapse, forces

never free, social isolation)

medication overdosage and toxicity
Surplus Suffering (inflicted by family)
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Re(defining) Me now that I have RRMS (normalcy, losses &
gains, working out work)
Husband dies, collapsing on top of

Holding Hands with Hope (restorative hope, functional hope,

her

defiant hope, purposeful positivity, optimism, faith, search for

and

trapping

survives…Joy

decides

Joy,

she

to

take

meaning)

control
Battling the Demons (all fears, worry & anxiety, uncertainty)
Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, negotiating normalcy)
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, getting a handle, resilience)
Sees a new neurologist

Holding Hands with Hope (restorative hope, purposeful
positivity, optimism)
Re(defining) Me now that I have RRMS (dare to compare)
Taming the Beast (getting a handle on RRMS, finding my
North Star, maintaining health & wellness, choosing my ATeam)

Diagnosed

with

co-morbidity

complex partial epilepsy, neurologist

Piecing Together the Puzzle (the day my life changes forever;
relief at the diagnosis, vivid recall)

unsure of cross-over between the
two neurological diseases, begins
treatment but remains off DMT since
Copaxone by choice
Battling the Demons (fear of burden, worry & anxiety, fear of
the wheelchair)
Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, negotiating normalcy)
Holding Hands with Hope (restorative hope, functional hope,
defiant hope, purposeful positivity, optimism, search for
meaning)
Offered

Tysabri®

DMT

by

neurologist but politely refuses

The DMT Dance (hardyards: decisions based on hope;
switching to a better life)
Battling the Demons (fear of burden, worry)
Holding Hands with Hope (restorative hope, purposeful
positivity, searching for meaning, faith)

Begins to improve, remission from

Re(defining) Me now that I have RRMS (dare to compare,

relapses, travels overseas for the first

normalcy)

time
Taming the Beast (support from family, friends and
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community, finding my North Star, maintaining health &
wellness, getting a handle, resilience)
Battling the Demons (uncertainty)
Gains

employment

in

a

Taming the Beast (support from family, friends and

community/counselling

community, finding my North Star, resilience, choosing my

environment, and thrives

A-Team)
Holding Hands with Hope (defiant hope, search for meaning)
Re(defining) Me now that I have RRMS (normalcy, working
out work, losses & gains)
High (In)visibility (welcome cloak)

Neurologist

retires,

new

young

neurologist takes an interest in the

Re(defining) Me now that I have RRMS (dare to compare,
normalcy, losses & gains)

case and revisiting investigations
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, choosing my A-Team)
Holding Hands with Hope (purposeful positivity, defiant
hope, search for meaning, sense of humour, giving back &
getting involved)
Advocates for others with MS,

Holding Hands with Hope (purposeful positivity, defiant

thriving

hope, search for meaning, sense of humour, giving back &

being

a

grandmother,

working and living well with RRMS

getting involved)
Taming the Beast (finding my North Star)
Re(defining) Me now that I have RRMS ( normalcy, losses &
gains)

13e. Jane’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

•

University degree

and clues to resilience

•

Very active and fit

•

Unmarried

•

World traveller, remote locations, adventurer

•

Works in education

•

No prior medical conditions

Onset of first symptoms
disturbance and headache

– visual

Piecing Together the Puzzle (what’s happening? Tests, tests,
tests)
Battling the Demons (fear)

Told possible brain tumour

Piecing Together the Puzzle (what’s happening? Tests, tests,
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tests)
Surplus Suffering (misdiagnosis)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Taming the Beast (maintaining health & wellness)
No diagnosis, continues on with

Battling the Demons (fear, worry & anxiety, despair,

intermittent symptoms

uncertainty)

New

symptoms-

referral

to

neurologist

Piecing together the Puzzle (what’s happening? Tests, tests,
tests)
Taming the Beast (support from family, friends and
community, choosing my A-Team)
High (In)visibility (strive to make visible)

Diagnosis of RRMS

Piecing Together the Puzzle (the day my life changed forever,
relief at diagnosis, disclosure, with-hold disclosure)
Battling the Demons (fear of wheelchair, fear of disability,
worry & anxiety)
Re(defining) Me now that I have RRMS (getting acquainted,
working out work, normalcy)

Decision not to have DMT at first

Re(defining) Me now that I have RRMS (getting acquainted,
working out work, dare to compare, normalcy, )
Battling the Demons (all fears, worry & anxiety)
High (In)visibility (welcome cloak, hide)

Living well with RRMS, raising

Battling the Demons (uncertainty)

money for MS research
Re(defining) Me now that I have RRMS (getting acquainted,
working out work, normalcy)
High (In)visibility (welcome cloak, hide)
Holding Hands with Hope (defiant hope, giving back &
getting involved)
Inconsideration

by

MS

event

Surplus Suffering (inflicted by community)

organisers
High (In)visibility (strive to make visible)
Piecing together the Puzzle (what’s happening?)
Going to MSL groups to meet others

Re(defining) Me now that I have RRMS (getting acquainted,

living with MS

dare to compare, normalcy)
Holding Hands with Hope (defiant hope, giving back &
getting involved)
Taming the Beast (finding my North Star, choosing my ATeam)
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Battling the Demons (fear of disability, of the wheelchair,
worry, despair, uncertainty)
High (In)visibility (strive to make visible)
Further relapses, decision to start

The DMT Dance (hardyards: decisions based on hope)

Rebif®
Holding Hands with Hope (restorative hope, restorative hope)
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, choosing my A-Team)
High (In)visibility (welcome cloak, hide)
Continuing to work, not disclosing

Piecing Together the Puzzle (with-hold disclosure)

diagnosis
Battling the Demons (worry, uncertainty)
Taming the Beast (getting a handle on RRMS, finding my
North Star, maintaining health & wellness)
High (In)visibility (welcome cloak, hide)
Issues taking DMT Rebif®

Re(defining) Me now that I have RRMS (working out work,
losses & gains)
Battling the Demons (worry & anxiety, despair, uncertainty,
social isolation)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)

Change to Gilenya®

Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, optimism)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)
High (In)visibility (welcome cloak, hide)
Re(defining) Me now that I have RRMS, losses & gains,
normalcy)

Masters degree at university

Holding Hands with Hope (purposeful positivity, defiant
hope, optimism)
Re(defining) Me now that I have RRMS, losses & gains,
normalcy)
Taming the Beast (getting a handle on RRMS, finding my
North Star, resilience)

Fear of losing contract at work is

Battling the Demons

RRMS disclosed

uncertainty)

(worry & anxiety, I’m never free,

Re(defining) Me now that I have RRMS (balancing losses &
gains, dare to compare, normalcy)
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Belief in future living with RRMS

Holding Hands with Hope (purposeful positivity, curative
hope, searching for meaning)
High (In)visibility (welcome cloak, hide)
Re(defining) Me now that I have RRMS ( normalcy, working
out work, losses and gains)
Taming the Beast (resilience, getting a handle, finding my
North Star, choosing my A-Team, support from family,
friends and community, health & wellness)

13f. Paul’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

•

University degree

and clues to resilience

•

Very active and fit

•

Unmarried

•

World traveller, remote locations, adventurer

•

Works in education

Onset of first symptoms five years

Piecing Together the Puzzle (what’s happening? Tests, tests,

before diagnosis – optic neuritis

tests)
Battling the Demons (fear)
High (In)visibility (welcome cloak, hide)
Surplus Suffering (misdiagnosis, brushed off)

Living well, no symptoms

Taming the Beast (maintaining health & wellness)

Two years later neck senstaions– in

Piecing Together the Puzzle (what’s happening? Tests, tests,

hindsight, L’hermittes

tests)
High (In)visibility (strive to make visible, welcome cloak,
hide)
Surplus Suffering (misdiagnosis, brushed off)

Onset cognitive “cloud”

High (In)visibility (strive to make visible)
Battling the Demons (all fears, worry & anxiety)
Taming the Beast (support from family, friends and
community, choosing my A-Team)

GP refers to a neurologist

Piecing

Together

the

Puzzle

(what’s

happening?,

Tests,tests,tests)
Battling the Demons (all fears, worry & anxiety)
High (In)visibility (strive to make visible)
Diagnosis of RRMS and referred to

Piecing Together the Puzzle (the day my life changed forever,

another neurologist with more MS

with-hold disclosure)

experience, awaiting appointment
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High Invisibility (welcome cloak, hide)
Re(defining) Me now that I have RRMS (getting acquainted,
working out work, dare to compare, normalcy, parenting with
RRMS)
Battling the Demons (fear of burden, worry & anxiety,
despair, saboteurs, uncertainty)
Panic attack shortly after diagnosis,

Piecing Together the Puzzle (what’s happening?)

new symptoms
Battling the Demons (worry & anxiety, despair, uncertainty)
Re(defining) Me now that I have RRMS (knowledge, dare to
compare)
Coincidental meeting with third

Surplus Suffering (inflicted by research care, brushed off)

neurologist- unsure of role- enters
clinical trial without explanation,
starts fingolimod
Re(defining) Me now that I have RRMS (getting acquainted)
Piecing Together the Puzzle (what’s happening?)
Learning to live with RRMS

Battling the Demons (all fears, worry & anxiety, depression &
despair, uncertainty)
High (In)visibility (welcome cloak, hide)
The DMT Dance (hardyards: decisions based on hope)
Holding Hands with Hope (defiant hope, giving back &
getting involved)
Taming the Beast (finding my North Star, choosing my ATeam)
Piecing Together the Puzzle (with-hold disclosure)

Meets new neurologist, life turns,

Holding Hands with Hope (defiant hope, restorative hope)

confidence rises
The DMT Dance (hardyards: decisions based on hope)
Taming the Beast (Finding my North Star, my A-Team)
High (In)visibility (welcome cloak, hide)
Well and relapse free on fingolimod

Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, choosing my A-Team)
Piecing Together the Puzzle (with-hold disclosure)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, curative hope searching for meaning)
Re(defining) Me now that I have RRMS (working out work,
parenting with RRMS balancing losses & gains)
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MSA meetings and meeting others

Battling the Demons (fear of disability, of the wheelchair,

with MS- confronting, chooses never

worry & anxiety, despair, uncertainty, social isolation)

to do this again
Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star)
High (In)visibility (welcome cloak, hide)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, curative hope)
Re(defining) Me now that I have RRMS (balancing losses &
gains, dare to compare, normalcy)
Constant research and reading – I

Holding Hands with Hope (purposeful positivity, defiant

want a more efficacious treatment

hope, functional hope, curative hope, optimism, searching for
meaning)
Re(defining) Me now that I have RRMS, losses & gains, dare
to compare, normalcy, parenting with RRMS)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)
Battling the Demons (fear, worry & anxiety)
Taming the Beast (resilience, choosing my A-Team)

New

MRI

lesion-

radiological

relapse

Battling the Demons (fear of the wheelchair & disability,
worry & anxiety, I’m never free, uncertainty)
Re(defining) Me now that I have RRMS (balancing losses &
gains, dare to compare, normalcy)
Piecing Together the Puzzle (what’s happening?)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)
High (In)visibility (welcome cloak, hide)
Holding Hands with Hope (purposeful positivity, defiant
hope, searching for meaning)

Fighting on, awaiting appointment

The DMT Dance (hardyards: decisions based on hope,

with a new neurologist to hopefully

switching to a better life)

escalate

treatment

(his

current

neurologist prefers not to)
Re(defining) Me now that I have RRMS (negotiating
normalcy, disability and independence, working out work,
balancing losses and gains, parenting with RRMS)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, curative hope, optimism, searching for
meaning)
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Taming the Beast (resilience, getting a handle, finding my
North Star, choosing my A-Team)

13g. Ruby’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

•

Child of a migrant family

and clues to resilience

•

University degree

•

Long distance relationship

•

Working in education

•

Married with two children, working full time

Onset of first symptoms

Piecing Together the Puzzle (what’s happening? Tests tests
tests)
Surplus Suffering (brushed off)
Battling the Demons (fear, worry & anxiety, uncertainty)

Consults a neurologist- it may be MS

Battling the Demons (fear, worry & anxiety, despair,

but not conclusive, told not to worry

uncertainty)

and to go away and have a family
Piecing Together the Puzzle (what’s happening?)
Surplus Suffering (brushed off)
Has two children, continues to work

Holding Hands with Hope (restorative hope, purposeful
positivity, optimism, defiant hope)
Re(defining) Me now that I have (may have) RRMS (dare to
compare, parenting with RRMS, normalcy)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)

Severe

relapse

–

reported

to

Surplus Suffering (brushed off)

neurologist by phone and posted a
prescription

for

steroids,

no

consultation
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
I can’t pick up my baby

Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, normalcy)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)

Referral to new neurologist and MS

Piecing Together the Puzzle (tests, tests, tests, the day my life

Clinic

changed forever)
Battling the Demons (fear, worry & anxiety, despair,
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uncertainty I’m never free)
Taming the Beast (finding my North Star, maintaining health
& wellness, getting a handle, resilience)
Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, normalcy, working out work, getting
acquainted)
The DMT Dance (hardyards: decisions based on hope)
Holding Hands with Hope (restorative hope, purposeful
positivity, optimism)
Commenced Tysabri®

The DMT Dance (hardyards: decisions based on hope)
Battling the Demons (fear, worry & anxiety, despair,
uncertainty)
Holding Hands with Hope (restorative hope, purposeful
positivity, optimism)
Taming the Beast (getting a handle, choosing my A-Team,
resilience)
Re(defining) Me now that I have RRMS (dare to compare,
normalcy, getting acquainted)

Continues to worsen on Tysabri®

Battling the Demons (fear, worry & anxiety, despair,

and now losing ambulatory function

uncertainty, social isolation, I’m never free)
Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, normalcy, working out work, getting
acquainted)
Piecing Together the Puzzle (what’s happening?)

Continuing to work, parent

Taming the Beast (finding my North Star, maintaining health
& wellness, getting a handle, resilience)
The DMT Dance (hardyards: decisions based on hope)
Battling the Demons (fears, worry, uncertainty)

Decision to stop Tysabri® and

The DMT Dance (hardyards: decisions based on fear,

change to Lemtrada® - guilt from

switching to a better life)

not starting Lemtrada® earlier
Battling the Demons (fear, worry & anxiety, despair,
uncertainty, I’m never free)
Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, normalcy, getting acquainted)
Taming the Beast (finding my North Star, getting a handle,
resilience)
Holding Hands with Hope (restorative hope, functional hope,
purposeful positivity, optimism)
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Piecing Together the Puzzle (what’s happening?)
Fall at work in front of others

Re(defining) Me now that I have RRMS (dare to compare,
working out work, normalcy)
Piecing Together the Puzzle (what’s happening?)
Battling the Demons (fear, uncertainty, I’m never free)

Life in limbo awaiting to see if

Piecing Together the Puzzle (what’s happening?)

Lemtrada® has been effective
Re(defining) Me now that I have RRMS (dare to compare,
parenting with RRMS, normalcy, working out work)
Battling the Demons (all fears, worry & anxiety, despair,
uncertainty, I’m never free)
Holding Hands with Hope (defiant hope, restorative hope,
functional hope, defiant hope, search for meaning)
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, getting a handle, choosing my A-Team, resilience)
The DMT Dance (hardyards: decisions based on hope)
Decision to work part-time next year

Holding Hands with Hope (defiant hope, restorative hope,

and concentrate of regaining strength

functional hope, defiant hope, search for meaning)

and adoring her children
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, getting a handle, resilience)

13h. Davina’s life journey reflecting the study themes and subthemes
Life events
Earlier life story: major life events

Links to study findings: themes and subthemes
•

and clues to resilience

Onset of first symptoms – visual

Felt vulnerable with father growing up (bullied), felt
isolated

•

Unwell often as a child

•

Physically and emotionally demanding employment

•

Working in healthcare

•

Marries early at 20 years of age

Piecing Together the Puzzle (what’s happening?)

disturbances – brushed off by GP
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)
Battling the Demons (fear, worry & anxiety)
Symptoms worsen – sees a different

Piecing Together the Puzzle (what’s happening?, tests, tests,
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GP

tests)
Surplus Suffering (brushed off)
Holding Hands with Hope (purposeful positivity)
Battling the Demons (all fears (uncle with MS), worry &
anxiety)

Further relapse- sudden and severe -

Surplus Suffering (inflicted by clinical care)

hospitalised, it could be MS
Battling the Demons (all fears, worry & anxiety, depression &
despair, uncertainty, social isolation)
Holding Hands with Hope (purposeful positivity)
Confirmed diagnosis of RRMS –

Piecing Together the Puzzle (the day my life changed forever)

traumatic diagnosis delivery
Re(defining) Me now that I have RRMS (getting acquainted,
normalcy, working our work, dare to compare)
Battling the Demons (fear of burden, wheelchair, disability)
Surplus Suffering (inflicted by clinical care)
Learning to live with RRMS

Re(defining) Me now that I have RRMS (getting acquainted,
dare to compare, parenting with RRMS)
Battling the Demons (all fears, worry & anxiety, despair)
High (In)visibility (strive to be visible)

Changes neurologist

Taming the Beast (support from family, friends and
community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, finding my A-Team)
Re(defining) Me now that I have RRMS (getting acquainted,
dare to compare, normalcy)

Regaining control, starting family

Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, search for meaning)
Re(defining) Me now that I have RRMS (working out work)
Taming the Beast (support from family (mother only) friends
and community)
Battling the Demons (all fears, worry & anxiety)
High (In)visibility (strive to be visible)

Further relapses and temporary loss

Taming the Beast (support from family (mother only) friends

of function managing a young

and community, resilience, finding my North Star, choosing

family of four children including

my A-Team)

newborn twins
Battling the Demons (all fears, worry & anxiety, uncertainty,
I’m never free, social isolation)
Piecing Together the Puzzle (what’s happening?)
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High (In)visibility (strive to be visible)
Starts interferon Avonex® when

The DMT Dance (hardyards: decisions based on hope)

released onto Australian market,
continues many years
Re(defining) Me now that I have RRMS (balancing losses &
gains, parenting with RRMS)
Battling the Demons (all fears, worry & anxiety)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, restorative hope, optimism)
Continues on managing family and

Taming the Beast (support from family, friends and

worklife through several relapses

community, getting a handle on RRMS, finding my North
Star, maintaining health & wellness, finding my A-Team)
Holding Hands with Hope (purposeful positivity, defiant
hope, functional hope, restorative hope, optimism)
Battling the Demons (all fears, worry & anxiety)
High (In)visibility (strive to be visible)

Death of much loved and supportive

Battling the Demons (all fears, worry, depression & despair,

mother

uncertainty)
Re(defining) Me now that I have RRMS (balancing losses &
gains, normalcy, parenting with RRMS)
Holding Hands with Hope (purposeful positivity)
Taming the Beast (resilience)

Seeks help from a psychologist,

Battling the Demons (all fears, worry, depression & despair,

diagnosed with depression, refuses

uncertainty, I’m never free)

medication but accepts counselling
Holding Hands with Hope (purposeful positivity, optimism)
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, choosing my A-Team)
Leaves marriage

Battling the Demons (all fears, worry, depression & despair,
uncertainty)
Taming the Beast (support from family, friends and
community, finding my North Star, maintaining health &
wellness, choosing my A-Team)
Holding Hands with Hope (purposeful positivity, optimism,
faith, sense of humour)

Meets new life partner, feels loved,

Taming the Beast (support from family, friends and

supported

community, finding my North Star, maintaining health &

Children grown up and moved on

wellness, choosing my A-Team)
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Holding Hands with Hope (purposeful positivity, optimism,
defiant hope)
Battling the Demons (fear of being a burden)
Lack of support from family with

Re(defining) Me now that I have RRMS (balancing losses &

new life

gains, parenting with RRMS)
Battling the Demons (all fears, worry, depression & despair,
uncertainty)
Holding Hands with Hope (purposeful positivity, optimism,
defiant hope)

Change of DMT to Gilenya®

The DMT Dance (decisions based on fear & hope)
Holding Hands with Hope (purposeful positivity, optimism,
restorative hope)
Re(defining) Me now that I have RRMS (getting acquainted)
Battling the Demons (all fears, worry & anxiety)
Holding Hands with Hope (purposeful positivity, optimism,
defiant hope)
Taming the Beast (support from family, friends and
community, resilience)

Life settles with RRMS- current

Holding Hands with Hope (optimism, giving back and getting

status quo

involved, faith)
Taming the Beast (support from family, friends and
community, maintaining health & wellness, finding my North
Star)

13i. Evie’s life journey reflecting the study themes and subthemes
Life events

Links to study findings: themes and subthemes

Earlier life story: major life events

•

Significant childhood illness

and clues to resilience

•

Felt bullied at primary school, ”left out”

•

Alcoholic, abusive father, loving and supportive
mother

Onset of first symptoms at 18 years

•

Later parental divorce

•

Estranged from only sibling

•

Same sex relationships

•

(Secretive) government career

Piecing Together the Puzzle (what’s happening?)

of age
High (In)visibility (strive to be visible)
Surplus Suffering (brushed off)
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Symptoms

worsen

–

still

no

diagnosis

Piecing Together the Puzzle (what’s happening?, tests, tests,
tests)
Battling the Demons (fear, worry)
High (In)visibility (strive to be visible)
Taming the Beast (resilience)

Finally

after

two

years,

MRI

Piecing Together the Puzzle (the day my life changed forever)

confirms RRMS
Holding Hands with Hope (purposeful positivity, optimism)
Re(defining) Me now that I have RRMS (getting acquainted,
negotiating normalcy)
Taming the Beast (choosing my A-Team)
Accepted diagnosis, moving on, but

Piecing Together the Puzzle (what’s happening?)

those around fall apart
Re(defining) Me now that I have RRMS (getting acquainted,
negotiating normalcy)
Taming the Beast (finding my North Star, maintaining health
& wellness, getting a handle, resilience)
I don’t jump in, I choose to be

Holding Hands with Hope (purposeful positivity, optimism,

positive

defiant hope, sense of humour, spirituality, searching for
meaning)
Re(defining) Me now that I have RRMS (getting acquainted,
negotiating normalcy, working out work, losses & gains)
High (In)visibility (welcome cloak)

Commences interferon Rebif®

The DMT Dance (hardyards: decisions based on hope)
Battling the Demons (fear, worry)
Re(defining) Me now that I have RRMS (getting acquainted,
losses & gains)
Holding Hands with Hope (restorative hope, functional hope,
purposeful positivity, optimism)

Intolerable side effects from Rebif®,
missed

doses

and

then

Battling the Demons (worry, uncertainty)

cease

medication altogether
Re(defining) Me now that I have RRMS (normalcy)
High (In)visibility (strive to be visible)
Relapses increase

The DMT Dance (hardyards: decisions based on hope)
Re(defining) Me now that I have RRMS (dare to compare,
normalcy, getting acquainted)
Battling the Demons (all fears, worry, I’m never free,
uncertainty)
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Constant life stressors persist

Battling the Demons (all fears, worry, despair, uncertainty)
High (In)visibility (strive to be visible)
Taming the Beast (finding my North Star, maintaining health
& wellness, getting a handle, resilience)
Re(defining) Me now that I have RRMS (getting acquainted,
normalcy)
Holding Hands with Hope (defiant hope, search for meaning,
spirituality)

Commences Betaferon®

Battling the Demons (all fears, worry, uncertainty)
Holding Hands with Hope (defiant hope, functional hope)
The DMT Dance (hardyards: decisions based on hope,
switching to a better life)

Enjoying

career

but

previous

Re(defining) Me now that I have RRMS (getting acquainted,

disclosure at work induces collision

normalcy, working put work, dare to compare, losses & gains)

between work and personal space
High (In)visibility (welcome cloak)
Further relapses, change of treatment

The DMT Dance (hardyards: decisions based on hope,

to Tysabri®, remains relapse free

switching to a better life)

and well for several years
Holding Hands with Hope (defiant hope, functional hope,
restorative hope)
Taming the Beast (support from family, friends and
community, finding my North Star, choosing my A-Team)
Re(defining) Me now that I have RRMS (getting acquainted)
JCV blood tests positive high titre-

The DMT Dance (hardyards: decisions based on fear)

ceases Tysabri® immediately
Battling the Demons (fear, worry, I’m never free, uncertainty)
Taming the Beast (getting a handle on RRMS, finding my
North Star, maintaining health & wellness)
Commences Tecfidera®

The DMT Dance (hardyards: decisions based on hope,
switching to a better (safer) life))
Re(defining) Me now that I have RRMS (normalcy)
Battling the Demons (all fears, worry & anxiety, uncertainty)

Side effects from Tecfidera® – cease

The DMT Dance (hardyards: decisions based on hope,
switching to a better (safer) life))
Taming the Beast (getting a handle on RRMS, finding my
North Star, maintaining health & wellness)

Decision to commence Lemtrada®

Holding Hands with Hope (purposeful positivity, defiant
hope, search for meaning, spirituality)
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The DMT Dance (hardyards: decisions based on hope,
switching to a better life)
Taming the Beast (support from family, friends and
community, maintaining health & wellness, resilience)
Re(defining) Me now that I have RRMS (losses & gains)
Battling the Demons (all fears, worry, uncertainty)
Relationship breakdown with partner

Battling the Demons (all fears, uncertainty)

– RRMS blamed by partner
Piecing Together the Puzzle (what’s happening?)
Re(defining) Me now that I have RRMS (losses & gains,
normalcy)
High (In)visibility (strive to be visible)
The DMT Dance (hardyards: decisions based on hope)
Taming the Beast (support from family, friends & community,
resilience)

Holding Hands with Hope (purposeful positivity, functional
hope, restorative hope)
Moving forward with RRMS and

Taming the Beast (support from family, friends and

advocacy work

community, maintaining health & wellness, resilience, finding
my North Star, choosing my A-Team)
Holding Hands with Hope (purposeful positivity, optimism,
giving back and getting involved, spirituality)
Re(defining) Me now that I have RRMS (getting acquainted,
normalcy, losses & gains, working out work)
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